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Phenotypes and genetic mechanisms of C. elegans enhanced RNAi 
RNA interference (RNAi) potently and specifically induces gene knockdown, and its potential 
for reverse genetics in Caenorhabditis elegans is enormous. However, even in these nematodes, 
RNAi can be induced more effectively via enhanced RNAi (Eri) mutant backgrounds. With 
advances in small RNA sequencing, evidence has suggested that the eri pathway plays an 
endogenous gene regulatory role, which competes with experimentally introduced RNAi triggers 
for limiting resources. However, the nature, cellular location, and physiological consequences of 
this small RNA pathways competition remain unclear. To answer these questions, I first fully 
characterized the genetic phenotypes of all known Eri mutants. I discovered that different 
components of the eri pathway have subtle differences upon mutation, which affects more than 
exogenous RNAi. I then attempted to screen for novel enhanced RNAi mutants, guided by 
hypothetical mechanisms or tissues of expression not associated with known mutants. After these 
attempts, I fully characterized the genetic mechanisms that account for enhanced RNAi. 
Surprisingly, I discovered that the nuclear Argonaute nrde-3 and the peri-nuclear P-granule 
component pgl-1 are necessary and sufficient for an Eri response. Finally, I examined the impact 
of the competition among microRNA, endogenous siRNA, and exogenous RNAi pathways. I 
discovered that C. elegans develops slower upon perturbations to its normal flux of small RNA 
pathways. Insights from these phenotypes and genetic mechanisms shed light on the importance 
of small RNA biology and offer a novel suite of tools for sensitizing RNAi in broader contexts, 
especially given the deep evolutionary conservation of most eri-associated genes. 
Abstract 
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 In Chapter One, I present my published review of RNAi (ZHUANG, J. J., and C. P. 
HUNTER, 2012. RNA interference in Caenorhabditis elegans: uptake, mechanism, and 
regulation. Parasitology 139: 560-573). In it, I discuss the mechanisms and regulation of RNAi 
in the context of C. elegans. I also highlight enhanced RNAi via both systemic and cell-
autonomous mechanisms. Using this survey of literature, I frame my thesis aims and questions 
that guided my research findings for the subsequent chapters.  
Thesis Outline 
 
In Chapter Two, I present my published report on phenotypic analyses of enhanced 
RNAi mutants (ZHUANG, J. J., and C. P. HUNTER, 2011. Tissue Specificity of Caenorhabditis 
elegans enhanced RNA interference mutants. Genetics 188: 235-237). In it, I report that RNAi 
responses follow a sigmoidal curve, that there are optimal tissue-specific enhanced RNAi 
differences amongst Eri mutants, and that the Eri phenotype is maternally rescued. 
 
In Chapter Three, I present my analyses of three screens designed to discover novel 
RNAi mutants. I analyzed a screen for enhanced systemic RNAi with 13 candidate mutants. I 
also probed for possible enhanced systemic RNAi amongst the nine known Eri mutants. Finally, 
I screened for somatic RNAi defective mutants and found one promising candidate. 
 
In Chapter Four, I present my in-press report on the role of nrde-3 in enhanced RNAi 
(ZHUANG, J. J., S.A. BANSE and C. P. HUNTER, 2013. The Nuclear Argonaute NRDE-3 
Contributes to Transitive RNAi in Caenorhabditis elegans. Genetics doi: 10.1534/genetics. 
113.149765). In it, I report that nuclear RNAi defective mutants are generally RNAi defective, 
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including for transgene silencing and trans-generational RNAi. I also report that nrde-3 is 
uniquely necessary and sufficient for enhanced RNAi, and that a possible mechanism for this 
may be the phenomenon of transitive RNAi. Finally, I report that eri-regulated gene targets also 
depend on nrde-3, suggesting a functional endogenous gene regulatory role for nuclear RNAi. 
 
In Chapter Five, I present my analysis of pgl-1’s contribution to enhanced RNAi. Within 
the in-press report from Chapter Four, I provide evidence that nrde-3 and pgl-1 contribute 
complementarily to enhanced RNAi; in the absence of both factors, the enhanced RNAi response 
is entirely absent. I also report that pgl-1 mutants do not exhibit common RNAi pathway defects, 
suggesting a uniquely parallel contribution to RNAi, which is confirmed by a drastically 
different expression profile of eri-regulated gene targets. Finally, I present techniques developed 
to pool small RNAs from pgl-1 mutants to better examine in the future endogenous small RNA 
expression via deep sequencing. 
 
In Chapter Six, I present my published report on small RNA competition’s impact on 
development (ZHUANG, J. J., and C. P. HUNTER, 2012. The influence of competition among 
C. elegans small RNA pathways on development. Genes 3: 671-685). In it, I report that the 
microRNAi, endogenous RNAi, and exogenous RNAi pathways interact with each other to 
perturb each others’ gene silencing efficacy. Furthermore, I report that this competition induces 
developmental delays when any of the pathways are perturbed from the wild type flux. 
 
In Chapter Seven, I present a historical discussion of the small RNA field and its likely 
future directions. I also contextualize some of my findings within these field trends. 
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Finally, in the Addendum, I present my analysis of the homologs of sid-1, a gene largely 
responsible for systemic RNA in C. elegans. In it, I show that RNAi knockdowns of these genes 
sometimes induce decreased RNAi sensitivity. 
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Chapter One 
RNA interference in C. elegans: uptake, mechanism, and regulation 
 
The majority of the contents were previously published in ZHUANG, J. J., and C. P. HUNTER, 2012. RNA 
interference in Caenorhabditis elegans: uptake, mechanism, and regulation. Parasitology 139: 560-573. Permission 
to reuse was granted by Cambridge University Press License Number 3060851284559. 
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ABSTRACT 
RNA interference (RNAi) is a powerful research tool that has enabled molecular insights 
into gene activity, pathway analysis, partial loss-of-function phenotypes, and large-scale 
genomic discovery of gene function. While RNAi works extremely well in the non-parasitic 
nematode C. elegans, it is also especially useful in organisms that lack facile genetic analysis. 
Extensive genetic analysis of the mechanisms, delivery, and regulation of RNAi in C. elegans 
has provided mechanistic and phenomenological insight into why RNAi is so effective in this 
species.  These insights are useful for the testing and development of RNAi in other nematodes, 
including parasitic nematodes where more effective RNAi would be extremely useful.  Here, we 
review the current advances in C. elegans for RNA delivery methods, regulation of cell 
autonomous and systemic RNAi phenomena, and implications of enhanced RNAi mutants. 
These discussions, with a focus on mechanism and cross-species application, provide new 
perspectives for optimizing RNAi in other species. 
 
RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA).  This dsRNA 
is processed into single-stranded small interfering RNAs (siRNAs) that act as guide sequences to 
target homologous mRNAs and nascent transcripts for post-transcriptional gene silencing 
(PTGS) (CHEKULAEVA and FILIPOWICZ 2009) and transcriptional gene silencing (TGS) 
(MOAZED 2009), respectively.  A broad array of endogenous RNAi-related mechanisms is used 
to control gene expression (MOCHIZUKI 2010; TEIXEIRA and COLOT 2010; WHITE and ALLSHIRE 
2008).  Likely because it accesses these endogenous gene activities, experimentally induced 
RNAi is potent and specific (SHARP 1999), leading to its popular and wide use as a genetic tool 
INTRODUCTION 
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(SIOUD 2011).  However, many challenges remain.  For many organisms, intracellular delivery of 
dsRNA presents a significant experimental obstacle; coupled to this is variable or low potency.  
In contrast, RNAi works very well in C. elegans because of ease of delivery coupled to efficient 
RNA-directed RNA polymerase (RdRP) amplification of effector siRNAs. Here we review what 
is known about RNA delivery and genetic control of RNAi efficacy in C. elegans with the goal 
of using this knowledge to enable RNAi in other organisms. 
Reverse genetics via RNAi has become extremely popular over the past decade (SILVA et 
al. 2004).  This is particularly true in organisms like C. elegans, Planaria, and Apidae that 
readily take up and apparently spread the triggering dsRNA and/or derived silencing signals.  
However, biological and methodlogical diversity in dsRNA delivery can lead to variability in 
RNAi efficacy.  Therefore, to maximize RNAi silencing, it is important to understand the 
organism-specific limitations as well as advantages of dsRNA uptake (GELDHOF et al. 2007; 
KNOX et al. 2007). The ease of both classic genetics and RNAi has made C. elegans the 
exemplary model organism for this analysis. 
 The discovery and subsequent in-depth mechanistic characterization of RNAi in C. 
elegans helped established the entire RNAi field (HANNON 2002).  RNAi in C. elegans is both 
easy and remarkably potent.  The ease of dsRNA delivery is unmatched, including most notably 
by ingestion – so called environmental RNAi.  However, a variety of enhanced RNAi (Eri) 
mutants show that even in C. elegans, RNAi can become even more potent (KENNEDY et al. 
2004).  Although not all nematodes in the Caenorhabditis genus are equally accessible for 
dsRNA delivery, most are capable of RNAi (FELIX 2008).  Interestingly, the identified eri genes 
are conserved across Caenorhabditis and in many instances, widely conserved across evolution.  
This indicates independent selection for delivery and regulation of potency.  Similar observations 
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have been made more broadly in the nematode phylum, as the Haemonchus, Heterohabditis, 
Ostertagia, Heterodera, Globodera, Meloidogyne, Panagrolaimus, and Brugia genera have all 
been shown to respond to at least some forms of RNAi delivery, though with different apparent 
potencies (FELIX 2008).  These observations indicate that comparative analysis of RNAi in 
nematodes is likely to reveal much about the selective pressures that modify small RNA 
pathways. In this review of C. elegans RNAi genetics and methods, we pay particular attention 
to conserved genetic networks with the goal of leveraging the wealth of mechanistic information 
available in C. elegans to the application of RNAi in less accessible nematodes.   
 
METHODS 
DISCUSSION 
The robustness of RNAi in C. elegans is likely due to both RdRP activity that amplifies 
silencing signals and the systemic nature of C. elegans RNAi that enables silencing signals to 
move between cells, tissues, and generations.  Thus, small amounts of locally delivered dsRNA 
can cause robust silencing in any tissue in the treated animal as well as its progeny.  Here, we 
compare the relative silencing potency of the three principal dsRNA delivery methods: 
microinjection, ingestion, and transgene expression (Figure 1.1).    
Microinjection is the most direct and potent way to introduce RNAi triggers. 
Microinjection also provides control over dsRNA concentration and the cell or tissue to score for 
knockdown. Control of concentration is critical to maximize the effective dose while 
simultaneously avoiding non-specific toxicity or off-target effects.  The concentration of dsRNA  
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Microinjection of concentrated dsRNA (red) into the large gut cells (yellow), the syncytial 
germline (blue), or the body cavity (white) affords the greatest control over delivery and the most 
potent response; however, throughput is limited.  Throughput is improved by soaking whole 
animals in dsRNA, or feeding worms bacteria engineered to express dsRNA.  Both soaking and 
feeding results in ingested dsRNA that requires the intestinal transmembrane protein SID-2 
(green) for delivery into the animal.  Finally, transgenic expression of double-stranded RNA or 
hairpin constructs can target dsRNA delivery to specific cell types not accessible by 
microinjection, and in sid-1 mutant backgrounds, can limit the RNAi knock-down effect to the 
targeted cells. 
Figure 1.1: Double-stranded RNA delivery in C. elegans 
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to inject will vary from organism to organism (KUWABARA and COULSON 2000; NASEVICIUS and 
EKKER 2000; SVOBODA and STEIN 2009), from cell type to cell type (GRISHOK and MELLO 2002; 
WANG et al. 2005), and even from gene target to gene target (KRUEGER et al. 2007). Although in 
C. elegans silencing signals can spread from the injected cell or tissue, this is not true of other, 
even closely related species (WINSTON et al. 2007). Therefore, initial analysis of RNAi 
effectiveness should be limited to scoring the injected cell or syncytial tissue.   
In some organisms, long dsRNA is toxic.  For example, in vertebrates, long dsRNA 
triggers a non-sequence specific interferon response that leads to cell death (CULLEN 2006).  
Whether long dsRNA is toxic to invertebrates is largely unexplored.  These toxic effects are 
avoided in mammalian cells by using siRNA to trigger RNAi; siRNAs are too short to trigger the 
non-specific effect (MITTAL 2004).  Microinjection of siRNAs is effective in C. elegans, but the 
response is attenuated compared to long dsRNA (YANG et al. 2000).  
Transgene-expressed dsRNA can also initiate RNAi and allows introduction of dsRNA 
into cells and tissues that are not accessible to microinjection, including neurons and muscle cells 
(SCHEPERS 2005).  Another advantage is that transgenic lines can be maintained indefinitely and 
expanded to large populations that are not accessible by microinjection.  In C. elegans, RNAi can 
be effectively triggered by either expressed hairpin RNA constructs or co-expressed sense and 
antisense RNA.  However, the production of dsRNA-expressing transgenic animals is more 
complicated and less controllable than injecting dsRNA.  First, it is difficult to avoid nonspecific 
expression of the transgene; the promoter may be active in unintended cells (GROVE et al. 2009).  
Second, it is difficult to assess the quality or quantity of RNAi trigger; unlike loading a 
microinjection needle with known concentrations of precisely defined dsRNA, endogenously 
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expressed dsRNA does not come with easily quantifiable measures.  As a consequence, RNAi 
potency can vary between independent lines (PRAITIS et al. 2001) and from simple structural 
changes to the same hairpin construct (BOUDREAU et al. 2008).  Third, transgenes in C. elegans 
are subject to spontaneous silencing via a mechanism that is at least in part dependent on RNAi 
silencing genes.  Since RNAi silencing is saturable, expressed dsRNA may interfere with such 
silencing in a dose-dependent and variable way (KIM et al. 2005b) which adds a confounding 
factor when evaluating the presence, absence or penetrance of RNAi silencing.  
Ingestion of dsRNA is the third principal means of introducing RNAi triggers into C. 
elegans.  Ingestion can be accomplished either by soaking worms in a concentrated solution of 
purified dsRNA (MAEDA et al. 2001) or more simply by feeding worms bacteria engineered to 
expressed dsRNA (TIMMONS et al. 2001; TIMMONS and FIRE 1998).  This mechanism of 
inducing effective RNAi is entirely dependent on systemic RNAi.  However, systemic RNAi is 
not sufficient as specialized dsRNA uptake machinery is also required (WINSTON et al. 2007). In 
C. elegans, the transmembrane proteins SID-1 and SID-2 are required independently for 
ingestion mediated RNAi.  SID-1 is required for the uptake of silencing signals into all cells, 
while SID-2 is required only for silencing initiated by ingested dsRNA.  SID-2 is expressed 
exclusively in the intestine and localizes primarily to the apical membrane, suggesting that SID-2 
may directly interact with ingested dsRNA for internalization (WINSTON et al. 2007).   
SID-2 homologs are highly divergent, recognizable in only Caenorhabditis nematodes, 
and even among these, ingested dsRNA induces RNAi in only a few species (WINSTON et al. 
2007). This molecular and functional divergence is consistent with the unpredictable distribution 
of organisms that are susceptible to ingested-dsRNA mediated RNAi (WHANGBO and HUNTER 
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2008).  Consequently, absence of ingestion-mediated RNAi should not be interpreted as absence 
of RNAi or even systemic RNAi. 
In organisms that are susceptible to ingestion mediated RNAi, the ability to easily subject 
animals to a large variety of dsRNA sequences has many advantages.  In C. elegans, the 
construction and availability of libraries of engineered “RNAi foods” targeting the entire genome 
has made “feeding RNAi” an extremely powerful genetic tool (KAMATH and AHRINGER 2003; 
KAMATH et al. 2003; RUAL et al. 2004).  Furthermore, feeding worms dsRNA expressing 
bacteria, like transgene-expressed dsRNA, enables large numbers of RNAi knock-down worms 
to be produced for genetic screens or biochemical assays; however, this conditional feeding 
RNAi has an advantage over transgene-expressed dsRNA when targeting genes important for 
growth, fertility, and viability.   The apparent delivered dose of ingested dsRNA, however, is less 
than is achieved by microinjection, causing less penetrant phenotypes, which makes it often 
necessary to expose animals to ingested dsRNA for multiple generations (TIMMONS and FIRE 
1998).  Furthermore, different tissues respond differently to RNAi triggers, making it difficult to 
score the relative efficacy of RNAi (CALIXTO et al. 2010).  
Other less frequently used means to introduce RNAi triggers into small metazoans 
include electroporation, transfection, and soaking in liposome-encapsulated dsRNA (GELDHOF et 
al. 2006; ISSA et al. 2005; KRAUTZ-PETERSON et al. 2007). These methods are not used in C. 
elegans. 
 
MECHANISMS OF dsRNA TRANSPORT BY SID-1 
Intercellular transport of dsRNA silencing signals in C. elegans requires the highly 
conserved dsRNA channel SID-1 (JOSE and HUNTER 2007). SID-1 is a transmembrane protein 
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with 11 predicted transmembrane domains, a 400+ amino acid extracellular N-terminal domain, 
and a short cytosolic C-terminal domain (FEINBERG and HUNTER 2003). Many recovered sid-1 
mutants have missense mutations in the transmembrane domains, suggesting that these 
sequences are essential for function. SID-1 is autonomously required for the import but not the 
export of RNAi triggers (JOSE et al. 2009). A sid-1 promoter gfp construct was found to be 
expressed from the late embryo throughout adulthood in all non-neuronal tissues (WINSTON et al. 
2002).  Interestingly, neuronal cells are resistant to RNAi triggered by ingested or injected 
dsRNA, but sensitive to neuronally expressed dsRNA, indicating the defect is in delivery of 
dsRNA to neurons, not RNAi effectiveness in neurons; consistent with this, transgenic 
expression of SID-1 in neurons enables efficient systemic RNAi (CALIXTO et al. 2010).   
Furthermore, such expression enhances RNAi efficacy in these cells at the expense of wild-type 
cells (CALIXTO et al. 2010).  These results suggest that SID-1 expression is limiting for systemic 
RNAi in C. elegans. 
Mechanistic studies performed in Drosophila S2 cells indicate that SID-1 functions as a 
dsRNA-gated channel. Drosophila lacks a SID-1 homolog and endogenous mechanisms of 
dsRNA uptake in S2 cells are relatively inefficient, making these cells an ideal “blank slate” 
system to investigate SID-1 dsRNA transport properties. SID-1 activity in S2 cells has been 
primarily measured by uptake of radio-labeled dsRNA and by RNAi silencing of reporter genes.  
Recent studies have also used whole-cell patch-clamp analysis to characterize SID-1 channel 
properties. 32P-labeled dsRNA added to the culture media of SID-1 expressing S2 cells is rapidly 
taken up, showing that SID-1 enables dsRNA transport (FEINBERG and HUNTER 2003; SHIH et al. 
2009).  To distinguish between active transport mechanisms that require continuous energy input 
(ATP) for dsRNA transport – i.e. pumps or receptors that require vesicle transport – versus 
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passive transport mechanisms that could transport dsRNA without additional energy input – i.e. 
channels or pores – the uptake assays were repeated in either ATP-depleted cells or in cells 
maintained at 4°C.  For both treatments, the endogenous S2 cell RNA uptake was eliminated, 
while SID-1 dependent uptake was still very productive (FEINBERG and HUNTER 2003).  These 
results indicate that SID-1 acts as a passive transporter, likely a channel or pore.  Consistent with 
SID-1 functioning as a channel, whole-cell patch-clamp analysis showed that adding dsRNA to 
the cell media increased the conductance (opened channels) of SID-1 expressing cells and that 
washing the dsRNA away led to a return to baseline conductance (SHIH and HUNTER 2011). 
Together these results indicate that SID-1 is a dsRNA-gated channel. 
These same transport and activity assays indicate that SID-1 nucleic acid transport is 
efficient, specific, and selective for dsRNA. SID-1 expression in S2 cells enabled detectable 
RNAi silencing at a 107-fold lower dsRNA concentration than in control cells (FEINBERG and 
HUNTER 2003; SHIH et al. 2009); this translates into less than one molecule of dsRNA per cell, 
indicating very efficient uptake. Similar results were obtained with cultured C. elegans cells 
(SHIH et al. 2009).  Although initial studies using RNAi silencing of luciferase reporters 
indicated that sid-1 dependent uptake efficiency is sensitive to dsRNA length (FEINBERG and 
HUNTER 2003), subsequent studies using radio-labeled 50 bp, 100 bp, and 500 bp dsRNAs 
showed indistinguishable results (SHIH et al. 2009).  Similarly sized dsRNAs also 
indistinguishably open channels on whole-cell patched SID-1 expressing cells (SHIH and 
HUNTER 2011).  Since size does not affect activation or transport, it is thought that longer 
dsRNA, when delivered systemically, is a more efficient silencing trigger.  The whole-cell patch 
clamp analysis also indicates that nucleic acid transport by SID-1 is specific to dsRNA 
containing molecules. First, neither dsDNA nor a DNA-RNA heteroduplex can activate SID-1 
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expressing cells.  Nucleotide substitution experiments indicate a requirement for the ribose 2’-
OH.  Although dsRNA is required for transport, molecules that contain single-stranded regions 
can be transported.  Transport of hairpin molecules containing greater than 300 nucleotide 
single-stranded loops as well as pre-microRNA precursors were also detected.  These results 
dramatically expand the possible repertoire of molecules transported by SID-1. 
SID-1 homologs are present in nematodes, diverse invertebrate phyla, and all sequenced 
vertebrate genomes (ALTSCHUL et al. 1997; GRIMSON et al. 2008) (Figure 1.2).   These proteins 
are highly conserved, which indicates a strongly selected function.  Although C. elegans SID-1 
has a demonstrated long-dsRNA transport activity, an activity or function remains unknown for 
all other homologs. C. elegans contains five SID-1 homologs (Figure 1.3) (GILLE 2004), some 
of which are more similar to vertebrate homologs than SID-1. However, alleles for none of these 
were recovered in the Sid screen. There are many reasons why mutations in these were not 
recovered in the Sid screen:  these genes may not function in dsRNA transport, their dsRNA 
transport function may be redundant with another gene(s), or they may have additional essential 
functions such that mutations that disrupted dsRNA transport may be lethal. Because mutations 
in these genes have not yet been recovered, only RNAi is available to study their possible role in 
systemic RNAi or other functions. A serious limitation of this approach is illustrated by our 
analysis of sid-1 by RNAi: repeated early attempts to produce an RNAi defect by sid-1(RNAi) 
failed. However, our certainty of the phenotype led us to continue pursuing RNAi of sid-1 by 
injection of dsRNA, which ultimately caused a reduction in RNAi sensitivity in up to 50% of the 
progeny of an injected animal. We theorize that our difficulty in producing a RNAi-defective 
phenotype reflects both a necessity of SID-1 function for RNAi and the tremendous efficiency of 
dsRNA transport by SID-1: moderate sid-1 knockdown may be sufficient to prevent further
12 
 
 
 
SID-1 homologs are present in many taxonomic groups, suggesting widespread conservation of a 
protein which may support systemic RNAi in these other species. The taxonomic tree of C. 
elegans SID-1 was created using Grishin (protein) distance, with a max sequence difference of 
0.85, a fast minimum evolution parameter, with radial display representing evolutionary 
distance. 
Figure 1.2: C. elegans SID-1 is widely conserved 
13 
 
Amino acid alignment of the six C. elegans genes homologous to human SidT2. sid-1, tag-130, 
C08A9.3, and Y37H2C.1 are similar in size and structure, while C30E1.3 and C30E1.4 are much 
more divergent. Yellow and orange indicate hydrophobic amino acids, green and purple indicate 
polar amino acids, red indicates acidic amino acids, cyan indicates basic amino acids, and brown 
indicates aromatic amino acids. Alignments are generated by Structure based Sequence 
Alignment Program (STRAP)’s built-in parameters (GILLE 2004). 
Figure 1.3: SID-1 has five homologs in C. elegans 
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knockdown of SID-1, but not sufficient to prevent detectable knock down of tester gene targets 
due to this high efficiency of transport for those SID-1 which remain. 
The vertebrate SID-1 homologs are unlikely to transport long dsRNA due to the 
interferon response (BRIDGE et al. 2003). This raises the possibility that because the C. elegans 
SID-1 homologs are more similar to the vertebrate proteins, they may share a function and/or 
nucleic acid specificity different than that of SID-1. These considerations, along with the 
possibility of functional redundancy, challenge the mirror assumptions that the presence of a 
SID-1 homolog is evidence for systemic RNAi capacity and the absence of systemic defect when 
a SID-1 homolog is knocked-down or knocked-out demonstrates lack of dsRNA transport 
activity for that homolog. 
 
ROLE OF SID-2 IN ENVIRONMENTAL RNAi 
For ingested dsRNA to initiate RNAi, it must be first transported into the gut cells’ 
cytoplasms. Because SID-1 expressed in Drosophila S2 cells is sufficient to enable uptake, one 
possibility is that SID-1 functions at the luminal membrane to transport ingested dsRNA across 
this membrane. However, in the worm, SID-1 is not sufficient, because sid-2 mutants are 
specifically defective for environmental RNAi.  Interestingly, SID-2 alone is also not sufficient, 
as sid-1 mutants exposed to dsRNA fail to show silencing in gut cells. This indicates that these 
two proteins function together, either cooperatively or sequentially, to import ingested dsRNA 
(WINSTON et al. 2007).   
 SID-2 is a 311 amino acid single-pass transmembrane protein that is expressed in all gut 
cells and localizes strongly to the apical/luminal membrane. This indicates that SID-2 may be 
specialized to interact with ingested dsRNA. Curiously, the presumed dsRNA-interacting 
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extracellular domain is much less conserved that the intracellular domain.  The C. briggsae 
species is unable to initiate RNAi from ingested dsRNA.  However, C. briggsae expresses and 
localizes Cb-SID-2 indistinguishably from Ce-SID-2.  Transgenic expression of Ce-SID-2 in C. 
briggsae enables environmental RNAi, suggesting either expression and/or functional 
differences between these two genes homologs.  In contrast, expressing Cb-SID-2 in a sid-2 
mutant C. elegans strain failed to rescue environmental RNAi.  The functional difference 
between the two SID-2 proteins has been mapped by domain swap experiments to the 
extracellular domain (MCEWAN et al. 2012).  The C. elegans extracellular domain attached to the 
C. briggsae transmembrane and cytoplasmic domains functionally rescue sid-2 mutants. The 
distribution of environmental RNAi-capable species within the known Caenorhabditis 
phylogeny is not consistent with either a simple loss or gain of ability.  Furthermore, the linkage 
of environmental RNAi ability with SID-2 function has only been established for C. elegans, C. 
briggsae, and C. remanei (M. Felix, personal communication). These observations, combined 
with the non-predictable nature of which species are capable of taking up ingested dsRNA, 
suggest that gain and loss of this ability is rapid and likely encompasses many different proteins 
that can perform SID-2’s function.   
 
AUTONOMOUS VERSUS SYSTEMIC RNA INTERFERENCE 
Systemic RNAi is the organism-wide spread of silencing either via distribution of the 
initial RNAi trigger or its effectors (JOSE and HUNTER 2007). In contrast, cell autonomous RNAi 
silencing is restricted to the cells and their descendants that directly encounter dsRNA by 
injection, infection, transfection, or expression. In C. elegans, cell autonomous RNAi is the 
activity that remains in a sid-1 mutant. In sid-1 mutants, transgene-expressed dsRNA and dsRNA 
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injected directly into the syncytial germline or into single gut cells causes efficient silencing in 
the germline and injected cell respectively, but no detectable silencing in other cells.   
The RNAi silencing machinery is highly conserved, yet not all organisms have been 
shown to be RNAi-capable. One explanation may be that the machinery is used for TGS or RNA 
directed DNA elimination (MOCHIZUKI 2010; PAL-BHADRA et al. 2002). However, the lack of 
systemic RNAi may impede the detection of experimentally induced silencing phenotypes in 
many situations. For Caenorhaditis nematode species that have systemic RNAi, either injection 
of dsRNA or transgenc expression of Ce-SID-2 enables whole-animal experimental RNAi and 
even transgenerational silencing.  However, at least one Caenorhabidits species, C. brenneri 
(Caenorhabditis sp. CB5161), apparently lacks systemic RNAi. This was discovered when 
dsRNA targeting the large subunit of RNA polymerase caused the expected early embryonic 
lethal phenotype when injected directly into the syncytial germline, but in contrast to all other 
tested species, failed to cause any detectable phenotype when injected into intestinal cells in C. 
brenneri (WINSTON et al. 2007); thus C. brenneri appears to be naturally systemic-RNAi-
defective. Interestingly, the C. brenneri genomic sequence indicates that SID-1 is intact, 
indicating that addtional components required for systemic RNAi may be disabled or missing in 
this species.  The apparent selection for an intact SID-1 in the absence of systemic RNAi 
indicates that SID-1 may have an additional function(s). While an ecologicaly important function 
for systemic RNAi in animals has not yet been reported, systemic RNAi appears to provide 
protection against viral spread in plants (MOURRAIN et al. 2000); however, this will remain 
speculative until a mutant that specifically disrupts systemic RNAi is recovered.   
The presence or absence of systemic RNAi in the target organism can have profound 
effects on both the determination of whether RNAi works in that organism and how dsRNA can 
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be effectively delivered. The wide-spread use of RNAi in Drosophila is illustrative of the 
challenges and solutions. Microinjection of dsRNA into early syncytial Drosophila embryo 
provides access to all nuclei and their transcripts, but the lack of a robust RdRP-based 
amplification coupled with cellularization restricts effective RNAi to genes that function in the 
early embryo.  This can be overcome by transgene-expressed dsRNA, which bypasses the 
complete lack of systemic RNAi in this organism (PERRIMON et al. 2010).  The lack of systemic 
RNAi is likely due to lack of a sid-1 homolog as well as other components required for systemic 
RNAi (SID-1 expression in Drosophila has not yet been reported to enable systemic RNAi, 
despite many groups attempting this approach - personal communications). Complementing the 
in vivo approach, RNAi screens have been applied to a variety of Drosophila-derived cultured 
cell lines, like S2 cells, where dsRNA added to the culture medium is taken up via endogenous 
scavenging receptors that rely on the endocytosis machinery (SALEH et al. 2006; ULVILA et al. 
2006) or via transgenic expression of C. elegans SID-1 (BARTSCHERER et al. 2006).   
Organisms in which RNAi works very well have both systemic RNAi and RdRP enabled 
amplification of RNAi triggers, leading to speculation that they may be mutually dependent.  In 
some organisms, like Arabidopsis, it is these amplified products that become systemically mobile 
(FAGARD and VAUCHERET 2000). 
Viral defense has been proposed as an evolutionary explanation for systemic RNAi. In 
Drosophila and C. elegans, some RNAi-related genes have antiviral roles, reducing viral titers in 
infected cells and animals (DING 2010; LU et al. 2005; SCHOTT et al. 2005; WILKINS et al. 2005).  
However, cultured sid-1 mutant C. elegans cells were not more susceptible to viral infections 
than wild-type cells (SCHOTT et al. 2005), suggesting that systemic RNAi may not play a vital 
role in viral defense.  The recent identification of viruses that can naturally infect whole worms 
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will provide an opportunity to properly test this hypothesis (FELIX et al. 2011).  However, the 
systemic antiviral interferon response in mammals, which is triggered in response to long dsRNA 
(SLEDZ et al. 2003), provides a contrapositive argument to this hypothesis.  In plants, viral 
infection induces a strong anti-viral RNAi response, which includes RdRP amplification of 
RNAi triggers, which then spread systemically to provide viral immunity to as yet uninfected 
cells and tissues (VANCE and VAUCHERET 2001). 
Whatever the evolutionary roles of systemic RNAi may be, it is widely regarded as a 
powerful addition to cell-autonomous RNAi. However, as stated previously, the absence of 
systemic RNAi is not evidence for the absence of RNAi in the organism. RNAi may simply be 
more difficult to trigger and therefore detect in the absence of efficient delivery to all cells. In the 
next section, as we describe the mechanism of cell autonomous RNAi, we make particular note 
of how understanding such mechanisms can help researchers enhance cell autonomous RNAi, 
and therefore increase the potency of experimentally-induced RNAi. 
 
MECHANISM OF AUTONOMOUS RNA INTERFERENCE 
Mechanism of Exogenous RNAi processing 
In C. elegans, when exogenously introduced long dsRNA (>100 basepairs) is introduced 
into a cell, it is bound by a protein complex that contains RDE-4 and DCR-1.  RDE-4 contains 
two copies of a conserved dsRNA binding motif and binds as a dimer to dsRNA (Knight and 
Bass, 2001; Tabara et al. 2002). DCR-1 is a well-conserved RNase III endoribonuclease that 
cleaves dsRNA into short (~22 nucleotide) interfering RNAs (siRNAs) (HABIG et al. 2008; 
KNIGHT and BASS 2001; PAK and FIRE 2007; ZAMORE et al. 2000).  Biochemically, these 
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double-stranded siRNAs have on each strand a 5’ monophosphate, a free 3’ hydroxyl group, and 
2 nucleotides of overhang at the 3’ end (MACRAE et al. 2006). 
The RDE-4/DCR-1 complex also includes two Dicer-related helicases of unknown 
function (DRH-1 and 2) (DUCHAINE et al. 2006) as well as various members of the large 
Argonaute (AGO) family, defined by signature PAZ and PIWI domains (SONG et al. 2004). The 
AGO proteins are thought to be the catalytic machinery of RNAi-based silencing (CZECH and 
HANNON 2011). The PAZ domain is hypothesized to interface with DCR-1 (PADDISON and VOGT 
2008). 
In C. elegans, the Ago protein RDE-1 binds to double-strand siRNA produced by the 
DCR-1 complex and cleaves the passenger strand to produce a single-stranded guide siRNA 
(STEINER et al. 2009; TOMARI et al. 2004).  In most species, the primary Ago protein – like 
RDE-1 – uses the guide strand to identify cognate mRNAs, and once bound, the slicer activity 
cleaves the mRNA between the 10th and 11th positions of the siRNA-mRNA complementary 
region via the activity of the Ago’s RNase H catalytic domain (HALL 2005); however this 
particular event seems to be absent in C. elegans (STEINER et al. 2009).  In C. elegans, single-
strand siRNA produced by the sequential action of DCR-1 and RDE-1 on the long triggering 
dsRNA is referred to as a primary siRNA. Through still-mysterious processes, an RdRP 
produces from the siRNA-mRNA complex many copies of so-called secondary siRNAs, that are 
principally anti-sense to and distributed towards the 5’ end of the cognate mRNA (PAK and FIRE 
2007).  In C. elegans somatic cells, the primary RdRP is RRF-1, while in the germline the 
primary RdRP appears to be EGO-1. These RdRPs are at least partially functionally redundant 
(SMARDON et al. 2000). The 5’ end of these RdRP dependent secondary siRNAs contain 
triphosphate residues, indicating that they represent primary synthesis products; that is, they are 
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not produced by DCR-1 cleavage reactions.  The secondary siRNAs are both more abundant than 
primary siRNAs and target an expanded sequence region on the cognate mRNA.  These 
abundant secondary siRNAs interact with so-called secondary Argonautes (SAGOs) (YIGIT et al. 
2006). These secondary siRNA-SAGO complexes appear to be directly involved in sequence-
dependent mRNA degradation. However, as many SAGOs lack an active RNase H domain, 
precisely how they degrade mRNA remains unclear. It has been suggested that in C. elegans, 
mRNA targeted for PTGS are preferentially transported to P bodies or GW bodies (DING et al. 
2005; JAKYMIW et al. 2005; LIU et al. 2005). It has been recently shown that these SAGOs, who 
seem to responsible for the bulk of the silencing, are poorly conserved compared to the other 
RNAi components, possibly providing another reason why C. elegans RNAi is so efficient 
compared to that of other species (DALZELL et al. 2011). 
While RDE-1 and most SAGOs function in the cytoplasm, recent work has shown that 
one of the SAGOs, NRDE-3, shuttles secondary siRNAs into the nucleus. NRDE-3 has the 
signature PIWI and PAZ domains of an Ago protein, but also contains a nuclear localization 
signal required for its function (GUANG et al. 2008). Once inside the nucleus, NRDE-3 interacts 
with a complex of nuclear RNAi silencing factors, including the well conserved novel protein 
NRDE-2 (GUANG et al. 2010). The nuclear RNAi complex is guided by the siRNA to nascent 
transcripts and effects transcriptional silencing by impeding RNA polymerase elongation and 
recruiting histone methyltransferase activity (GUANG et al. 2010). This mechanism is likely the 
basis for heterochromatin modifications and other transcriptional gene silencing phenomena 
phenotypically linked to RNAi (CLAYCOMB et al. 2009; GRISHOK et al. 2005; MOTAMEDI et al. 
2004).  The synergistic PTGS and TGS mechanisms are summarized in Figure 1.4. 
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1) Post delivery in vitro synthesized long (>100 bp) dsRNA (red) with 5’ triphosphate (yellow) 
ends is 2) bound by the RDE-4 (purple) and DCR-1 (cyan) complex. 3) The endonuclease DCR-
1 dices the long dsRNA into of ~20 nucleotide ds-siRNAs with two nucleotide single stranded 3’ 
ends.  The dicer products have 5’ monophosphate and 3’ hydroxyl ends. 4) Interaction with the 
Argonaute RDE-1 (pink) leads to slicing of the passenger strange producing 5) a single-stranded 
guide siRNA bound to RDE-1.   6) This primary ss-siRNA guides RDE-1 to its cognate mRNA 
(black). 7) In a mechanistically unclear step, the RdRP RRF-1 (coffee) is recruited to the RDE-1-
siRNA-mRNA complex 8) leading to the production of many unprimed secondary siRNAs with 
5’triphosphate ends. 9) Most of these secondary siRNAs match the originally targeted region, but 
secondary siRNAs anti-sense to regions both 5’ and 3’ to the originally introduced long dsRNA 
are also produced. 10a) In a second mechanistically unclear step, these secondary siRNAs 
become associated with cytoplasmic secondary Argonautes (SAGOs – orange) or 10b) the 
nuclear localized Argonaute NRDE-3. 11a) The secondary siRNAs then guide the cytoplasmic 
SAGOs to cognate mRNAs and via yet another mechanistically unclear step lead to the 
elimination of the mRNAs. 11b) NRDE-3 shuttles the secondary siRNAs into the nucleus where 
they guide transcriptional gene silencing processes. 
Figure 1.4: Summary of the exogenous RNAi pathway in C. elegans 
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Figure 1.4 (Continued): Summary of the exogenous RNAi pathway in C. elegans 
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Regulators of Exogenous RNAi 
Mutations that enhance RNAi silencing have been identified by various means.  
Mutations in genes required for production of endogenous siRNA silencing pathways were 
identified in screens for enhanced neuronal RNAi (Eri mutants) and discovered serendipitously 
when analyzing the phenotype of worms deleted for the RdRP rrf-3 (KENNEDY et al. 2004; 
SIMMER et al. 2002). Another large class of mutants is in the worm Rb Tumor suppressor 
pathway, which appears to enhance RNAi by partial soma to germline transformation (WANG et 
al. 2005). It is not clear if this transformation replaces somatic RNAi with germline RNAi, which 
is particularly robust, or adds additional capacity to the somatic RNAi pathway. Eri mutants were 
initially sought for their ability to increase the discovery of RNAi phenotypes in large-scale 
feeding RNAi screens. For example, feeding wild-type worms 447 different RNAi foods resulted 
in only 307 expected loss-of-function phenotypes, while performing the same screen in the rrf-3 
mutant background resulted in 436 loss-of-function phenotypes (SIMMER et al. 2003). Because 
these mutants are enhanced for RNAi, it indicates that the wild-type eri genes function directly 
or indirectly to inhibit RNAi. Mechanistic investigations to date indicate that the enhanced RNAi 
phenotypes reflect indirect effects rather than the action of direct negative regulators.   
The Eri class of enhancers are related by their facultative association with DCR-1 
(DUCHAINE et al. 2006; GENT et al. 2009; PAVELEC et al. 2009).  To date, nine Eri loci have been 
described (Table 1.1), including five in widely conserved genes (DUCHAINE et al. 2006; FISCHER 
et al. 2008; KENNEDY et al. 2004; PAVELEC et al. 2009; SIMMER et al. 2002). These genes are 
required for the production or stability of endogenous siRNAs. The current model for this eri-
class is that the relatively abundant endogenous siRNAs compete with siRNAs produced from 
experimentally introduced dsRNA for limiting effector molecules, for example the SAGO 
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Table 1.1: Negative Regulators of RNA Interference in C. elegans 
Gene Name Conservation Homologous Domains Notes 
eri-1 Wide siRNase; RNA binding domains Temperature sensitive sterile at 25ºC 
rrf-3/eri-2 Wide RdRP Temperature sensitive sterile at 25ºC 
eri-3 Caenorhabditis Hydrolase Temperature sensitive sterile at 25ºC  
dcr-1/eri-4 Wide Helicase domain of DCR-1 Temperature sensitive sterile at 25ºC; weak Eri phenotype 
eri-5 Nematodes Tudor domain Germline-specific Eri phenotype 
eri-6/7 Wide Helicase Retrotransposon homolog 
ergo-1/eri-8 Wide Argonaute  
eri-9 Caenorhabditis RNA transferase  
eri-11 Caenorhabditis Oligosaccharyl transferase  
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proteins (LEE et al. 2006; YIGIT et al. 2006). Thus mutations in the Eri genes reduce the number 
of endogenous siRNAs and indirectly increase access to limiting components of silencing 
pathway(s).  These limiting RNAi resources have been proposed to be secondary AGOs (YIGIT 
et al. 2006), DICER (MIKUMA et al. 2004), and even the dsRNA channel SID-1 (CALIXTO et al. 
2010; WINSTON et al. 2002); in each case, over-expression increases RNAi efficacy.  
Tissue-specific differences in RNAi sensitivity among the Eri mutants provides 
additional support for the competition model, and further suggest that the extent of competition 
differs among tissues (ZHUANG and HUNTER 2011). The tissue-specific differences can be 
explained by tissue-specific components of a competing small RNA pathway, by relative tissue-
specific activities of multiple competing pathways, and even by multiple limiting resources, 
which may show tissue-specific biases. Interestingly, all nine Eri mutants show robust maternal 
rescue and showed enhanced RNAi in the germline.  These observations indicate that not only 
are these Eri genes expressed and active in the germline, but that maternally synthesized product 
or the product(s) of their activity is apparently well distributed to somatic tissues in the progeny. 
This also suggests that the maternal contribution to the embryo directly or indirectly includes 
small RNAs (ZHUANG and HUNTER 2011). 
These data indicate that exogenous RNAi capacity is regulated by or is responsive to 
endogenous small RNA silencing activity levels. Thus the sensitivity of the animal to exogenous 
dsRNA, whether experimentally introduced, the outcome of a viral infection, or other 
environmental or genomic stresses, may be tuned by intrinsic or extrinsic events (e.g. pathogens, 
DNA damage);  for instance, systemic RNAi appears to be enhanced by starvation (WINSTON et 
al. 2002).  This could reflect increased dsRNA transport or enhanced RNAi responsiveness 
mediated by changes in the level of endogenous siRNA levels.  Analysis of the Eri class of genes 
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indicates that the endogenous siRNA pathways are important for maturation of sperm (GENT et 
al. 2009; PAVELEC et al. 2009), and proper chromosomal segregation cannot take place without 
the secondary Ago csr-1 (CLAYCOMB et al. 2009).  In contrast, rde-4 and rde-1 mutants, which 
appear to be specific to exogenous RNAi, do not seem to have any non-RNAi phenotypes 
(TABARA et al. 1999). 
The nature of conservation among the eri genes should also be of interest in studying 
RNAi in other organisms (ALTSCHUL et al. 1997) (Figure 1.5; Table 1.1). ERI-1 is a well 
conserved nuclease with siRNase activity (KENNEDY et al. 2004); RRF-3 is a well conserved 
RdRP (CROMBACH and HOGEWEG 2011; SIJEN et al. 2001); the dcr-1/eri-4(mg375) mutant is a 
point mutation in the helicase domain of the well conserved DICER protein (MACRAE et al. 
2006; PAVELEC et al. 2009); ERI-6/7 is a conserved helicase domain (FISCHER et al. 2008); and 
ERGO-1/ERI-8 (PAVELEC et al. 2009) is a well conserved Ago protein. Mutations to these 
conserved genes in other organisms have been shown to have some similar endogenous defects, 
such as general RNA processing defects (ANSEL et al. 2008), but assays in RNAi efficacy have 
not been thoroughly performed. This area of research holds vast potential for dramatically 
increasing RNAi applicability and technology. Even more interesting are the potential roles 
played by the non-conserved eri genes specific to C. elegans or Caenorhabditis; their predicted 
molecular identities (KELLEY and STERNBERG 2009) suggest that hydrolyases and transferases 
play a large role in small RNA production in C. elegans (Table 1.1). Perhaps such class-specific 
genes in other organisms hold the key to decreasing the competitive regulation of RNAi. 
Moreover, mutations to novel or non-conserved genes are less likely to have wide-ranging 
impacts, while maintaining similar degrees of RNAi hypersensitivity. Therefore, studying 
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ERI-1, which is important for the production or stability of endogenous siRNA in C. elegans, has 
homologs in many taxonomic groups.  Since it is likely that endogenous RNAi processes will 
compete with exogenous RNAi processes in these species, researchers should not only consider 
the possibility of enhancing RNAi, but the possibility that exogenous RNAi will interfere with 
essential endogenous processes (e.g. eri-1 and rrf-3 are required for sperm function). The 
taxonomic tree of C. elegans ERI-1 was created using Grishin (protein) distance, with a max 
sequence difference of 0.85, a fast minimum evolution parameter, and displayed with a forced 
equidistance representation.  
Figure 1.5: C. elegans ERI-1 is widely conserved 
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organism-specific eri genes through genetic screens, if possible, holds tremendous promise for 
understanding (and pragmatically overcoming) RNAi regulation. 
Finally, given that the products of eri pathway are effective competitors of the rde 
pathway, it is worthwhile to examine the chemical structures of small RNAs produced by the eri 
pathway. The eri gene products produce endogenous siRNAs of 22 or 26 nucleotides that usually 
begin with a G (22G or 26G siRNAs) and contain a 5’ triphosphates (CONINE et al. 2010; GENT 
et al. 2010; VASALE et al. 2010; WELKER et al. 2010). Perhaps unknown chemical properties of 
these siRNAs are important for their relative enhanced activity. Attempting to introduce 
experimental siRNAs which share such properties may thus enhance RNAi efficacy as well (KIM 
et al. 2005a). 
In C. elegans, the core of the RNAi machinery that interacts with experimentally 
introduced RNAi signals (whether long dsRNAs or siRNAs) is a relatively well-understood 
framework. Recent advances in deep sequencing revealed more and more of the intricacy and 
potency of the endogenous small RNA network, as well as its competitive regulation of the 
exogenous RNAi pathway. Researchers frustrated by the limited utility of RNAi in other species 
should examine the RNAi regulation perspective to perhaps overcome this seeming impasse. 
Once the RNAi silencing signal is inside the cell, most organisms from protists to fungi, and 
from plants to animals, all have some part of the conserved RNAi processing machinery, whether 
cytoplasmic PTGS or nuclear TGS (SHABALINA and KOONIN 2008). It is the relative 
effectiveness of RNAi that vastly differs (MAIDA and MASUTOMI 2011) and is possibly thwarting 
broader use of RNAi as a technological resource. 
 
IMPLEMENTATION 
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The hallmarks of RNAi are specificity and potency. In C. elegans, dsRNA is not toxic 
and studies indicate that increasing dsRNA concentration can increase RNAi potency (REA 2007; 
ZHUANG and HUNTER 2011). Similarly, mutations in the Eri genes that reduce competition for 
limiting small RNA resources (LEE et al. 2006) and overexpression of these limiting resources 
can also increase RNAi potency (CALIXTO et al. 2010; MIKUMA et al. 2004; YIGIT et al. 2006). 
However, there is some possibility that these measures reduce specificity (PAVELEC et al. 2009). 
Furthermore, tissues differ in their relative sensitivity: for example, neurons are fairly refractory 
of RNAi (KAMATH and AHRINGER 2003; KAMATH et al. 2003) whereas the germline is 
hypersensitive to RNAi (SIJEN and PLASTERK 2003). Consequently, mutations that transform 
somatic cells towards germline can increase RNAi potency (WANG et al. 2005). Similarly, 
developmental stages or environmental conditions can also influence RNAi sensitivity: starved 
worms are slightly more sensitive to RNAi (JOSE and HUNTER 2007). Therefore, in assaying for 
RNAi efficacy, the gene target expression profile – both temporal and spatial – as well as 
environmental conditions need to be considered for optimal phenotypic output. These C. elegans 
tissue-specific and developmental sensitivities may be paralleled in other species and should be 
optimized when implementing RNAi. These considerations should be appropriately 
supplemented with the aforementioned methods for introducing RNAi to increase RNAi 
efficacy. For example, while microinjection of dsRNA into a mutant with a soma-to-germline 
transformation is an obvious means to increase the RNAi efficacy, transgenic expression of 
hairpin constructs under germline promoters – which are normally spontaneously suppressed 
(KIM et al. 2005b) – may become more effective as well in a soma-to-germline mutant. 
Although RNAi potency increases with dsRNA dose, it is a common misperception that 
this relationship is linear.  When RNAi potency (phenotypic penetrance) is plotted versus dsRNA 
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dose, one clearly observes a sigmoidal curve (Figure 1.6).  Curiously, for most phenotypes, the 
expressivity (the severity of the phenotype) is nearly constant, thus the great variability at the 
empirically determined intermediate dose range reflects a mixture of strongly affected and non-
affected individuals.  This dose sensitivity likely underlies much of variation in reported RNAi 
effects, which in some cases are even contradictory (REA 2007).  It is obvious best to use the 
maximum possible dose, but for potent foods, a simple dose response curve can determine an 
effective range with minimal variability. 
Finally, the majority of the studies on C. elegans RNAi, including those referenced in this 
text, specifically refer to the N2 Bristol strain – the commonly used “wild type” strain for C. 
elegans research. However, there are variations in RNAi efficacy among wild isolates of C. 
elegans (FELIX et al. 2011). While the genetic basis for some of these variations is known, such 
as a polymorphism in a specific RNAi gene (SIMMER et al. 2002), other sources for such 
differences remain to be found. Future research into these population-specific RNAi efficacy 
differences for C. elegans and other species will be extremely relevant because it provides a clue 
as to the evolutionary scale at which changes in RNAi pathways may occur.  
It seems reasonable to apply the lessons of the deep mechanistic and phenomenological 
observation made in C. elegans, as a first step towards enabling the highest probability of 
optimizing RNAi in other species. There will inevitably be species in which RNAi does not 
work, but the conservation of basal RNAi machinery suggests that more often than not, RNAi 
will function in most species. 
32 
 
 
 
Measurements of RNAi potency (penetrance) versus dsRNA dose show a sigmoidal relationship 
with high variability surround the inflection point (B).  At low (A) and high (C) dsRNA dose, 
most worms do not at all or completely do respond.  However, slight variations in delivered 
dsRNA dose at intermediate concentrations can have dramatic effects on perceived phenotypes.  
Mutations that enhance RNAi tend to shift such dose-response curves toward lower dsRNA dose 
(red) without noticeably affecting the shape of the curve. 
Figure 1.6: RNAi phenotypic penetrance is sensitive to dsRNA dose 
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 Given what is known about enhanced RNAi in C. elegans, my research was driven by 
three main questions. First, aside from hypersensitivity to exogenous RNAi triggers, what are the 
characteristics of the known Eri mutants and how are they different from other classes of 
enhanced RNAi? Second, what is the genetic mechanism behind enhanced RNAi? That is, why 
is an Eri mutant Eri? And third, what are the broader physiological impacts, if any, of the loss of 
the eri pathway on C. elegans? 
AIMS AND QUESTIONS 
 I answer the first question in chapters two and three by performing in-depth phenotypic 
analysis of the known Eri mutants and by analyzing screens for novel RNAi factors under 
different contexts. These findings contribute to the field’s understanding of exogenous RNAi, 
especially for inducing more effective use of enhanced RNAi technology through deeper 
understanding of its characteristics. 
 I answer the second question in chapters four and five by examining the role of nuclear 
RNAi as the genetic mechanism behind enhanced RNAi. These findings contribute to the field’s 
understanding of the eri pathway’s endogenous gene regulatory roles, and further underscore the 
spatial complexity of competing cellular small RNA pathways. 
 I answer the third question in chapter six by examining developmental markers in Eri 
mutants. These findings contribute to the field’s understanding of the general physiological 
impact caused by the loss of eri endo-siRNAs in C. elegans.  
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Chapter Two 
Tissue-specificity of C. elegans enhanced RNAi mutants 
 
The contents were previously published in ZHUANG, J. J., and C. P. HUNTER, 2011. Tissue Specificity of 
Caenorhabditis elegans enhanced RNA interference mutants. Genetics 188: 235-237. Permission to reuse was 
granted by the Genetics Society of America. 
43 
 
Gene knockdown by RNA interference (RNAi) in Caenorhabditis elegans is readily 
achieved by feeding bacteria expressing double-stranded RNA (dsRNA). Enhanced RNAi (Eri) 
mutants facilitate RNAi due to their hypersensitivity to dsRNA. Here, we compared eight Eri 
mutants for sensitivity to ingested dsRNA targeting a variety of tissue-specific genes. 
ABSTRACT 
 
The effectiveness of double-strand RNA (dsRNA) delivery in Caenorhabditis elegans 
has made high-throughput RNA interference (RNAi) screens an essential research tool (MITANI 
2009). For RNAi screens, dsRNA is usually administered via feeding RNAi, whereby worms 
ingest bacteria expressing gene-specific dsRNA (referred to as RNAi food). This is less potent 
than microinjecting dsRNAs, perhaps due to the lower amounts of internalized dsRNA 
(TIMMONS and FIRE 1998).  The discovery of enhanced RNAi (Eri) mutants, which increases the 
sensitivity of worms to dsRNA, increases the discovery of RNAi phenotypes in large-scale 
screens. Nine Eri loci have been discovered thus far (DUCHAINE et al. 2006; FISCHER et al. 2008; 
KENNEDY et al. 2004; PAVELEC et al. 2009; SIMMER et al. 2002). 
INTRODUCTION 
Although a variety of Eri mutants are used in RNAi screens, their selection has been ad 
hoc, as no systematic comparative analysis of the Eri strains has been reported.  Such an analysis 
would provide a logical basis for selecting the most sensitive Eri mutant for general and tissue-
specific screens. Here, we comprehensively characterize the tissue-specific RNAi sensitivities of 
eight Eri mutants. 
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To characterize phenotypic differences among Eri mutants, we compared the relative 
penetrance of RNAi sensitivity at varying doses of dsRNA expressing bacteria (REA 2007).  For 
each bacterial strain that expresses dsRNA targeting a C. elegans gene, we scored only one 
defined knockdown phenotype (Table 2.1). A representative dilution series is shown in Figure 
2.1 (Table 2.2). We sought to use this dose-response data to compare the enhanced silencing for 
each Eri mutant. For all strains, the variability in penetrance is greatest at intermediate dsRNA 
doses, suggesting a threshold effect.  This variability, best observed via coefficient of variations 
(Table 2.3), strongly interferes with determining the onset of silencing.  In contrast, the trend 
towards reduced variability at higher dsRNA doses provides a means to discriminate among Eri 
mutants. Based on this analysis, we developed a criterion for selecting the “most effective” Eri: 
one(s) that causes near complete (upper bound of 95% confidence interval at least 100% 
penetrant) and robust (less than 10% standard deviation) silencing at the lowest dsRNA dose. 
RESULTS AND DISCUSSION 
We used the methods and criterion described to evaluate eight Eri mutants on 24 RNAi 
foods in eight tissues. The results of this analysis are presented in Figure 2.2 (Tables 2.4-2.27).  
The majority of Eri mutants enhanced RNAi for nearly all tested tissues, but all showed relative 
differences in RNAi hypersensitivity for some foods. Our comprehensive phenotypic analysis of 
the Eri mutants indicates that they are not equivalent, consistent with the reported non-
overlapping expression profiles of eri-1 and rrf-3 mutants (LEE et al. 2006). 
In all experiments, we observed a sigmoidal curve for silencing penetrance versus RNAi 
concentration; at intermediate concentrations, the variance was highest.  Therefore, to minimize 
variability associated with dose, all feeding RNAi assays should be preceded by a dilution series 
control to ensure that the RNAi food is not used at an “inflection point” concentration.
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The tissue-specific phenotype for each of the genes targeted by RNAi foods in Figure 2.2 are 
listed and referenced. Single asterisk (*) indicates foods whose gene targets are grouped to a 
tissue due to high expression in that particular tissue. Double asterisks (**) indicate food whose 
gene target is grouped to a tissue due to phenotype scored resulting from defects within that 
particular tissue. The remaining foods are grouped to a tissue due to both expression and 
phenotype arising from a particular tissue’s effects. 
Table 2.1: Phenotypes scored for RNAi foods 
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Table 2.1 (Continued): Phenotypes scored for RNAi foods 
Tissue Food Phenotype Reference 
Epidermis bli-1 Large blisters on animals (MYLLYHARJU and KIVIRIKKO 2004) 
Epidermis dpy-11 Severely dumpy animals whose length is at most 3X its width (KO and CHOW 2003) 
Epidermis dpy-13 Severely dumpy animals whose length is at most 3X its width (BIRD 1992) 
Gonad fkh-6 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (CHANG et al. 2004) 
Gonad gon-1 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent 
(TAMAI and NISHIWAKI 
2007) 
Gonad gon-4 Severely protruding or absent gonad (CHURCH and LAMBIE 2003) 
Intestine act-5 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (MACQUEEN et al. 2005) 
Intestine gtl-1* 
Brood size reduction in developed L3s or older worms  
Affected animals are significantly smaller in 
morphology 
(XING et al. 2008) 
Intestine ifc-2 Bent posterior body morphology that paralyzes locomotion (HUSKEN et al. 2008) 
Muscle act-3 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (MEISSNER et al. 2009) 
Muscle myo-3 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (AHNN and FIRE 1994) 
Muscle unc-22 Severe twitching that paralyzes locomotion (FIRE et al. 1991) 
Neuron hbl-1** Paralysis Thompson-Peer, K.L. 2009 (unpublished) 
Neuron hmr-1* 
Brood size reduction in developed L3s or older worms  
Affected animals are significantly smaller in 
morphology 
(BROADBENT and PETTITT 
2002) 
Neuron unc-73 Paralysis (VANDERZALM et al. 2009) 
Pharynx div-1* 
Brood size reduction in developed L3s or older worms  
Affected animals are significantly smaller in 
morphology 
(MCKAY et al. 2003) 
Pharynx pbs-6* 
Brood size reduction in developed L3s or older worms  
Affected animals are significantly smaller in 
morphology 
(WANG et al. 2006) 
Pharynx pha-4 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (MANGO 2007) 
Ubiquitous cdk-1 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (SEYDOUX and FIRE 1994) 
Ubiquitous knl-3 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (CHEESEMAN et al. 2004) 
Ubiquitous vha-15 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent 
(HUNT-NEWBURY et al. 
2007) 
Germline glp-1 Absent germline in adult hermaphrodites (VOUGHT et al. 2005) 
Germline par-1 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (BOWERMAN et al. 1997) 
Germline pos-1 Brood size reduction in developed L3s or older worms  Affected animals are lethally absent (TABARA et al. 1999) 
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Single L3-stage larvae were placed on RNAi food targeting ifc-2; 4 days later, the percent of 
progeny showing the expected bent posterior and accompanying paralysis at each indicated 
concentration (OD at 600 nm) of initial bacterial culture were determined. For clarity, three 
bacterial culture concentrations (OD600nm of 0.1, 0.25, and 0.75), which produced similar Eri 
penetrances as adjacent concentrations, are not included. Error bars represent standard deviation. 
Figure 2.1: Dilution series of Eri responses by RNAi feeding against ifc-2 
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Single L3-stage larvae were placed on RNAi food targeting ifc-2; 4 days later, the percent of 
progeny showing the expected bent posterior and accompanying paralysis at each indicated 
concentration (OD at 600 nm) of initial bacterial culture were determined. For clarity, three 
bacterial culture concentrations (OD600nm of 0.1, 0.25, and 0.75), which produced similar Eri 
penetrances as adjacent concentrations, are not included. The tabulated mean (Avg) and standard 
deviation (SD) for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype 
(Eri?), with p<0.05 as the criterion to denote significant difference from wild type response 
levels. A strain which fits the “best eri” criterion described in text is marked as “best”, with 
asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.2: Dilution series of Eri responses by RNAi feeding against ifc-2 
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Table 2.2 (Continued): Dilution series results for ifc-2 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wild type 
(N2) 
0.5 0/22 0/27 0/20 0/23 1/60   0 0.01  
1 1/24 3/22 1/26 0/23 0/24   0.04 0.06  
2 0/20 3/59 3/31 2/24 2/32   0.06 0.04  
3 2/27 2/30 1/35 4/36 0/23   0.06 0.04  
4 5/36 2/26 4/30 4/33 8/39 2/31 2/31 0.11 0.05  
  
eri-1 
(mg366)  
0.5 3/20 1/22 2/32 2/16 10/48   0.12 0.07 Yes 
1 6/21 8/34 5/29 4/33 5/24   0.20 0.06 Yes 
2 7/28 11/18 13/24 21/30 11/29   0.50 0.18 Yes 
3 17/24 20/31 19/32 22/29 23/29   0.70 0.08 Yes 
4 33/33 39/42 54/57 41/43 23/23 21/22 25/28 0.95 0.04 Yes 
  
rrf-3 
(pk1426) 
0.5 
*Best*  
5/25 0/38 4/28 0/10 12/39   0.13 0.13  
1 20/28 25/28 35/46 20/23 33/33   0.85 0.11 Yes 
2** 32/39 24/25 22/25 13/18 22/28   0.83 0.09 Yes 
3** 15/19 22/23 16/21 45/47 33/39   0.86 0.09 Yes 
4** 29/30 28/30 10/10 29/30 20/20 40/40 29/30 0.98 0.03 Yes 
  
eri-3 
(tm1361) 
0.5 6/80 2/90 5/60 1/20 2/40   0.06 0.02 Yes 
1 6/17 4/23 7/18 6/25 7/19   0.30 0.09 Yes 
2 12/16 5/14 12/30 7/16 6/16   0.46 0.16 Yes 
3 16/19 12/13 12/16 17/23 11/14   0.81 0.08 Yes 
4 15/20 17/19 11/17 12/15 8/17 17/26 16/20 0.72 0.14 Yes 
  
eri-5 
(tm1705) 
0.5 4/80 2/60 0/20 0/20 0/20   0.02 0.02  
1 0/44 3/60 0/20 3/40 2/50   0.03 0.03  
2 0/20 2/80 3/80 0/20 2/40   0.02 0.02  
3 0/28 1/40 1/40 2/60 4/80   0.03 0.02  
4 1/31 4/30 3/48 3/22 5/33 7/54  0.11 0.05  
  
eri-6/7 
(tm1917) 
0.5 2/27 3/21 2/34 3/37 2/33   0.08 0.03 Yes 
1 13/26 8/26 6/25 5/19 9/27   0.33 0.10 Yes 
2 8/26 10/33 11/34 8/23 12/39   0.32 0.02 Yes 
3 9/22 13/22 16/30 10/20 13/25   0.51 0.07 Yes 
4 14/36 15/35 10/27 28/37 12/19 8/19 23/30 0.54 0.18 Yes 
  
eri-8 
(gg100)  
0.5 3/23 2/28 4/42 2/39 2/39   0.08 0.03 Yes 
1 4/22 2/25 7/25 9/32 6/18   0.23 0.10 Yes 
2 9/23 12/26 13/27 10/23 11/23   0.45 0.04 Yes 
3 11/23 20/24 10/23 12/20 36/47   0.62 0.17 Yes 
4 17/24 24/27 24/28 20/30 31/36 31/34 45/48 0.83 0.10 Yes 
  
eri-9 
(gg106) 
0.5 2/26 6/26 2/32 5/39 1/35   0.04 0.08  
1 7/32 10/41 8/40 4/37 6/31   0.09 0.05 Yes 
2 3/20 3/27 3/32 4/27 5/41   0.12 0.02 Yes 
3 13/26 21/27 8/25 12/24 11/28   0.50 0.17 Yes 
4 9/21 10/21 14/30 16/28 17/24 13/21 10/10 0.61 0.20 Yes 
  
eri-11 
(gg99)  
0.5 0/32 1/30 2/30 2/45 3/31   0.05 0.04  
1 6/25 6/29 3/24 10/37 5/27   0.21 0.06 Yes 
2 13/31 13/26 13/28 11/23 10/24   0.46 0.04 Yes 
3 12/20 23/29 14/23 23/37 21/30   0.66 0.08 Yes 
4 18/26 24/25 30/35 19/27 21/30 22/28 18/28 0.76 0.11 Yes 
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Table 2.3: Coefficient of variation for Eri responses by RNAi feeding against ifc-2 
       Strains 
OD600 
Wild type 
(N2) 
eri-1 
(mg366) 
rrf-3 
(pk1426) 
eri-3 
(tm1361) 
eri-5 
(tm1705) 
eri-6/7 
(tm1917) 
eri-8 
(gg100) 
eri-9 
(gg106) 
eri-11 
(gg99) 
0.5 2.24 0.56 1.02 0.43 1.41 0.41 0.42 0.75 0.75 
1 1.29 0.30 0.13 0.31 0.99 0.31 0.44 0.27 0.27 
2 0.64 0.36 0.11 0.35 0.99 0.06 0.08 0.19 0.08 
3 0.77 0.12 0.11 0.09 0.68 0.13 0.28 0.35 0.12 
4 0.44 0.04 0.03 0.19 0.45 0.33 0.12 0.32 0.15 
 
Variability strongly interferes with determining the onset of RNAi silencing. Therefore, those 
strains with the lowest coefficient of variation at the lowest dosage of RNAi triggers, such as rrf-
3(pk1426) during ifc-2(RNAi) – highlighted in yellow – are deemed the “best” Eri strains. 
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Summary of Eri efficiency for the eight Eri strains tested on 24 RNAi foods representing eight 
tissues. A strain exhibiting significantly higher (t test p<0.05) penetrance than the N2 wild type 
strain’s penetrance (green), at any tested bacterial RNAi food concentration, is marked as Eri 
(yellow or red). Strains exhibiting an Eri phenotype that have an upper bound of 95% confidence 
interval at least 100% penetrant with a less than 10% standard deviation are marked as the “best” 
Eri (red). “T.S. sterile” indicates strains that exhibit temperature-sensitive sterility at 25ºC. 
Figure 2.2: Summary metric of tissue-specific Eri efficacy 
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Single L3-stage larvae were placed on RNAi food targeting bli-1; 4 days later, the percent of 
progeny showing the expected large blisters on the animals at each indicated concentration (OD 
at 600 nm) of initial bacterial culture were determined. For clarity, three bacterial culture 
concentrations (OD600nm of 0.025, 0.25, and 4), which produced similar Eri penetrances as 
adjacent concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.4: Dilution series of Eri responses by RNAi feeding against bli-1 
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Table 2.4 (Continued): Dilution series results for bli-1 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.1 1/86 0/32 1/64 2/80 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0.01  
0.5 23/83 30/123 23/102 23/97 0/20 0/20 0/20 0/20 1/45   0.11 0.13  
1 24/124 2/18 6/38 5/47 9/47 4/26      0.15 0.04  
2 81/163 98/178 78/164 46/134 39/113 45/109 45/107 19/40 27/41 9/26  0.45 0.10  
3 16/27 131/196 132/212 45/53 38/52 46/57 60/70 43/53    0.74 0.10  
  
eri-1 
(mg366) 
0.1 
*Best* 
9/80 13/73 12/61 11/79 24/76 0/64 0/40 0/20 0/20 0/20 1/60 0/20 0.08 0.11  
0.5 37/82 12/29 37/90 59/116 51/93 48/90 23/58 10/34 10/38 12/51 21/34 6/23 0.41 0.13 Yes 
1 63/87 34/36 45/56 27/31 40/45 44/48 33/39      0.86 0.07 Yes 
2 71/84 59/73 43/60 69/82 86/102 44/51 31/37 44/53     0.82 0.05 Yes 
3** 57/59 95/110 66/80 68/74 20/20 84/92 68/85      0.90 0.07 Yes 
  
rrf-3 
(pk1426)  
0.1 6/48 0/20 0/20 0/20 0/20 0/20    0.02 0.05  
0.5 83/115 55/108 14/27 28/54 21/46 20/45 21/43   0.52 0.09 Yes 
1 88/121 66/84 37/73 70/123 18/35 60/70 58/84 45/60 78/91 0.70 0.14 Yes 
2 102/104 74/87 34/42 33/42 45/56 28/38 44/51 7/9  0.83 0.07 Yes 
3 110/112 73/79 5/7 31/43 39/46 37/42 42/50 60/65  0.85 0.10 Yes 
  
eri-3 
(tm1361) 
0.1 16/81 23/69 22/92 5/87 16/119 17/58 7/57 1/40 0/20 0/20 0/20 0/20 0.12 0.12  
0.5 88/128 63/64 97/139 32/93 66/126 26/76 24/65 1/30 7/20 10/31 30/47 17/30 0.49 0.25 Yes 
1 62/96 88/105 57/100 7/25 28/106 25/72 9/40 12/58 21/41 12/44 18/42 19/51 0.41 0.19 Yes 
2 76/102 54/68 84/108 41/54 51/55 27/30 35/43 40/45     0.83 0.07 Yes 
3 84/99 54/67 95/103 54/78 43/48 21/26 7/9 42/52 37/44    0.82 0.07 Yes 
  
eri-5 
(tm1705) 
0.1 3/80 2/80 0/23 1/50 0/20 0/20 0/20 0/20 0/20    0.01 0.01  
0.5 3/63 5/25 0/20 1/60 6/50 5/50 0/20      0.07 0.07  
1 80/168 60/159 70/184 13/46 41/96 9/24 8/26 2/33 3/49 8/40 4/52 23/109 0.27 0.15  
2 59/146 60/166 63/162 25/62 10/26 21/63 18/45 15/41     0.38 0.02  
3 42/54 59/66 47/66 29/44 29/38        0.76 0.09  
  
eri-6/7 
(tm1917) 
0.1 20/138 14/115 7/59 0/20 0/20 0/20 0/20     0.06 0.07  
0.5 46/146 74/191 14/59 22/53 11/54 14/49 1/7     0.28 0.10 Yes 
1 40/156 45/145 24/122 1/5 11/64 21/69 14/44 15/33 10/27 13/41 14/45 0.29 0.08 Yes 
2 79/121 29/40 16/35 17/34 16/36       0.56 0.13 Yes 
3 30/48 49/61 19/28 22/29 32/42       0.73 0.07 Yes 
  
eri-8 
(gg100) 
0.1 6/90 12/120 24/123 11/120 33/128 17/120 10/80 0/20 0/20 0/20 0/20 0/20 0.08 0.09  
0.5 51/134 54/130 54/120 43/105 59/133 41/95 36/117 10/90 0/90 2/90 12/32  0.30 0.17 Yes 
1 76/164 84/188 94/193 48/142 100/181 34/88 5/11 38/79 14/52 3/18 4/19 9/19 0.39 0.12 Yes 
2 66/135 59/126 6/12 33/55 33/54 23/32 24/39 22/32     0.59 0.09 Yes 
3 34/44 29/34 29/39 24/32 39/48        0.79 0.05 Yes 
  
eri-9 
(gg106) 
0.1 7/90 5/69 2/56 0/20 0/20 0/20 0/20 0/20   0.02 0.03  
0.5 90/202 51/154 32/143 49/130 57/124 32/80 42/105 11/34 19/45 6/22 0.37 0.08 Yes 
1 17/29 33/52 31/48 19/28 33/45      0.66 0.05 Yes 
2 65/128 103/181 86/172 46/52 53/60 48/57 32/42 24/39   0.70 0.17 Yes 
3 40/44 54/58 7/8 6/7 23/29      0.87 0.05 Yes 
  
eri-11 
(gg99)  
0.1 6/95 2/107 16/132 13/97 16/75 3/90 11/105 0/20 0/20 0/20 0/20 0/20 0.06 0.07  
0.5 68/170 72/188 52/153 25/91 37/96 37/118 19/112 5/20 7/20 3/22 0/20 13/50 0.27 0.12 Yes 
1 74/189 68/139 25/38 16/27 12/24 15/31 21/36      0.53 0.09 Yes 
2 3/5 6/8 26/32 15/19 32/38        0.76 0.09 Yes 
3 17/22 7/9 20/24 13/24 32/43        0.73 0.11 Yes 
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Single L3-stage larvae were placed on RNAi food targeting dpy-11; 4 days later, the percent of 
progeny showing the expected severe dumpiness, in which an animal’s length is at most three 
times its width, at each indicated concentration (OD at 600 nm) of initial bacterial culture were 
determined. For clarity, one bacterial culture concentration (OD600nm of 4), which produced 
similar Eri penetrances as adjacent concentrations, is not included. The tabulated mean (Avg) 
and standard deviation (SD) for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.5: Dilution series of Eri responses by RNAi feeding against dpy-11 
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Table 2.5 (Continued): Dilution series results for dpy-11 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.05 0/20 0/20 0/40 1/70 0/20 0/20 0/20 0 0.01  
0.1 0/20 0/60 0/20 0/20 0/20 0/20 1/45 0 0.01  
0.5 4/78 16/78 8/49 6/38 3/20 11/27 4/30 0.18 0.11  
1 27/43 13/20 18/28 13/27 13/25 29/59 14/29 0.56 0.08  
3 41/42 36/38 14/19 20/20 20/20 18/20 29/31 0.93 0.09  
  
eri-1 
(mg366) 
0.05 
*Best* 
9/38 14/32 11/47 9/30 4/31 7/47 12/37 0.26 0.11 Yes 
0.1 6/62 15/75 19/29 20/44 22/49 5/16 9/29 0.35 0.18 Yes 
0.5** 39/49 51/54 49/50 20/20 63/75 20/20 20/20 0.94 0.08 Yes 
1** 20/20 20/20 20/20 20/20 40/40 20/20 20/20 1.00 0 Yes 
3 20/20 20/20 20/20 20/20 59/60 20/20 20/20 1.00 0.01  
  
rrf-3 
(pk1426)  
0.05 2/30 2/41 4/57 4/47 3/53 5/52 7/46 0.08 0.03 Yes 
0.1 31/82 35/96 9/35 14/46 11/32 14/39 10/28 0.34 0.04 Yes 
0.5 38/53 26/27 20/20 20/20 20/20 20/20  0.95 0.11 Yes 
1 20/20 20/20 30/30 20/20 20/21 20/20  0.99 0.02 Yes 
3 20/20 20/20 20/20 20/20 20/20 20/20  1.00 0  
  
eri-3 
(tm1361) 
0.05 3/29 2/32 9/52 6/41 3/30 5/52 9/66 0.12 0.04 Yes 
0.1 5/25 6/74 14/60 11/35 23/71 9/39 7/39 0.22 0.08 Yes 
0.5 36/52 32/43 15/22 27/34 15/24 18/23 24/29 0.74 0.07 Yes 
1 20/20 20/20 20/20 20/20 29/30 20/20 20/20 1.00 0.01 Yes 
3 20/20 20/20 20/20 20/20 59/60 20/20 20/20 1.00 0.01  
  
eri-5 
(tm1705)  
0.05 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0  
0.1 0/60 0/60 0/28 0/20 0/20 0/30 0/20 0 0  
0.5 18/69 10/74 11/34 7/25 10/28 14/37 13/40 0.29 0.08  
1 15/29 25/40 11/38 11/19 12/26 14/40 15/31 0.47 0.12  
3 79/80 80/80 20/20 20/20 20/20 39/40 54/60 0.98 0.04  
  
eri-6/7 
(tm1917) 
0.05 2/40 0/20 0/20 9/70 3/30 0/20 7/40 0.06 0.07  
0.1 0/8 16/35 8/35 7/27 9/27 6/24 9/29 0.26 0.14 Yes 
0.5 27/43 27/35 20/20 20/20 30/35 20/20 40/45 0.88 0.14 Yes 
1 20/20 20/20 60/60 30/30 39/40 77/80 20/20 0.99 0.02 Yes 
3 42/42 18/19 20/20 20/20 20/20 20/20 20/20 0.99 0.02  
  
eri-8 
(gg100)  
0.05 3/21 3/17 10/39 8/27 3/19 6/28 7/34 0.21 0.05 Yes 
0.1 4/79 29/107 3/14 15/18 8/18 13/31 6/24 0.35 0.25 Yes 
0.5 65/82 44/58 20/20 20/20 20/20 20/20 36/40 0.92 0.11 Yes 
1 20/20 20/20 20/20 39/40 20/20 20/20 69/70 0.99 0.01 Yes 
3 20/20 20/20 20/20 20/20 20/20 20/20 20/20 1.00 0  
  
eri-9 
(gg106)
0.05 
 
*Best* 
9/24 8/21 6/29 4/15 2/35 11/34 17/37 0.30 0.13 Yes 
0.1 19/84 4/73 12/21 23/33 20/34 13/26 24/38 0.47 0.24 Yes 
0.5** 50/59 38/38 20/20 19/20 20/20 20/20 40/40 0.97 0.06 Yes 
1** 20/20 20/20 20/20 74/80 20/20 20/20 20/20 0.99 0.03 Yes 
3 20/20 20/20 20/20 20/20 20/20 20/20 20/20 1.00 0  
  
eri-11 
(gg99)  
0.05 5/19 5/25 4/25 3/20 2/18 3/25 7/34 0.17 0.05 Yes 
0.1 14/98 4/22 4/21 6/18 8/19 5/18 3/21 0.24 0.11 Yes 
0.5 27/37 20/26 20/20 20/20 20/20 20/20 48/53 0.91 0.12 Yes 
1 16/20 20/20 20/20 20/20 20/20 20/20 20/20 0.97 0.08 Yes 
3 20/20 20/20 20/20 20/20 20/20 20/20 20/20 1.00 0  
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Single L3-stage larvae were placed on RNAi food targeting dpy-13; 4 days later, the percent of 
progeny showing the expected severe dumpiness, in which an animal’s length is at most three 
times its width, at each indicated concentration (OD at 600 nm) of initial bacterial culture were 
determined. For clarity, four bacterial culture concentrations (OD600nm of 0.01, 0.02, 1.5, and 4), 
which produced similar Eri penetrances as adjacent concentrations, are not included. The 
tabulated mean (Avg) and standard deviation (SD) for N2 wild type were used as the basis to 
indicate an Eri or a Rde phenotype (Eri?), with p<0.05 as the criterion to denote significant 
difference from wild type response levels. A strain which fits the “best eri” criterion described in 
text is marked as “best”, with asterisks indicating concentrations of RNAi food at which it 
fulfilled the criterion. 
Table 2.6: Dilution series of Eri responses by RNAi feeding against dpy-13 
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Table 2.6 (Continued): Dilution series results for dpy-13 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.04 0/20 0/20 0/20 0/20 0/20 0/20 0/20   0 0  
0.1 0/20 0/20 0/20 0/20 0/20 1/37 0/20   0 0.01  
0.25 0/20 0/20 0/20 0/20 0/20 0/20 0/20   0 0  
0.75 0/20 0/20 0/20 0/20 1/105 0/20 0/20   0 0.01  
3 5/98 22/122 4/84 14/165 4/131 4/103 1/112 3/119 6/116 0.06 0.05  
  
eri-1 
(mg366) 
0.04 
*Best* 
0/12 0/8 0/36 0/73 0/20 0/20 0/20   0 0  
0.1 4/46 12/30 8/68 36/68 35/60 13/82 22/54 31/50  0.36 0.22 Yes 
0.25 17/28 44/44 9/19 67/78 60/73 4/5 20/20 20/20 20/20 0.84 0.19 Yes 
0.75** 34/35 20/20 58/60 51/51 20/20 20/20 20/20   0.99 0.02 Yes 
3** 9/9 6/6 12/12 58/58 20/20 20/22 20/20   0.99 0.03 Yes 
  
rrf-3 
(pk1426)  
0.04 0/20 0/20 0/20 0/20 0/20 0/20    0 0  
0.1 0/20 0/20 0/20 7/62 10/96 2/44 4/54 2/50 2/61 0.05 0.04 Yes 
0.25 3/58 6/57 80/115 71/78 37/48 25/56 38/65 23/61  0.49 0.31 Yes 
0.75 51/80 36/56 43/100 44/45 20/20 20/20 66/70 56/57 58/59 0.84 0.21 Yes 
3 67/67 20/20 42/44 20/20 20/20 20/20 20/20   0.99 0.02 Yes 
  
eri-3 
(tm1361) 
0.04 0/20 0/20 0/20 0/20 0/20 0/20    0 0  
0.1 3/62 0/55 3/77 13/88 5/80 3/44 1/14 7/55  0.07 0.05 Yes 
0.25 6/52 3/54 6/52 22/54 38/51 32/87 41/74 17/64 24/58 0.34 0.23 Yes 
0.75 37/75 64/80 48/81 76/89 87/94 94/101 62/84 86/90 43/52 0.79 0.16 Yes 
3 62/67 80/85 48/49 20/20 20/20 20/20    0.97 0.03 Yes 
  
eri-5 
(tm1705) 
0.04 0/20 0/20 0/20 0/20 0/20 0/20 0/20  0 0  
0.1 0/20 0/20 0/20 0/20 0/27 0/20   0 0  
0.25 0/20 0/20 0/20 0/20 0/20 0/20 0/20  0 0  
0.75 0/52 0/67 0/42 0/20 0/20 0/20 2/50  0.01 0.02  
3 3/80 2/67 8/90 17/95 11/80 6/61 24/88 10/103 0.12 0.08  
  
eri-6/7 
(tm1917) 
0.04 0/25 0/22 0/20 0/20 0/20     0 0  
0.1 2/63 1/60 1/84 3/74 0/58 1/82 0/20   0.02 0.02  
0.25 1/60 4/56 2/51 23/101 29/129 33/144 22/111 8/81 17/95 0.14 0.09 Yes 
0.75 102/103 30/87 75/102 71/80 136/154 94/105 125/155 80/126 70/137 0.74 0.21 Yes 
3 94/96 88/91 61/70 20/20 96/100     0.96 0.05 Yes 
  
eri-8 
(gg100) 
0.04 0/29 0/33 1/120 0/20 0/20 2/100    0 0.01  
0.1 2/68 1/86 0/70 8/101 20/113 16/82 9/99 1/85  0.07 0.08  
0.25 6/106 4/83 11/72 82/100 49/94 52/94 110/131 91/128 36/37 0.52 0.35 Yes 
0.75 55/60 57/80 52/57 118/120 117/120 20/20 20/20 114/161 20/20 0.91 0.12 Yes 
3 102/105 77/81 99/106 20/20 99/100     0.97 0.03 Yes 
  
eri-9 
(gg106) 
0.04 0/64 0/55 0/57 0/20 0/20     0 0  
0.1 0/67 0/58 0/49 5/76 8/86 3/109 8/103 2/63 5/74 0.04 0.04  
0.25 7/79 10/106 4/79 24/126 39/109 35/108 22/131 14/98 68/122 0.22 0.16 Yes 
0.75 76/114 81/108 82/130 20/20 20/20 103/108 116/120 80/95 95/103 0.86 0.14 Yes 
3 95/100 74/78 89/94 20/20 99/100     0.97 0.03 Yes 
  
eri-11 
(gg99) 
0.04 
*Best* 
0/20 0/20 0/20 4/77 2/70 0/20 0/20   0.01 0.02  
0.1 4/85 9/77 6/65 55/64 53/83 39/75 3/80 1/80  0.29 0.33  
0.25 53/72 40/60 37/58 67/97 77/95 45/67 57/91 54/73 35/60 0.68 0.07 Yes 
0.75** 20/20 20/20 125/130 20/20 20/20 99/100 56/60 73/76  0.98 0.03 Yes 
3** 20/20 94/100 20/20 20/20 20/20 20/20 20/20 98/100 20/20 0.99 0.02 Yes 
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Single L1-stage larvae were placed on RNAi food targeting fkh-6; 5 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.25 and 0.5), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.7: Dilution series of Eri responses by RNAi feeding against fkh-6 
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Table 2.7 (Continued): Dilution series results for fkh-6 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.002 207 230 208 233 220  220 12 0.03 0.10  
0.01 200 184 232 184 248 240 215 29 0.05 0.15  
0.02 120 224 160 232 272 176 197 55 0.13 0.26  
0.04 167 128 103 55 106 80 107 39 0.53 0.18  
0.1 2 4 7 4 59 0 13 23 0.94 0.10  
   
eri-1 
(mg366)  
0.002 46 67 25 42 56  47 16 0.70 0.10 Yes 
0.01 57 37 43 31 24 22 36 13 0.77 0.08 Yes 
0.02 38 21 1 27 23 22 22 12 0.86 0.08 Yes 
0.04 0 38 55 35 6 33 28 21 0.82 0.13 Yes 
0.1 3 0 6 28 8 4 8 10 0.95 0.06  
   
rrf-3 
(pk1426)
0.002 
 
*Best* 
36 33 21 19 41 23 29 9 0.78 0.07 Yes 
0.01** 14 18 29 16 10 43 22 12 0.84 0.09 Yes 
0.02** 27 13 0 28 30 17 19 12 0.86 0.09 Yes 
0.04** 20 16 5 22 18 0 14 9 0.90 0.07 Yes 
0.1** 0 0 13 0 0 0 2 5 0.98 0.04  
   
eri-3 
(tm1361)  
0.002 112 171 140 128 108 148 135 24 0.14 0.17  
0.01 120 125 88 104 42 68 91 32 0.41 0.21 Yes 
0.02 15 96 15 41 46 15 38 32 0.76 0.20 Yes 
0.04 68 43 45 37 31 1 38 22 0.76 0.14 Yes 
0.1 26 2 16 0 0 9 9 10 0.94 0.07  
   
eri-5 
(tm1705)  
0.002 152 154 192 184 203  177 23 0 0.17  
0.01 188 199 184 205 152 167 183 20 0 0.16  
0.02 148 120 112 114 125 137 126 14 0.26 0.11  
0.04 70 97 71 79 112 84 86 16 0.50 0.11  
0.1 1 17 5 3 33 4 11 12 0.94 0.07  
   
eri-6/7 
(tm1917)  
0.002 184 156 184 160 148  166 17 0 0.14  
0.01 75 90 144 160 88 168 121 41 0.22 0.27  
0.02 192 160 64 45 92  111 63 0.29 0.41  
0.04 80 58 27 81 105 20 62 33 0.60 0.22  
0.1 0 0 0 0 0 0 0 0 1.00 0  
   
eri-8 
(gg100)  
0.002 215 162 162 182 160 152 172 23 0.23 0.11 Yes 
0.01 148 160 203 154 159 158 164 20 0.26 0.09 Yes 
0.02 162 92 112 152 192 136 141 36 0.37 0.16  
0.04 136 128 144 120 120 125 129 10 0.42 0.05  
0.1 1 7 20 1 0 0 5 8 0.98 0.04  
   
eri-9 
(gg106) 
0.002 208 217 188 272 211 216 219 28 0.09 0.13  
0.01 175 216 180 184 171 153 180 21 0.25 0.10 Yes 
0.02 184 248 224 205 153 168 197 36 0.18 0.16  
0.04 32 136 200 168 154 198 148 62 0.38 0.26  
0.1 0 39 0 7 46 3 16 21 0.93 0.09  
   
eri-11 
(gg99)  
0.002 216 224 270 233 312  251 40 0.08 0.16  
0.01 109 82 115 120 192 152 128 38 0.53 0.14 Yes 
0.02 86 85 156 160 64 96 108 40 0.61 0.15 Yes 
0.04 140 76 108 9 35 30 66 51 0.76 0.19  
0.1 1 0 0 1 39 4 8 16 0.97 0.06 Yes 
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Single L1-stage larvae were placed on RNAi food targeting gon-1; 5 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, one bacterial culture concentration (OD600nm 
of 0.1), which produced similar Eri penetrances as adjacent concentrations, is not included. The 
tabulated mean (Avg) and standard deviation (SD) were normalized to the brood sizes of each 
strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) and standard 
error of the mean (SEM). The normalized mean and the standard error of the mean for N2 wild 
type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 as the 
criterion to denote significant difference from wild type response levels. A strain which fits the 
“best eri” criterion described in text is marked as “best”, with asterisks indicating concentrations 
of RNAi food at which it fulfilled the criterion. 
Table 2.8: Dilution series of Eri responses by RNAi feeding against gon-1 
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Table 2.8 (Continued): Dilution series results for gon-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.25 238 259 208 160 216 240 168 213 37 0.06 0.19  
0.5 208 192 162 120 246 208 171 187 40 0.18 0.19  
1 66 59 101 166 160 150 152 122 46 0.46 0.21  
2 35 75 120 132 138 118  103 40 0.55 0.18  
3 4 19 28 21 39 60 0 24 21 0.89 0.09  
   
eri-1 
(mg366)
0.25 
 
*Best* 
102 72 20 32 43 11  47 34 0.71 0.22 Yes 
0.5 2 4 11 42 25 2  14 16 0.91 0.10 Yes 
1** 0 5 14 1 1 3 9 5 5 0.97 0.03 Yes 
2** 1 2 1 10 3 11 1 4 4 0.97 0.03 Yes 
3** 4 3 1 0 20 20 2 7 9 0.95 0.06  
   
rrf-3 
(pk1426)
0.25 
 
*Best* 
54 40 43 0 11 13  27 22 0.80 0.16 Yes 
0.5 53 31 40 15 8 2 11 23 19 0.83 0.14 Yes 
1** 1 0 0 1 1 11 2 2 4 0.98 0.03 Yes 
2** 1 5 1 0 1 18 2 4 6 0.97 0.05 Yes 
3** 0 0 0 0 0 2 0 0 1 1.00 0.01 Yes 
   
eri-3 
(tm1361)  
0.25 44 61 4 72 40 64  48 25 0.70 0.16 Yes 
0.5 95 72 5 49 37 18  46 34 0.70 0.22 Yes 
1 74 42 8 39 80 30  46 27 0.71 0.18 Yes 
2 54 64 8 36 33 13  35 22 0.78 0.14 Yes 
3 5 4 2 1 1 0 0 2 2 0.99 0.01 Yes 
   
eri-5 
(tm1705)  
0.25 152 144 166 168 125 136  149 17 0.13 0.13  
0.5 144 126 137 90 128   125 21 0.27 0.14  
1 11 78 1 78 87   51 41 0.70 0.24  
2 100 10 2 28 82 76 66 52 38 0.69 0.23  
3 1 1 1 40 0   9 18 0.95 0.10  
   
eri-6/7 
(tm1917)  
0.25 97 139 188 70 104 99  116 42 0.25 0.27  
0.5 141 190 86 92 88 80 99 111 40 0.29 0.27  
1 1 26 30 40 64 98 64 46 32 0.70 0.21  
2 1 0 0 0 9 1 1 2 3 0.99 0.02 Yes 
3 0 2 2 2 1 2 2 2 1 0.99 0.01 Yes 
   
eri-8 
(gg100)  
0.25 192 162 184 96 144   156 38 0.30 0.17 Yes 
0.5 64 108 30 81 54 47 97 69 28 0.69 0.13 Yes 
1 2 0 4 80 56 43 52 34 32 0.85 0.14 Yes 
2 1 0 2 1 1 49 12 9 18 0.96 0.08 Yes 
3 30 0 1 0 2 3 0 5 11 0.98 0.05  
   
eri-9 
(gg106) 
0.25 144 160 148 88 97   127 33 0.47 0.14 Yes 
0.5 114 120 80 71 94   96 21 0.60 0.09 Yes 
1 4 0 1 63 104 42  36 42 0.85 0.18 Yes 
2 1 0 1 42 58 0  17 26 0.93 0.11 Yes 
3 0 1 0 8 23 2 57 13 21 0.95 0.09  
   
eri-11 
(gg99)  
0.25 102 112 112 57 120 144  108 29 0.61 0.11 Yes 
0.5 94 128 3 47 0 2  46 55 0.83 0.20 Yes 
1 1 60 62 46 47 85 87 55 29 0.80 0.11 Yes 
2 0 1 0 1 58 34 34 18 24 0.93 0.09 Yes 
3 1 0 34 0 0 0 0 5 13 0.98 0.05 Yes 
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Single L3-stage larvae were placed on RNAi food targeting gon-4; 5 days later, the percent of 
progeny showing the expected severely protruding or absent gonads at each indicated 
concentration (OD at 600 nm) of initial bacterial culture were determined. The tabulated mean 
(Avg) and standard deviation (SD) for N2 wild type were used as the basis to indicate an Eri or a 
Rde phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild 
type response levels. A strain which fits the “best eri” criterion described in text is marked as 
“best”, with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.9: Dilution series of Eri responses by RNAi feeding against gon-4 
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Table 2.9 (Continued): Dilution series results for gon-4 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.5 1/29 1/39 0/40 0/20 0/20 1/40  0.01 0.02  
1 0/22 0/18 2/43 0/20 2/40 0/20 1/30 0.02 0.02  
2 2/24 2/30 2/21 0/20 2/60   0.06 0.04  
3 6/19 5/24 1/18 5/56 0/47 2/28 5/64 0.12 0.11  
4 1/6 11/76 2/30 1/5 1/20   0.13 0.06  
  
eri-1 
(mg366)  
0.5 2/22 3/32 1/23 0/20 0/20 1/30 0.04 0.04  
1 9/18 6/30 3/28 0/20 0/20 2/12 0.16 0.19  
2 22/26 24/24 15/18 4/25 0/20 6/18 0.53 0.42 Yes 
3 34/47 17/17 28/32 5/12 7/17 7/21 0.63 0.28 Yes 
4 19/20 10/21 20/22 7/16 11/13  0.72 0.25 Yes 
  
rrf-3 
(pk1426) 
0.5 
*Best* 
2/20 1/20 0/20 1/30 1/13 0/20 0.04 0.04  
1 0/20 0/20 0/20 1/20 0/20 0/20 0.01 0.02  
2 21/40 21/25 18/32 11/19 0/20 17/40 0.49 0.28 Yes 
3 28/35 29/34 29/41 17/20 15/21 22/23 0.81 0.09 Yes 
4** 20/20 20/20 19/23 7/9 20/20 17/19 0.92 0.10 Yes 
  
eri-3 
(tm1361) 
0.5 0/20 1/20 1/16 0/20 1/24 0/20  0.03 0.03  
1 4/30 3/20 1/30 1/20 0/20 1/30  0.07 0.06  
2 9/20 17/31 19/31 10/20 18/55   0.49 0.11 Yes 
3 27/30 27/28 17/20 5/15 9/20 18/20  0.73 0.27 Yes 
4 33/35 21/25 32/35 26/30 12/14 39/50 26/35 0.85 0.07 Yes 
  
eri-5 
(tm1705)  
0.5 2/20 2/20 3/20 0/20 0/8 0/62 0/20 0.05 0.06  
1 3/40 6/50 0/20 0/20 0/20 1/40  0.04 0.05  
2 3/22 10/25 6/21 0/20 0/20 1/20 0/20 0.12 0.16  
3 3/15 8/24 8/34 4/39 0/20 0/20 11/56 0.15 0.12  
4 0/20 5/34 4/42 0/20 0/20 4/20 3/42 0.07 0.08  
  
eri-6/7 
(tm1917) 
0.5 2/33 2/26 2/43 0/20 0/20 1/40 1/50 0.03 0.03  
1 2/40 1/80 3/27 0/20 4/60 13/34 11/80 0.11 0.13  
2 3/31 2/22 6/30 2/40 14/90 11/80  0.12 0.05  
3 5/14 8/20 10/19 2/8 13/18 8/22  0.44 0.17 Yes 
4 11/20 7/9 16/19 21/29 3/8   0.65 0.19 Yes 
  
eri-8 
(gg100)  
0.5 0/20 0/20 1/40 0/20 2/40 0/20 0/20 0.01 0.02  
1 3/40 0/20 0/20 0/20 1/60 0/20 0/20 0.01 0.03  
2 15/45 24/46 13/33 0/20 1/11 0/20 0/20 0.19 0.22  
3 7/20 10/23 28/35 4/10 14/64 9/39  0.41 0.21 Yes 
4 8/12 9/19 19/24 12/15 5/8   0.67 0.13 Yes 
  
eri-9 
(gg106)  
0.5 1/60 1/20 0/20 0/20 1/20 0/20 0/20 0.02 0.02  
1 1/20 4/30 0/15 2/8 12/90 2/30  0.11 0.09  
2 14/17 11/15 15/19 11/19 20/35 30/65  0.66 0.14 Yes 
3 10/13 10/14 20/27 11/16 20/38   0.69 0.10 Yes 
4 24/35 24/36 20/25 10/14 11/15   0.72 0.05 Yes 
  
eri-11 
(gg99)  
0.5 0/20 1/40 1/40 0/20 0/20 1/30 0/20 0.01 0.02  
1 0/20 1/40 0/20 0/20 1/10 0/20  0.02 0.04  
2 7/55 14/56 6/32 11/30 8/28   0.24 0.09 Yes 
3 6/29 7/27 12/36 6/12 15/40   0.33 0.11 Yes 
4 7/14 19/20 20/22 6/20 7/31   0.58 0.34 Yes 
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Single L3-stage larvae were placed on RNAi food targeting act-5; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. The tabulated mean (Avg) and standard deviation (SD) 
were normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain 
the normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and 
the standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.10: Dilution series of Eri responses by RNAi feeding against act-5 
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Table 2.10 (Continued): Dilution series results for act-5 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.001 288 264 248 216 224 198  240 32 0 0.18  
0.002 175 160 157 166 94 134 172 151 29 0.33 0.14  
0.005 112 118 71 61 69 118 66 88 27 0.61 0.12  
0.01 79 97 76 82 118   90 17 0.60 0.09  
0.02 76 80 0 0 3 41  33 38 0.85 0.17  
   
eri-1 
(mg366) 
0.001 99 108 81 85 107 102  97 11 0.39 0.08 Yes 
0.002 57 91 97 50 44 65 59 66 20 0.58 0.13 Yes 
0.005 65 77 23 41 24 86 65 54 25 0.66 0.16  
0.01 18 29 26 23 25   24 4 0.85 0.03 Yes 
0.02 1 0 4 21 0 8  6 8 0.96 0.05  
   
rrf-3 
(pk1426)
0.001 
 
*Best* 
66 85 89 76 115 88  87 16 0.35 0.13 Yes 
0.002 1 8 39 0 15 12 18 13 13 0.90 0.10 Yes 
0.005** 0 0 1 26 0 1 5 5 10 0.96 0.07 Yes 
0.01** 30 5 0 0 1 1 6 6 11 0.95 0.08 Yes 
0.02** 0 1 0 2 0 1 0 1 1 1.00 0.01 Yes 
   
eri-3 
(tm1361) 
0.001 47 84 51 80 69   66 17 0.57 0.11 Yes 
0.002 52 74 30 42 31 41 62 47 16 0.70 0.11 Yes 
0.005 40 18 26 6 40 54 27 30 16 0.81 0.10 Yes 
0.01 12 8 25 22 18 25  18 7 0.88 0.05 Yes 
0.02 0 2 1 1 22 14 15 8 9 0.95 0.06  
   
eri-5 
(tm1705)  
0.001 192 168 180 164 204   182 17 0 0.15  
0.002 168 87 142 164 134 144  140 29 0.18 0.19  
0.005 73 92 108 93 78   89 14 0.48 0.10  
0.01 114 17 17 69 92 89  66 41 0.61 0.24  
0.02 55 39 0 0 0 18 3 16 22 0.90 0.13  
   
eri-6/7 
(tm1917) 
0.001 158 151 189 157 144   160 17 0 0.14  
0.002 85 90 61 109 119   93 23 0.40 0.15  
0.005 40 99 111 55 46   70 32 0.55 0.21  
0.01 17 3 20 11 26   15 9 0.90 0.06 Yes 
0.02 1 7 8 32 0 42 5 14 17 0.91 0.11  
   
eri-8 
(gg100)  
0.001 144 120 104 148 168 256 153 156 49 0.30 0.22 Yes 
0.002 57 78 154 97 97 125  101 34 0.54 0.15 Yes 
0.005 34 82 103 38 95 29 74 65 31 0.71 0.14  
0.01 28 1 38 16 17   20 14 0.91 0.06 Yes 
0.02 1 67 37 0 9 27 0 20 25 0.91 0.11  
   
eri-9 
(gg106) 
0.001 128 128 138 103 125   124 13 0.48 0.06 Yes 
0.002 125 118 99 69 109 110 95 104 18 0.57 0.08 Yes 
0.005 42 140 84 97 47 100  85 37 0.65 0.15  
0.01 18 0 0 1 1 1  4 7 0.99 0.03 Yes 
0.02 81 0 1 1 0 25 21 18 30 0.92 0.12  
   
eri-11 
(gg99) 
0.001 128 216 152 232 140 168 212 178 41 0.35 0.16 Yes 
0.002 75 111 99 88 98 176  108 36 0.61 0.13 Yes 
0.005 68 62 71 18 52 122 97 70 33 0.74 0.12  
0.01 11 0 88 85 55 22  44 38 0.84 0.14 Yes 
0.02 0 16 1 4 1 31 29 12 14 0.96 0.05  
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Single L3-stage larvae were placed on RNAi food targeting gtl-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.01 and 0.02), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.11: Dilution series of Eri responses by RNAi feeding against gtl-1 
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Table 2.11 (Continued): Dilution series results for gtl-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.04 216 216 207 162 189 200 192 197 19 0.13 0.12  
0.1 190 220 240 224 64 112 128 168 67 0.26 0.30  
0.5 224 210 232 207 189 180 187 204 20 0.10 0.12  
1 204 168 160 128 144 84 88 139 43 0.38 0.20  
2 189 168 160 22 28 40 52 94 74 0.58 0.33  
   
eri-1 
(mg366) 
0.04 192 144 76 80 136 112 176 131 45 0.17 0.29  
0.1 144 96 104 81 88 80 72 95 24 0.40 0.16  
0.5 128 104 128 56 72 64 79 90 30 0.43 0.19 Yes 
1 36 7 60 37 13 35 35 32 17 0.80 0.11 Yes 
2 40 48 45 48 54 39 40 45 6 0.72 0.04  
   
rrf-3 
(pk1426)
0.04 
 
*Best* 
36 77 62 65 108 65 71 69 21 0.48 0.16 Yes 
0.1 49 42 63 38 63 73 62 56 13 0.58 0.10 Yes 
0.5 39 45 54 40 24 34 45 40 9 0.70 0.07 Yes 
1** 19 8 16 30 30 0 28 19 12 0.86 0.09 Yes 
2** 7 16 8 22 15 18 38 18 10 0.87 0.08 Yes 
   
eri-3 
(tm1361)  
0.04 152 128 135 88 112 102 68 112 29 0.28 0.20  
0.1 21 136 96 76 44 72 72 74 37 0.53 0.24  
0.5 25 95 15 68 6 72 40 46 33 0.71 0.21 Yes 
1 80 27 56 20 15 35 20 36 24 0.77 0.15 Yes 
2 20 45 17 40 32 40 10 29 13 0.81 0.09  
   
eri-5 
(tm1705)  
0.04 184 240 231 168 216 153 160 193 36 0 0.24  
0.1 174 176 200 128 112 128 144 152 32 0.11 0.21  
0.5 204 210 176 88 184 160 125 164 44 0.04 0.28  
1 148 94 141 84 81 72 96 102 30 0.40 0.19  
2 152 144 182 52 48 44 42 95 61 0.44 0.37  
   
eri-6/7 
(tm1917)  
0.04 60 76 75 176 136 184 202 130 59 0.16 0.39  
0.1 47 43 74 61 62 104 90 69 22 0.56 0.15 Yes 
0.5 44 36 84 82 79 100 67 70 23 0.55 0.15 Yes 
1 16 20 22 65 34 42 17 31 18 0.80 0.12 Yes 
2 4 9 22 29 21 9 15 16 9 0.90 0.06 Yes 
   
eri-8 
(gg100)  
0.04 120 136 85 137 88 104 120 113 21 0.49 0.10 Yes 
0.1 104 112 114 52 51 82  86 29 0.61 0.13 Yes 
0.5 44 44 68 68 79 72 80 65 15 0.71 0.07 Yes 
1 39 28 23 42 43 64 27 38 14 0.83 0.06 Yes 
2 12 20 20 12 17 14 24 17 5 0.92 0.02 Yes 
   
eri-9 
(gg106) 
0.04 232 296 248 128 160 120 152 191 68 0.20 0.29  
0.1 48 246 120 50 64 100 81 101 69 0.58 0.29  
0.5 144 175 128 64 80 104  116 41 0.52 0.17 Yes 
1 32 39 49 84 72 68 98 63 24 0.74 0.10 Yes 
2 16 19 32 14 20 25 14 20 7 0.92 0.03 Yes 
   
eri-11 
(gg99)
0.04 
 
*Best* 
192 160 196 120 104 104 192 153 42 0.44 0.16 Yes 
0.1 98 168 128 96 72 90 88 106 32 0.61 0.12 Yes 
0.5 80 96 104 48 56 104 60 78 24 0.71 0.09 Yes 
1** 70 72 68 20 45 9 41 46 25 0.83 0.09 Yes 
2** 35 43 85 21 28 14 16 35 25 0.87 0.09 Yes 
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Single L3-stage larvae were placed on RNAi food targeting act-3; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 0.1, 0.25, and 0.5), which produced similar Eri penetrances as adjacent 
concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) were 
normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the 
normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and the 
standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.12: Dilution series of Eri responses by RNAi feeding against act-3 
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Table 2.12 (Continued): Dilution series results for act-3 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.002 200 208 232 200 192 216  208 14 0.08 0.10  
0.005 206 234 198 184 210 208  207 16 0.09 0.11  
0.01 176 216 207 203 180 210 216 201 17 0.11 0.11  
0.02 230 234 54 165 80 204 154 160 71 0.29 0.32  
0.05 9 19 28 6 9 58 18 21 18 0.91 0.08  
   
eri-1 
(mg366) 
0.002 132 144 148 120 136 104 136 131 15 0.17 0.11  
0.005 24 53 132 102 84 90 82 81 35 0.49 0.22 Yes 
0.01 36 63 57 34 69 37 88 55 20 0.65 0.13 Yes 
0.02 2 5 32 5 37 77 0 23 28 0.86 0.18 Yes 
0.05 0 4 0 1 0 12 0 2 4 0.98 0.03  
   
rrf-3 
(pk1426)
0.002 
 
*Best* 
200 56 116 78 117 129 112 115 45 0.13 0.34  
0.005 65 28 49 93 67 104 88 71 27 0.47 0.20 Yes 
0.01 17 31 39 66 21 18 23 31 17 0.77 0.13 Yes 
0.02** 2 19 2 0 0 0 0 3 7 0.98 0.05 Yes 
0.05** 0 0 0 0 1 0 0 0 0 1.00 0 Yes 
   
eri-3 
(tm1361)  
0.002 73 32 128 133 104 94 89 93 34 0.40 0.23 Yes 
0.005 40 31 33 101 58 66 100 61 30 0.61 0.19 Yes 
0.01 59 43 37 89 83 39 66 59 21 0.62 0.14 Yes 
0.02 46 9 8 0 59 16 1 20 23 0.87 0.15 Yes 
0.05 0 0 0 0 62 39 0 14 26 0.91 0.16  
   
eri-5 
(tm1705)  
0.002 222 203 116 176 144 150 168 168 36 0.01 0.23  
0.005 180 188 210 200 126 140 130 168 35 0.02 0.23  
0.01 123 116 136 144 152 112  131 16 0.23 0.12  
0.02 148 72 36 41 133 28  76 52 0.55 0.31  
0.05 0 3 21 26 12 4  11 11 0.94 0.06  
   
eri-6/7 
(tm1917) 
0.002 184 168 31 115 128 62 71 108 57 0.30 0.37  
0.005 189 147 55 114 61 115 114 114 47 0.27 0.31  
0.01 135 34 64 88 16 27 104 67 44 0.57 0.29 Yes 
0.02 81 3 4 2 3 1 2 14 30 0.91 0.19 Yes 
0.05 1 0 0 1 0 0 0 0 0 1.00 0 Yes 
   
eri-8 
(gg100) 
0.002 
*Best* 
272 264 112 160 128 96 136 167 72 0.25 0.32  
0.005 63 42 112 160 160 162 174 125 53 0.44 0.24 Yes 
0.01 121 69 144 56 72 51 128 92 38 0.59 0.17 Yes 
0.02** 34 2 1 1 11 15 35 14 15 0.94 0.07 Yes 
0.05** 0 1 1 0 1 1 3 1 1 1.00 0 Yes 
   
eri-9 
(gg106) 
0.002 205 192 180 170 190 192 66 171 47 0.29 0.20 Yes 
0.005 176 186 176 174 161 152 168 170 11 0.29 0.06 Yes 
0.01 164 56 141 156 174 210 155 151 47 0.37 0.20 Yes 
0.02 88 60 152 0 70 23 95 70 50 0.71 0.21 Yes 
0.05 1 28 1 12 4 5 0 7 10 0.97 0.04  
   
eri-11 
(gg99) 
0.002 195 224 188 232 276 152 216 212 39 0.23 0.15  
0.005 155 160 288 176 248 203 176 201 50 0.27 0.19  
0.01 138 152 152 160 208 162 41 145 51 0.47 0.19 Yes 
0.02 172 23 72 6 59 100 76 73 54 0.73 0.20 Yes 
0.05 5 0 8 17 16 12 46 15 15 0.95 0.05  
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Single L3-stage larvae were placed on RNAi food targeting myo-3; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 0.05, 0.1, and 0.25), which produced similar Eri penetrances as adjacent 
concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) were 
normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the 
normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and the 
standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.13: Dilution series of Eri responses by RNAi feeding against myo-3 
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Table 2.13 (Continued): Dilution series results for myo-3 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.5 241 205 164 170 228 181 226 202 31 0.11 0.16  
0.75 248 256 196 193 259 168 202 217 36 0.04 0.18  
1 220 230 201 183 147 129 127 177 43 0.22 0.20  
2 176 165 146 139 196 128 90 149 35 0.34 0.16  
3 102 91 69 94 65 78 106 86 16 0.62 0.08  
   
eri-1 
(mg366) 
0.5 92 98 68 74 85 55 58 76 17 0.52 0.11 Yes 
0.75 82 54 49 55 42 42 78 57 16 0.64 0.10 Yes 
1 13 58 9 25 18 19 40 26 17 0.84 0.11 Yes 
2 0 2 2 5 12 0  4 5 0.98 0.03 Yes 
3 0 0 0 1 0 0 0 0 0 1.00 0 Yes 
   
rrf-3 
(pk1426)
0.5 
 
*Best* 
74 58 68 18 42 55 19 48 22 0.64 0.17 Yes 
0.75 31 0 0 2 45 0 5 12 18 0.91 0.14 Yes 
1** 0 0 2 3 0 0 1 1 1 0.99 0.01 Yes 
2** 0 0 0 0 2 0 9 2 3 0.99 0.03 Yes 
3** 1 2 0 0 0 4 0 1 2 0.99 0.01 Yes 
   
eri-3 
(tm1361)  
0.5 105 122 78 105 84 100 99 99 15 0.36 0.11 Yes 
0.75 76 122 66 75 74 64 47 75 23 0.52 0.15 Yes 
1 12 95 94 69 29 24 90 59 36 0.62 0.24 Yes 
2 3 25 0 2 0 5 0 5 9 0.97 0.06 Yes 
3 0 0 0 0 0 1 0 0 0 1.00 0 Yes 
   
eri-5 
(tm1705)  
0.5 176 192 196 180 188 204  189 10 0 0.10  
0.75 174 118 176 180 130 120 112 144 31 0.15 0.31  
1 168 176 84 146 192 188  159 40 0.07 0.40  
2 166 167 168 76 144 132 132 141 33 0.17 0.33  
3 96 45 40 32 30 48 58 50 22 0.71 0.22  
   
eri-6/7 
(tm1917) 
0.5 196 186 206 218 180 206 196 198 13 0 0.13  
0.75 82 111 96 94 114 110 120 104 13 0.33 0.10 Yes 
1 104 49 106 46 106 80 101 85 27 0.46 0.18 Yes 
2 0 0 2 0 10 0 0 2 4 0.99 0.02 Yes 
3 0 0 0 2 0 0 1 0 1 1.00 0.01 Yes 
   
eri-8 
(gg100)  
0.5 238 216 222 216 196 184 206 211 18 0.05 0.09  
0.75 224 240 206 196 180 206  209 21 0.06 0.10  
1 112 120 96 80 76 86 90 94 16 0.58 0.07 Yes 
2 0 0 0 1 0 2 11 2 4 0.99 0.02 Yes 
3 0 0 1 2 0 0  1 1 1.00 0 Yes 
   
eri-9 
(gg106) 
0.5 264 272 240 232 232 222  244 20 0 0.10  
0.75 224 264 260 196 208 220 201 225 27 0.06 0.13  
1 11 160 90 5 60 40 55 60 53 0.75 0.22 Yes 
2 0 12 2 11 7 0 5 5 5 0.98 0.02 Yes 
3 1 3 0 0 0 0 1 1 1 1.00 0 Yes 
   
eri-11 
(gg99) 
0.5 272 230 216 224 230 270  240 24 0 0.11  
0.75 232 208 196 238 240 216 208 220 17 0 0.08  
1 156 181 144 144 106 134 98 138 29 0.50 0.11 Yes 
2 0 2 18 35 30 0 14 14 14 0.95 0.05 Yes 
3 0 0 0 5 0 5 6 2 3 0.99 0.01 Yes 
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Single L3-stage larvae were placed on RNAi food targeting unc-22; 4 days later, the percent of 
progeny showing the expected paralysis due to severe twitching at each indicated concentration 
(OD at 600 nm) of initial bacterial culture were determined. For clarity, two bacterial culture 
concentrations (OD600nm of 3 and 4), which produced similar Eri penetrances as adjacent 
concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) for N2 
wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 as the 
criterion to denote significant difference from wild type response levels. A strain which fits the 
“best eri” criterion described in text is marked as “best”, with asterisks indicating concentrations 
of RNAi food at which it fulfilled the criterion. 
Table 2.14: Dilution series of Eri responses by RNAi feeding against unc-22 
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Table 2.14 (Continued): Dilution series results for unc-22 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.1 3/28 3/18 1/16 5/31 0/13 3/25 1/17 0.10 0.06  
0.25 8/30 9/35 8/29 5/30 5/22 5/20  0.24 0.04  
0.5 8/31 8/36 10/28 8/27 8/27 8/30 11/26 0.30 0.07  
1 7/24 7/25 12/21 11/22 6/16 10/19 11/27 0.42 0.11  
2 26/31 27/36 22/26 25/27 29/36 26/29 28/33 0.84 0.06  
  
eri-1 
(mg366)  
0.1 3/26 3/35 1/22 4/32 2/27 0/30 2/19 0.08 0.04  
0.25 8/42 5/23 9/21 8/19 6/25 6/21 10/23 0.32 0.11  
0.5 18/33 27/33 8/17 19/41 26/37 19/34 19/22 0.63 0.16 Yes 
1 46/55 6/7 20/22 31/32 45/50 19/21 24/30 0.88 0.06 Yes 
2 47/50 37/39 20/20 20/20 19/20 48/50 18/20 0.96 0.04 Yes 
  
rrf-3 
(pk1426) 
0.1 
*Best* 
15/37 18/27 12/41 2/41 7/33 2/36 6/36 0.26 0.22  
0.25 20/32 27/37 36/48 24/31 18/24 30/35 34/36 0.78 0.10 Yes 
0.5** 36/41 51/58 37/41 46/51 32/34 39/46 44/44 0.91 0.05 Yes 
1** 31/33 45/49 20/20 46/50 20/20 20/20 19/21 0.95 0.04 Yes 
2** 54/56 20/20 20/20 40/40 20/20 46/47 20/20 0.99 0.01 Yes 
  
eri-3 
(tm1361) 
0.1 4/15 9/19 2/30 3/54 6/36 2/31 2/37 0.16 0.16  
0.25 3/30 5/24 5/24 5/31 9/40 10/35 6/31 0.20 0.06  
0.5 28/31 20/31 29/46 30/40 14/18 24/34 17/22 0.74 0.09 Yes 
1 42/46 48/52 40/42 20/20 19/20 20/20 31/33 0.95 0.03 Yes 
2 24/26 46/52 20/20 20/20 19/20 20/20 21/23 0.95 0.05 Yes 
  
eri-5 
(tm1705)  
0.1 3/28 3/37 2/28 4/30 5/47 4/35 3/26 0.10 0.02  
0.25 5/49 3/21 1/25 6/25 7/36 7/27 6/34 0.17 0.08  
0.5 4/33 11/48 19/39 8/29 10/19 4/37  0.29 0.18  
1 22/47 9/29 19/34 14/28 24/44 19/40 13/30 0.47 0.08  
2 37/47 26/38 27/30 19/23 20/22 24/27 46/49 0.85 0.09  
  
eri-6/7 
(tm1917) 
0.1 2/21 13/34 4/39 6/33 13/39 14/30 5/24 0.25 0.14 Yes 
0.25 14/42 15/37 17/36 10/19 6/20 14/29 11/24 0.43 0.08 Yes 
0.5 29/40 22/29 28/32 25/28 30/33 32/37  0.84 0.08 Yes 
1 51/55 20/20 39/40 78/80 30/30 20/20  0.98 0.03 Yes 
2 20/20 29/30 20/20 20/20 20/20 20/20 38/41 0.98 0.03 Yes 
  
eri-8 
(gg100)  
0.1 4/30 4/25 5/27 1/27 1/35 3/25  0.11 0.06  
0.25 9/22 11/31 6/23 14/34 8/18 5/16 10/27 0.37 0.06 Yes 
0.5 22/30 30/38 26/32 22/30 28/36 12/16 14/17 0.77 0.04 Yes 
1 46/49 44/47 20/20 20/20 37/40 63/69 19/20 0.95 0.03 Yes 
2 17/18 23/25 58/60 20/20 68/70 28/29 20/20 0.97 0.03 Yes 
  
eri-9 
(gg106)  
0.1 5/38 3/34 1/22 0/22 1/14 1/19 1/17 0.06 0.04  
0.25 3/14 3/20 4/21 3/16 14/28 12/30 8/29 0.27 0.13  
0.5 12/22 18/27 20/26 20/27 14/19 29/37 14/19 0.71 0.08 Yes 
1 10/11 37/41 37/41 20/20 20/20 70/72 31/32 0.95 0.04 Yes 
2 51/56 44/46 20/20 20/20 44/47 40/40 20/20 0.97 0.04 Yes 
  
eri-11 
(gg99)  
0.1 6/37 12/26 2/31 8/33 6/26 6/21 6/31 0.23 0.12 Yes 
0.25 13/37 9/29 6/18 11/21 11/30 12/19 10/30 0.41 0.12 Yes 
0.5 13/18 10/19 22/30 18/29 31/33 17/22 20/26 0.73 0.13 Yes 
1 10/24 18/23 22/23 41/42 20/20 17/20  0.83 0.22 Yes 
2 29/33 37/41 38/40 37/42 20/20 20/20 69/72 0.94 0.05 Yes 
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Single L3-stage larvae were placed on RNAi food targeting hbl-1; 4 days later, the percent of 
progeny showing the expected paralysis at each indicated concentration (OD at 600 nm) of initial 
bacterial culture were determined. For clarity, two bacterial culture concentrations (OD600nm of 
0.02 and 0.5), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) for N2 wild type were used as 
the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 as the criterion to denote 
significant difference from wild type response levels. A strain which fits the “best eri” criterion 
described in text is marked as “best”, with asterisks indicating concentrations of RNAi food at 
which it fulfilled the criterion. 
Table 2.15: Dilution series of Eri responses by RNAi feeding against hbl-1 
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Table 2.15 (Continued): Dilution series results for hbl-1 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.1 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0  
0.25 0/20 0/20 2/78 1/98 0/62 0/20   0.01 0.01  
0.75 0/20 2/100 1/100 12/89 16/104 16/83 1/80 4/90 0.07 0.08  
1.5 5/95 6/80 4/83 43/110 14/93 17/81 12/124 16/135 0.14 0.11  
3 16/59 15/76 22/91 24/105 23/109 34/108 46/143 21/140 0.24 0.06  
  
eri-1 
(mg366)  
0.1 3/50 2/50 0/50 0/20 0/20 0/20 3/74 1/56 0.02 0.02  
0.25 7/62 10/44 0/20 6/90 2/50 68/71 20/60  0.25 0.33  
0.75 8/13 13/33 34/53 24/67 20/20 17/21 16/29 17/33 0.61 0.21 Yes 
1.5 11/14 37/45 25/27 74/78 84/88 65/100 37/41 21/32 0.83 0.12 Yes 
3 17/22 8/10 6/8 51/56 69/75 46/50 48/70 14/16 0.83 0.09 Yes 
  
rrf-3 
(pk1426) 
*Best*
0.1 
  
4/50 6/60 6/60 1/50 0/20 0/20 7/79  0.06 0.05  
0.25 15/38 16/52 16/75 13/82 10/72 26/64 12/54  0.26 0.11 Yes 
0.75 37/57 31/72 51/99 20/20 27/30 26/30 34/43 34/55 0.72 0.20 Yes 
1.5** 20/20 20/20 20/20 20/20 28/30 20/20 33/35 27/29 0.98 0.03 Yes 
3** 20/20 20/20 20/20 20/20 20/20 20/20 20/20  1.00 0 Yes 
  
eri-3 
(tm1361) 
0.1 9/81 1/15 5/78 0/20 5/80 0/20 3/68 4/60 0.05 0.04  
0.25 12/56 13/38 11/58 0/53 9/77 14/79 20/73 19/80 0.19 0.10 Yes 
0.75 15/27 13/18 28/54 19/20 29/30 159/174 34/40 24/36 0.77 0.18 Yes 
1.5 20/20 20/20 20/20 20/20 20/20 145/155 20/20 20/20 0.99 0.02 Yes 
3 20/20 20/20 20/20 18/19 20/20 90/127 20/20 20/20 0.96 0.10 Yes 
  
eri-5 
(tm1705) 
0.1 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0  
0.25 0/20 0/20 0/20 0/20 0/20 0/20 2/50 1/50 0.01 0.01  
0.75 3/100 3/100 5/100 5/93 17/107 28/149 2/31 10/68 0.09 0.06  
1.5 19/107 20/100 23/81 9/111 1/12 8/79 16/50 15/46 0.20 0.10  
3 27/87 31/109 25/71 14/111 13/80 24/132 10/57 24/56 0.25 0.11  
  
eri-6/7 
(tm1917) 
0.1 9/66 0/20 1/50 3/50 1/50 1/15 1/58  0.05 0.06  
0.25 23/118 16/86 7/89 11/56 10/120 16/84 8/54 24/63 0.18 0.09 Yes 
0.75 23/89 5/69 28/59 20/20 59/82 79/90 36/50 20/20 0.64 0.34 Yes 
1.5 24/88 30/32 20/20 34/43 20/20 50/90 24/48 38/40 0.75 0.28 Yes 
3 20/20 20/20 20/20 73/80 20/20 28/30 20/20  0.98 0.04 Yes 
  
eri-8 
(gg100)
0.1 
 
*Best* 
3/100 9/100 7/150 4/70 5/150 1/90   0.04 0.03  
0.25 16/95 9/91 38/143 24/111 26/129 29/105 21/92  0.21 0.06 Yes 
0.75 20/21 20/21 27/27 138/148 28/30 43/47 48/104 68/98 0.86 0.18 Yes 
1.5** 20/20 20/20 20/20 26/29 20/20 27/29 20/20 140/150 0.97 0.04 Yes 
3** 20/20 20/20 20/20 20/20 20/20 78/89 20/20 20/20 0.98 0.04 Yes 
  
eri-9 
(gg106) 
0.1 5/100 5/100 6/100 0/20 0/20 0/20 0/53 0/20 0.02 0.03  
0.25 20/115 13/85 19/96 7/103 9/160 14/180 34/168 2/6 0.16 0.09 Yes 
0.75 67/78 57/91 39/97 117/147 116/166 96/121 35/124 40/87 0.61 0.21 Yes 
1.5 62/69 49/50 159/178 26/165 27/151 49/69 104/115  0.67 0.36 Yes 
3 22/22 14/14 99/100 81/135 47/50 20/20 96/103  0.92 0.15 Yes 
  
eri-11 
(gg99)  
0.1 1/100 0/20 0/20 4/150 2/120 0/20 4/150 2/80 0.01 0.01  
0.25 8/86 10/54 7/56 12/105 8/82 9/113 9/61 11/63 0.13 0.04 Yes 
0.75 12/55 8/22 43/85 63/133 55/91 34/66 21/88  0.42 0.15 Yes 
1.5 18/18 20/22 44/77 85/108 76/114 76/129   0.75 0.18 Yes 
3 13/14 14/14 17/19 115/137 20/20 103/143 20/20 20/20 0.92 0.10 Yes 
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Single L3-stage larvae were placed on RNAi food targeting hmr-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 0.01, 1, and 2), which produced similar Eri penetrances as adjacent concentrations, 
are not included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the 
brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean 
(N.Avg) and standard error of the mean (SEM). The normalized mean and the standard error of 
the mean for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), 
with p<0.05 as the criterion to denote significant difference from wild type response levels. A 
strain which fits the “best eri” criterion described in text is marked as “best”, with asterisks 
indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.16: Dilution series of Eri responses by RNAi feeding against hmr-1 
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Table 2.16 (Continued): Dilution series results for hmr-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.02 224 208 240 198 232 248  225 19 0.01 0.12  
0.05 184 200 240 272 248 256  233 34 0 0.18  
0.1 252 224 200 240 256 220 238 233 20 0 0.13  
0.25 288 264 200 210 225 252 224 238 32 0 0.17  
0.5 225 240 264 259 224 208 228 235 20 0 0.13  
   
eri-1 
(mg366) 
0.02 104 128 120 114 144 88 80 111 22 0.30 0.15 Yes 
0.05 72 56 78 96 70 84 72 75 12 0.52 0.08 Yes 
0.1 53 25 71 58 83 53 61 58 18 0.64 0.12 Yes 
0.25 54 0 23 14 8 22 0 17 19 0.89 0.12 Yes 
0.5 13 0 0 20 19 0 60 16 21 0.90 0.13 Yes 
   
rrf-3 
(pk1426)
0.02 
 
*Best* 
78 101 85 48 80 63 71 75 17 0.44 0.13 Yes 
0.05 89 42 49 53 45 63 100 63 23 0.53 0.17 Yes 
0.1** 0 0 1 1 0 6 21 4 8 0.97 0.06 Yes 
0.25** 22 0 1 2 24 0 18 10 11 0.93 0.08 Yes 
0.5** 0 0 0 0 0 0 0 0 0 1.00 0 Yes 
   
eri-3 
(tm1361)  
0.02 72 102 72 85 120 128  97 24 0.38 0.17 Yes 
0.05 120 108 128 144 90   118 20 0.24 0.15 Yes 
0.1 29 23 37 25 13 17 40 26 10 0.83 0.07 Yes 
0.25 0 19 12 3 0 3  6 8 0.96 0.05 Yes 
0.5 0 0 0 0 1 6 3 1 2 0.99 0.01 Yes 
   
eri-5 
(tm1705)  
0.02 144 184 203 217 152 168 193 180 27 0 0.19  
0.05 216 168 216 192 152   189 29 0 0.20  
0.1 152 168 152 176 184 184 128 163 21 0.04 0.15  
0.25 168 144 116 156 170 125 136 145 21 0.15 0.15  
0.5 192 184 156 160 176 152 175 171 15 0 0.13  
   
eri-6/7 
(tm1917)  
0.02 132 105 93 84 108 90 98 101 16 0 0.11  
0.05 136 160 128 168 104 168 136 143 24 0.08 0.17  
0.1 33 26 20 46 35 112 68 49 32 0.69 0.21 Yes 
0.25 46 29 0 36 42 45  33 17 0.79 0.11 Yes 
0.5 10 0 0 4 3 0 1 3 4 0.98 0.02 Yes 
   
eri-8 
(gg100) 
0.02 
*Best* 
96 168 136 142 153 160 169 146 25 0 0.12  
0.05 128 72 144 104 128 56 128 109 33 0.51 0.15 Yes 
0.1** 3 25 17 25 5 16 12 15 9 0.93 0.04 Yes 
0.25** 1 1 0 4 0 8 3 2 3 0.99 0.01 Yes 
0.5** 0 1 0 0 0 1 0 0 0 1.00 0 Yes 
   
eri-9 
(gg106) 
0.02 180 232 168 168 176 196 187 187 22 0.22 0.10 Yes 
0.05 160 176 120 200 112 128 204 157 38 0.34 0.16 Yes 
0.1 15 168 160 72 114 104 71 101 54 0.58 0.23 Yes 
0.25 37 87 33 52 27 67 72 54 23 0.78 0.09 Yes 
0.5 8 12 0 9 34 0 15 11 12 0.95 0.05 Yes 
   
eri-11 
(gg99) 
0.02 256 184 208 200 168 184 180 197 29 0.28 0.12 Yes 
0.05 152 160 180 205 200 198  183 22 0.33 0.09 Yes 
0.1 64 66 95 56 96 162 80 88 36 0.68 0.13 Yes 
0.25 48 0 15 80 30 50 52 39 27 0.86 0.10 Yes 
0.5 6 0 11 0 0 0 7 3 5 0.99 0.02 Yes 
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Single L3-stage larvae were placed on RNAi food targeting unc-73; 4 days later, the percent of 
progeny showing the expected paralysis at each indicated concentration (OD at 600 nm) of initial 
bacterial culture were determined. For clarity, three bacterial culture concentrations (OD600nm of 
0.03, 0.25, and 1), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) for N2 wild type were used as 
the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 as the criterion to denote 
significant difference from wild type response levels. A strain which fits the “best eri” criterion 
described in text is marked as “best”, with asterisks indicating concentrations of RNAi food at 
which it fulfilled the criterion. 
Table 2.17: Dilution series of Eri responses by RNAi feeding against unc-73 
80 
 
 
Table 2.17 (Continued): Dilution series results for unc-73 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
0.1 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0  
0.5 0/20 0/20 0/20 0/20 1/30 0/20 1/40 0.01 0.01  
0.75 0/20 0/20 0/20 0/20 0/20 0/20 0/20 0 0  
2 0/20 0/20 0/20 2/50 0/30 0/20 2/80 0.01 0.02  
3 0/20 0/20 0/20 6/90 3/80 0/20 0/20 0.01 0.03  
  
eri-1 
(mg366)  
0.1 0/20 0/20 0/20 0/26 0/35 0/20 0/20 0 0  
0.5 5/50 8/67 13/61 17/47 6/27 14/32 12/33 0.26 0.13 Yes 
0.75 12/40 14/50 9/47 13/35 20/57 27/48 26/54 0.36 0.13 Yes 
2 21/23 74/78 22/38 21/31 73/84 30/53  0.76 0.17 Yes 
3 20/20 103/112 20/20 28/30 20/20 42/47  0.96 0.05 Yes 
  
rrf-3 
(pk1426)  
0.1 0/20 0/20 0/20 1/29 2/60 0/20 0/20 0.01 0.02  
0.5 1/60 4/50 3/70 4/15 13/67 6/48  0.12 0.10 Yes 
0.75 3/6 10/42 10/31 13/37 38/61 44/61 21/48 0.46 0.17 Yes 
2 18/39 19/77 22/58 46/54 43/55 81/91 88/97 0.65 0.27 Yes 
3 18/64 18/47 25/54 27/30 88/90 58/68  0.64 0.30 Yes 
  
eri-3 
(tm1361) 
0.1 0/20 0/20 0/12 0/20 1/30 0/20 0/20 0 0.01  
0.5 2/50 3/60 5/50 1/15 2/23 12/56 15/40 0.13 0.12 Yes 
0.75 18/52 16/48 13/32 13/35 11/22 26/36 13/30 0.44 0.13 Yes 
2 11/44 22/46 16/65 19/46 6/10 32/36 80/82 0.55 0.29 Yes 
3 29/46 25/44 26/48 53/60 18/20 22/24 43/44 0.77 0.19 Yes 
  
eri-5 
(tm1705) 
0.1 0/20 0/20 2/30 0/20 0/20 0/20 1/108 0.01 0.02  
0.5 0/20 0/20 0/20 0/20 0/20 0/20  0 0  
0.75 1/40 0/20 0/20 0/20 1/30 12/120 4/120 0.03 0.04  
2 0/20 0/20 1/20 1/30 0/20 2/89 0/20 0.02 0.02  
3 1/20 2/30 4/50 2/60 1/30 5/103 0/20 0.04 0.03  
  
eri-6/7 
(tm1917) 
0.1 0/20 0/20 0/20 0/67 1/53 1/90 0/20 0 0.01  
0.5 3/40 7/50 2/60 4/57 6/78 1/32 8/69 0.08 0.04 Yes 
0.75 6/22 17/77 17/69 26/39 10/17 11/90 17/83 0.33 0.21 Yes 
2 34/43 47/50 44/50 23/40 38/66 34/40 14/60 0.69 0.25 Yes 
3 46/50 47/50 20/20 20/20 20/20 30/33 50/53 0.96 0.04 Yes 
  
eri-8 
(gg100)
0.1 
 
*Best* 
0/20 0/20 2/50 2/50 3/60 0/23 0/29 0.02 0.02  
0.5 8/90 8/60 4/70 14/73 28/78 34/82 17/68 0.21 0.14 Yes 
0.75 56/73 86/101 46/53 41/51 29/45 32/57 30/65 0.71 0.16 Yes 
2** 20/20 20/20 20/20 19/24 20/20 117/122 81/81 0.96 0.08 Yes 
3** 20/20 20/20 20/20 20/20 20/20 124/133 20/20 0.99 0.03 Yes 
  
eri-9 
(gg106) 
0.1 1/50 0/20 0/20 4/71 5/57 1/130 0/20 0.02 0.03  
0.5 3/100 8/100 2/80 9/54 24/83 13/51  0.14 0.11 Yes 
0.75 9/60 8/69 25/78 11/62 6/48 34/64 15/47 0.25 0.15 Yes 
2 40/48 43/65 35/46 29/94 19/71 52/57 31/72 0.60 0.26 Yes 
3 48/50 83/90 89/90 67/88 107/115 41/49  0.90 0.09 Yes 
  
eri-11 
(gg99)  
0.1 0/20 1/40 0/20 0/20 1/30 0/20 2/80 0.01 0.02  
0.5 11/122 6/72 10/87 7/50 4/72 6/44 21/53 0.15 0.11 Yes 
0.75 24/55 7/64 21/73 36/79 21/66 27/84 29/86 0.32 0.11 Yes 
2 32/79 20/71 22/67 11/59 53/72 12/35 35/66 0.40 0.18 Yes 
3 51/83 112/118 20/20 20/20 56/66 91/107 61/67 0.88 0.13 Yes 
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Single L3-stage larvae were placed on RNAi food targeting div-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. The tabulated mean (Avg) and standard deviation (SD) 
were normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain 
the normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and 
the standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.18: Dilution series of Eri responses by RNAi feeding against div-1 
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Table 2.18 (Continued): Dilution series results for div-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.5 95 104 128 105 128 160 146 124 24 0.45 0.12  
1 86 57 69 72 33 37 56 59 19 0.74 0.09  
2 88 53 50 47 79 33 37 55 21 0.76 0.09  
3 59 62 49 54 84 33 50 56 16 0.75 0.07  
4 63 50 58 83 50 34 32 53 18 0.77 0.08  
   
eri-1 
(mg366) 
0.5 98 100 64 120 66 99 80 90 20 0.43 0.13  
1 60 96 78 68 36 48 46 62 21 0.61 0.13  
2 29 63 59 10 55 31 40 41 19 0.74 0.12  
3 50 50 56 44 23 35 59 45 13 0.71 0.08  
4 51 74 19 64 39 10 47 43 23 0.73 0.15  
   
rrf-3 
(pk1426)  
0.5 64 96 63 84 102 57 54 74 19 0.44 0.15  
1 36 65 75 35 34 41 26 45 18 0.67 0.14  
2 36 42 66 27 25 10 11 31 19 0.77 0.15  
3 26 23 1 25 10 27 15 18 10 0.86 0.07 Yes 
4 20 24 17 17 19 43 15 22 10 0.83 0.07  
   
eri-3 
(tm1361)
0.5 
 
*Best* 
47 54 79 55 51 55 37 54 13 0.65 0.09  
1 94 34 47 25 45 27 50 46 23 0.70 0.15  
2** 18 36 13 10 14 19  18 9 0.88 0.06 Yes 
3** 10 24 32 18 15 17 8 18 8 0.89 0.05 Yes 
4** 8 16 9 10 15 32 12 15 8 0.91 0.05 Yes 
   
eri-5 
(tm1705)  
0.5 46 72 88 104 112 120 81 89 26 0.48 0.16  
1 32 28 40 7 48 39 13 30 15 0.83 0.09  
2 23 25 26 22 18 23 18 22 3 0.87 0.02 Yes 
3 18 20 18 23 9 21 16 18 5 0.90 0.03 Yes 
4 30 25 20 9 22 25 19 21 7 0.87 0.04 Yes 
   
eri-6/7 
(tm1917)  
0.5 106 108 90 88 72 84 105 93 13 0.40 0.10  
1 38 34 31 36 44 37 61 40 10 0.74 0.07  
2 52 38 26 29 34 2 30 30 15 0.81 0.10  
3 44 14 23 51 31 27 48 34 14 0.78 0.09  
4 19 25 29 28 16 6 33 22 9 0.86 0.06 Yes 
   
eri-8 
(gg100)  
0.5 104 108 135 162 166 180 168 146 31 0.34 0.14  
1 192 86 102 60 78 76  99 48 0.56 0.21  
2 128 108 90 36 32 56 33 69 40 0.69 0.18  
3 29 70 106 39 44 36 39 52 27 0.77 0.12  
4 74 78 25 30 27 19  42 26 0.81 0.12  
   
eri-9 
(gg106) 
0.5 114 148 120 76 122 88 98 109 24 0.54 0.10  
1 72 130 112 30 24 18 24 59 47 0.76 0.19  
2 72 42 114 31 26 29 22 48 34 0.80 0.14  
3 75 88 65 30 35 20 21 48 28 0.80 0.12  
4 25 43 33 29 23 24 20 28 8 0.88 0.03 Yes 
   
eri-11 
(gg99) 
0.5 112 232 160 136 162 200 176 168 40 0.39 0.15  
1 98 102 118 37 72 96 82 86 26 0.68 0.10  
2 104 44 90 33 45 28 34 54 30 0.80 0.11  
3 44 98 96 40 35 34 35 55 29 0.80 0.11  
4 31 42 34 25 37 37  34 6 0.87 0.02 Yes 
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Single L3-stage larvae were placed on RNAi food targeting pbs-6; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 0.005, 0.01, and 1), which produced similar Eri penetrances as adjacent 
concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) were 
normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the 
normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and the 
standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.19: Dilution series of Eri responses by RNAi feeding against pbs-6 
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Table 2.19 (Continued): Dilution series results for pbs-6 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.02 205 227 224 244 207 240 207 222 16 0.02 0.11  
0.05 244 256 216 134 264 200 160 211 49 0.07 0.23  
0.1 172 190 84 53 210 41 93 120 69 0.47 0.31  
0.25 62 50 39 20 21 60  42 19 0.81 0.08  
0.5 32 12 15 13 23 20 22 20 7 0.91 0.03  
   
eri-1 
(mg366) 
0.02 107 137 120 72 80 80 80 97 25 0.39 0.16 Yes 
0.05 134 88 84 64 44 60 75 78 29 0.50 0.18 Yes 
0.1 110 33 56 66 40 33 36 53 28 0.66 0.18  
0.25 20 48 6 9 4 3 11 14 16 0.91 0.10  
0.5 4 1 2 11 4 4 0 4 4 0.98 0.02 Yes 
   
rrf-3 
(pk1426)  
0.02 122 152 120 128 120 138 112 127 14 0.04 0.12  
0.05 144 135 96 104 126 84 78 110 26 0.18 0.20  
0.1 51 85 38 25 96 43 84 60 28 0.55 0.21  
0.25 0 2 2 7 9 87 23 19 31 0.86 0.23  
0.5 0 1 1 0 0 0 3 1 1 0.99 0.01 Yes 
   
eri-3 
(tm1361)
0.02 
 
*Best*  
152 176 42 144 104 156 75 121 49 0.22 0.32  
0.05 156 99 32 45 19 84 31 67 49 0.57 0.32 Yes 
0.1 41 25 72 22 56 80 72 53 24 0.66 0.15  
0.25** 16 4 2 3 7 8 2 6 5 0.96 0.03 Yes 
0.5** 2 11 0 0 1 0 3 2 4 0.98 0.03 Yes 
   
eri-5 
(tm1705)  
0.02 170 162 160 152 90 112 95 134 34 0.21 0.22  
0.05 165 144 66 48 62 49 49 83 50 0.51 0.29 Yes 
0.1 56 133 71 42 30 21 33 55 38 0.68 0.23  
0.25 16 18 6 20 13 23 13 16 6 0.91 0.03 Yes 
0.5 2 3 4 2 5 2 2 3 1 0.98 0.01 Yes 
   
eri-6/7 
(tm1917)
0.02 
 
*Best* 
176 192 168 184 232 190 112 179 36 0 0.25  
0.05 150 162 96 96 100 104 126 119 27 0.23 0.19  
0.1 40 35 23 112 66 40  53 32 0.66 0.21  
0.25** 24 11 3 9 2 3 6 8 8 0.95 0.05 Yes 
0.5** 0 0 2 3 4 3 1 2 2 0.99 0.01 Yes 
   
eri-8 
(gg100)  
0.02 234 232 266 248 240 224 232 239 14 0 0.07  
0.05 280 272 144 192 152 193  206 58 0.08 0.26  
0.1 105 28 77 75 45 120  75 35 0.66 0.16  
0.25 18 19 11 56 22 19 16 23 15 0.90 0.07  
0.5 2 3 13 0 3 7 3 4 4 0.98 0.02 Yes 
   
eri-9 
(gg106) 
0.02 216 192 250 210 192 208 222 213 20 0.11 0.10  
0.05 217 227 190 160 192 184 170 191 24 0.20 0.11  
0.1 124 66 160 167 126 112 44 114 45 0.52 0.19  
0.25 26 69 14 16 27 32 16 29 19 0.88 0.08  
0.5 2 0 2 8 9 13 22 8 8 0.97 0.03 Yes 
   
eri-11 
(gg99) 
0.02 161 227 116 146 136 168 135 156 36 0.43 0.14 Yes 
0.05 192 224 126 88 112 128  145 52 0.47 0.19 Yes 
0.1 26 158 136 128 128 67 33 97 54 0.65 0.20  
0.25 51 66 26 24 8 37  35 21 0.87 0.08  
0.5 0 3 12 7 7 8 8 6 4 0.98 0.01 Yes 
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Single L3-stage larvae were placed on RNAi food targeting pha-4; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.05 and 0.5), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.20: Dilution series of Eri responses by RNAi feeding against pha-4 
86 
 
 
Table 2.20 (Continued): Dilution series results for pha-4 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.01 208 199 210 233 240 264 260 231 26 0 0.15  
0.02 210 272 280 256 252 244  252 25 0 0.15  
0.04 176 189 240 255 224 234 200 217 29 0.04 0.16  
0.1 149 160 176 168 152 140  158 13 0.30 0.09  
0.25 147 158 164 168 136 174  158 14 0.30 0.09  
   
eri-1 
(mg366) 
0.01 98 133 160 128 152 130 176 140 25 0.12 0.17  
0.02 70 85 61 100 73 130 47 81 27 0.49 0.18 Yes 
0.04 11 0 57 46 73 94 108 56 40 0.65 0.25 Yes 
0.1 0 45 28 71 61 62  45 27 0.72 0.17 Yes 
0.25 31 15 47 12 17 13  23 14 0.86 0.09 Yes 
   
rrf-3 
(pk1426)  
0.01 114 101 120 112 104 106  110 7 0.18 0.08 Yes 
0.02 76 81 47 92 64 90  75 17 0.44 0.13 Yes 
0.04 6 54 49 61 43 10  37 23 0.72 0.18 Yes 
0.1 1 0 7 19 34 44 57 23 22 0.83 0.17 Yes 
0.25 6 1 0 0 16 9 0 5 6 0.97 0.05 Yes 
   
eri-3 
(tm1361)
0.01 
 
*Best* 
162 142 115 54 45 42 82 92 49 0.41 0.32 Yes 
0.02 46 87 72 74 54 75 29 62 20 0.60 0.13 Yes 
0.04 60 79 15 23 7 4 53 34 29 0.78 0.19 Yes 
0.1** 28 25 23 14 3 16 33 20 10 0.87 0.07 Yes 
0.25** 10 15 3 5 17 3 3 8 6 0.95 0.04 Yes 
   
eri-5 
(tm1705)  
0.01 194 192 170 178 190 176 184 183 9 0 0.12  
0.02 192 182 160 200 170 160 167 176 16 0 0.14  
0.04 168 144 184 168 152 168  164 14 0.04 0.13  
0.1 100 86 100 133 132 93 65 101 24 0.41 0.16  
0.25 55 62 35 57 33 50 20 45 15 0.74 0.09 Yes 
   
eri-6/7 
(tm1917) 
0.01 216 240 169 200 205 163 162 194 30 0 0.22  
0.02 217 266 156 132 172 182  188 48 0 0.32  
0.04 179 126 73 62 112 114 88 108 39 0.31 0.26 Yes 
0.1 52 74 41 63 56 63 41 56 12 0.64 0.08 Yes 
0.25 60 0 28 30 64 54 47 40 23 0.74 0.15 Yes 
   
eri-8 
(gg100)  
0.01 236 248 232 224 216 235  232 11 0 0.06  
0.02 86 164 144 176 176 154 160 151 31 0.32 0.14 Yes 
0.04 61 82 64 84 92 63 100 78 16 0.65 0.07 Yes 
0.1 7 3 28 4 3 47 30 17 18 0.92 0.08 Yes 
0.25 25 10 52 55 63 32 9 35 22 0.84 0.10 Yes 
   
eri-9 
(gg106) 
0.01 244 246 272 240 256 256  252 12 0 0.08  
0.02 216 176 216 240 280 278  234 40 0.02 0.18  
0.04 164 171 208 248 224 170 220 201 33 0.16 0.14  
0.1 36 57 114 92 90 123  85 33 0.64 0.14 Yes 
0.25 89 107 87 106 74 146  102 25 0.58 0.11 Yes 
   
eri-11 
(gg99) 
0.01 292 260 320 264 274 312  287 25 0 0.11  
0.02 264 254 240 248 341 324 304 282 40 0 0.16  
0.04 153 116 216 216 200 209 226 191 41 0.30 0.16 Yes 
0.1 85 81 228 200 240 256 176 181 72 0.34 0.27  
0.25 65 72 80 93 96 112  86 17 0.68 0.07 Yes 
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Single L3-stage larvae were placed on RNAi food targeting cdk-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 0.025, 0.25, and 0.75), which produced similar Eri penetrances as adjacent 
concentrations, are not included. The tabulated mean (Avg) and standard deviation (SD) were 
normalized to the brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the 
normalized mean (N.Avg) and standard error of the mean (SEM). The normalized mean and the 
standard error of the mean for N2 wild type were used as the basis to indicate an Eri or a Rde 
phenotype (Eri?), with p<0.05 as the criterion to denote significant difference from wild type 
response levels. A strain which fits the “best eri” criterion described in text is marked as “best”, 
with asterisks indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.21: Dilution series of Eri responses by RNAi feeding against cdk-1 
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Table 2.21 (Continued): Dilution series results for cdk-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.1 248 284 222 192 248 248  240 31 0 0.17  
0.5 194 244 224 239 157   212 36 0.07 0.18  
1 124 4 9 17 0   31 52 0.86 0.23  
2 87 137 4 6 3 51 3 42 53 0.82 0.23  
3 0 11 0 6 2 2 3 3 4 0.98 0.02  
   
eri-1 
(mg366) 
0.1 13 127 192 120 123 84 148 115 56 0.27 0.35  
0.5 77 75 65 36 47   60 18 0.62 0.12 Yes 
1 22 0 2 0 1 0  4 9 0.97 0.06  
2 2 40 0 0 0 0 0 6 15 0.96 0.09  
3 1 0 0 1 0 1 0 0 1 1.00 0  
   
rrf-3 
(pk1426) 
0.1 
*Best* 
50 76 123 156 160 192 160 131 51 0.02 0.39  
0.5** 2 0 3 0 0 0 0 1 1 0.99 0.01 Yes 
1** 1 0 0 0 0 0  0 0 1.00 0  
2** 0 0 0 0 0 0 1 0 0 1.00 0  
3** 0 0 0 1 0 0 0 0 0 1.00 0  
   
eri-3 
(tm1361) 
0.1 134 6 126 108 104 120 120 103 44 0.34 0.29  
0.5 67 5 0 0 11 38  20 27 0.87 0.17 Yes 
1 26 65 0 1 0 14 34 20 24 0.87 0.15  
2 0 0 1 1 0 0 0 0 0 1.00 0  
3 9 1 0 0 0 0 0 1 3 0.99 0.02  
   
eri-5 
(tm1705) 
0.1 189 210 174 186 140 148 195 177 25 0 0.18  
0.5 106 126 58 8 99   79 47 0.53 0.28 Yes 
1 58 72 0 0 0 0 0 19 32 0.89 0.19  
2 81 5 0 0 0 0 0 12 30 0.93 0.18  
3 0 1 0 0 0 0 0 0 0 1.00 0  
   
eri-6/7 
(tm1917) 
0.1 99 220 182 216 176 240 168 186 47 0 0.31  
0.5 51 9 4 3 11   16 20 0.90 0.13 Yes 
1 33 0 0 0 0 0  6 13 0.96 0.09  
2 4 1 0 1 0 0 0 1 1 0.99 0.01  
3 0 2 0 1 0 0 0 0 1 1.00 0.01  
   
eri-8 
(gg100) 
0.1 262 276 194 248 240 240 272 247 28 0 0.13  
0.5 24 93 1 0 6   25 39 0.89 0.18 Yes 
1 8 19 0 0 0 44 17 13 16 0.94 0.07  
2 0 2 0 0 0 0 0 0 1 1.00 0  
3 1 0 0 0 0 2 1 1 1 1.00 0  
   
eri-9 
(gg106) 
0.1 282 270 224 184 214 240 248 237 34 0.01 0.15  
0.5 20 0 4 9 3 0  6 8 0.97 0.03 Yes 
1 124 0 0 0 2 2  21 50 0.91 0.21  
2 3 127 0 0 3 1 1 19 48 0.92 0.20  
3 0 0 0 0 0 0 1 0 0 1.00 0  
   
eri-11 
(gg99) 
0.1 272 298 264 216 272 224 260 258 29 0.06 0.12  
0.5 181 282 64 78 38 104 192 134 87 0.51 0.32 Yes 
1 47 0 0 2 5 4 3 9 17 0.97 0.06  
2 32 2 3 0 0 0 0 5 12 0.98 0.04  
3 0 0 0 0 0 0 0 0 0 1.00 0  
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Single L3-stage larvae were placed on RNAi food targeting knl-3; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, three bacterial culture concentrations 
(OD600nm of 2, 3, and 4), which produced similar Eri penetrances as adjacent concentrations, are 
not included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the 
brood sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean 
(N.Avg) and standard error of the mean (SEM). The normalized mean and the standard error of 
the mean for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), 
with p<0.05 as the criterion to denote significant difference from wild type response levels. A 
strain which fits the “best eri” criterion described in text is marked as “best”, with asterisks 
indicating concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.22: Dilution series of Eri responses by RNAi feeding against knl-3 
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Table 2.22 (Continued): Dilution series results for knl-3 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.1 256 242 184 210 180 232 200 215 29 0.05 0.16  
0.25 264 240 237 216 260 235 224 239 18 0 0.12  
0.5 240 192 148 168 208 191  191 32 0.16 0.16  
0.75 212 200 176 162 180 169 203 186 19 0.18 0.11  
1 99 63 84 47 77   74 20 0.67 0.09  
   
eri-1 
(mg366) 
0.1 63 40 168 155 162 151  123 56 0.22 0.36  
0.25 100 152 96 120 120 184 156 133 32 0.16 0.21  
0.5 50 1 55 111 81 114 77 70 39 0.56 0.25 Yes 
0.75 81 74 50 54 75 56 49 63 13 0.60 0.09 Yes 
1 1 0 0 0 0 66 13 11 25 0.93 0.15 Yes 
   
rrf-3 
(pk1426)
0.1 
 
*Best*  
108 62 97 97 113 91 115 98 18 0.27 0.14 Yes 
0.25 68 130 110 89 78 105 100 97 21 0.27 0.16 Yes 
0.5 96 62 108 58 96 72 81 82 19 0.39 0.15 Yes 
0.75 69 64 102 93 80 109 89 87 17 0.35 0.13 Yes 
1** 0 0 15 0 10 5 1 4 6 0.97 0.04 Yes 
   
eri-3 
(tm1361) 
0.1 99 91 210 200 195 208 220 175 55 0 0.37  
0.25 85 184 89 189 78 170  133 54 0.15 0.35  
0.5 62 83 185 168 76 82  109 53 0.30 0.35  
0.75 128 123 126 101 96 113 103 113 13 0.28 0.11  
1 0 22 12 16 59 36 10 22 20 0.86 0.13 Yes 
   
eri-5 
(tm1705)  
0.1 224 184 243 216 236 200 168 210 27 0 0.20  
0.25 240 244 198 232 200 168 180 209 30 0 0.22  
0.5 82 109 132 144 157 187 136 135 34 0.21 0.22  
0.75 114 121 113 132 128 104 117 118 10 0.30 0.09 Yes 
1 0 0 28 22 44 0 23 17 17 0.90 0.10 Yes 
   
eri-6/7 
(tm1917) 
0.1 133 151 170 210 216 214 203 185 34 0 0.24  
0.25 180 188 216 198 232 232  208 22 0 0.18  
0.5 105 86 160 155 168 222  149 48 0.04 0.32  
0.75 133 164 168 144 160 184  159 18 0 0.14  
1 0 31 1 8 20 0 40 14 16 0.91 0.11 Yes 
   
eri-8 
(gg100) 
0.1 
*Best* 
194 256 292 252 272 216 240 246 33 0 0.15  
0.25 215 220 210 210 214 243 241 222 14 0 0.07  
0.5 176 186 200 186 200 202  192 11 0.14 0.06  
0.75 131 157 142 131 152 140 156 144 11 0.35 0.05 Yes 
1** 0 0 0 13 11 9 7 6 6 0.97 0.03 Yes 
   
eri-9 
(gg106) 
0.1 234 240 280 272 288 244  260 23 0 0.11  
0.25 192 240 264 240 248 232 225 234 22 0.02 0.11  
0.5 216 224 137 149 168 174 150 174 34 0.27 0.15  
0.75 132 126 126 138 131 159 146 137 12 0.43 0.06 Yes 
1 10 5 40 38 19 12 78 29 26 0.88 0.11 Yes 
   
eri-11 
(gg99)
0.1 
 
*Best* 
292 280 272 320 258 288 304 288 20 0 0.10  
0.25 248 256 280 264 224 254 320 264 30 0.04 0.13  
0.5 236 248 156 288 224 235 256 235 40 0.14 0.16  
0.75 68 81 116 92 109 97 83 92 17 0.66 0.06 Yes 
1** 1 1 15 0 3 21 6 7 8 0.98 0.03 Yes 
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Single L3-stage larvae were placed on RNAi food targeting vha-15; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.1 and 0.5), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.23: Dilution series of Eri responses by RNAi feeding against vha-15 
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Table 2.23 (Continued): Dilution series results for vha-15 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.03 231 205 185 216 179 229 208 208 20 0.08 0.12  
0.25 170 181 190 288 127 136 183 182 53 0.20 0.24  
1 73 128 127 97 222 135 122 129 46 0.43 0.21  
2 117 79 79 164 78 122  107 35 0.53 0.16  
3 30 66 97 100 65 105  77 29 0.66 0.13  
   
eri-1 
(mg366) 
0.03 155 173 77 128 140 151 156 140 31 0.12 0.20  
0.25 45 69 77 41 83 97 68 69 20 0.57 0.13 Yes 
1 3 18 3 42 51 44 30 27 20 0.83 0.12 Yes 
2 0 6 0 40 7 10 12 11 14 0.93 0.09 Yes 
3 1 2 0 0 1 12 0 2 4 0.99 0.03 Yes 
   
rrf-3 
(pk1426) 
*Best*
0.03 
  
144 59 196 148 195 97  140 54 0 0.41  
0.25 29 3 77 57 34 33 0 33 27 0.75 0.21 Yes 
1** 0 1 0 24 1   5 11 0.96 0.08 Yes 
2** 0 0 0 0 0 0 0 0 0 1.00 0 Yes 
3** 0 0 0 0 0 0 0 0 0 1.00 0 Yes 
   
eri-3 
(tm1361) 
0.03 135 155 164 133 162 86 145 140 27 0.10 0.19  
0.25 63 40 66 52 62 9 19 44 23 0.71 0.15 Yes 
1 0 18 1 0 1 0 46 9 17 0.94 0.11 Yes 
2 0 0 0 0 0 17 0 2 6 0.98 0.04 Yes 
3 0 0 0 0 0 1 1 0 0 1.00 0 Yes 
   
eri-5 
(tm1705) 
0.03 97 126 163 195 208 102 153 149 43 0.12 0.27  
0.25 127 238 106 165 173 114 85 144 52 0.15 0.32  
1 34 64 43 11 102 65  53 31 0.69 0.19 Yes 
2 5 7 204 26 34 23 45 49 70 0.71 0.41  
3 24 19 12 67 113 34  45 39 0.74 0.23  
   
eri-6/7 
(tm1917) 
0.03 219 143 148 226 127 161  171 42 0 0.28  
0.25 127 78 51 113 128 78  96 31 0.38 0.21  
1 0 22 51 9 60 16 5 23 23 0.85 0.15 Yes 
2 2 1 0 15 46 9 26 14 17 0.91 0.11 Yes 
3 1 0 1 1 0 1 15 3 5 0.98 0.04 Yes 
   
eri-8 
(gg100) 
0.03 
*Best* 
180 256 209 242 251 273  235 34 0 0.16  
0.25 48 46 27 125 154 49 25 68 51 0.70 0.23 Yes 
1** 1 0 20 1 2 0 0 3 7 0.98 0.03 Yes 
2** 0 0 0 1 1 1 4 1 1 1.00 0.01 Yes 
3** 0 2 0 3 0 0 0 1 1 1.00 0.01 Yes 
   
eri-9 
(gg106) 
0.03 219 238 284 246 233 257 237 245 21 0 0.11  
0.25 192 150 179 55 167 150 114 144 46 0.40 0.20  
1 102 114 62 6 101 53 49 70 38 0.71 0.16 Yes 
2 3 0 1 34 105 46 28 31 37 0.87 0.16 Yes 
3 1 0 0 1 10 1 0 2 4 0.99 0.02 Yes 
   
eri-11 
(gg99) 
0.03 292 246 239 247 258 285 228 256 24 0.06 0.11  
0.25 123 135 220 224 189 249 185 189 47 0.31 0.18  
1 24 8 2 50 1 66 43 28 26 0.90 0.09 Yes 
2 5 60 0 125 1 43 15 36 46 0.87 0.17 Yes 
3 0 1 0 1 0 82 0 12 31 0.96 0.11 Yes 
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Single L3-stage larvae were placed on RNAi food targeting glp-1; 4 days later, the percent of 
progeny showing the expected absent germline at each indicated concentration (OD at 600 nm) 
of initial bacterial culture were determined. The tabulated mean (Avg) and standard deviation 
(SD) for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with 
p<0.05 as the criterion to denote significant difference from wild type response levels. A strain 
which fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.24: Dilution series of Eri responses by RNAi feeding against glp-1 
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Table 2.24 (Continued): Dilution series results for glp-1 feeding 
Strain OD600 Penetrance readings Avg SD Eri? 
Wildtype 
(N2) 
1 2/56 2/67 1/80 0/20 0/20 0/20 1/60 0.01 0.01  
2 3/67 1/18 2/40 0/20 2/60   0.04 0.02  
3 9/31 6/25 8/27 6/25 10/31 12/39 8/24 0.29 0.04  
4 26/61 24/52 7/14 9/28 9/25 9/26 12/36 0.39 0.07  
5 11/29 26/53 16/31 13/25 18/28 20/34 19/36 0.52 0.08  
  
eri-1 
(mg366)  
1 4/49 5/46 6/42 8/47 3/25 3/20 8/45 0.14 0.03 Yes 
2 12/38 13/33 17/39 9/32 8/23 11/30 18/41 0.37 0.06 Yes 
3 14/28 17/33 14/43 16/32 13/28 24/48 22/39 0.48 0.07 Yes 
4 23/34 29/41 38/52 16/23 24/40   0.68 0.05 Yes 
5 24/28 21/27 28/37 25/35 24/31 32/42 31/38 0.78 0.05 Yes 
  
rrf-3 
(pk1426)  
1 7/47 8/61 12/39 4/39 3/38 5/37  0.15 0.08 Yes 
2 10/41 16/50 26/47 39/54 15/34 14/27 18/38 0.47 0.16 Yes 
3 53/57 41/51 18/36 21/28 41/57 29/39  0.74 0.14 Yes 
4 31/33 42/54 21/27 29/40 36/49 27/40 39/50 0.77 0.08 Yes 
5 31/37 25/30 33/38 28/42 23/25 28/34 28/33 0.83 0.08 Yes 
  
eri-3 
(tm1361) 
1 3/36 5/45 7/25 2/28 2/29 5/37 4/35 0.12 0.07 Yes 
2 10/36 6/19 19/37 22/63 21/47 12/27 11/35 0.38 0.09 Yes 
3 17/39 22/48 14/30 25/37 15/26 19/36 27/49 0.53 0.08 Yes 
4 14/18 39/48 22/33 40/47 22/30 19/24 44/47 0.80 0.09 Yes 
5 19/24 8/9 27/38 17/22 22/30 23/27 21/25 0.80 0.07 Yes 
  
eri-5 
(tm1705) 
1 
*Best* 
3/29 4/28 4/37 3/30 2/60 3/50 0/20 0.08 0.05 Yes 
2 21/34 13/20 10/21 10/30 10/22 12/22  0.51 0.12 Yes 
3 7/11 7/14 11/28 8/21 5/14 25/40 12/28 0.47 0.12 Yes 
4 27/36 25/32 20/29 22/27 14/22 22/29 23/28 0.75 0.07 Yes 
5** 11/13 12/13 34/35 27/29 30/33 19/21 13/13 0.93 0.05 Yes 
  
eri-6/7 
(tm1917) 
1 2/36 4/61 7/32 5/30 5/34 6/40 6/46 0.13 0.06 Yes 
2 12/28 11/27 9/35 8/33 8/35 6/28 12/26 0.32 0.11 Yes 
3 18/31 24/34 20/29 14/25 11/19 26/37  0.64 0.07 Yes 
4 30/35 24/37 24/31 23/29 13/17 27/36 23/29 0.77 0.06 Yes 
5 19/26 18/21 14/25 23/27 26/30 18/20 24/30 0.80 0.12 Yes 
  
eri-8 
(gg100)  
1 7/79 8/78 7/29 9/50 6/42 2/23 3/35 0.13 0.06 Yes 
2 17/38 7/18 9/54 8/24 10/29 18/47 15/49 0.34 0.09 Yes 
3 17/32 15/29 16/30 29/47 20/43 35/58 27/44 0.55 0.06 Yes 
4 20/23 49/68 26/36 24/40 33/47 12/17 32/54 0.70 0.09 Yes 
5 20/32 33/40 22/25 25/30 24/30 23/26 25/34 0.80 0.09 Yes 
  
eri-9 
(gg106) 
1 8/75 1/48 8/60 2/28 4/46 6/63 11/93 0.09 0.04 Yes 
2 13/39 8/24 11/39 12/39 18/53 5/32 4/16 0.29 0.07 Yes 
3 12/28 20/39 20/36 19/34 21/35 14/25 24/45 0.54 0.05 Yes 
4 28/31 30/40 17/27 20/23 17/28 30/39 15/22 0.74 0.11 Yes 
5 43/65 40/51 16/28 34/38 16/18 24/28 26/32 0.78 0.12 Yes 
  
eri-11 
(gg99)  
1 4/69 5/53 0/20 0/20 2/40 0/20 0/20 0.03 0.04  
2 17/53 11/37 5/19 3/10 9/28 7/24  0.30 0.02 Yes 
3 24/39 16/25 7/20 23/49 10/19 12/28 27/55 0.50 0.10 Yes 
4 44/57 36/44 27/41 27/39 17/27 41/49 19/25 0.74 0.08 Yes 
5 31/36 52/58 16/20 34/39 13/16 24/26 29/37 0.85 0.05 Yes 
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Single L3-stage larvae were placed on RNAi food targeting par-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.25 and 0.75), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.25: Dilution series of Eri responses by RNAi feeding against par-1 
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Table 2.25 (Continued): Dilution series results for par-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.1 196 248 256 220 216 232  228 22 0 0.13  
0.5 196 184 200 160 212   190 20 0.16 0.12  
1 133 109 130 108 94   115 16 0.49 0.09  
2 97 49 65 192 36   88 63 0.61 0.28  
3 10 14 17 18 17 9 6 13 5 0.94 0.02  
   
eri-1 
(mg366) 
0.1 130 208 184 168 192 216  183 31 0 0.21  
0.5 79 95 31 131 104 116 128 98 35 0.38 0.22  
1 35 57 87 34 6 41  43 27 0.73 0.17 Yes 
2 4 19 6 18 9 18  12 7 0.92 0.04 Yes 
3 7 26 15 12 9 23 5 14 8 0.91 0.05  
   
rrf-3 
(pk1426)  
0.1 18 38 176 112 104 87 118 93 53 0.30 0.40  
0.5 11 10 10 18 21 14  14 5 0.90 0.04 Yes 
1 7 19 12 12 16 12 2 11 6 0.91 0.04 Yes 
2 7 12 5 13 10 12 9 10 3 0.93 0.02 Yes 
3 8 10 10 6 7 3 4 7 3 0.95 0.02  
   
eri-3 
(tm1361) 
0.1 27 5 19 90 69 90 144 63 49 0.59 0.32 Yes 
0.5 18 18 11 8 11 4 54 18 17 0.89 0.11 Yes 
1 5 8 3 10 6 40 18 13 13 0.92 0.08 Yes 
2 12 3 1 1 2 1 5 4 4 0.98 0.03 Yes 
3 15 7 21 17 3 2 6 10 7 0.93 0.05  
   
eri-5 
(tm1705)
0.1 
 
*Best* 
8 94 77 47 248 136 184 113 82 0.33 0.49  
0.5** 4 15 10 14 19 11 28 14 8 0.92 0.05 Yes 
1** 5 10 7 6 10 11 4 8 3 0.96 0.02 Yes 
2** 4 14 9 8 3 4 7 7 4 0.96 0.02 Yes 
3 18 21 10 2 10 9 7 11 6 0.94 0.04  
   
eri-6/7 
(tm1917) 
0.1 159 168 200 208 232 186  192 27 0 0.20  
0.5 15 12 35 232 13 31 12 50 81 0.68 0.52  
1 3 3 5 11 10 8  7 4 0.96 0.02 Yes 
2 45 19 11 12 5 13 11 17 13 0.89 0.09 Yes 
3 6 3 6 5 8 3 8 6 2 0.96 0.01 Yes 
   
eri-8 
(gg100)  
0.1 228 184 220 243 248 208 270 229 28 0 0.13  
0.5 9 27 268 173 159 100 176 130 91 0.41 0.41  
1 119 80 188 40 39 64 20 79 58 0.65 0.26  
2 16 21 8 11 60 12 17 21 18 0.91 0.08 Yes 
3 6 16 9 14 10 26 10 13 7 0.94 0.03  
   
eri-9 
(gg106) 
0.1 272 244 232 219 255 244  244 18 0 0.10  
0.5 14 26 148 137 172 200 196 128 77 0.47 0.32  
1 137 144 86 150 176   139 33 0.42 0.14  
2 23 17 48 117 13 121 140 68 55 0.71 0.23  
3 2 8 97 40 12 15 5 26 34 0.89 0.14  
   
eri-11 
(gg99) 
0.1 280 292 216 252 270 260 243 259 25 0.05 0.11  
0.5 96 20 113 132 248 164  129 76 0.53 0.28 Yes 
1 86 62 200 196 51 121 99 116 60 0.57 0.22  
2 60 62 17 10 22 17  31 23 0.89 0.09 Yes 
3 11 6 8 4 16 9 8 9 4 0.97 0.01 Yes 
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Single L3-stage larvae were placed on RNAi food targeting pos-1; 4 days later, the number of 
progeny surviving to L3-stage larvae or older at each indicated concentration (OD at 600 nm) of 
initial bacterial culture was determined. For clarity, two bacterial culture concentrations (OD600nm 
of 0.03 and 2), which produced similar Eri penetrances as adjacent concentrations, are not 
included. The tabulated mean (Avg) and standard deviation (SD) were normalized to the brood 
sizes of each strain fed empty RNAi vector (Table 2.27), to obtain the normalized mean (N.Avg) 
and standard error of the mean (SEM). The normalized mean and the standard error of the mean 
for N2 wild type were used as the basis to indicate an Eri or a Rde phenotype (Eri?), with p<0.05 
as the criterion to denote significant difference from wild type response levels. A strain which 
fits the “best eri” criterion described in text is marked as “best”, with asterisks indicating 
concentrations of RNAi food at which it fulfilled the criterion. 
Table 2.26: Dilution series of Eri responses by RNAi feeding against pos-1 
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Table 2.26 (Continued): Dilution series results for pos-1 feeding 
Strain OD600 Brood Size Avg SD N.Avg SEM Eri? 
Wildtype 
(N2) 
0.1 216 205 272 180 196 232 205 217 30 0.04 0.17  
0.25 184 168 10 248 231 240  180 89 0.20 0.40  
0.5 201 170 169 150 153   169 20 0.26 0.11  
0.75 147 37 3 2 133 74 118 66 61 0.71 0.28  
1 30 0 3 2 0 4 71 7 27 0.97 0.05  
   
eri-1 
(mg366) 
0.1 123 128 154 164 164 171 192 151 24 0.05 0.14  
0.25 132 107 130 188 220 133 168 152 40 0.04 0.28  
0.5 39 0 7 6 10   13 15 0.92 0.11 Yes 
0.75 74 0 2 0 0 0 22 13 28 0.92 0.19  
1 64 55 2 0 1 0 0 20 29 0.87 0.19  
   
rrf-3 
(pk1426)  
0.1 91 176 162 126 168 184 186 151 35 0 0.28  
0.25 138 61 8 204 8 82  84 77 0.37 0.64  
0.5 0 50 1 2 0 0 1 8 19 0.93 0.15 Yes 
0.75 0 0 0 0 0 0 0 0 0 1.00 0 Yes 
1 0 0 0 0 0 0 0 0 0 1.00 0  
   
eri-3 
(tm1361) 
0.1 109 90 124 140 125 192 144 130 32 0.17 0.24  
0.25 142 136 100 27 10 36 25 75 56 0.52 0.38  
0.5 11 32 41 2 7 5 7 16 15 0.90 0.10 Yes 
0.75 0 0 0 8 4 0 17 2 6 0.99 0.02 Yes 
1 0 2 2 1 18   5 8 0.97 0.05  
   
eri-5 
(tm1705)
0.1 
 
*Best* 
129 174 192 228 85 244 200 175 56 0 0.37  
0.25 78 85 208 184 35 252 136 140 79 0.18 0.51  
0.5** 1 5 3 0 0 2 16 2 6 0.99 0.01 Yes 
0.75** 0 0 0 1 0 0 0 0 0 1.00 0 Yes 
1 10 0 0 0 0 0 0 2 4 0.99 0.02  
   
eri-6/7 
(tm1917) 
0.1 166 156 144 128 164 167  154 15 0.01 0.13  
0.25 186 200 15 97 128 168 184 132 66 0.15 0.45  
0.5 68 0 20 0 23 22  22 25 0.86 0.18 Yes 
0.75 1 1 0 0 2 0 0 1 1 1.00 0.01 Yes 
1 0 0 1 1 0 0 0 0 0 1.00 0  
   
eri-8 
(gg100)  
0.1 232 256 184 252 304 240 204 245 39 0 0.18  
0.25 168 264 99 75 29 129 236 127 85 0.43 0.37  
0.5 40 0 1 50 84 2  35 34 0.84 0.16 Yes 
0.75 32 11 0 0 0 0 1 7 12 0.97 0.06 Yes 
1 44 30 0 1 1 1 0 13 18 0.94 0.09  
   
eri-9 
(gg106) 
0.1 224 248 252 200 168 228 210 220 29 0.08 0.14  
0.25 144 172 164 62 128 192  134 46 0.44 0.19  
0.5 47 71 4 2 0 1 2 21 29 0.91 0.13 Yes 
0.75 5 0 0 1 0 0 21 1 8 1.00 0.01 Yes 
1 0 0 0 0 0 0 9 0 3 1.00 0  
   
eri-11 
(gg99) 
0.1 240 208 250 244 256 224 216 237 18 0.13 0.09  
0.25 252 214 272 258 228 243 192 245 28 0.11 0.10  
0.5 212 230 296 77 202 128  191 78 0.30 0.29  
0.75 64 67 0 0 1 3  26 33 0.90 0.13  
1 0 0 6 0 0 37 8 7 14 0.97 0.05  
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Table 2.27: Different Eri strains’ brood sizes upon L4440 vector feeding 
Strain Brood Size Avg SD 
Wildtype 
(N2) 185 218 237 242 208 247 248 222 215 244 227 21 
eri-1 
(mg366) 168 156 151 162 149 167 167 147   158 9 
rrf-3 
(pk1426) 137 137 142 135 143 138 139 117 127 119 133 9 
eri-3 
(tm1361) 169 160 146 134 151 176 167 143   156 16 
eri-5 
(tm1705) 150 188 189 144 173 177 186 172 177 147 170 17 
eri-6/7 
(tm1917) 145 143 154 176 143 168 168 148 152  155 12 
eri-8 
(gg100) 226 229 208 230 219 234 219 221 218  223 8 
eri-9 
(gg106) 221 249 233 231 237 227 262 254 241  239 13 
eri-11 
(gg99) 285 242 274 284 297 279 268 285 249  274 18 
sid-1 
(qt9) 178 206 214 238 211 224 218 260 243 231 222 23 
 
The presented means and standard deviations were used for normalized means and standard 
errors of the means in RNAi feeding assays that caused lethality phenotypes. 
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When dsRNA doses cannot be controlled, using the most appropriate Eri mutant maximizes 
robustness and sensitivity. 
We selected RNAi targets based on tissue-specific gene expression and/or phenotypes, 
and interpreted the data based on these differences, but it’s important to consider that the 
differences in responses might relate to unknown relationships between the genes.  Consistent 
with our goal, most sets of tissue-specific genes show consistent phenotypes within Eri mutant 
classes.  For rrf-3 and ergo-1/eri-8, we analyzed a second independent allele, finding similar 
tissue specificity.  Therefore, the observed tissue specificity is likely a property of the eri genes 
rather than a consequence of unique alleles (Figure 2.3). 
 To further document tissue-specific Eri phenotypes, we crossed all the Eri mutants into a 
sur-5::gfp strain that ubiquitously expresses GFP in all cells (GU et al. 1998). All the eri(-);sur-
5::gfp doubles exhibited spontaneous transgene silencing (Figure 2.4),  which interfered with the 
effect of gfp dsRNA.  However, consistent with the tissue-specific effects described above, the 
relative differences in spontaneous gfp silencing in the intestinal nuclei among eri-1;sur-5::gfp, 
rrf-3;sur-5::gfp, and ergo-1/eri-8;sur-5::gfp strains corresponded with their relative differences 
in RNAi efficacy against endogenous intestinal targets (Table 2.28). 
A limited comparison of the Eri phenotypes of retinoblastoma pathway mutants lin-
15b(n744) and lin-35(n745) (Wang et al. 2005) with eri-1 and rrf-3 showed that their sensitivity 
and robustness were less than the Eri mutants’ (Figure 2.5). 
We also found that all the Eri mutants show strong maternal rescue (Figures 2.6, 2.7; 
Tables 2.29-2.32). However, there is no maternal rescue for the temperature-sensitive (T.S.) 
sterility phenotype of T.S. Eri mutants (Table 2.33). This is not due to a perdurance problem in 
which the maternally-loaded products are depleted before eri-related spermatogenesis begins, 
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Single L3-stage larvae were placed on RNAi food targeting act-3 (A), hmr-1 (B), and vha-15 
(C); 4 days later, the percent of progeny showing the expected knockdown phenotypes, as listed 
in Table 2.1, at each indicated concentration (OD at 600 nm) of initial bacterial culture were 
determined.  Error bars represent 95% confidence intervals. 
Figure 2.3: Dilution series of Eri responses of different rrf-3 and eri-8 alleles by RNAi feeding 
against act-3, hmr-1, and vha-15 
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Figure 2.3 (Continued): Dilution series of Eri responses of different rrf-3 and eri-8 alleles by RNAi 
feeding against act-3, hmr-1, and vha-15 
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Eri mutants enhance transgene silencing in a sur-5::gfp background. GFP images were exposed 
for 100 milliseconds. Red scale bar indicates 0.2 mm. 
Figure 2.4: All Eri mutants enhance transgene silencing 
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Table 2.28: Transgene silencing penetrance of eri-1, rrf-3, and eri-8 in the sur-5::gfp 
background 
Strain Penetrance of spontaneous intestinal TGS at 20ºC Mean STD 
N2 wild type 3/98 1/88 2/109 1/19 0/82 0.02 0.02 
eri-1 (mg366) 48/62 28/46 31/54   0.65 0.11 
rrf-3 (pk1426) 73/83 76/91 38/45 39/57 97/107 0.83 0.09 
eri-8 (gg100) 30/38 24/42 25/35 42/53 28/40 0.71 0.09 
 
Single L3-stage larvae were placed on OP50 food; 4 days later, the percent of progeny showing 
spontaneous transgene silencing in the intestinal nuclei was determined. For consistency, only 
worms with distinctly absent gfp expression in intestinal nuclei, as shown in Figure 2.4, are 
scored as having spontaneous transgene silencing. 
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Single L3-stage larvae were placed on RNAi food targeting dpy-13 (A), unc-22 (B), and unc-73 
(C); 4 days later, the percent of progeny showing the expected knockdown phenotypes, as listed 
in Table 2.1, at each indicated concentration (OD at 600 nm) of initial bacterial culture were 
determined.  Error bars represent 95% confidence intervals. 
Figure 2.5: Dilution series of Eri responses of eri-1 and rrf-3 versus lin-15b and lin-35 by RNAi 
feeding against dpy-13, unc-22, and unc-73 
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Figure 2.5 (Continued): Dilution series of Eri responses of eri-1 and rrf-3 versus lin-15b and lin-
35 by RNAi feeding against dpy-13, unc-22, and unc-73
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An outcross between an Eri (e/e) hermaphrodite and a N2 wild type (+/+) male begets a 1:2:1 
(e/e):(e/+):(+/+) genotypic ratio at the F2. Assuming a single-locus recessive trait, the expectation 
is that one quarter of the F2 progeny should be Eri. (A) Out-crossed eri-1 (which is sterile at 
25ºC), eri-6/7, and eri-8 (which are not sterile at 25ºC) show significantly lower than expected 
levels (p<10-9) of the Eri phenotype at the F2.  Similarly, the F3 progeny of the F2 show 
significantly higher than expected levels (p<10-5) of wild-type progeny. (B) Out-crossed eri-1 
and rff-3 (which are both sterile at 25ºC) show expected levels (p>0.18) of the temperature-
sensitive sterile progeny at the F2. Figure 2.7 eliminates other possible parental rescue/effect 
mechanisms. Tables 2.29 and 2.32 show data used for p values. 
Figure 2.6: Somatic maternal rescue of the Eri phenotype 
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The progeny of a heterozygous Eri male crossed to homozygous Eri hermaphrodite versus a 
homozygous Eri male crossed to a heterozygous Eri hermaphrodite are compared for Eri 
phenotypes. Assuming a single-locus recessive trait, the expectation is that the F1 should be 50% 
Eri in both reciprocal crosses. (A) The cross progeny of eri-1, eri-6/7, and eri-8 show expected 
levels (p>0.48) of Eri phenotype when the mother is homozygous Eri.  (B) The cross progeny of 
eri-1, eri-6/7, and eri-8 show significantly lower than expected levels (p<10-13) of Eri phenotype 
when the mother is heterozygous Eri. See Tables 2.30 and 2.31 for data used in determining p 
values. 
Figure 2.7: Somatic maternal rescue of the Eri phenotype 
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Table 2.29: Maternal rescue of Eri phenotype on dpy-13 feeding via outcrossing 
Strain F2 Dpy:Non-Dpy χ2 value 
eri-1 (mg366) 0:60 0:30 0:40 0:80 0:50  1.5e-23 
rrf-3 (pk1426) 0:120 0:80 0:80    4.4e-22 
eri-3 (tm1361) 0:50 0:40 0:50 0:80 0:80  1.5e-23 
eri-6/7 (tm1917) 0:80 0:100 0:100 0:80 0:60  2.7e-32 
eri-8 (gg100) 4:29 2:34 4:48 4:25   9.4e-9 
eri-9 (gg106) 1:59 0:40 2:78 0:80 1:49 0:60 2.3e-26 
eri-11 (gg99) 0:40 3:32 2:31 2:38 0:60  5.8e-13 
 
Strain F3 100% Dpy: 25% Dpy: 100% Non-Dpy χ2 value 
eri-1 (mg366) 6:0:10 5:0:11 3:0:13   9.1e-15 
rrf-3 (pk1426) 6:0:10 2:0:12 4:0:12   2.8e-15 
eri-3 (tm1361) 2:0:14 4:0:12 3:0:13   2.2e-20 
eri-6/7 (tm1917) 5:0:11 5:0:11 5:0:11 3:0:13 5:0:11 2.3e-24 
eri-8 (gg100) 5:8:3 4:7:5 2:8:5 3:0:13 6:0:10 4.0e-5 
eri-9 (gg106) 4:0:12 3:0:13 2:0:14 5:0:11 3:0:13 1.4e-29 
eri-11 (gg99) 5:0:11 5:0:11 3:0:13 4:0:12 6:0:10 2.3e-24 
 
Corresponding to Figure 2.6A, the observed phenotypic ratios of the outcross progeny in the F2 
and F3 are as indicated. At the F2, the expected phenotypic ratio of 1:3 Dpy:non-Dpy is used as 
the basis for chi-squared test calculations; at the F3, the expected phenotypic ratio of 1:2:1 100% 
Dpy: 25% Dpy:100% Non-Dpy is used as the basis for chi-squared test calculations. Observed 
results are summed for chi-squared test calculations. 
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Strain 
Table 2.30: Maternal rescue of Eri phenotype on dpy-13 feeding via a heterozygous Eri male 
crossed with a homozygous Eri hermaphrodite 
F1 Dpy:Non-Dpy χ2 value 
eri-1 (mg366) 18:20 24:25 10:8 13:16 18:17 0.82 
rrf-3 (pk1426) 11:10 6:8 13:14   0.80 
eri-3 (tm1361) 5:8 4:6 13:10   0.77 
eri-6/7 (tm1917) 14:9 6:4 4:6   0.45 
eri-8 (gg100) 21:28 12:11 20:18 16:18 8:11 0.48 
eri-9 (gg106) 12:18 18:13 10:14 15:15  0.64 
eri-11 (gg99) 11:16 10:14 12:10 10:7 13:10 0.93 
 
Corresponding to Figure 2.7A, the observed phenotypic ratios of the cross progeny are as 
indicated. The expected phenotypic ratio of 1:1 Dpy:non-Dpy is used as the basis for chi-squared 
test calculations. Observed results are summed for chi-squared test calculations. 
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Table 2.31: Maternal rescue of Eri phenotype on dpy-13 feeding via a homozygous Eri male 
crossed with a heterozygous Eri hermaphrodite 
Strain F1 Dpy:Non-Dpy χ2 value 
eri-1 (mg366) 0:16 0:14 0:33   2.1e-15 
rrf-3 (pk1426) 0:18 0:13 0:23 0:16  5.9e-17 
eri-3 (tm1361) 0:40 0:20 0:20   3.7e-19 
eri-6/7 (tm1917) 0:60 0:60 0:80 0:80 0:50 9.6e-74 
eri-8 (gg100) 1:14 5:14 4:17 5:28 2:22 1.7e-13 
eri-9 (gg106) 0:25 0:29 0:16   5.9e-17 
eri-11 (gg99) 0:19 0:20 0:21 0:24  4.9e-20 
 
 
Corresponding to Figure 2.7B, the observed phenotypic ratios of the cross progeny are as 
indicated. The expected phenotypic ratio of 1:1 Dpy:non-Dpy is used as the basis for chi-squared 
test calculations. Observed results are summed for chi-squared test calculations. 
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Table 2.32: Maternal rescue of Eri phenotype on hmr-1 and unc-73 feeding via outcrossing 
Strain Food F2 Phenotype:No-Phenotype χ2 value 
eri-1 (mg366) unc-73 0:76 0:45 0:35 0:45  2.7e-16 
rrf-3 (pk1426) unc-73 0:34 0:36 0:23   2.6e-8 
eri-8 (gg100) unc-73 8:24 3:27 3:28 3:38 2:34 3.1e-5 
 
Strain Food F3 100% Phenotype: 25%Phenotype:No-Phenotype χ2 value 
eri-1 (mg366) unc-73 4:0:12 5:0:11 4:0:12 3:0:13 1.4e-21 
rrf-3 (pk1426) unc-73 5:0:11 5:0:11 2:0:14 3:0:13 1.8e-22 
eri-3 (tm1361) hmr-1 6:0:10 2:0:14 3:0:13 4:0:12 1.8e-22 
eri-6/7 (tm1917) hmr-1 3:0:13 3:0:13 2:0:14  2.1e-20 
eri-8 (gg100) hmr-1 2:0:14 1:0:15 3:0:13  7.1e-23 
 
Corresponding to Figure 2.6A, the observed phenotypic ratios of the outcross progeny in the F2 
and F3 are as indicated when fed the three respective RNAi foods. At the F2, the expected 
phenotypic ratio of 1:3 with-phenotype:without-phenotype is used as the basis for chi-squared 
test calculations; at the F3, the expected phenotypic ratio of 1:2:1 100% with-phenotype: 25% 
with-phenotype: 100% without-phenotype is used as the basis for chi-squared test calculations. 
Observed results are summed for chi-squared test calculations. 
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Table 2.33: No maternal rescue of Eri phenotype-related spermatogenesis defects 
Strain F2 Sterile:Non-sterile χ2 value 
eri-1 (mg366) 2:14 3:13 3:12 0.18 
rrf-3 (pk1426) 5:11 3:13 5:11 0.74 
eri-3 (tm1361) 3:13 4:12 3:13 0.50 
 
Corresponding to Figure 2.6B, the observed phenotypic ratios of the outcross progeny are as 
indicated. The expected phenotypic ratio of 1:3 sterile:not-sterile is used as the basis for chi-
squared test calculations. Observed results are summed for chi-squared test calculations.
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because we utilized bli-1 RNAi – whose target is expressed only during the fourth larval stage 
(PAGE 1997) when spermatogenesis begins – and found penetrant maternal rescue of the Eri 
phenotype (Table 2.34). Eri maternal rescue could suggest that part of the maternal contribution 
to the embryo includes small RNAs or their associates. 
The described tissue-specific RNAi sensitivities, T.S. sterility data, maternal rescue 
penetrance, brood size (Table 2.27), and effect on transgenes provide a practical guide to the 
selection of Eri mutants. There are other weaker enhanced RNAi mutants, including dcr-1/eri-
4(mg375) (PAVELEC et al. 2009), tissue-specific sid-1 overexpressers (CALIXTO et al. 2010), and 
transgene-specific silencers (KNIGHT and BASS 2002). Though these may not be versatile genetic 
tools, their future phenotypic analysis is equally important, because understanding the 
interactions amongst all eri genes provides insights about small RNA pathways. 
 
As listed in Table 2.1, some RNAi foods had relatively extreme loss-of-function 
phenotypes scored for the sake of more explicit precision. For example, unc-22 RNAi is usually 
scored just for the mere presence of twitching (FIRE et al. 1991). However, unc-22 RNAi still 
causes twitching down to a 1/200,000 dilution of bacterial RNAi food in both N2 and eri-1 (data 
not shown), at which point, errors from dilution is probably more variable than the phenotypic 
penetrance. Therefore, the more extreme phenotype of twitching to the point of paralysis is more 
appropriate for our dilution series’ scoring purposes. Knockdown assays in general should 
therefore similarly consider the relationship between expressivity and penetrance at the 
concentrations of RNAi foods used. Although expressivity is another factor usually 
SUPPLEMENTAL RESULTS AND DISCUSSION 
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Strain 
Table 2.34: Maternal rescue of Eri phenotype on bli-1 feeding via outcrossing 
Penetrance of Bli at F2 Mean STD p value 
N2 wild type 39/86 63/144 58/119  0.46 0.03  
eri-1 (mg366) 78/87 66/97 65/70  0.84 0.13 0.008 
rrf-3 (pk1426) 46/51 34/41 38/41  0.89 0.05 0.0002 
eri-8 (gg100) 46/67 45/69 47/80  0.64 0.05 0.006 
N2 x eri-1 63/134 51/116 74/139 34/80 0.47 0.05 0.78 
N2 x rrf-3 36/73 64/123 15/37 32/74 0.46 0.05 1 
N2 x eri-8 75/145 48/101 36/72 52/97 0.51 0.03 0.11 
 
Corresponding to Figure 2.6A, the observed phenotypic penetrances of the outcross progeny in 
the F2 are as indicated. The N2 wild type penetrance was used as the basis for a t test, to compare 
an Eri mutant’s or an outcrossed-Eri mutant’s penetrance, with a two-tailed p value as indicated. 
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considered for RNAi efficacy, it is much harder to quantify objectively. Penetrance of one very 
specific phenotype was therefore used as the sole measure of knockdown efficacy. 
RNAi phenotypes were scored in the next generation for of three reasons. One, this 
practice is more common in the field for reverse genetics applications, so our method would 
serve as a more fitting guideline. Two, putting L3s on RNAi food and scoring the next 
generation versus putting embryos on RNAi food and scoring the same generation results in 
almost identical phenotypic penetrance (data not shown; (VASTENHOUW et al. 2006)). Three, 
scoring in the next generation allows for a more consistent method across all the to-be tested 
RNAi foods, including those with germline phenotypes that cannot be assayed in the same 
generation. 
The data in Figure 2.2 and Tables 2.2-2.26 should not be construed as an absolute scale 
(that feeding a particular Eri mutant on a particular RNAi food concentration will result in the 
listed penetrance), due to differences between protocols. Rather, the relative differences between 
conditions (that one particular Eri mutant has different penetrance on different concentrations of 
an RNAi food) are the trends that should be robust. 
Previous reports showed that a portion of the spontaneous transgene silencing is due to 
mobile silencing signals (JOSE et al. 2009) and the silenced cells in the gut correspond to the 
position of the developing gonad, suggestive that silencing signals emanate from the germline.  
We tested this by ablating the gonad of L1 animals and found that the extent of silencing was 
unchanged (Figure 2.8). Thus the silencing is either entirely of somatic origin or is initiated in 
the embryo. 
The strong germline-specific eri-5(tm1705) phenotype was unexpected.   This may reflect 
the incomplete penetrance eri-5 has on small RNA metabolism; eri-5 mutants show reduced but 
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eri-8 (gg100); sur-5::gfp animals exhibit spontaneous transgene silencing (A) even with a laser 
ablated germline (B) (see Supplemental Materials and Methods). eri-8 (gg100); sur-5::gfp 
animals fed RNAi targeting glp-1 still exhibit spontaneous transgene silencing (C), despite also 
lacking germlines (D). GFP images were exposed for 100 milliseconds. Red scale bar indicates 
0.2 mm. 
Figure 2.8: Transgene silencing seen in Eri mutants is not from a germline source 
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not eliminated endo-siRNA processing (DUCHAINE et al. 2006).  To date, no screens have been 
performed for germline-specific Eri mutants; such a screen could reveal the different 
requirements for endogenous small RNA pathways. 
Duchaine et al. 2006 reported a rather weak Eri phenotype for eri-5(mg392) for some 
somatic targets, whereas we generally did not see a somatic Eri phenotype for eri-5(tm1705). 
This difference could be due to the fact that we systemically enumerated the RNAi food 
concentrations at which we scored our animals, whereas Duchaine et al. did not; it is quite likely 
that when they scored their animals, they were at a concentration of food that may have produced 
a weak Eri phenotype. Furthermore, we scored only penetrance of a strict phenotype, whereas 
Duchaine et al. scored a combination of expressivity and penetrance, also possibly accounting 
for our differences. 
 
 
MATERIALS AND METHODS 
Strains  
Strains used in this study are listed in Table 2.35. All strains and their assays were maintained 
and performed at 20ºC, except heat shift experiments for temperature-sensitive alleles, which 
were performed at 25ºC. 
 
Dilution series procedure 
Single colonies from the Ahringer library (KAMATH and AHRINGER 2003) were inoculated and 
grown using previously described methods (TIMMONS et al. 2001). The final optical density 
(OD) of bacteria was determined by spectrometry at 600 nm. For dilution series, the bacteria 
were diluted in either LB media for final OD of 1.0 or greater, or in neutral carrier bacteria 
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Strain 
Table 2.35: Strains used in this study 
Allele Reference 
N2 Bristol Wild type  
GR1373 eri-1(mg366) Kennedy et al. 2004 
NL2099 rrf-3(pk1426) Simmer et al. 2002 
YY13 rrf-3(mg373) Pavelec et al. 2009 
WM172 eri-3(tm1361) Duchaine et al. 2006 
WM171 eri-5(tm1705) Duchaine et al. 2006 
FX01917 eri-6/7(tm1917) Fischer et al. 2008 
YY168 eri-8(gg100) Pavelec et al. 2009 
WM158 eri-8(tm1860) Pavelec et al. 2009 
YY216 eri-9(gg106) Pavelec et al. 2009 
YY209 eri-11 (gg99) Unpublished. S. Kennedy 
MT2495 lin-15b(n744) Wang et al. 2005 
MT10430 lin-35(n745) Wang et al. 2005 
HC195 nrIs20[sur-5::gfp] Jose et al. 2009 
HC745 eri-1(mg366); nrIs20 [sur-5::gfp]  
HC746 rrf-3(pk1426); nrIs20 [sur-5::gfp]  
HC747 eri-3(tm1316); nrIs20 [sur-5::gfp]  
HC748 eri-6/7(tm1917); nrIs20 [sur-5::gfp]  
HC749 ergo-1/eri-8(gg100); nrIs20 [sur-5::gfp]  
HC750 eri-9(gg106); nrIs20 [sur-5::gfp]  
HC751 eri-11(gg99); nrIs20 [sur-5::gfp]  
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(E.coli HT115(DE3) containing  an empty L4440 vector) to maintain a minimal total bacteria 
concentration of 1.0 OD. This minimal bacterial concentration was found necessary to maintain 
worm growth.  In each case 20 µL of RNAi food (which is enough to support the progeny from 
one worm) at the desired concentrations were seeded onto and grown overnight at room 
temperature onto 1mM isopropyl-β-D-thiogalactopyranoside (GoldBio), 1mM carbenicillin 
(EMD Biosciences) NG plates (BRENNER 1974) in 30mm petri dishes (Greiner Bio-One) to 
induce dsRNA production. Non-starved third-larval stage single C. elegans worms of the desired 
strain were placed onto each seeded plate at 20ºC, with the exception of fkh-6, gon-1, and gon-4 
RNAi foods, which required first-larval stage single worms to be placed to ensure the 
elimination of the gonad.  
Observed knockdown phenotypes were similar to previously observed RNAi experiments 
with the same gene targets, as reported in WormBase Release WS217. A single scored 
phenotype, as listed in Table 2.1, was scored for penetrance in the progeny generation of each 
plate’s single worm four days later. HC196:sid-1(qt9) was used as a negative control and, as 
expected, did not show any RNAi knockdown phenotypes across all foods tested (WINSTON et 
al. 2002). Each Eri strain on each concentration of RNAi food was replicated between five to 12 
times, as indicated in Tables 2.2 & 2.4-2.26. 
Means and standard deviations were calculated for each Eri strain on each RNAi food 
concentration for nonlethal/non-growth-defective phenotypes. Normalized mean and standard 
errors of the mean were calculated for each Eri strain on each RNAi food concentration for 
lethal/growth-defective phenotypes, with brood sizes of each Eri strain feeding on vector RNAi 
food (Table 2.27) – which agreed very well with previously published data (DUCHAINE et al. 
2006; PAVELEC et al. 2009) – used for normalization. A t test analysis of the N2 wild-type 
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response on each RNAi food concentration is the basis for determining an Eri phenotype on that 
RNAi food concentration, with a two-tailed p value less than 0.05 indicating significant 
difference. Coefficients of variation were tabulated by dividing the standard deviation by the 
mean. 
 
Maternal rescue analysis: 
Genetic cross analysis for an Eri phenotype on dpy-13 RNAi food was tested at OD600nm 1.5, on 
hmr-1 RNAi food at OD600nm 0.5, and on unc-73 RNAi food at OD600nm 3.0, using the same 
aforementioned setup for inoculating, growing, and seeding the RNAi plates. The shift to 25ºC to 
test for maternal rescue of temperature-sensitive sterility was made at the third-larval stage to 
ensure that spermatogenesis occurred at 25ºC. 
 
Imaging: 
All images were initially analyzed on an Olympus dissecting scope, with Illumatool Tunable 
Lighting System, attached to an EXFO X-Cite Fluorescence Illumination System for fluorescent 
detection assays. All presented images were captured on a Zeiss Axiophot, attached to a Zeiss 
AttoArc for fluorescent detection assays, using a Hamamatsu Digital Camera, with Openlab 
software. Scale bar was measured using a 0.01 mm stage micrometer (Olympus). After initial 
image capture, all subsequent analysis of images was performed using ImageJ software (National 
Institutes of Health, USA). 
 
Laser ablation: 
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The eri-8; sur-5::gfp strain underwent germline removal via laser ablation as described in 
Bargmann and Avery 1995. Technical assistance courtesy of Stephen A. Banse. 
 
AHNN, J., and A. FIRE, 1994 A screen for genetic loci required for body-wall muscle 
development during embryogenesis in Caenorhabditis elegans. Genetics 137: 483-498. 
LITERATURE CITED 
 
BIRD, D. M., 1992 Sequence comparison of the Caenorhabditis elegans dpy-13 and col-34 genes, 
and their deduced collagen products. Gene 120: 261-266. 
 
BOWERMAN, B., M. K. INGRAM and C. P. HUNTER, 1997 The maternal par genes and the 
segregation of cell fate specification activities in early Caenorhabditis elegans embryos. 
Development 124: 3815-3826. 
 
BRENNER, S., 1974 The genetics of Caenorhabditis elegans. Genetics 77: 71-94. 
 
BROADBENT, I. D., and J. PETTITT, 2002 The C. elegans hmr-1 gene can encode a neuronal 
classic cadherin involved in the regulation of axon fasciculation. Curr Biol 12: 59-63. 
 
CALIXTO, A., D. CHELUR, I. TOPALIDOU, X. CHEN and M. CHALFIE, 2010 Enhanced neuronal 
RNAi in C. elegans using SID-1. Nat Methods 7: 554-559. 
 
CHANG, W., C. TILMANN, K. THOEMKE, F. H. MARKUSSEN, L. D. MATHIES et al., 2004 A 
forkhead protein controls sexual identity of the C. elegans male somatic gonad. 
Development 131: 1425-1436. 
 
CHEESEMAN, I. M., S. NIESSEN, S. ANDERSON, F. HYNDMAN, J. R. YATES, 3RD et al., 2004 A 
conserved protein network controls assembly of the outer kinetochore and its ability to 
sustain tension. Genes Dev 18: 2255-2268. 
 
CHURCH, D. L., and E. J. LAMBIE, 2003 The promotion of gonadal cell divisions by the 
Caenorhabditis elegans TRPM cation channel GON-2 is antagonized by GEM-4 copine. 
Genetics 165: 563-574. 
 
DUCHAINE, T. F., J. A. WOHLSCHLEGEL, S. KENNEDY, Y. BEI, D. CONTE, JR. et al., 2006 
Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple 
small-RNA-mediated pathways. Cell 124: 343-354. 
 
FIRE, A., D. ALBERTSON, S. W. HARRISON and D. G. MOERMAN, 1991 Production of antisense 
RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. 
Development 113: 503-514. 
 
123 
 
FISCHER, S. E., M. D. BUTLER, Q. PAN and G. RUVKUN, 2008 Trans-splicing in C. elegans 
generates the negative RNAi regulator ERI-6/7. Nature 455: 491-496. 
 
GU, T., S. ORITA and M. HAN, 1998 Caenorhabditis elegans SUR-5, a novel but conserved 
protein, negatively regulates LET-60 Ras activity during vulval induction. Mol Cell Biol 
18: 4556-4564. 
 
HUNT-NEWBURY, R., R. VIVEIROS, R. JOHNSEN, A. MAH, D. ANASTAS et al., 2007 High-
throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol 5: 
e237. 
 
HUSKEN, K., T. WIESENFAHRT, C. ABRAHAM, R. WINDOFFER, O. BOSSINGER et al., 2008 
Maintenance of the intestinal tube in Caenorhabditis elegans: the role of the intermediate 
filament protein IFC-2. Differentiation 76: 881-896. 
 
JOSE, A. M., J. J. SMITH and C. P. HUNTER, 2009 Export of RNA silencing from C. elegans 
tissues does not require the RNA channel SID-1. Proc Natl Acad Sci U S A 106: 2283-
2288. 
 
KAMATH, R. S., and J. AHRINGER, 2003 Genome-wide RNAi screening in Caenorhabditis 
elegans. Methods 30: 313-321. 
 
KENNEDY, S., D. WANG and G. RUVKUN, 2004 A conserved siRNA-degrading RNase negatively 
regulates RNA interference in C. elegans. Nature 427: 645-649. 
 
KNIGHT, S. W., and B. L. BASS, 2002 The role of RNA editing by ADARs in RNAi. Mol Cell 10: 
809-817. 
 
KO, F. C., and K. L. CHOW, 2003 A mutation at the start codon defines the differential 
requirement of dpy-11 in Caenorhabditis elegans body hypodermis and male tail. 
Biochem Biophys Res Commun 309: 201-208. 
 
LEE, R. C., C. M. HAMMELL and V. AMBROS, 2006 Interacting endogenous and exogenous RNAi 
pathways in Caenorhabditis elegans. RNA 12: 589-597. 
 
MACQUEEN, A. J., J. J. BAGGETT, N. PERUMOV, R. A. BAUER, T. JANUSZEWSKI et al., 2005 ACT-
5 is an essential Caenorhabditis elegans actin required for intestinal microvilli formation. 
Mol Biol Cell 16: 3247-3259. 
 
MANGO, S. E., 2007 The C. elegans pharynx: a model for organogenesis, pp. 1-26 in WormBook. 
 
MCKAY, S. J., R. JOHNSEN, J. KHATTRA, J. ASANO, D. L. BAILLIE et al., 2003 Gene expression 
profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold 
Spring Harb Symp Quant Biol 68: 159-169. 
 
124 
 
MEISSNER, B., A. WARNER, K. WONG, N. DUBE, A. LORCH et al., 2009 An integrated strategy to 
study muscle development and myofilament structure in Caenorhabditis elegans. PLoS 
Genet 5: e1000537. 
 
MITANI, S., 2009 Nematode, an experimental animal in the national BioResource project. Exp 
Anim 58: 351-356. 
 
MYLLYHARJU, J., and K. I. KIVIRIKKO, 2004 Collagens, modifying enzymes and their mutations 
in humans, flies and worms. Trends Genet 20: 33-43. 
 
PAGE, A. P., JOHNSTONE, I.L., 1997 The cuticle (March 19, 2007), pp. WormBook, ed. The C. 
elegans Research Community, WormBook, doi/10.1895/wormbook.1.138.1, 
http://www.wormbook.org.  
 
PAVELEC, D. M., J. LACHOWIEC, T. F. DUCHAINE, H. E. SMITH and S. KENNEDY, 2009 
Requirement for the ERI/DICER complex in endogenous RNA interference and sperm 
development in Caenorhabditis elegans. Genetics 183: 1283-1295. 
 
REA, S. L., VENTURA, N., JOHNSON, T.E., 2007 Relationship between mitochondrial electron 
transport chain dysfunction, development, and life extension in Caenorhabditis elegans. 
PLoS Biology 5: 2312-2329. 
 
SEYDOUX, G., and A. FIRE, 1994 Soma-germline asymmetry in the distributions of embryonic 
RNAs in Caenorhabditis elegans. Development 120: 2823-2834. 
 
SIMMER, F., M. TIJSTERMAN, S. PARRISH, S. P. KOUSHIKA, M. L. NONET et al., 2002 Loss of the 
putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to 
RNAi. Curr Biol 12: 1317-1319. 
 
TABARA, H., R. J. HILL, C. C. MELLO, J. R. PRIESS and Y. KOHARA, 1999 pos-1 encodes a 
cytoplasmic zinc-finger protein essential for germline specification in C. elegans. 
Development 126: 1-11. 
 
TAMAI, K. K., and K. NISHIWAKI, 2007 bHLH transcription factors regulate organ morphogenesis 
via activation of an ADAMTS protease in C. elegans. Dev Biol 308: 562-571. 
 
TIMMONS, L., D. L. COURT and A. FIRE, 2001 Ingestion of bacterially expressed dsRNAs can 
produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263: 
103-112. 
 
TIMMONS, L., and A. FIRE, 1998 Specific interference by ingested dsRNA. Nature 395: 854. 
 
VANDERZALM, P. J., A. PANDEY, M. E. HURWITZ, L. BLOOM, H. R. HORVITZ et al., 2009 C. 
elegans CARMIL negatively regulates UNC-73/Trio function during neuronal 
development. Development 136: 1201-1210. 
 
125 
 
VASTENHOUW, N. L., K. BRUNSCHWIG, K. L. OKIHARA, F. MULLER, M. TIJSTERMAN et al., 2006 
Gene expression: long-term gene silencing by RNAi. Nature 442: 882. 
 
VOUGHT, V. E., M. OHMACHI, M. H. LEE and E. M. MAINE, 2005 EGO-1, a putative RNA-
directed RNA polymerase, promotes germline proliferation in parallel with GLP-1/notch 
signaling and regulates the spatial organization of nuclear pore complexes and germline P 
granules in Caenorhabditis elegans. Genetics 170: 1121-1132. 
 
WANG, P., J. ZHAO and A. K. CORSI, 2006 Identification of novel target genes of CeTwist and 
CeE/DA. Dev Biol 293: 486-498. 
 
WINSTON, W. M., C. MOLODOWITCH and C. P. HUNTER, 2002 Systemic RNAi in C. elegans 
requires the putative transmembrane protein SID-1. Science 295: 2456-2459. 
 
XING, J., X. YAN, A. ESTEVEZ and K. STRANGE, 2008 Highly Ca2+-selective TRPM channels 
regulate IP3-dependent oscillatory Ca2+ signaling in the C. elegans intestine. J Gen 
Physiol 131: 245-255. 
 
 
 
 
 
Chapter Three 
Analyses of three screens for novel RNAi mutants
Some contents were previously presented as a part of the Ph.D. qualification report and its accompanying 
preliminary data (May, 2010).
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The identification of the currently known enhanced RNAi mutants was a result of a 
variety of approaches, many of which were mutually confirmatory. Of the canonical eri mutants 
described in Chapter Two, rrf-3 was the first discovered, and characterized completely 
fortuitously during an analysis of the four C. elegans RNA-dependent RNA polymerases 
(RdRPs) (SIMMER et al. 2002). It was re-discovered along with eri-1, eri-3, eri-4/dcr-1, eri-5, 
and eri-6/7 in a forward genetic screen for enhanced neuronal silencing (KENNEDY et al. 2004). 
In this screen, gfp was driven by the neuronal promoter of unc-47, and because C. elegans 
neurons are normally recalcitrant to RNAi, mutant strains exhibiting knockdown of gfp were thus 
deemed enhanced for RNAi. Around the same time, another group was attempting to analyze the 
biochemical interactions of dicer; because C. elegans only has one dicer homolog in its genome, 
this “chokepoint” analysis was extremely insightful (DUCHAINE et al. 2006). In this study, 
although most DCR-1-interacting genes were expectedly RNAi-defective (Rde) when mutated, 
ERI-3 and ERI-5 were found to interact as well. Finally, eri-6/7 was re-discovered along with 
eri-8/ergo-1, eri-9, and eri-11 in a forward genetic screen for enhanced pan-operon silencing 
(PAVELEC et al. 2009). In this screen, lin-15b(RNAi) was fed to worms, and while wild type 
strains exhibited no effect, enhanced RNAi animals knocked down both lin-15b and lin-15a 
transcripts because the two are in an operon, which causes a multi-vulva phenotype. 
INTRODUCTION 
 Besides these canonical eri mutants, the lin-15(n765) mutant was discovered to be 
enhanced for RNAi ad hoc (WANG et al. 2005). Subsequently, large portions of the C. elegans 
synMuv rb pathway were similarly implicated as Eri, including hpl-2, lin-35, dpl-1, lin-13, lin-9, 
lin-38, lin-56, let-60, and efl-1 (LEHNER et al. 2006; WANG et al. 2005). Recently, small RNA 
sequencing of some rb mutants found that many RNAi components, especially those in the 
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germline, like worm-specific secondary Argonautes (WAGOs), are overexpressed in these rb 
mutants (WU et al. 2012), thus partially explaining their mechanism of action. 
 Both the eri and rb class not only enhance RNAi against exogenous double-stranded 
RNA (dsRNA), but also enhance spontaneous transgene silencing (ZHUANG and HUNTER 2011). 
If the definition of enhanced RNAi is extended to include enhanced transgene silencing, then 
transcriptional regulators such as components of the DRM/dREAM protein complex or the 
nucleosome remodeling and deacetylase complex can also be classified as Eri mutants (WU et al. 
2012). However, the exact nature of how these genes affect responses to small RNAs is still 
unclear. A fascinating example of enhanced transgene silencing not corresponding to enhanced 
exogenous RNAi is the case of the adr mutants. C. elegans adenosine deaminases (ADAR-1, 
ADAR-2) deaminate adenosines to inosines in dsRNAs in order to prevent transgenes from 
being somatically silenced. In adr-1 and adr-2 mutants, there is enhanced transgene silencing, 
but no changes in sensitivity to exogenous dsRNA (KNIGHT and BASS 2002). 
 While enhanced RNAi is the focus of my research, it’s noteworthy to point out that many 
screens for what was expected to be an Rde phenotype turned up Eri mutants, such as the 
aforementioned cases of rrf-3, eri-3, and eri-5, and the candidate screen I performed in Chapter 5 
(Table 5.1). Thus, discussing the nature of the Rde screens performed to date is similarly 
important for examining the potential landscape of enhanced RNAi. The first screen performed 
for Rde mutants fed worms dsRNA against pos-1, a germline gene target, and selected for 
survivors (TABARA et al. 1999). Based on a hypothesis presented in the first screen, another 
group performed a candidate screen of strains unable to repress Tc1 transposition, and some 
turned out to also be RNAi-insensitive (KETTING et al. 1999). Biochemical analysis of DCR-1 
and its interacting components also yielded many factors whose loss expectedly caused an Rde 
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phenotype (DUCHAINE et al. 2006; KNIGHT and BASS 2001). Another forward genetic screen 
performed for systemic RNAi defective (Sid) mutants examined worms with body-wall muscle 
gfp (myo-3::gfp), pharyngeal gfp (myo-2::gfp), and a pharyngeal dsRNA source (myo-2::pfg-
gfp). A worm that is Sid but not Rde will have desilencing of the bodywall muscle gfp, but 
maintain silencing of the pharyngeal gfp (WINSTON et al. 2002). The most recent forward genetic 
screen for Rde mutants used a neuronal dsRNA source (snb-1::pfg-gfp) and the ubiquitous sur-
5::gfp marker. An Rde worm in this screen will remain gfp positive (ZHANG et al. 2012). Finally, 
fortuitous discoveries of background mutations (ZHANG et al. 2011) and natural variations 
among C. elegans strains (TIJSTERMAN et al. 2002) that cause an Rde phenotype also occurred 
over the years.  
 With the recent advances in small RNA sequencing technology and the observations that 
eri mutants are defective for endogenous small RNA production, more and more approaches for 
understanding all the genes implicated in RNAi rely on genome-scale analysis. Many RNAi 
genes with weak phenotypes, which were perhaps previously bypassed in the genetic screens, are 
now having redoubled efforts devoted to their analysis because of confirmation through deep-
sequencing. For example, mutation to the RdRP rrf-2 was initially thought to be absent of any 
RNAi phenotypes; however, the fact that it was found to be misexpressed in a rb mutant made it 
a promising candidate for reexamination. And indeed, it was found to be very weakly Rde upon 
reanalysis (WU et al. 2012). 
 However, despite these advances, completely novel mechanisms for RNAi or its 
regulation may still be missed if deep sequencing is performed mostly in the context of already-
known RNAi mutants. Therefore, it’d be informative to examine areas that the published screens 
may have missed to possibly elucidate truly novel RNAi components. 
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The systemic effect of RNAi in C. elegans, whereby silencing spreads between cells and 
tissues, contributes significantly to its potency (FIRE et al. 1998). Because of this potency, 
unintended silencing must be avoided, suggesting significant levels of negative regulation; 
however, no known Eri mutant fits this model, especially at the systemic RNAi level. 
Furthermore, the distinction between regulating cell autonomous RNAi and systemic transport of 
silencing signals has not been characterized for any known Eri mutant, even though studies in 
plant RNAi transport have discovered roles played by proteins molecularly similar to the C. 
elegans ERIs (BROSNAN et al. 2007; DUNOYER et al. 2007; DUNOYER et al. 2005; HIMBER et al. 
2003; SCHWACH et al. 2005; SMITH et al. 2007; VOINNET 2008; YOO et al. 2004). 
SCREEN FOR ENHANCED SYSTEMIC RNAi 
A pilot screen of ~2,000 animals from 2002 (performed by W.M. Winston and C. 
Molodowitch) identified 13 enhanced RNAi spreader (Ersr) mutants. This screen was similar in 
design to the screen that identified the dsRNA channel sid-1 (FEINBERG and HUNTER 2003; 
WINSTON et al. 2002). In the pilot screen (Figure 3.1A), a pharyngeally-expressed gfp reporter 
(myo-2::gfp) and a bodywall muscle-expressed GFP reporter (myo-3::gfp) were silenced by a 
pharyngeally-expressed hairpin gfp (myo-2::pfg-gfp). In wild-type animals, the hairpin silences 
pharyngeal GFP modestly and bodywall muscle GFP along a gradient (Figure 3.1B); in Ersr 
mutants, pharyngeal GFP silenced at wild-type levels but bodywall muscle GFP was silenced to 
a greater extent, possibly because of greater spread of silencing. 
My analysis of these 13 Ersr mutants identified three classes (Figure 3.1C). In the first 
class, eight strong Ersr alleles failed to complement each other, mapped to a region near eri-6/7, 
and representative alleles failed to complement eri-6/7. The preponderance of eri-6/7 alleles may 
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Figure 3.1: Screen for enhanced RNAi spreader (Ersr) mutations and analysis of mutant alleles 
(A) Schematic of strain construction and expected phenotypes of RNAi defective (Rde) mutants, 
wild-type animals, and Ersr mutants. (B) GFP expression pattern of a wild-type animal in the 
screen background. Red arrow points to myo-2::gfp (pharyngeal) expression. White arrows point 
to myo-3::gfp (bodywall muscle) expression. There is increasing GFP expression with increasing 
distance away from the pharyngeal silencing source myo-2::pfg-gfp. (C) Alleles of each of the 
three classes of Ersrs found in the screen, the results of complementation analysis, and their 
phenotype by feeding RNAi. The three class II ersrs were independent, complementing alleles, 
whereas complementation between the two class III ersrs was not performed. (D) GFP 
expression pattern of a class I or class II ersr animal; qt71 was used as the representative allele. 
Red arrow points to myo-2::gfp (pharyngeal) expression. White arrows point to the weak 
remaining myo-3::gfp (bodywall muscle) expression. (E) GFP expression pattern of a class III 
ersr animal; qt74 was used as the representative allele. Red arrow points to myo-2::gfp 
(pharyngeal) expression. The was almost no myo-3::gfp (bodywall muscle) expression. All 
images are representative. Pharynx of worms are all pointing towards the upper left corner. 
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Figure 3.1 (Continued): Screen for enhanced RNAi spreader (Ersr) mutations and analysis of 
mutant alleles
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be expected, as the screen was performed at 25ºC, where most other eris are sterile (FISCHER et 
al. 2008). In the second class, three independent alleles became successively weaker after 
outcrossing; after three outcrosses, their phenotypic penetrance decreased to ~5%, making 
analysis difficult. Figure 3.1D shows representative gfp-reporter phenotypes of class 1 and 2 
Ersr alleles. The two remaining alleles in the third class strongly enhanced silencing of the gfp 
reporter (Figure 3.1E), but did not enhance RNAi for endogenous genes by feeding. An 
independent gfp reporter (sur-5::gfp) crossed into these two alleles showed similarly enhanced 
silencing. It’s likely that these alleles enhance only transgene silencing, a process actively 
involving RNAi (GRISHOK et al. 2005). Absence of a non-reporter phenotype again makes 
subsequent analysis difficult. However, it’s promising that a small screen captured a variety of 
Eris/Ersrs, encouraging future larger screen for unidentified RNAi regulators. 
Even though eight out the 13 candidates isolated did not complement eri-6/7(tm1917), 
surprisingly, we were not able to identify a molecular lesion by sequencing the genomic region 
of both eri-6 and eri-7 for the strongest mutant qt66. However, because eri-6/7 is a trans-spliced 
product, defects outside of the genomic region could still impact the complete assembly of a 
functional gene product (FISCHER et al. 2008). Interestingly enough, four of the six splice forms 
of eri-6 (c-f) contain three sets of direct repeats and a region with 99.3% nucleotide identity to 
K09B11.4, a paralog of retr-1; in fact, eri-6 was even initially annotated as rag-1-related. 
Furthermore, C. briggsae’s eri-6/7 is a fused (not trans-spliced) product while it has no 
K09B11.4 homolog. These facts suggest a possibility that C. elegans eri-6/7 evolved its structure 
in response to an adjacent insertion of a retrotransposon-like element. If true, the lack of 
molecular lesions within the eri-6/7 genomic region in our eight candidates could be related to 
the intricate assembly C. elegans eri-6/7 requires. 
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Analysis of the Ersr mutants from the pilot screen failed to identify new regulators, but 
the effort highlighted the subtlety of enhanced RNAi spreading phenotypes, suggesting a 
platform for analysis of Eri mutants that might regulate transport. To determine whether any of 
the published Eri mutants affect specific transport steps, I crossed each available eri mutant (and 
sid-1 as a control) into a sur-5::gfp background which expresses ubiquitous gfp (eri-x; sur-
5::gfp). I then crossed in a pharyngeally-expressed hairpin GFP (myo-2::pfg-gfp) and examined 
the silencing patterns to identify candidates for detailed analysis. 
CANDIDATE SCREEN FOR ENHANCED SYSTEMIC TRANSGENE SILENCING  
Ubiquitous gfp expression in sur-5::gfp worms is silenced in a gradient fashion when the 
myo-2::pfg-gfp hairpin is present (Figure 3.2A, B). The gfp expression is weakest near the 
source of the hairpin and gradually increases along the anterior-posterior axis of the worm. As 
expected, sid-1; myo-2::pfg-gfp; sur-5::gfp (Figure 3.2S, T) did not show any silencing 
spreading from the pharynx. This transgenic platform makes RNAi spreading visually accessible.  
For all the eris in the sur-5::gfp background (with or without the gfp hairpin), there is 
spontaneous transgene silencing near the middle of the worm (Figure 3.2C). This spontaneous 
silencing seems to be another competing RNAi pathway for limited resources because knocking 
out the endogenous RNAi pathway (eri mutants) or knocking down the exogenous RNAi 
pathway (Figure 3.3) increases its potency. Because this silencing “hole” is present in all eris, it 
somewhat impedes visualizing RNAi spreading, but patterns of gfp expression can still be 
examined in the remainder of the worm. 
eri-1, rrf-3, eri-4, eri-6/7, and eri-8 in the myo-2::pfg-gfp; sur-5::gfp background caused 
uniformly decreased gfp expression throughout the worm. While this observation cannot 
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N2 wild type, eri-1(mg366), rrf-3(pk1426), eri-3(tm1361), eri-4/dcr-1(mg375), eri-6/7(tm1917), 
eri-8(gg100), eri-9(gg106), eri-11(gg99), and sid-1(qt9) in an ubiquitously expressed sur-5::gfp 
background (A, C, E, G, I, K, M, O, Q, S) and with the addition of a hairpin pfg-gfp expressed 
in the pharynx by the myo-2 promoter (B, D, F, H, J, L, N, P, R, T). eri-3 (H), eri-9 (P), and eri-
11(R) show perturbed spreading patterns in the presence of the hairpin gfp (boxed in red), 
suggestive of enhanced transport. All other Eri strains show uniformly decreased gfp expression 
pattern in the presence of the hairpin pgf-gfp: images in D, F, J, L, N show at least 2x lower 
quantifiable GFP expression upon ImageJ analysis than images in C, E, I, K, M, respectively. 
All Eri strains show spontaneous transgene silencing near the middle of the worm – a “hole” of 
absent GFP expression – with boundaries demarcated by white arrows for eri-1; sur-5::gfp as 
illustration (C). All images are representative. All images are exposed for 100 milliseconds. 
Pharynx of worms are all pointing towards the upper left corner. 
Figure 3.2: Eri mutants’ effects on RNAi silencing spread 
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Figure 3.2 (Continued): Eri mutants’ effects on RNAi silencing spread
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(A) RDE-4 knockdown in wild-type sur-5::gfp animals causes spontaneous gfp silencing, 
indicated by the white arrows. (B) DCR-1 knockdown in wild-type sur-5::gfp animals also 
causes spontaneous gfp silencing, indicated by the white arrows. (C) UNC-22 knockdown in 
wild-type sur-5::gfp animals does not cause spontaneous gfp silencing. All images are 
representative. All images are exposed for 100 milliseconds. Pharynx of worms are all pointing 
towards the upper left corner. 
Figure 3.3: Knockdown of exogenous RNAi pathway genes rde-4 and dcr-1 causes spontaneous 
transgene silencing 
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preclude enhancing RNAi spreading, especially since the gradient seen in Figure 3.2 seems to be 
absent (possibly due to lower signals overall), these eris don’t exhibit patently perturbed 
spreading patterns. 
eri-3; sur-5::gfp with myo-2::pfg-gfp and eri-11; sur-5::gfp with myo-2::pfg-gfp (Figure 
3.2H, R) show complete anterior silencing. The enhanced silencing phenotype of eri-3 and eri-
11 varies from silencing just past the vulva (Figure 3.4A) to silencing of the entire worm except 
three tail cells (Figure 3.4B). eri-3 and eri-11 could potentially enhance uptake of RNAi 
silencing in the anterior of the worm. 
eri-9; sur-5::gfp with myo-2::pfg-gfp (Figure 3.2P) shows an “inverse gradient” pattern: 
silencing is weakest near the hairpin GFP and increases towards the posterior of the animal. The 
“inverse gradient” phenotype is independent of the transgene silencing “hole” (Figure 3.4C). 
eri-9 could potentially enhance export of RNAi silencing to the posterior of the worm. 
~90% of eri-3 worms and ~20-30% of eri-9 worms exhibit these described phenotypes 
(Figure 3.4D); these penetrances increase at lower temperatures, consistent with previously 
reported myo-2::pfg-gfp potency (WINSTON et al. 2002). To confirm the enhanced RNAi 
phenotypes, feeding E. coli expressing dsRNA gfp was used as an alternate silencing source; 
upon diluted feeding, wild-type sur-5::gfp animals were partially silenced, but eri-3; sur-5::gfp 
and eri-9; sur-5::gfp became completely silenced (Figures 3.4E, F, G), suggesting that the 
unsilenced cells in Figure 3.2H, P are still RNAi responsive. The described phenotypes for eri-3 
and eri-9 are present throughout larval development and adulthood (Figures 3.4H-M). 
eri-3, eri-9, and eri-11 are promising candidate negative regulators of RNA transport 
because of their interesting RNAi spreading patterns. eri-3, eri-9, and eri-11 are all cloned novel 
genes, making them intriguing candidates to propose a transport role for. I attempted to dissect 
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(A) The “weakest” extreme of eri-3 spreading, where silencing is only up to the vulva. (B) The 
“strongest” extreme of eri-3 spreading, where silencing is the entire animal except 3 tail cells, 
indicated by the white arrow. (C) eri-9 animals show the transgene silencing “hole”, indicated by 
the white arrows, as well as the “inverse” silencing gradient; enhanced spreading seems 
independent of transgene silencing. (D) penetrance of eri-3 and eri-9 phenotypes is highest at 15 
degrees and lowest at 25 degrees. (E, F, G) eri-3 (F) and eri-9 (G) animals without the gfp 
hairpin still silences gfp at a low concentration of gfp(RNAi) feeding compared to wild type (E). 
The enhanced silencing pertains generally to all RNAi sources. (H, I, J) The eri-3 spreading 
phenotype is consistently present throughout larval development. (K, L, M) The eri-9 spreading 
phenotype is consistently present through larval development. All images are exposed for 100 
milliseconds, except B, which was exposed for 400 milliseconds. All images are representative. 
Pharynx of worms are all pointing towards the upper left corner.  
Figure 3.4: Further characterization of eri-3 and eri-9’s enhanced spreading phenotypes 
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Figure 3.4 (Continued): Further characterization of eri-3 and eri-9’s enhanced spreading 
phenotypes 
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their possible roles in transport regulation via mosaic analysis by using transcriptional and 
translational fusion constructs, which also elucidates the in vivo expression patterns for eri-3, eri-
9, and eri-11. Mechanistically, there are broadly four possible mutations from which an Eri 
phenotype may result (Figure 3.5): first, cell autonomously, a mutation may increase sensitivity 
or decrease turnover of RNAi signals (i.e. deficiency in an exonuclease that degrades lingering 
dsRNA); second, a mutation may increase export of RNAi signals (i.e. deficiency in a regulator 
that gates dsRNA exit); third, a mutation may increase extracellular transport of RNAi signals 
(i.e. deficiency in a dsRNA binding protein that slows extracellular trafficking); fourth, a 
mutation may increase uptake of RNAi signals (i.e. deficiency in a SID-1 regulator). These 
mechanisms can be distinguished from one another by mosaic analysis. 
My data suggest eri-3, eri-9, eri-11 exert an effect on receiving cells along the anterior-
posterior axis.  Therefore, I was hoping to examine seam cells during mosaic analysis because 
they are also aligned along the A-P axis; their lineage is also ideal for mosaic analysis because 
many adjacent seam cells derive from early ancestors that diverged 7 to 11 cell divisions before 
their terminal differentiation (ALTUN and HALL 2005). I microinjected the wild-type copy eri-3, 
eri-9, or eri-11 along with red fluorescent marker (DsRed), which are inherited as semi-stable 
extra-chromosomal arrays, with technical assistance courtesy of C. Roehrig. Theoretically, array 
loss during any of the 7 to 11 cell divisions before adjacent seam cells’ terminal differentiation in 
one lineage but not the other will create adjacent red and non-red cells, indicative of adjacent 
mosaic ERI rescue.  
However, the gfp and dsRed expression were both quite noisy. Expression was only 
detectable in the vulva, gonad sheath, some pharyngeal and epithelial cells, and the tail sphincter 
using transcriptional or translational reporters (Figures 3.6-3.12). This expression pattern 
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Figure 3.5: Schematic of the four possible mechanisms for RNAi enhancement and mutations 
which can cause an Eri phenotype 
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All stitched images were exposed for the same amount of time, indicating perhaps that eri-3 is 
more highly expressed in the anterior than the posterior. In the absence of the gfp marker, there is 
still robust gut autofluorescence, suggesting noise in the readout. 
Figure 3.6: eri-3-gfp translational fusion expression – whole worm 
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There is robust gfp expression in the epithelial cells (A, B), faint expression in the vulva (C), and 
very robust expression in the spermatheca (D) and the gonad sheath (E), consistent perhaps with 
the eris’ roles in the germline. In the absence of the gfp marker, there is almost no 
autofluorescence in the vulva, gonad, or epithelial cells, suggesting a more genuine readout. All 
images were exposed for the same amount of time. 
Figure 3.7: eri-3-gfp translational fusion expression – parts 
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All stitched images were exposed for the same amount of time, indicating perhaps that eri-9 is 
more highly expressed in the anterior than the posterior. In the absence of the gfp marker, there is 
still robust gut autofluorescence, suggesting noise in the readout. 
Figure 3.8: eri-9p::gfp transcriptional fusion expression – whole worm 
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There is faint gfp expression in the tail sphincter cells (A, B) and the vulva (C). In the absence of 
the gfp marker, there is almost no autofluorescence in the tail or vulva, suggesting a more 
genuine readout. All images were exposed for the same amount of time. 
Figure 3.9: eri-9p::gfp transcriptional fusion expression – parts 
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All stitched images were exposed for the same amount of time, indicating perhaps that eri-11 is 
slightly more highly expressed in the posterior than the anterior. In the absence of the gfp 
marker, there is still robust gut autofluorescence, suggesting noise in the readout. 
Figure 3.10: eri-11-gfp translational fusion expression – whole worm 
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There is robust gfp expression in the tail sphincter (A), some epithelial cells (B), and faint 
expression in the gonad sheath (C) and the vulva (D), consistent perhaps with the eris’ roles in 
the germline. In the absence of the gfp marker, there is almost no autofluorescence in the tail 
sphincter, epithelial cells, gonad sheaths, and the vulva, suggesting a more genuine readout. All 
images were exposed for the same amount of time. 
Figure 3.11: eri-11-gfp translational fusion expression – parts 
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There is robust gfp expression in the pharyngeal support cells (A), pharyngeal muscle cells (B), 
and around the bulbs of the pharynx (C). In the absence of the gfp marker, there is almost no 
autofluorescence in the pharyngeal area, suggesting a more genuine readout. All images were 
exposed for the same amount of time. 
Figure 3.12: eri-11-gfp translational fusion expression – pharynx 
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makes it difficult to compare adjacent eri(+) and eri(-) cells for discovery of specific transport 
functions, but to my knowledge this was the first reported expression profile for these genes. 
More mosaic rescue lines could potentially generate defined eri(+) and eri(-) cells. 
Therefore, future experiments in which such lineage discriminations are possible should perform 
the following three experiments to discriminate amongst the potential mechanisms of enhanced 
systemic RNAi as outlined in Figure 3.5.  
The first future experiment should discriminate mechanism 1 from 2 and those from 3 or 
4 (Figure 3.13). I would express in an eri minus sid-1 minus animal – which cannot import but 
can export RNAi signals – hairpin GFP and GFP in all cells, and mosaic rescue with ERI. I will 
compare level of GFP expression between an eri(+) versus eri(-) cell. If enhanced RNAi is 
caused by increased cell autonomous RNAi, then silencing should be lower in eri(+) cells. 
Conversely, if enhanced RNAi is due to enhanced export of silencing signals, then silencing 
should be higher in eri(+) cells because they would retain more silencing signals than eri(-) cells. 
Because this first experiment is performed in a sid-1(-) background, eri mutants that act via 
enhancing extracellular transport or import would not be affected by ERI rescue. 
The second future experiment should discriminate mechanisms 1 or 4 from 2 or 3 
(Figure 3.14). I would express in an eri minus animal hairpin GFP in one cell type (“sending”) 
that’s rescued with ERI, and GFP reporter in a different cell type (“receiving”) which is 
mosaically rescued with ERI. I will compare the level of GFP expression between an eri(+) 
versus an eri(-) receiving cell. If enhanced RNAi is caused by increased cell autonomous RNAi, 
then silencing should be lower in eri(+) cells compared to eri(-) cells. Similarly, if enhanced 
RNAi is due to enhanced uptake of silencing signals, then silencing should be lower in eri(+) 
cells compared to eri(-) cells. Because this experiment is performed with eri(+) sending cells, eri 
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Wild type baseline silencing of GFP is indicated by “++”.  
Figure 3.13: Schematic of the first hypothetical mosaic analysis experiment, its construct, and its 
expected results 
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Wild type baseline silencing of GFP is indicated by “++”. 
Figure 3.14: Schematic of the second hypothetical mosaic analysis experiment, its construct, and 
its expected results 
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mutants that act via enhancing export would not be affected by receiving cell ERI rescue. 
Similarly, because there is always expression of wild-type ERI somewhere in the animal in this 
experiment, eri mutants that act via enhancing extracellular transport would not be affected by 
receiving cell ERI rescue. 
The third future experiment should discriminate mechanisms 1 or 4 from 2 and from 3 
(Figure 3.15). I would express in an eri minus animal hairpin gfp in one cell type (“sending”), 
and gfp reporter in a different cell type (“receiving”) which is mosaically rescued with ERI. I 
will compare the level of gfp expression between an eri(+) versus an eri(-) receiving cell. If 
enhanced RNAi is caused by increased cell autonomous RNAi, then silencing should be lower in 
eri(+) cells compared to eri(-) cells. Similarly, if enhanced RNAi is due to enhanced uptake of 
silencing signals, then silencing should be lower in eri(+) cells compared to eri(-) cells. 
However, because this experiment is performed with eri(-) sending cells, if enhanced RNAi is 
due to enhanced export of silencing signals, then silencing would be higher-than-wild-type 
regardless of receiving cell ERI rescue. Conversely, because there is always expression of wild-
type ERI, upon mosaic rescue, somewhere in the animal in this experiment, eri mutants that act 
via enhancing extracellular transport would not be affected by receiving cell ERI rescue. 
Nevertheless, the findings from this screen combined with the previous one are quite 
promising. Unlike the other eri genes, eri-6/7 was not found in the DCR-1 immunoprecipitation 
(DUCHAINE et al. 2006); and unlike the other eri genes, eri-3, eri-9, and eri-11 are not widely 
conserved. These unique features make them appropriate candidates for systemic RNAi 
enhancers, and perhaps they are regulators for C. elegans’ especially sensitive systemic RNAi 
response. Therefore, reverse genetic analysis of systemic gene targets can perhaps utilize these 
eri mutants to optimize knockdown phenotypes. 
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Wild type baseline silencing of GFP is indicated by “++”. 
Figure 3.15: Schematic of the third hypothetical mosaic analysis experiment, its construct, and 
its expected results 
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Previously published screens for Rde mutants have used either RNAi against germline 
targets (TABARA et al. 1999) or relied on transgenes as the initial filter (WINSTON et al. 2002; 
ZHANG et al. 2012). Along with my advisor, I designed and taught a discovery-based laboratory 
course (Harvard College MCB153 Spring 2011) based on a genetic screen for Rde mutants 
challenged with dsRNA-based RNAi targeting somatic genes.  
SCREEN FOR SOMATIC RNAi DEFECTIVE MUTANTS 
The students in the course screened 100,000 genomes mutated with EMS grown on dpy-
11(RNAi) for non-Dpy F2 progeny at 20°C. These starting strain worms also contained myo-
2::pfg-gfp, myo-2::gfp, and myo-3::gfp as a confirmation mechanism for ensuring that feeding 
RNAi phenotypes corresponded with RNAi silencing induced by transgenes. This background 
also allows easy distinction between Rde or Sid phenotypes. 
The class discovered four candidate Rde mutants and one candidate Eri mutant. I 
followed up the class’ analysis and confirmed one of the Rde mutants as insensitive to bli-
1(RNAi), dpy-11(RNAi), and unc-22(RNAi) by feeding (Figure 3.16). Furthermore, there is a 
lack of gfp silencing for both myo-2- and myo-3- driven gfp in this mutant, suggesting that it’s 
likely a true Rde and not a Sid. I also confirmed the Eri mutant as hypersensitive to hmr-1(RNAi) 
by feeding (Figure 3.17). I froze and archived the Rde candidate as HC785 and the Eri candidate 
as HC787 for future in-depth analysis. 
 This screen suggests that previous screens may not have been saturating in discovering 
the full landscape of RNAi pathway components. The unique conditions of a somatic RNAi 
target by feeding RNAi may have had advantages that previous screens did not, thus providing a 
proof-of-principle that future unique forward genetic screens for RNAi factors remain fruitful 
endeavors.
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Feeding N2 worms OD600nm 3.5, 1.0, and 1.0 bli-1(RNAi), dpy-11(RNAi), unc-22(RNAi) induced 
very penetrant blisters that caused paralysis (A), extreme dumpiness (C), and muscle emaciation 
and paralysis (E) in N2 wild type worms, respectively. In the HC785 strains containing the 
candidate Rde mutant, these phenotypes are largely absent when the same RNAi dosages were 
fed to the worms (B, D, F).  
Figure 3.16: HC785 is Rde to feeding RNAi assays 
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Figure 3.16 (Continued): HC785 is Rde to feeding RNAi assays
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Chapter Four 
Enhanced RNAi is dependent on nrde-3 
 
The contents are a part of the in-press report ZHUANG, J. J., S.A. BANSE, and C. P. HUNTER, 2013. The Nuclear 
Argonaute NRDE-3 Contributes to Transitive RNAi in Caenorhabditis elegans. Genetics doi: 10.1534/genetics. 
113.149765. Portions of the transitive RNAi studies were performed in collaboration with Dr. Stephen A. Banse, as 
denoted. Permission to reuse was granted by the Genetics Society of America. 
163 
 
The Caenorhabditis elegans nuclear RNAi 
ABSTRACT 
de
 
fective (Nrde) mutants were identified by their 
inability to silence polycistronic transcripts in enhanced RNAi (Eri) mutant backgrounds. Here, 
we report additional nrde-3-dependent RNAi phenomena that extend the mechanisms, roles, and 
functions of nuclear RNAi. We show that nrde-3 mutants are broadly RNAi deficient and that 
over-expressing NRDE-3 enhances RNAi. Consistent with NRDE-3 being a dose-dependent 
limiting resource for effective RNAi, we find that NRDE-3 is required for eri-dependent 
enhanced RNAi phenotypes, although only for a subset of target genes. These results suggest that 
nrde-3 define a limiting RNAi resource pathway. Limiting RNAi resources are proposed to 
primarily act via endogenous RNA silencing pathways. Consistent with this, we find that nrde-3 
mutants mis-express genes regulated by endogenous siRNAs and incompletely silence repetitive 
transgene arrays. Finally, we find that nrde-3 contributes to transitive RNAi, whereby amplified 
silencing triggers act in trans to silence sequence-similar genes. Because nrde-dependent 
silencing is thought to act in cis to limit the production of primary transcripts, this result reveals 
an unexpected role for nuclear processes in RNAi silencing. 
Genetic analysis of RNA interference (RNAi) in C. elegans initially identified and characterized 
genes and activities important for post-transcriptional gene silencing (PTGS) in response to 
exogenous double-stranded RNA (dsRNA) (TABARA et al. 1999; TABARA et al. 2002). Because 
these gene products target mature mRNAs, they were presumed to act in the cytoplasm (FIRE et 
al. 1998). However, a genetic screen for mutants specifically defective for pan-operon RNAi 
silencing (BOSHER et al. 1999) identified genes important for transcriptional gene silencing 
INTRODUCTION 
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(TGS) processes that operate in the nucleus (BURKHART et al. 2011; BURTON et al. 2011; GUANG 
et al. 2010; GUANG et al. 2008). These genes were termed nuclear RNAi de
The best-characterized nrde is NRDE-3, an Argonaute that shuttles secondary short-
interfering RNAs (siRNAs) from the cytoplasm to the nucleus (GUANG et al. 2008). When 
siRNA are absent or reduced, NRDE-3 is primarily detected in the cytoplasm, and when siRNAs 
are abundant, NRDE-3 is readily detected in the nucleus. In the nucleus, the siRNA-bound 
NRDE-3 forms a complex with the nuclear restricted NRDE-1, 2, and 4 (BURTON et al. 2011). 
The associated siRNA guides the NRDE-complex to cognate nascent mRNA transcripts, which 
impedes RNA polymerase II transcription elongation and further initiates histone methylation 
dependent TGS (BURTON et al. 2011; GUANG et al. 2010). This RNA-directed epigenetic 
mechanism also enables multi-generational silencing (GU et al. 2012); the recently identified  
germline nuclear Argonaute HRDE-1 functions like the soma-restricted NRDE-3 to enable this 
multigenerational silencing (BUCKLEY et al. 2012). hrde-1 is also important for germline 
immortality. As these enlightening studies on mechanisms and downstream endogenous roles of 
nuclear RNAi have progressed, broader identification of other nuclear RNAi dependent upstream 
processes and their interactions with cytoplasmic RNAi therefore becomes ever more important. 
fective (nrde).  
Enhanced RNAi (Eri) mutant backgrounds have been important for the discovery and 
characterization of nrde functions. Eri mutants identify genes important for the production or 
stability of endogenous short-interfering RNAs (endo-siRNAs) (DUCHAINE et al. 2006; FISCHER 
et al. 2008; KENNEDY et al. 2004; PAVELEC et al. 2009; SIMMER et al. 2002). Genes 
complementary to endo-siRNAs are mis-regulated in Eri mutants (GENT et al. 2010). 
Interestingly, these endo-siRNAs also make up the bulk of siRNAs associated with NRDE-3 in 
vivo (GUANG et al. 2008). Thus, a role for nrde-3 in the enhanced RNAi silencing associated 
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with the eri mutants is expected, although the scope and significance of this role has not been 
investigated. 
Here, we report our identification of additional nrde-3-dependent processes. We define a 
significant and broad contribution of nrde-3 to exogenous RNAi silencing and determine that 
NRDE-3 is a distinct limiting RNAi resource. As expected, nrde-3 is important for enhanced 
RNAi phenotypes, but unexpectedly only for a subset of targeted genes. We also provide 
evidence that nrde-3 is important for endo-siRNA regulated gene expression and multi-copy 
transgene silencing. Finally, we show that nrde-3 contributes to transitive RNAi, revealing an 
unexpected role for nuclear processes in exogenous RNAi. 
 
Nuclear RNAi mutants are broadly deficient for dsRNA-induced silencing 
RESULTS 
RNAi effectiveness in wild-type animals is dependent on dsRNA dose. Consequently, high 
concentrations of dsRNA can compensate for, or mask, weak RNAi-defective (Rde) phenotypes 
(ZHUANG and HUNTER 2011). To determine whether nrde-3 mutants have a weak Rde phenotype 
when dsRNA is limiting, we measured RNAi efficacy in nrde-3 mutants in response to a dsRNA 
dilution series. We found that the silencing responses to dpy-11(RNAi), par-1(RNAi), qua-
1(RNAi), and unc-22(RNAi) were significantly reduced in nrde-3(gg66) mutants (Figure 4.1A; 
Tables 4.1, 4.2, 4.3).  Because reduced RNAi efficacy could be caused by background mutations 
(ZHANG et al. 2011), we confirmed the above results with a second nrde-3 allele, gg64, (Figure 
4.2; Table 4.3) and showed that an nrde-3-gfp transgene construct completely rescued the RNAi 
defects (Figure 4.2).  Therefore, in addition to RNAi targeting operons, nrde-3 is also required 
for efficient RNAi targeting conventionally transcribed and processed genes. However, RNAi 
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Figure 4.1: nrde-3 is required for robust exogenous RNAi 
(A) The penetrance of dpy-11(RNAi) relative to dose of feeding RNAi bacteria for the indicated 
strains is shown. The progeny of L3 larvae placed on the RNAi food were scored as L4 larvae. 
(B) Schematic of trans-generational RNAi assay. Dpy or Unc L4 larvae grown on either dpy-11 
or unc-22 dsRNA expressing bacteria were transferred to non-RNAi bacteria. The non-exposed 
progeny were scored for Dpy-11 or Unc-22 phenotypes as L4 larvae. (C-F) The fraction of N2 
and nrde-3(gg66) broods that transmitted dpy-11(RNAi) (C) or unc-22(RNAi) (E) silencing to 
non-exposed progeny and the penetrance of the Dpy (D) and Unc (F) phenotypes within 
individual N2 and nrde-3(gg66) broods. (G-I) The penetrance of Dpy phenotypes within 
individual broods from the indicated crosses. (J) The penetrance of dpy-11(RNAi) relative to 
dose of feeding RNAi bacteria for the indicated strains is shown. Embryos from unexposed 
mothers hatched in the presence of RNAi food and were scored as L4 larvae. The phenotypes 
scored for all assays are listed in Table S1. The dpy-11(RNAi) bacteria OD600nm=2.0 and the unc-
22(RNAi) bacteria OD600nm=1.0. The numbers of animals scored for (A) and (J) are listed in 
Table S2. p-values calculated by t-test; * indicates p<0.05 and ** indicates p<0.01. 
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Figure 4.1 (Continued): nrde-3 is required for robust exogenous RNAi 
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Table 4.1: Phenotypes and expressivities scored in various RNAi assays 
RNAi 
Target 
Phenotype Scored 
dpy-11  
-Super dumpy: severely dumpy animals whose length is at most 3X its width 
-Weak dumpy: mildly dumpy animals at most 80% the length of N2 worms 
*When not specified, both categories are scored as dumpy 
dpy-13  
I: no phenotype 
II: very slightly shorter than wild type animals (much less severe than dpy-11 weak 
dumpy; see Figure 4.6A) 
III: Severely dumpy animals whose length is at most 3X its width 
dpy-28  Mildly dumpy animals at most 80% the length of N2 worms 
elt-1 -Embryonic lethal: dead embryos -Developmental defect: arrested larval growth and deformed tail morphologies 
hmr-1  Dead embryos and animals with significantly smaller in morphology and head deformities 
ifc-2  Bent posterior body morphology that paralyzes locomotion 
lir-1  
I: no phenotype, normal growth 
II: arrest during L1/L2 
III: embryonic lethality 
myo-3 Paralyzed worms with rigid columnar body morphologies 
par-1  Dead embryos 
qua-1  Abnormally rigid body morphology and paralyzed movement 
unc-15  
I: no phenotype, normal movement 
II: paralyzed movement 
III: abnormally rigid body morphology and paralyzed movement 
unc-22  Abnormally rigid body morphology and paralyzed movement and/or twitching upon 10mM levamisole treatment 
unc-73  Paralysis with bulging and curled body morphology 
 
These phenotypes are the basis for the various penetrance recordings in all figures and tables for 
the indicated genes targeted by feeding RNAi assays. For representative phenotypes scored for 
dpy-11(RNAi), dpy-13(RNAi), and ifc-2(RNAi), see Figures 4.2, 4.3, and 4.6. 
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Table 4.2: n-values for dpy-11(RNAi) Rde penetrance for various strains shown in Figure 4.1A, 
J 
Assay OD600nm Strain Number Tested 
Feed from L3 (4.1A) 1.0 N2 117 
Feed from L3 (4.1A) 1.0 nrde-3(gg66) 119 
Feed from L3 (4.1A) 1.0 nrde-2(gg91) 44 
Feed from L3 (4.1A) 1.0 nrde-3(gg66); SV40NLS-nrde-3 72 
Feed from L3 (4.1A) 1.0 nrde-3(gg66); *NLS-nrde-3 61 
Feed from L3 (4.1A) 2.0 N2 98 
Feed from L3 (4.1A) 2.0 nrde-3(gg66) 91 
Feed from L3 (4.1A) 2.0 nrde-2(gg91) 28 
Feed from L3 (4.1A) 2.0 nrde-3(gg66); SV40NLS-nrde-3 50 
Feed from L3 (4.1A) 2.0 nrde-3(gg66); *NLS-nrde-3 50 
Feed from L3 (4.1A) 3.0 N2 93 
Feed from L3 (4.1A) 3.0 nrde-3(gg66) 69 
Feed from L3 (4.1A) 3.0 nrde-2(gg91) 56 
Feed from L3 (4.1A) 3.0 nrde-3(gg66); SV40NLS-nrde-3 42 
Feed from L3 (4.1A) 3.0 nrde-3(gg66); *NLS-nrde-3 47 
Feed from L3 (4.1A) 4.0 N2 104 
Feed from L3 (4.1A) 4.0 nrde-3(gg66) 75 
Feed from L3 (4.1A) 4.0 nrde-2(gg91) 30 
Feed from L3 (4.1A) 4.0 nrde-3(gg66); SV40NLS-nrde-3 60 
Feed from L3 (4.1A) 4.0 nrde-3(gg66); *NLS-nrde-3 37 
Bleached embryo (4.1J) 2.0 N2 259 
Bleached embryo (4.1J) 2.0 nrde-3(gg66) 203 
Bleached embryo (4.1J) 2.0 nrde-2(gg91) 164 
Bleached embryo (4.1J) 2.0 nrde-3(gg66); SV40NLS-nrde-3 170 
Bleached embryo (4.1J) 2.0 nrde-3(gg66); *NLS-nrde-3 190 
Bleached embryo (4.1J) 3.0 N2 255 
Bleached embryo (4.1J) 3.0 nrde-3(gg66) 215 
Bleached embryo (4.1J) 3.0 nrde-2(gg91) 238 
Bleached embryo (4.1J) 3.0 nrde-3(gg66); SV40NLS-nrde-3 191 
Bleached embryo (41J) 3.0 nrde-3(gg66); *NLS-nrde-3 159 
Bleached embryo (4.1J) 4.0 N2 280 
Bleached embryo (4.1J) 4.0 nrde-3(gg66) 178 
Bleached embryo (4.1J) 4.0 nrde-2(gg91) 201 
Bleached embryo (4.1J) 4.0 nrde-3(gg66); SV40NLS-nrde-3 238 
Bleached embryo (4.1J) 4.0 nrde-3(gg66); *NLS-nrde-3 177 
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Table 4.3: Penetrance readings for nrde-3’s decreased RNAi response of gg64 and gg66 alleles 
to various RNAi targets 
RNAi Target Method of RNAi N2 
nrde-3 
(gg66) 
nrde-3 
(gg64) 
dpy-11 Feed L3 of mom 
0.93 
n=28 
Figure 
4.1A 
0.08 
n=13 
par-1 Feed L3 of mom 
1.00 
n=35 
0.86 
n=190  
qua-1 Feed L3 of mom 
0.65 
n=52 
0.11 
n=46  
unc-22 Feed L3 of mom 
0.95 
n=20 
0.43 
n=14  
qua-1 Bleached embryos 
0.69 
n=89 
0.47 
n=183  
 
 
Single L3-stage larvae (“feed L3 of mom”) or bleached embryos were placed on RNAi food 
targeting dpy-11 (at OD600nm 1.0), par-1 (at OD600nm 1.0), qua-1 (at OD600nm 1.0), and unc-22 (at 
OD600nm 2.0); 4 days later, the percent of progeny showing the expected phenotypes described in 
Table 4.1 were determined for the listed strains. 
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Figure 4.2: nrde-3(gg64) is Rde to dpy-11(RNAi) and nrde-3(gg66) is rescued by nrde-3-gfp 
 (A-B) Representative images of (A) wild type (N2) and (B) nrde-3(gg66) progeny from L3 
hermaphrodites grown on dpy-11(RNAi) RNAi bacteria at OD600nm 1.0. N2 worms were more 
sensitive to dpy-11(RNAi) by feeding than nrde-3(gg66) worms were. Penetrance differences 
between the strains are shown in Figure 4.1A and Table 4.2. (C-D) Representative images of 
(C) N2 wild type and (D) nrde-3(gg64) progeny from L3 hermaphrodites grown on dpy-
11(RNAi) RNAi bacteria at OD600nm 1.0. N2 worms were more sensitive to dpy-11(RNAi) by 
feeding than nrde-3(gg66) worms were. Penetrance differences between the strains are shown in 
Table 4.3. (E-G) Representative images of (E) N2 wild type, (F) nrde-3(gg66), and (G) nrde-
3(gg66); nrde-3-gfp progeny from L3 hermaphrodites grown on dpy-11(RNAi) RNAi bacteria at 
OD600nm 1.0. Fewer nrde-3(gg66) animals are dumpy compared to N2 and nrde-3(gg66); nrde-3-
gfp animals treated with the same dosage of dsRNA. (H) The penetrance of dpy-11(RNAi)’s 
expected phenotype described in (E-G) are indicated. 
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remains effective in nrde-3 mutant backgrounds when the trigger dsRNA is not limiting (Figure 
4.1A), indicating that nuclear-dependent RNAi silencing is particularly important when dsRNA 
is limited. 
 NRDE-3 is an Argonaute that has been proposed to shuttle siRNA from the cytoplasm to 
the nucleus where they associate with nuclear restricted factors, including NRDE-2, to effect 
transcriptional gene silencing (BURTON et al. 2011; GUANG et al. 2010).To determine whether 
these broad RNAi deficiencies reveal an undetected role for NRDE-3 in the cytoplasm, we 
similarly tested nrde-2(gg91) mutants. The results show that NRDE-2 is similarly required for an 
efficient response to exogenous RNAi (Figure 4.1A, 4.3; Table 4.2). Because NRDE-2 is 
thought to be completely nuclear localized (BURTON et al. 2011), these results support a nuclear-
acting step for efficient exogenous RNAi. To provide additional support for this conclusion, we 
compared the rescue of nrde-3(gg66) mutant animals by nrde-3-gfp transgene constructs that 
either lack a nuclear localization signal (“*NLS-nrde-3”) or in which the NRDE-3 NLS has been 
replaced with a Simian virus 40 nuclear localization signal (“SV40NLS-nrde-3”) (GUANG et al. 
2008). We found that the *NLS-nrde-3 construct failed to rescue the nrde-3(gg66) RNAi defect, 
while the SV40NLS-nrde-3 construct provided at least a wild-type response to dpy-11(RNAi) 
(Figure 4.1A). These results show that nuclear localized activities broadly contribute to RNAi 
triggered by exogenous dsRNA. 
  
nrde-3 contributes to inter- and intra-generational responses to exogenous RNAi 
The nrde genes have recently been implicated in the transmission of silencing to the progeny 
(BURTON et al. 2011; GU et al. 2012). A remarkable feature of RNAi in C. elegans is that 
silencing initiated in the mother can be efficiently transmitted via the germline to the progeny, 
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Figure 4.3: nrde-2(gg91) is less sensitive to dpy-11(RNAi) than N2 
Representative images of N2 and nrde-2(gg91) from L3 hermaphrodites grown on dpy-11(RNAi) 
RNAi bacteria at OD600nm 2.0 ((A) & (B)) and at OD600nm 4.0 ((D) & (E)). Fewer nrde-2(gg91) 
animals are dumpy compared to N2 animals treated with the same dosage of dsRNA, although 
the difference is markedly larger at OD600nm 2.0. The penetrance of dpy-11(RNAi)’s expected 
phenotype is shown in Figure 4.1A and Table 4.2. 
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and once established, can persist for at least 80 generations (VASTENHOUW et al. 2006). Analysis 
of this multigenerational silencing demonstrated that PTGS mechanisms are required to initiate 
silencing, and implicated TGS mechanisms in its maintenance (GRISHOK et al. 2000). The most 
convenient methods for performing exogenous RNAi in C. elegans involve exposing both the 
mother and her progeny to the silencing trigger: i.e. feeding dsRNA-expressing E. coli to a 
mother and scoring her progeny brood for phenotypes on that same plate. Therefore, the 
requirement for nrde function for efficient silencing (Figure 4.1A) may reflect a requirement for 
TGS-dependent maintenance mechanisms in the progeny rather than PTGS mechanisms in the 
mother. To investigate whether nrde-3 function is required in the mother or the progeny for 
silencing, we exposed either mothers or their progeny to the dsRNA trigger, and compared in 
both cases RNAi silencing efficiency in the progeny. 
First, we asked whether nrde-3 is important for transmission of silencing from dsRNA-
exposed mothers to non-exposed progeny. Specifically, we grew wild-type and nrde-3(gg66) 
worms from hatching to the fourth larval stage (L4) on either dpy-11 or unc-22 dsRNA 
expressing bacteria. We then transferred the RNAi-affected Dpy or Unc L4 worms to control 
bacteria and scored their non-exposed progeny for Dpy-11 or Unc-22 phenotypes (Figure 4.1B). 
We found that the fraction of broods inheriting RNAi silencing was two-to-four-fold higher in 
the wild-type background (Figure 4.1C, E; Table 4.4). Furthermore, the penetrance of Dpy or 
Unc within each RNAi-inheriting brood was also higher in the wild-type background (Figure 
4.1D, F; Table 4.4). Thus, in the absence of continued exposure to the dsRNA trigger, NRDE-3 
is important for the transmission of RNAi silencing. 
We next asked whether introducing wild-type NRDE-3 to the progeny of nrde-3(gg66) 
mothers could restore the penetrance of the inherited silencing. Specifically, we crossed dsRNA-
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exposed nrde-3(gg66) hermaphrodites to wild-type males and scored the penetrance of inherited 
silencing in the heterozygous wild-type progeny. In wild-type by wild-type positive control 
crosses, almost all mothers transmitted the Dpy-11 RNAi phenotype to their progeny (Figure 
4.1G), while in nrde-3(gg66) by nrde-3(gg66) negative control crosses, almost none of the 
mothers transmitted the phenotype (Figure 4.1I). However, in only one out of 10 crosses did 
nrde-3(gg66) mothers robustly (>80% penetrant) transmit the Dpy-11 RNAi phenotype to their 
wild-type cross progeny, while most nrde-3(gg66) mothers only partially transmitted the Dpy-11 
RNAi phenotype (Figure 4.1H; Table 4.5).  These results indicate that, although NRDE-3 
activity in the mother is important for the production of a transmissible silencing signal or state, 
NRDE-3 function in the progeny is also important.  
To directly determine whether nuclear processes, in the absence of maternal 
contributions, are important for silencing, we hatched L1 larvae in the presence of dpy-11 or 
qua-1 dsRNA expressing bacteria and scored the resulting adults for Dpy-11 or Qua-1 
phenotypes. We found that nrde-2(gg91), nrde-3(gg66), and *NLS-nrde-3 rescued nrde-3(gg66) 
mutant strains all showed reduced silencing compared to wild type and SV40NLS-nrde-3 rescued 
nrde-3(gg66) mutant strains (Figure 4.1J; Tables 4.2, 4.3). Together, these results suggest that 
the weak Rde effect observed in nrde-3 mutants is due to both reduced transmission of a trans-
generational silencing signal or state, likely silenced chromatin, and decreased de novo silencing 
within dsRNA exposed animals.  
 
nrde-3 overexpression causes enhanced RNAi independent of sago-1 
While analyzing the weak Rde phenotype of nrde-3 mutants, we noticed that the transgenic 
rescue strains often exhibited a stronger RNAi response than the wild type animals (Figure 4.2E, 
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G). Because C. elegans multi-copy transgenes are often over-expressed (PRAITIS et al. 2001), we 
hypothesized that NRDE-3 overexpression may enhance RNAi. We therefore crossed the 
transgene array into a wild-type background (so that there are at least two wild type copies of 
nrde-3) and compared the RNAi effectiveness of this strain to wild type. We found that this 
strain exhibited enhanced RNAi to dpy-13(RNAi) (Figure 4.4A-C; Table 4.6), as well as to unc-
15(RNAi) and unc-73(RNAi) (Figure 4.4C; Table 4.6). As a control, we then crossed the *NLS-
nrde-3-gfp transgene array into a wild-type background, and found that this array did not 
robustly enhance RNAi compared to wild type (Figure 4.4C; Table 4.6), suggesting again that it 
is predominantly the nuclear functions of nrde-3 that are contributing to exogenous RNAi. 
 A previous report had analogously overexpressed the cytoplasmic secondary 
Argonautes SAGO-1 and SAGO-2, necessary for endogenous secondary RNAi, and found that 
those particular strains enhanced RNAi (YIGIT et al. 2006). The SAGOs and NRDEs function in 
distinct cellular compartments and thus likely function in independent pathways. However, it is 
possible that nrde-3 activity is required for the SAGO-overexpression associated Eri phenotype. 
Therefore, we crossed nrde-3(gg66) into a strain containing the myo-3p::gfp-sago-1 construct 
used previously to demonstrate over-induced enhanced RNAi in muscle cells (Figure 4.4D-G). 
We observed that the nrde-3(gg66); myo-3p::gfp-sago-1 strain remained Eri (Figure 4.4H; 
Table 4.7).  Thus, SAGO-1 enhanced RNAi is independent of nrde-3. Furthermore, these results 
suggest that sago-1 and nrde-3 may define complementary silencing pathways. 
 
nrde-3 is partially required for Eri mutants’ enhanced RNAi  
The availability of enzymes utilized by both endogenous and exogenous RNAi pathways, like 
SAGO-1 and SAGO-2 (YIGIT et al. 2006), plays a large role in determining the efficacy of 
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Figure 4.4: nrde-3 overexpression causes enhanced RNAi independent of sago-1 
(A-B) Representative images of progeny from L3 hermaphrodites of the indicated strains grown 
on dpy-13(RNAi) bacteria. (C) Penetrance of dpy-13(RNAi), unc-15(RNAi), and unc-73(RNAi) 
phenotypes for the indicated strains is shown. (D-G) Representative images of progeny from L3 
hermaphrodites of the indicated strains grown on myo-3(RNAi) bacteria. (H) Penetrance of myo-
3(RNAi)-induced paralysis for the indicated strains is shown. The dpy-13(RNAi) bacteria 
OD600nm=1.5, unc-15(RNAi) bacteria OD600nm=1.0, unc-73(RNAi) bacteria OD600nm=4.0, and 
myo-3(RNAi) bacteria OD600nm=3.0. The penetrances scored for (C) are listed in Table 4.6 and 
for (H) in Table 4.7. p-values calculated by t-test; * indicates p<0.05 and ** indicates p<0.01.
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Table 4.6: Penetrance readings of nrde-3-overexpression Eri phenotypes shown in Figure 4.4C 
dpy-13(RNAi) Average SD 
N2 1/92 1/119 1/58 0.012 0.005 
WT + [nrde-3-gfp] 69/72 66/73 59/64 0.928 0.028 
WT + [*NLS-nrde-3-gfp] 7/79 14/79 11/99 0.126 0.046 
unc-15(RNAi) 
N2 12/77 19/100 19/90 0.186 0.028 
WT + [nrde-3-gfp] 29/44 23/44 46/69 0.616 0.081 
WT + [*NLS-nrde-3-gfp] 16/66 18/82 13/68 0.218 0.026 
unc-73(RNAi) 
N2 0/30 0/30 0/30 0 0 
WT + [nrde-3-gfp] 42/59 39/49 32/50 0.716 0.078 
WT + [*NLS-nrde-3-gfp] 4/39 3/61 3/94 0.061 0.037 
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Table 4.7: Penetrance readings of sago-1-overexpression Eri phenotypes shown in Figure 4.4H 
Strain Penetrance Average SD 
N2 14/135 3/119 2/108 0.049 0.047 
nrde-3(gg66) 12/81 7/100 15/137 0.109 0.039 
WT+[sago-1-gfp] 98/112 91/114 32/57 0.745 0.163 
nrde-3(gg66)+[sago-1-gfp] 108/118 146/173 88/116 23/25 0.859 0.076 
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exogenous RNAi. For example, mutations that reduce the abundance of endogenous siRNAs 
competing for SAGOs are thought to enhance exogenous RNAi silencing (Figure 4.5) 
(DUCHAINE et al. 2006). If this model is true, then mutations to these limiting RNAi resources 
should attenuate the Eri phenotype. Several observations indicate that nrde-3 is a candidate for 
such a limiting RNAi resource. First, NRDE-3 nuclear localization is sensitive to endo- and exo-
siRNA levels (GUANG et al. 2008). Second, like the SAGOs, nrde-3 overexpression enhances 
RNAi (Figure 4.4C). Third, nrde-3 was identified as a mutant that abolished the eri-1-dependent 
phenotype of pan-operon silencing (GUANG et al. 2008). Fourth, nrde-3 is auxiliary to RNAi 
silencing: the Rde phenotype is only apparent when dsRNA trigger is limiting (Figure 4.1A).    
 To determine whether nrde-3 is important for enhanced RNAi, we compared the 
penetrance and expressivity of RNAi silencing between eri single mutants and eri;nrde-3(gg66) 
double mutants. For these tests, we used each of the four widely conserved C. elegans eri genes 
(eri-1, rrf-3, eri-6/7, and ergo-1/eri-8). nrde-3 is known to be important for RNAi targeting the 
lir-1-lin-26 operon via lir-1(RNAi) (GUANG et al. 2008), and indeed in all four tested eri; nrde-3 
double mutants, silencing of lin-26 by lir-1(RNAi) was eliminated (Tables 4.8, 4.9, 4.10).  
However, the nrde-3-dependence for enhanced RNAi is not limited to operons; all four eri; nrde-
3 double mutants also showed reduced RNAi efficacy targeting a variety of genes (Tables 4.1, 
4.8, 4.9, 4.10; Figure 4.6). A second allele of nrde-3, gg64, in an eri-1(mg366) double mutant 
behaved similarly (Table 4.11). Furthermore, in an eri-1(mg366);nrde-3(gg66) background, the 
cytoplasmic-only *NLS-nrde-3 construct failed to rescue the enhanced RNAi, while the nuclear 
localized SV40NLS-nrde-3 construct rescued the enhanced RNAi (Table 4.8, 4.10). Consistent 
with these results, nrde-2(gg91) mutants also disrupted enhanced silencing of non-operon genes 
(Table 4.11). These results suggest that nrde-3 is a key factor whose accessibility is a rate 
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Figure 4.5: Model of competing small RNA pathways producing an Eri phenotype 
Exogenous RNAi (exo-RNAi) and endogenous RNAi (endo-RNAi) pathways compete for 
limiting common resources, which limits the efficacy of the experimentally measurable, or 
exogenous, RNAi pathway. Mutations that disrupt the production or stability of endo-siRNAi 
(right) results in increased access to these limiting resources, thereby enhancing the exo-RNAi 
pathway. The identity of these limiting resources is largely speculative. 
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Table 4.8: eri-1 mutant partially requires nrde-3 for enhanced RNAi 
The severity of RNAi phenotypes, from ‘-’ to ‘+ + + + +’, based on expressivity described in 
Table 4.1 (illustrated for select mutants in Figure 4.6) and penetrances tabulated in Table 4.10 
of indicated strains for indicated RNAi gene targets are shown. All scores are normalized to the 
strongest Eri response for a particular RNAi assay as ‘+ + + + +’ and no response as ‘-’. The 
enhanced RNAi response against genes in operons or with many homologs (highlighted in 
yellow) is most dependent on nrde-3. The number of homologous sequences was determined by 
the number unique genes with at least a 26mer match of perfect identity in mRNA. The bacteria 
OD600nm concentrations used were lir-1(RNAi)=3.0, dpy-13(RNAi)=1.5, ifc-2(RNAi)=3.5, unc-
15(RNAi)=1.0, hmr-1(RNAi)=1.0, dpy-28(RNAi)=4.0, and unc-73(RNAi)=4.0. 
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Figure 4.6: nrde-3-dependent enhanced dpy-13(RNAi) and ifc-2(RNAi) phenotypes 
(A-D) Representative images of (A) N2, (B) nrde-3(gg66), (C) eri-1(mg366), and (D) eri-
1(mg366);nrde-3(gg66) progeny from L3 hermaphrodites grown on dpy-13(RNAi) RNAi 
bacteria at OD600nm  1.5. N2 animals exhibited very mild dumpiness, nrde-3(gg66) animals were 
unaffected, eri-1(mg366) animals exhibited grotesque dumpiness, and eri-1(mg366);nrde-
3(gg66) animals exhibited very mild dumpiness. Scores from Table 4.8 are indicated on the 
micrographs. Penetrances are shown in Table 4.10. (E-H) Representative images of (E) N2, (F) 
nrde-3(gg66), (G) eri-1(mg366), and (H) eri-1(mg366);nrde-3(gg66) progeny from L3 
hermaphrodites grown on ifc-2(RNAi) RNAi bacteria at OD600nm  3.5.  N2 animals exhibited mild 
emaciation and posterior paralysis, nrde-3(gg66) animals were unaffected, eri-1(mg366) animals 
exhibited grotesque emaciation and paralysis, and eri-1(mg366);nrde-3(gg66) animals exhibited 
mild emaciation and posterior paralysis. Scores from Table 4.8 are indicated on the micrographs. 
Penetrances are shown in Table 4.10. 
186 
 
 
Figure 4.6 (Continued): nrde-3-dependent enhanced dpy-13(RNAi) and ifc-2(RNAi) phenotypes 
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limiting factor for exogenous RNAi and that nuclear RNAi plays an important role in enhanced 
RNAi silencing phenomena. 
Interestingly, the enhanced RNAi phenotype of some genes was completely dependent on 
nrde-3, while that of others was completely independent of nrde-3 (Table 4.8). This suggests 
that expression of some genes may be more sensitive than others to nuclear RNAi silencing.  In 
our limited analysis, dpy-13 and ifc-2 showed the most pronounced nrde-3-dependent enhanced 
RNAi phenotype (Table 4.8; Figure 4.4). These two genes are members of conserved and 
expansive gene families that share significant nucleotide identity (COX 1985; WOO et al. 2004). 
One possibility is that nrde-3 dependent nuclear RNAi processes may preferentially silence 
multiple related genes. 
 
nrde-3 contributes to transitive RNAi 
Intriguingly, a mechanism that could explain the nrde-3-dependent enhanced RNAi targeting 
sequence-related multi-gene families is transitive RNAi. Transitive RNAi is the observation that 
RNAi silencing specificity can spread in cis along a target mRNA to target sequences not in the 
original trigger dsRNA. Mechanistically, this occurs during RNA directed RNA polymerase 
(RdRP) production of secondary siRNAs. Subsequently, and most importantly, these secondary 
siRNAs can then target other mRNA transcripts in trans (such as homologous transcripts), which 
is essential for the potency of RNAi in C. elegans (PAK et al. 2012). Transitive RNAi can be 
detected by sequencing small RNAs in response to exogenous RNAi (PAK and FIRE 2007), but it 
is more readily detected in C. elegans using transgenes that artificially fuse separate genes, 
resulting in secondary siRNAs that independently target both sequences (ALDER et al. 2003; 
HANNON 2002). 
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 To determine whether nrde-3 can contribute to transitive RNAi, we used a strain with 
an elt-1-gfp fusion transgene that when exposed to gfp dsRNA causes elt-1-related 
developmental defects (Figure 4.7A) (ALDER et al. 2003; SMITH et al. 2005). Specifically, we 
exposed wild-type, nrde-3(gg66), and eri-1(mg366) strains that express the elt-1-gfp transgene to 
gfp dsRNA and scored the progeny for elt-1-related developmental defects. In a wild-type 
background, feeding gfp dsRNA to worms expressing the elt-1-gfp fusion causes mild levels of 
developmental deformities and embryonic lethality (Figure 4.7B, E), while in an eri-1(mg366) 
background, gfp(RNAi) causes near complete elt-1-related embryonic lethality (Figure 4.7C, E). 
In contrast, gfp(RNAi) in the nrde-3(gg66) single mutant and the eri-1(mg366);nrde-3(gg66) 
double mutant caused almost no elt-1-related phenotypes (Figure 4.7D, E). Furthermore, the 
*NLS-nrde-3 transgene failed to rescue transitive RNAi in an nrde-3(gg66) mutant, while the 
SV40NLS-nrde-3 transgene-rescued nrde-3(gg66) strain behaved like wild type (Figure 4.7E), 
indicating that only nuclear localized NRDE-3 can contribute to transitive RNAi. Importantly, 
we also observed that elt-1(RNAi) was fully penetrant in all strains, thus nrde-3 is not simply 
required for efficient silencing of the elt-1 locus. Therefore, these results show that nuclear 
NRDE-3 contributes to transitive RNAi, which may in turn be the mechanism behind nrde-3’s 
contributions to exogenous RNAi silencing. 
 
nrde-3 is required for endogenous gene regulation 
Previous reports indicate that NRDE-3 nuclear localization is dependent on eri endo-siRNA 
levels and it co-immunoprecipitates with eri endo-siRNAs (GUANG et al. 2008). Furthermore, we 
observed that it is necessary and sufficient for enhanced RNAi (Figure 4.4C, Table 4.8). These 
observations suggest that nrde-3 may function endogenously to regulate endo-siRNA targeted 
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Figure 4.7: nrde-3 contributes to transitive RNAi 
(A) Schematic for transitive RNAi showing the 5’ spread of secondary siRNAs triggered by the 
introduced gfp dsRNA. The secondary siRNAs, which now include siRNAs complementary to 
elt-1, can act in trans to target the endogenous elt-1 locus. (B-D) Representative phenotypes of 
(B) wild type (N2), (C) eri-1(mg366), and (D) nrde-3(gg66) and eri-1(mg366);nrde-3(gg66) 
strains expressing an elt-1-gfp fusion transgene grown on gfp RNAi bacteria. Wild type animals 
had modest amounts of elt-1 related developmental defects while eri-1(mg366) animals exhibited 
elt-1 related embryonic lethality. In contrast, nrde-3(gg66) and eri-1(mg366);nrde-3(gg66) 
animals had very few, if any, elt-1-related developmental defects. (E) The penetrance of elt-1-
like phenotypes for the indicated strains expressing an elt-1-gfp fusion transgene grown on 
gfp(RNAi) bacteria is shown. Images (A-D) courtesy of Dr. Stephen Banse. The wild type, eri-
1(mg366), and eri-1(mg366);nrde-3(gg66) strains with the elt-1-gfp transgene were constructed 
and initially characterized by Dr. Stephen Banse. 
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Figure 4.7 (Continued): nrde-3 contributes to transitive RNAi 
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genes. To test this, we used qPCR to measure the expression level of five target genes of endo-
siRNAs that are up-regulated in rrf-3(pk1426) mutants (GENT et al. 2010). If NRDE-3 uses rrf-3-
dependent endo-siRNAs to repress gene expression, then the expression levels of these five 
genes should increase in nrde-3 mutants. Specifically, we compared transcript abundances in 
wild type, eri-1(mg366), rrf-3(mg373), rrf-3(pk1426) and nrde-3(gg66) L4 larvae. We found that 
expressions of all five rrf-3 siRNA target genes were increased in both rrf-3 mutant alleles and 
the nrde-3(gg66) mutant (Figure 4.8A). To our knowledge, this is the first report of an 
endogenous function for nrde-3, as previous reports on nrde roles in germline maintenance 
implicated only nrde-1, nrde-2, and nrde-4. Consistent with previous reports, we observed that 
eri-1 and rrf-3 mutants had overlapping but incompletely shared effects on endogenous gene 
expression (Figure 4.8A) (ASIKAINEN et al. 2007; LEE et al. 2006). 
 
nrde-3 is required for transgene silencing 
Enhanced RNAi mutant backgrounds often enhance the frequency and penetrance of 
spontaneous silencing of multi-copy repetitive transgenes (KIM et al. 2005). To determine 
whether nrde-2 and nrde-3 are required for eri-enhanced silencing of repetitive transgene arrays, 
we compared the extent of silencing of the ubiquitously expressed sur-5p::gfp transgene in eri-
1(mg366) single mutant to the silencing in the eri-1(mg366);nrde-2(gg91) and eri-
1(mg366);nrde-3(gg66) double mutants. We found that both nrde genes are required for eri-1-
induced silencing (Figure 4.8E-H). To determine whether this nrde-dependent transgene 
silencing activity represents an endogenous nrde function, or reflects only the unusual 
circumstances present in eri-mutant backgrounds, we examined nrde-dependent transgene 
expression in non-Eri backgrounds. Specifically, we compared the extent of silencing of 
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Figure 4.8: nrde-3-dependent silencing of endogenous RNAi targets and transgenes 
(A) eri- and nrde-3-dependent changes in relative mRNA levels for select endo-siRNA target 
genes. Log2 ratio (relative to N2 = 0) of qPCR determined mRNA levels for the indicated genes 
from L4 larvae of the indicated genotypes. Expression of these five genes, which are targets of 
rrf-3-dependent endo-siRNAs, was previously reported to be up-regulated in rrf-3 mutants 
(GENT et al. 2010). p-values calculated by t-test; *indicates p<0.05; ** indicates p<0.01. (B-G) 
Representative photomicrographs of Psur-5::gfp expression in (B) wild type (C) nrde-2(gg91) 
(D) nrde-3(gg66) (E) eri-1(mg366) (F) eri-1(mg366);nrde-2(gg91) and (G) eri-1(mg366);nrde-
3(gg66) strains. The extensive transgene silencing that is readily apparent in intestinal cells 
(yellow arrows) in the eri-1(mg366) background is dependent on nrde-2 and nrde-3. Compared 
to nrde-2(gg91) and nrde-3(gg66), wild type animals show reduced gfp levels. (H) Average gfp 
fluorescence of hatch-synchronized 24 hour adult (20 ºC) worms. For each genotype the average 
whole body fluorescence (0.1 second exposure) of 10 worms is shown. Error bars represent 
standard deviation. p-values calculated by t-test; red asterisks are p<0.01 compared to wild type 
(N2) and blue asterisks are p<0.01 compared to eri-1(mg366). 
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Figure 4.8 (Continued): nrde-3-dependent silencing of endogenous RNAi targets and transgenes 
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sur-5p::gfp in wild type versus nrde-2(gg91) and nrde-3(gg66) backgrounds. We found that the 
loss of nrde-2 and nrde-3 also increased transgene expression in non-Eri backgrounds (Figure 
4.8B, C, D, H), indicating that silencing repetitive transgenes is likely another endogenous 
function of nrde-3. 
 
rrf-3(pk1426) is likely associated with a non-allelic background mutation 
During this analysis, we noticed that the well-characterized deletion allele of rrf-3, pk1426, 
behaved differently in several assays from the missense rrf-3(mg373) allele, which is roughly 
indistinguishable from eri-1(mg366). First, the rrf-3(pk1426);nrde-3(gg66) double mutant was, 
like the eri-1; nrde-3; pgl-1 triple mutant, non-Eri for all tested genes. This is at odds with all the 
other eri; nrde-3(gg66) double mutants, including the rrf-3(mg373);nrde-3(gg66) and rrf-
3(pk2042);nrde-3(gg66) strains (Table 4.12, 4.13). Second, genes that were previously shown to 
be down-regulated in an rrf-3(pk1426) background (ASIKAINEN et al. 2007; LEE et al. 2006) 
showed a significantly different expression profile in an rrf-3(mg373) background (Figure 
4.9A). Previous gene expression profile analyses also show little overlap between rrf-3(pk1426) 
and eri-1(mg366) (ASIKAINEN et al. 2007; LEE et al. 2006). This indicates either a different 
mechanism or set of targets for endogenous gene regulation. Third, qPCR designed to measure 
dpy-13 mature and pre-mRNA transcript levels showed that dpy-13(RNAi) in rrf-3(pk1426) 
mutants more effectively reduced both mature and pre-mRNA levels than RNAi in eri-1(mg366) 
and rrf-3(mg373) mutants (Figure 4.9B). Given that two of the three rrf-3 alleles are 
phenotypically similar to the other eri mutants, we hypothesize that these apparently allele-
specific phenotypes are due to a pk1426 allele-associated background effect. 
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The RNAi phenotypes whose penetrances are tabulated and their corresponding descriptions for 
I, II, and III are listed in Table 4.1. All rrf-3 alleles are temperature sensitive sterile at 25°C, 
even in an nrde-3(gg66) background. The rescue construct restores viability at 25°C. A 
transgenic rescue using rrf-3 with its native UTRs of the NL2099 strain containing the pk1426 
allele does not fully restore the wild type RNAi response against gene targets most dependent on 
pgl-1. The trans-heterozygous strains were mated using rrf-3(pk1426) or rrf-3(pk1426);nrde-
3(gg66) hermaphrodites and rrf-3(mg373);sur-5::gfp or rrf-3(mg373);nrde-3(gg66);sur-5::gfp 
males for green cross progeny. 
Table 4.13: Penetrance readings for rrf-3(pk1426)’s unique dependence on nrde-3 for enhanced 
RNAi 
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To test this hypothesis, we determined whether a wild-type rrf-3 genomic fragment could 
rescue each distinct rrf-3(pk1426) phenotype. We found that rrf-3(pk1426); [rrf-3(wild type)] 
transgenic animals were rescued for the temperature sensitive sterility associated with all rrf-3 
alleles (Table 4.13) (GENT et al. 2009; PAVELEC et al. 2009). In addition, these animals were 
rescued for the Eri phenotypes against the nrde-3-dependent target genes (e.g. lir-1(RNAi), dpy-
13(RNAi), ifc-2(RNAi)), but not against the pgl-1-dependent target genes (e.g. dpy-28(RNAi), 
unc-73(RNAi)) (Table 4.12). Thus, the wild-type rrf-3 transgene specifically failed to rescue a 
phenotype that is unique to the pk1426 allele, implicating a non-rrf-3 lesion in the background of 
the pk1426 strain. We also constructed and scored an rrf-3(mg373/pk1426); nrde-3(gg66) strain 
(Table 4.12). Consistent with a semi-dominant effect, the rrf-3 trans-heterozygote strain was, at 
a very reduced level, Eri for some pgl-1-dependent targets. In summary, our results indicate that 
an rrf-3(pk1426) associated background effect, which may act via a pgl-1-dependent pathway, 
accounts for the unusual properties associated with the rrf-3(pk1426) strain. 
 
We show that the nuclear RNAi Argonaute nrde-3 contributes broadly and potently to RNAi 
triggered by exogenous dsRNA. Specifically, we found that nuclear RNAi contributes to 
silencing of genes that are members of multi-gene families and multi-copy transgenes, as well as 
the phenomena of transitive RNAi. Particularly intriguing was the finding that overexpression of 
NRDE-3 enhances RNAi, suggesting that, like the cytoplasmic secondary Argonautes, nuclear 
Argonautes may also be a limiting silencing resource. Furthermore, our analyses of pgl-1 show 
that it is important for the enhanced RNAi phenotypes of a non-overlapping subset of target 
genes. These results thus define two separate and independent limiting RNAi resource pathways, 
DISCUSSION 
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which establish pgl-1 and nrde-3 as two parallel activities that together are required for all 
detectable enhanced RNAi associated with eri-1 and the other conserved eri mutants. Finally, 
our analysis of trans-generational silencing identified roles for nuclear RNAi in both the exposed 
parent and the unexposed progeny, which may indicate that a nuclear limited step mediates the 
transition from short-term RNAi processes that include PTGS of mature transcripts and longer-
term RNAi processes, such as transgene silencing and trans-generational RNAi. 
 
nrde-3 functions in exogenous RNAi are predominantly nuclear 
NRDE-3 is a siRNA-binding protein that shuttles siRNAs between the cytoplasm and the 
nucleus, thus there is a possibility that NRDE-3 could function in either compartment.  However, 
our analyses of nuclear restricted nrde-2, (BURTON et al. 2011; GUANG et al. 2010), as well as 
the *NLS-nrde-3 and SV40NLS-nrde-3 constructs, provide strong evidence for the primary 
importance of nuclear limited RNAi steps. Nevertheless, this does not preclude prior or 
subsequent non-nuclear activities in these silencing processes. For example, transgene silencing, 
which is completely dependent on NRDE-3 in an Eri background, is partially dependent on SID-
1, a dsRNA transporter that enables cell-to-cell spreading of RNAi silencing signals (JOSE et al. 
2009). Therefore, NRDE-3 may either directly or indirectly use mobile silencing signals and/or 
NRDE-3-dependent processes may produce a silencing signal that can move between cells. Once 
the structure and origin of mobile silencing signals is known, it will be interesting to determine 
whether nrde-3 is required for their biogenesis.  
Interestingly, some of our analysis indicates that the *NLS-nrde-3-gfp transgene 
sometimes do partially rescue the nrde-3(gg66) defects, especially in the contexts of weak 
exogenous Rde (Figure 4.1A, J) and overexpressor-induced Eri (Figure 4.4C) phenotypes. This 
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may be due to an incomplete removal of nuclear localization, although the lack of gfp nuclear 
localization suggests otherwise. This may also be due to the perhaps overexpressed transgene 
soaking up endogenous siRNAs – even if it’s only present in the cytoplasm – so that the 
exogenous RNAi triggers have more access to competed-for cytoplasmic RNAi resources, hence 
creating an ever slight advantage in RNAi efficacy. 
nrde-2 was initially characterized as a nrde-3 effector (GUANG et al. 2010), thus it is 
interesting that many nrde-dependent functions, such as RNAi transmission and interaction with 
hrde-1, involve nrde-2 but not nrde-3 (BUCKLEY et al. 2012; BURKHART et al. 2011). 
Furthermore, nrde-2 mutants have defects that nrde-3 mutants do not, including germline 
mortality, suggesting that nrde-2 responds to multiple inputs (GUANG et al. 2010). Additionally, 
at least four other loci were identified in the Nrde screen, suggesting that nrde-3 may not 
function exclusively via nrde-2. Consequently, these observations may provide an explanation 
for why the nrde-2 RNAi defects are less penetrant than nrde-3 RNAi defects (Figure 4.1A, J). 
We therefore limit our interpretation of nrde-2 results as an approximate confirmation of nrde-
3’s RNAi functions within the nucleus. 
 
nrde-3 is required for enhanced RNAi in eri mutants 
Eri mutants are depleted for endogenous siRNAs, which are proposed to compete with 
exogenous siRNAs for silencing resources. It is this absence of competition for limiting RNAi 
resources that presumably accounts for enhanced exo-RNAi efficacy (Figure 4.5). sago-1 has 
previously been proposed to be a downstream effector of the eri pathway, not because its 
absence attenuates the Eri phenotype, but because its over-expression relieves the competition 
for this limiting resource (YIGIT et al. 2006). Here we show that nrde-3 is Rde (Figure 4.1A), 
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thus establishing a role for NRDE-3 in the exo-RNAi pathway. We also show that nrde-3 
mutations disrupt the expression of endogenous siRNA regulated genes (Figure 4.8A), 
confirming a role for NRDE-3 in the endogenous RNAi pathway(s). We then show that loss of 
nrde-3 attenuates the Eri phenotype, at least for some genes (Table 4.8). Finally, we show that, 
like sago-1, over-expression enhances RNAi (Figure 4.4A-C). This preponderance of evidence 
supports a role for nrde-3 as a downstream effector of the eri pathway. 
 
Transitive RNAi and nrde-3’s contributions to RNAi 
The result that transitive RNAi was not detectable in nrde-3 mutants (Figure 4.7) may provide 
insight into the role of nuclear RNAi. The contribution of NRDE-3 to RNAi was most apparent 
when dsRNA is limiting (Figure 4.1A), thus it is reasonable to infer that trans-acting siRNAs are 
also limiting. This can be readily explained by the favorable stoichiometric ratio of siRNAs to 
expressed loci in the nucleus versus exported transcripts in the cytoplasm. While a relative few 
siRNAs may be sufficient to silence a gene in the nucleus, they would be insufficient to silence 
hundreds or thousands of cytoplasmic transcripts. This implies that, while at high dsRNA dose 
PTGS mechanisms are sufficient to enable nrde-3-independent silencing, at low dsRNA dose, 
the primary gene silencing response may be nuclear-based transcriptional gene silencing. 
This model of complementary cytoplasmic and nuclear RNAi silencing processes also 
provides an attractive explanation for the enhanced silencing of both multi-gene families and 
multi-copy transgenes. In both cases, partial or incomplete gene silencing will not produce a 
phenotype, providing an explanation for why these target genes show exceptionally strong 
enhanced RNAi potential. For example, because dpy-13(RNAi) causes a much stronger Dpy 
phenotype than does a dpy-13 null allele, it is likely that the RNAi targets other functionally 
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redundant collagen genes. In fact, the ingested dpy-13 dsRNA trigger corresponds directly to a 
conserved collagen domain with near perfect identity with at least 30 other collagen members 
(COX 1985). Thus, a limited number of siRNAs targeting this conserved region could – if 
efficiently imported into the nucleus – effectively silence many genes in the nucleus, but would 
be ineffective targeting the very abundant cytoplasmic collagen transcripts. This model does not 
provide an explanation for nrde-3-dependent enhanced operon silencing; however, only two 
operons out of over 1300 C. elegans operons have been shown to be sensitive to eri-enhanced 
silencing.  
 
Non-allelic background effects of rrf-3(pk1426) 
Amongst the eri mutants, rrf-3(pk1426) has frequently been used as a reference allele for 
enhanced RNAi. In fact, it was the first Eri reported (SIMMER et al. 2002), first Eri implicated in 
endogenous gene regulation (GENT et al. 2009; PAVELEC et al. 2009), amongst the first Eri deep-
sequenced for its endogenous small RNA profile (GENT et al. 2010), and is phenotypically the 
most robust (ZHUANG and HUNTER 2011). However, this allele has had two reported 
discrepancies. First, although it is phenotypically almost identical to eri-1(mg366), two different 
groups reported that its gene expression profile is drastically different from eri-1(mg366) 
(ASIKAINEN et al. 2007; LEE et al. 2006). Second, biochemical analysis indicates that the rrf-
3(pk1426) mutant fails to form a RRF-3/ERI-5/DCR-1 endo-RNAi protein complex that is 
formed in the rrf-3(mg373) missense mutant (THIVIERGE et al. 2011). 
Our results suggest that there’s no simplistic model which could explain all the 
discrepancies in the rrf-3(pk1426) background. It is not a simple background Rde, because a 
rescued strain is still partially Eri (Table 4.12) and rrf-3(pk1426) exogenous RNAi seems more 
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robust (Figure 4.9B). It is not a simple background Eri, because a rrf-3(pk1426);nrde-3(gg66) 
double mutant is weaker in its RNAi responses than the rrf-3(mg373);nrde-3(gg66) and rrf-
3(pk2042);nrde-3(gg66) double mutants (Table 4.12). Furthermore, our observations that rrf-
3(pk1426/mg373);nrde-3(gg66) trans-heterozygotes behave mostly like rrf-3(pk1426);nrde-
3(gg66) do not suggest simple recessive background effect(s) (Table 4.12). 
Fortunately, it seems like most of the previously reported analysis of rrf-3(pk1426) is still 
valid. For instance, endo-siRNA targets found in the rrf-3(pk1426) background (GENT et al. 
2010) seem to be confirmed in the rrf-3(mg373) background as well (Figure 4.8A), which makes 
us comfortable in using that reference dataset. With the three exceptions we described (Table 
4.12; Figure 4.9), rrf-3(pk1426) seems to behave the same as all the other Eri mutants in all the 
rest of our analysis. Previously reported reference datasets of rrf-3(pk1426), however, should 
still be used with caution without second-allele verification. 
 
Endo-siRNA targeting and transgenes silencing are endogenous NRDE-3 functions 
The depletion of endo-siRNAs that apparently underlies many nrde-3-dependent Eri phenotypes 
suggests that nrde-3 might have a role in endo-siRNA target gene regulation. Indeed, similar to 
the eri mutants, we found that loss of nrde-3 affects the gene expression of eri endo-siRNA 
targets (Figure 4.8A), supporting the hypothesis that endo-siRNAs mediate TGS in somatic 
cells.  This is consistent with recent reports of nrde-1,-2, and -4 functions in the germline, 
including transmission and maintenance of gene silencing (BUCKLEY et al. 2012).   
Furthermore, it may be noteworthy that eri-6/7 endo-siRNA targets show enrichment for 
duplicated genes (FISCHER et al. 2011), which suggests that RNAi targeting specific gene 
structures may indeed be a possible mechanism of action. An artificial analog to endogenous 
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repetitive arrays in the C. elegans genome is transgenes, because simple transgenic arrays are 
often incorporated as repetitive elements (PRAITIS et al. 2001). Our discovery of nrde-3’s 
contribution to transgene silencing in both Eri and non-Eri backgrounds further supports the 
broad endogenous roles nrde-3 may play. These findings thus begin to form the funnel of broad 
upstream roles in endogenous and exogenous nuclear RNAi that ultimately channels into 
downstream effectors like the germline nuclear Ago hrde-1 that impact fundamental biological 
processes such as germline maintenance. 
 
Strains: The following strains were used: (FX1917) eri-6/7(tm1917), (GR1373) eri-1(mg366), 
(HC195) nrIs20 (sur-5::NLS-GFP), (HC745) eri-1(mg366);nrIs20, (HC758) eri-1(mg366);nrde-
3(gg66), (HC759) eri-1(mg366);nrde-3(gg64), (HC760) rrf-3(pk1426);nrde-3(gg66), (HC761) 
eri-6/7(tm1917);nrde-3(gg66), (HC762) eri-8(gg100);nrde-3(gg66), (HC763) eri-
1(mg366);vpIs9, (HC764) eri-1(mg366);nrde-3(gg66);vpIs9, (HC765) nrde-3(gg66);nrIs20, 
(HC766) eri-1(mg366);nrde-3(gg66);nrIs20, (HC767) rrf-3(pk1426);nrde-3(gg66);nrIs20, 
(HC792) eri-1(mg366);nrde-2(gg91), (HC794) nrde-3(gg66);ggls01(nrde-3p::FLAG3x-gfp-
nrde-3), (HC824) nrde-2(gg91) nrIs20, (HC831) nrde-3(gg66); vpIs9, (HC833) eri-1(mg366) 
nrde-2(gg91) nrIs20, (HC838) eri-1(mg366); nrde-3(gg66); (nrde-3p::FLAG3x-gfp-nrde-3;  
*NLS), (HC839) nrde-3(gg66);(nrde-3p::FLAG3x-gfp-nrde-3; *NLS);vpIs9,  (HC840) rrf-
3(mg373);nrde-3(gg66), (HC848)  nrde-3(gg66);  (nrde-3p::FLAG3x-gfp-nrde-3; *NLS, 
SV40NLS); vpIs9, (HC860) nrde-3(gg66); neIs11, (HC888) rrf-3(pk2042), (HC889) rrf-
3(pk2042); nrde-3(gg66), (HC891) (nrde-3p::FLAG3x-gfp-nrde-3; *NLS), (HC895) rrf-
3(mg373); nrIs20; nrde-3(gg66), (HC896) rrf-3(pk1426); (rrf-3p::rrf-3; myo-3p::dsRed), (JG33) 
MATERIALS AND METHODS 
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vpIs9 (unc-119(+) + elt-1::GFP), (NL2099) rrf-3(pk1426), (WM120) Mago; neIs11(myo-
3p::GFP::sago-1 + pRF4(rol-6(su1006))), (YY13) rrf-3(mg373), (YY158) nrde-3(gg66), 
(YY168) eri-8(gg100), (YY174) ggIs01(nrde-3p::FLAG3x-gfp-nrde-3), (YY186) nrde-2(gg91), 
(YY238) nrde-3(gg64), (YY298) nrde-3(gg66); (nrde-3p::FLAG3x-gfp-nrde-3;*NLS), and 
(YY362) nrde-3(gg66); (nrde-3p::FLAG3x-gfp-nrde-3; *NLS,SV40NLS).  
All strains tested wild type for the mut-16(mg461) background Rde allele. All strains and 
assays were maintained and performed at 20ºC as previously described (BRENNER 1974), except 
where indicated. The YY298 and YY362 strains that affect the nuclear localization signal of 
nrde-3 were previously characterized (GUANG et al. 2008) and used in the same context as our 
experiments. The YY174 strain that rescues nrde-3(gg66) was previously characterized (GUANG 
et al. 2008) and used in the same context as our experiments. All three transgenes were 
documented to be expressed at comparable levels as wild type nrde-3. The WM120 strain that 
causes an Eri phenotype by sago-1 overexpression was also previously characterized (YIGIT et 
al. 2006) and used in the same context as our experiments. 
 
RNAi: RNAi assays were performed as previously described (TIMMONS and FIRE 1998). 
Bacteria engineered to express dsRNA against genes listed in Table 4.1 were obtained from the 
Ahringer library (KAMATH and AHRINGER 2003) and verified by sequencing. Bacteria 
engineered to express dsRNA against gfp were prepared as previously described (WINSTON et al. 
2002). All RNAi assays involving the dilution series were performed as previously described 
(ZHUANG and HUNTER 2011), unless explicitly stated otherwise. Briefly, individual L3 animals 
were placed on RNAi food at the indicated concentrations and their progeny were scored for 
previously published knockdown phenotypes. Feeding RNAi assays from the L1 were performed 
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by hypochlorite treating gravid adults on RNAi plates and scoring the surviving embryos in the 
same generation. All feeding RNAi assays were performed in triplicate and repeated three times. 
The penetrance shown is representative of all the assays performed. 
 The (JG33) elt-1-gfp strain was previously described (SMITH et al. 2005). In performing 
the transitive RNAi assay (Figure 4.7), knockdown of gfp levels was consistent across all strains 
tested, ensuring that the intake of dsRNA trigger was unaffected. In previously published 
transitive RNAi assays, the elt-1-gfp transgene was deemed the most efficacious in causing 
transitive RNAi (ALDER et al. 2003). The vpIs9 (unc-119(+) + elt-1::GFP) insertion is <2cM 
from nrde-2, and we were thus not able to make the nrde-2(gg91);elt-1-gfp double mutant. 
 
Reverse transcription quantitative PCR: Hatch-synchronized (within 1 hour) mid-L4 worms 
from five NG large plates grown at 15ºC for 91 hours were pooled, washed extensively (M9) and 
allowed to swim for 20 minutes to clear gut content.  RNA was isolated with Trizol (Invitrogen) 
followed by phenol:chloroform extraction (Amresco).  The RNA pellets were subjected to 
DNase I (Roche) treatment, removed by RNeasy (Qiagen) per manufacturer’s instruction.  All 
RNA stock concentrations were adjusted to 150 ng/µL. 
 Reverse transcription was performed using 300 ng of input RNA by Thermoscript RT 
(Invitrogen), using gene specific RT primers (available upon request). cDNA quantification was 
performed using 2 µL of the 20 µL RT reaction in a 50 µL QuantiTect SYBR Green (Qiagen) 
reaction with nested PCR primers. The PCR reaction cycles were: 15 minutes 95 degrees, 15 
seconds 94 degrees, 30 seconds 52 degrees, 1 minute 72 degrees, read, cycle to step 2 for 45 
cycles, using an Eppendorf Mastercycler Realplex4 and Noiseband quantification. Subsequent 
analysis was performed using a ΔΔCT approach (LIVAK and SCHMITTGEN 2001), using  gpd-3 
210 
 
RNA levels for normalization (WELKER et al. 2010), as previously described (ZHUANG and 
HUNTER 2012). 
 
Cross Progeny Assays: Males were marked by the sur-5::gfp transgene while hermaphrodites 
were unmarked. Only green cross progeny were scored in all assays. 
 
Transgene Silencing Assay: Hatch-synchronized (within 1 hour) young adult worms grown at 
20ºC for 53 hours were imaged, at the same magnification and exposure for all strains indicated 
in Fig. 4. Outlined individual worms were analyzed using ImageJ (National Institutes of Health) 
by first “subtract background” and then “measure” functions for determining gfp-intensity units. 
 
Penetrance calculations and statistical notes: All penetrance results were representative of at 
least three independent trials performed in triplicate. All assays with binary phenotypic 
penetrances (i.e. Dpy or WT) are represented by individual trials and their standard deviations or 
a representative trial set. All assays with trinomial phenotypic penetrances (i.e. emb. lethal, dev. 
arrest, or WT) are represented by sums of all trials; breakdown of individual trials are available 
upon request. All error bars indicate standard deviation. p-values calculated by t-test; * indicates 
p<0.05 and ** indicates p<0.01. 
 
ALDER, M. N., S. DAMES, J. GAUDET and S. E. MANGO, 2003 Gene silencing in Caenorhabditis 
elegans by transitive RNA interference. RNA 9: 25-32. 
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Chapter Five 
Enhanced RNAi is dependent on pgl-1 
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We identified pgl-1 as an additional limiting RNAi resource important for eri-dependent 
silencing of a non-overlapping subset of target genes to nrde-3, so that an nrde-3; pgl-1; eri-1 
triple mutant fails to show enhanced RNAi for any tested gene. These results suggest that nrde-3 
and pgl-1 define separate and independent limiting RNAi resource pathways. We discovered that 
like NRDE-3, a PGL-1 functions to modulate endogenous siRNA gene regulation. However, we 
were unable to elucidate a mechanism of contribution for pgl-1 after analyzing common RNAi 
mechanisms. Therefore, we prepared preliminary protocols for C. elegans small RNA 
sequencing in hopes of using the pgl-1 mutant small RNA profile to better understand the 
mechanism of pgl-1’s roles in RNAi. 
ABSTRACT 
 
Few concrete details are known about the function of PGL-1 and its interaction with RNAi. 
Some reports have suggested that it is as a component of germline perinuclear P-granule 
structures which are sites of mRNA export and possibly degradation (KAWASAKI et al. 1998; 
SHETH et al. 2010), and others have shown that these P-granules’ structure or stability depends, 
at least indirectly, on RNAi components including CSR-1, EGO-1, DCR-1, DRH-3, PRG-1, and 
RDE-4 (BESHORE et al. 2011; CLAYCOMB et al. 2009; SPIKE et al. 2008; UPDIKE and STROME 
2009). While PGL-1’s link to RNAs is genetically and biochemically well-established 
(HANAZAWA et al. 2011; SCHISA et al. 2001), especially for those in the germline, there are 
conflicting reports on its role in RNAi. One report was unable to observe any effects on somatic 
RNAi via 3’UTR-targeted RNAi in a transgene (SHETH et al. 2010), while another report 
INTRODUCTION 
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suggested that germline RNAi silencing of a transgene was perturbed in a pgl-1 mutant (ROBERT 
et al. 2005). 
 Perhaps the clearest link between RNAi and pgl-1 was the observation that PGL-1 was 
overexpressed in the soma of an rb mutant, which is enhanced for RNAi (WANG et al. 2005). 
However, this enhanced RNAi was attributed more to the overall germline-to-soma 
transformation in an rb mutant, and pgl-1 was simply used as a marker for demonstrating the 
presence of germline components. Indeed, a follow-up report showed that along with pgl-1, 
many germline components, including many involved in RNAi, were overexpressed an rb 
mutant’s soma to induce enhanced RNAi (WU et al. 2012). 
Here, we identify the peri-nuclear protein PGL-1 as important for the enhanced RNAi 
phenotypes of a non-overlapping subset of target genes to NRDE-3. These results thus define a 
unique and independent limiting RNAi resource pathway. 
 
pgl-1 acts in parallel to nrde-3  
RESULTS 
Mutants that disrupt core RNAi functions, such as rde-1 and dcr-1, have near 100 percent Rde 
penetrance (TABARA et al. 1999; TABARA et al. 2002), while the nrde-3 Rde phenotype is only 
apparent at limiting dsRNA concentrations (Figure 4.1A). Furthermore, nrde-3 is only essential 
for the enhanced RNAi phenotypes of a subset of target genes (Table 4.8). These observations 
indicate that nrde-3 likely acts after the core RNAi components and that one or more additional 
post-core activities may act in parallel with nrde-3 to mediate the full spectrum of enhanced 
RNAi phenotypes. The SAGOs are candidates for this parallel activity, as their overexpression 
enhances exo-RNAi independent of nrde-3. However, their functional redundancy (YIGIT et al. 
218 
 
2006) challenges analysis of eri(-);sago(-) double mutants. Therefore, to discover what other 
secondary RNAi pathways may act in parallel to nrde-3, we screened available mutants with 
functions associated with the nucleus for RNAi phenotypes analogous to nrde-3(-) mutants: 
weak Rde to exogenous RNAi and enhanced RNAi when overexpressed as a transgene (Table 
5.1). 
Among these mutants, the perinuclear P-granule component pgl-1 emerged as a 
promising candidate. Like nrde-3, three different pgl-1 mutant alleles were weakly Rde, while 
worms carrying a pgl-1-gfp transgene showed enhanced RNAi (Figure 5.1A-C; Table 5.2). To 
analyze the effects of pgl-1 loss-of-function on the eri-1 phenotype, we constructed and tested an 
eri-1(mg366); pgl-1(bn101) double mutant and an eri-1(mg366); pgl-1(bn101); nrde-3(gg66) 
triple mutant. Surprisingly, the eri-1;pgl-1 double mutants maintained enhanced RNAi 
phenotypes for the target genes that require nrde-3, but failed to show enhanced RNAi 
phenotypes for the nrde-3-independent target genes (Figure 5.1D, E). The complementary 
nature of this pattern was confirmed by analyzing the eri-1;pgl-1;nrde-3 triple mutant, which 
was non-Eri for all tested target genes (Figure 5.1D, E). A second allele, pgl-1(bn102), behaved 
the same way (Table 5.3).  The effect pgl-1 loss had on enhanced RNAi was also observed for 
the other conserved Eri mutants: rrf-3, eri-6/7, and ergo-1/eri-8 (Table 5.3). Finally, because 
PGL-1 is over-expressed in the rb mutants that enhance RNAi (WANG et al. 2005), we tested 
both lin-15ab and lin-35 for pgl-1 dependent Eri phenotypes. We found that pgl-1(bn101);lin-
15ab (n765) and pgl-1(bn101);lin-35(n745) double mutants were non-Eri for the same subset of 
target genes as the pgl-1(bn101); eri-1(mg366) double mutants (Table 5.3). These results thus 
suggest pgl-1 and nrde-3 act as parallel activities that seemingly account for all eri mutant 
enhanced RNAi effects. 
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Candidate 
Table 5.1: Candidate screen of nuclear-associated factors with available mutants that may 
contribute to nrde-3-independent enhanced RNAi 
dpy-11(RNAi)  Annotation and Notes 
N2 wild type Dpy Almost completely penetrant 
ceh-30(n4289) Dpy Homeodomain protein 
chd-3(ok1651) Mild Rde Chromodomain protein Sensitive to unc-22(RNAi) and bli-1(RNAi) like WT 
daf-21(p673) Dpy Hsp90 chaperone 
daf-3(ok3610) Dpy SMAD transcriptional regulator 
daf-5(e1386) Dpy  
daf-8(e1393) Dpy SMAD transcriptional regulator 
efl-1(se1) Dpy E2F transcriptional repressor 
egl-27(ok1670) Dpy MTA1 nucleosome remodeling deacetylase 
gfl-1(gk321) Dpy ENL-class transcriptional factor 
hpl-1(tm1624) Dpy Heterochromatin protein 1 
let-418(n3536) Dpy CHD3 homolog nucleosome remodeling deacetylase 
mab-10(e1248);him-5(e1490) Dpy  
mes-1(ok2467) Dpy Receptor tyrosine kinase-like protein 
mes-3(bn21) Dpy Polycomb chromatin repressive complex component 
met-1(n4337) Mild Eri Histone methyltransferase Mild Eri to lir-1(RNAi) as well 
mev-1(kn1) Mild Eri 
Cytochrome b integral membrane protein 
Eri to lir-1(RNAi), dpy-13(RNAi), unc-73(RNAi), and 
hmr-1(RNAi) as well 
pag-3(n3098) Dpy C2H2 zinc-finger protein 
pgl-1(bn101) Rde RNA-binding protein with RGG box motifs See data presented within text 
pop-1(hu9) Mild Eri TCF/LEF family transcription factor 
prmt-5(gk357) Dpy Protein arginine Methyltransferase 
sex-1(gk808) Dpy Nuclear hormone receptor family DNA-binding protein 
sin-3(tm1276);him-5(e1490) Dpy Histone deacetylase subunit 
sma-9(tm572) Dpy Zinc-finger domain protein 
taf-11.1(gk648) Dpy TBP-associated transcription factor 
taf-11.2(gk682) Dpy TBP-associated transcription factor 
taf-4(ok1399) Rde 
TATA-binding protein associated factor  
Rde to unc-22(RNAi), bli-1(RNAi), lir-1(RNAi), and 
par-1(RNAi) as well 
taf-7.1(gk696) Dpy TATA-binding protein associated factor 
taf-9(ok2871) Dpy TBP-associated transcription factor 
tag-235(ok1265) Dpy Histone Acetyltransferase 
tbx-2(ut180) Dpy T-box transcription factor 
unc-37(e262) Dpy Transducin-like WD-repeat protein 
zag-1(zd86) Dpy ZFH class homeodomain protein 
zfp-1(ok554) Dpy Leucin-zipper containing protein 
The indicated strains were placed onto OD600nm 1.0 dpy-11(RNAi) food as L3s and scored in the 
next generation. Any Rde phenotypes were followed up with additional RNAi tests as described.
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Figure 5.1: Complementary contributions of pgl-1 and nrde-3 to eri-dependent enhanced RNAi 
phenotypes 
(A) RNAi phenotypic penetrance for the indicated genes in N2 and three pgl-1 alleles is shown. 
The progeny of L3 larvae placed on the RNAi food were scored as L4 larvae. The RNAi bacteria 
concentrations, phenotypes, and penetrances are listed in Table 5.2. p-values calculated by t-test; 
** indicates p<0.01. (B-C) Representative images of progeny from L3 hermaphrodites of the 
indicated strains grown on dpy-13(RNAi) bacteria. (D) The severity of RNAi phenotypes, as 
described in Table 4.8, is based on expressivity measurements presented in Table 4.1.  
Representative examples are presented in (E). Complete penetrances are tabulated in Table 5.3. 
The enhanced RNAi response targeting genes in operons or with many homologs (highlighted in 
yellow) is most dependent on nrde-3. The enhanced RNAi response targeting genes with few or 
no homologs (highlighted in green) is most dependent on pgl-1. The eri-1; nrde-3; pgl-1 triple 
mutant (highlighted in salmon) is non-Eri. (E) Representative images of the expressivity of dpy-
13(RNAi), unc-15(RNAi), and unc-73(RNAi) for the indicated strains is shown. The progeny of 
L3 larvae placed on the RNAi food were scored as L4 larvae. The stars correspond to RNAi 
responses as scored in (D). The eri-1(mg366);nrde-3(gg66) double mutant is most like wild type 
in RNAi targeting genes with many homologs, like dpy-13(RNAi) (bracketed in yellow). The eri-
1(mg366);pgl-1(bn101) double mutant is most like wild type in RNAi targeting unique genes, 
like unc-73(RNAi) (bracketed in green). The RNAi bacteria concentrations used in (D) and (E) 
were the same as Table 4.8. 
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Figure 5.1 (Continued): Complementary contributions of pgl-1 and nrde-3 to eri-dependent 
enhanced RNAi phenotypes 
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The RNAi phenotypes whose penetrances are tabulated and their corresponding descriptions for 
I, II, and III are listed in Table 4.1. The RNAi bacteria OD600nm concentrations used were the 
same as Table 4.8. The eri-class enhanced RNAi response against gene targets most dependent 
on pgl-1 holds the same pattern of RNAi responses as eri-1(mg366) and eri-1(mg366);pgl-
1(bn101) for rrf-3(pk1426), eri-6/7(tm1917), eri-8(tm1860), and their doubles with pgl-
1(bn101). The impact on the enhanced RNAi response for pgl-1(bn102) holds the same pattern 
of RNAi responses as pgl-1(bn101) mutants. The eri-1(mg366);nrde-3(gg66);pgl-1(bn101) 
strain is completely wild type in its response to all tested RNAi targets. The rb-class (lin-
15ab(n765) and lin-35(n745)) enhanced RNAi response against gene targets do not depend on 
nrde-3(gg66), but against gene targets most dependent on pgl-1 in the eri-class, the lin-
15ab(n765);pgl-1(bn101) and lin-35(n745);pgl-1(bn101) mutants hold the same pattern of RNAi 
responses as eri-1(mg366);pgl-1(bn101). 
Table 5.3: Penetrance readings for Eri mutants’ partial requirement of pgl-1 for enhanced RNAi 
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pgl-1 acts to regulate endo-RNAi target gene expression 
NRDE-3 interacts with endo-siRNAs and is required to regulate rrf-3 endo-siRNA target genes 
(Figure 4.8A) (GUANG et al. 2008). To determine whether pgl-1 is also required for endo-siRNA 
target gene regulation, we used qPCR to measure the RNA levels for seven endo-siRNA 
regulated genes in embryos, L4 larvae, and mixed stage worms, comparing wild-type, rrf-3, and 
pgl-1 mutants. In all three conditions, a subset of these genes showed significant changes in the 
pgl-1 mutant compared to wild type (Figure 5.2A-C), although we failed to discern a definitive 
pattern among these changes. However, despite our lack of mechanistic insight, our results 
suggest that pgl-1 is important for endo-siRNA regulated gene expression via a process that may 
compete with exogenous RNAi. 
 
Possible mechanisms of pgl-1’s contribution to enhanced RNAi 
Our observations that a pgl-1 mutant is weakly defective for RNAi against both germline and 
somatic targets in both Eri and non-Eri backgrounds (Figure 5.1A, D) leads us to believe that 
pgl-1 is indeed involved in RNAi. These RNAi assays were performed via standard feeding of 
L3 mothers and scoring in the next generation; we were unable to observe a difference between 
N2 wild type and pgl-1 mutants’ dpy-11(RNAi) responses in same-generation RNAi assays via 
feeding from a bleached embryo (25±2% versus 21±4% penetrance, n>50 in each of the 
triplicates). Therefore, pgl-1’s contribution to exogenous RNAi is likely through the germline. 
Because of the overwhelming number of germline components associated with P-granules 
(UPDIKE and STROME 2010), it is challenging to find a mechanism of how pgl-1 contributes to 
general exogenous RNAi. 
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Figure 5.2: pgl-1 mutant misexpression of rrf-3 siRNA targets 
rrf-3(pk1426) and pgl-1(bn101) dependent changes in relative mRNA levels for select endo-
siRNA target genes. Log2 ratio (relative to N2 = 0) of qPCR determined mRNA levels for the 
indicated genes from (A) mixed-stage worms, (B) embryos, and (C) L4 worms of the indicated 
genotypes. These seven genes were previously reported to be targets of rrf-3-dependent endo-
siRNAs (GENT et al. 2010). p-values calculated by t-test; * indicates p<0.05 and ** indicates 
p<0.01. 
227 
 
However, our findings that pgl-1 contributes to eri mutants’ enhanced RNAi in a 
complementary fashion to nrde-3 and that pgl-1 impacts some of rb mutant’s enhanced RNAi 
responses (Table 5.3) allowed us a significantly narrower guided search for possible 
mechanisms. We therefore examined roles analogous to nrde-3’s contribution to the eri pathway 
and developmentally-related roles that rb genes control (which have RNAi implications) as the 
bases of a candidate search for a possible pgl-1 RNAi mechanism(s). 
 
pgl-1 does not contribute to transgene silencing 
Enhanced RNAi mutants show increased spontaneous transgene silencing (Figure 4.8E, H). 
Since we observed that nrde-3 loss alleviates some of this spontaneous transgene silencing 
(Figure 4.8G, H), we wondered if pgl-1 loss does the same. We compared the extent of silencing 
of the ubiquitously expressed sur-5p::gfp transgene in eri-1(mg366) single mutant to the 
silencing in the eri-1(mg366);nrde-3(gg66) and eri-1(mg366);pgl-1(bn101) double mutants. We 
found that pgl-1 was not required for eri-1-induced silencing (Figure 5.3A-C). Therefore, it 
seems that pgl-1 does not contribute to enhanced RNAi via facilitating the silencing of repetitive 
transgene arrays. 
 
pgl-1 does not contribute to NRDE-3 nuclear localization 
Although nrde-3 and pgl-1 seem to act in parallel pathways due to their contribution to the Eri 
response against non-overlapping sets of gene targets (Figure 5.1D-E), we nevertheless 
wondered if pgl-1 loss had any impact on nrde-3 nuclear localization due to PGL-1’s perinuclear 
location. In wild type backgrounds, nrde-3-gfp localizes to the nucleus, most prominently 
observed in the seam cells (Figure 5.3D). In a pgl-1(bn101) background, this localization still 
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Figure 5.3: pgl-1 does not contribute to common RNAi-related processes 
(A-C) Representative micrographs of (A) eri-1(mg366), (B) eri-1(mg366);nrde-3(gg66), and (C) 
eri-1(mg366);pgl-1(bn101) strains expressing a Psur-5::gfp transgene. In the eri-1(mg366) 
background, there is extensive silencing of gfp (red arrows) in the intestinal cells; in the eri-
1(mg366);nrde-3(gg66) strains, there is no such extensive transgene silencing. The eri-
1(mg366);pgl-1(bn101) strain still exhibits extensive silencing of gfp (red arrows) in the 
intestinal cells, suggesting no alleviation of spontaneous transgene silencing like nrde-3 loss 
exhibits. (D-E) Representative micrographs of (D) nrde-3(gg66) and (E) pgl-1(bn101) strains 
expressing an nrde-3-gfp transgene. In both backgrounds, there is nuclear localization of the gfp 
in the seam cells (red arrows), suggesting pgl-1 loss does not affect nrde-3 nuclear localization. 
(F) The severity of RNAi phenotypes, from ‘-’ to ‘+ + + + +’, based on expressivity described in 
Table S1 of indicated strains for dpy-13(RNAi) and unc-73(RNAi), with the same OD600nm 
concentrations as Table 1, are scored. All scores are normalized to the strongest Eri response for 
a particular RNAi assay as ‘+ + + + +’ and no response as ‘-’. DCAP-1 and SMG-7 are P-granule 
components proposed to interact with PGL-1; dcap-1, smg-7, and mes-4 have also all been 
previously implicated in RNAi-processes, especially in the germline, where pgl-1 is expressed. 
The eri-1(mg366) enhanced RNAi response does not hold the same pattern upon pgl-1 loss as 
dcap-1, mes-4, or smg-7 loss. (G-I) Representative micrographs of (G) lin-15ab(n765), (H) lin-
15ab(n765);pgl-1(bn101), (I) let-23(sa62), and (J) let-23(sa62);pgl-1(bn101) strains’ multi-
vulva (Muv) phenotype. Inappropriate induction of growth in the rb mutants (lin-15ab) can cause 
germline-to-soma transformations which lead to enhanced RNAi. pgl-1 loss however only 
suppresses the Muv phenotype of the rb mutant, but not a general growth induction pathway like 
the EGF receptor mutant let-23(sa62). (K-L) rb mutants are perturbed in their starvation 
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response and starved worms are more RNAi-sensitive than well-fed ones. During starvation, daf-
16::gfp localizes to the nucleus; in a rb mutant, this nuclear localization is increased with or 
without food. The knockdown of pgl-1 had no effect on daf-16::gfp nuclear localization as 
indicated by the penetrance of the indicated strains who were placed onto pgl-1(RNAi) food as 
L3s and scored in the next generation (K), even though pgl-1(RNAi) increased the penetrance of 
temperature-sterility at 25°C like pgl-1 loss does (L), suggesting a functional knockdown. pgl-1 
loss thus does not seem to impact the daf-16 starvation response. 
Figure 5.3 (Continued): pgl-1 does not contribute to common RNAi-related processes 
(M) rb mutants misexpress 
germline genes in the soma, including pgl-1. qPCR of 15ºC hour 122 adult worms for their 
expression levels of the indicated genes in the various mutant strains are shown, with expression 
of N2 wild type set to 1.0 for each gene. Compared to the “amount” of germline, approximated 
by mex-3 expression, lin-35(n745) mutants have overexpression of pgl-1, consistent with 
previous reports. eri-1 or rrf-3 loss does not seem to perturb pgl-1 expression, suggesting pgl-1 
overexpression is unlikely to be a mechanism of eri-class enhanced RNAi. p-values calculated 
by t-test; ** indicates p<0.01. 
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Figure 5.3 (Continued): pgl-1 does not contribute to common RNAi-related processes 
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occurs (Figure 5.3E). Therefore, it seems that pgl-1 loss does not impact enhanced RNAi via 
perturbing nrde-3 nuclear localization. 
 
dcap-1, mes-4, and smg-7 loss do not affect enhanced RNAi the way pgl-1 loss does 
Due to the motifs present in PGL-1, one mechanistic possibility is that it plays a structural role in 
maintaining P-granules (KAWASAKI et al. 1998), whose components include the RNAi 
effector(s) responsible for contributing to enhanced RNAi. We therefore selected three 
candidates, dcap-1, mes-4, and smg-7, who interacts with PGL-1 within P-granules (UPDIKE and 
STROME 2010) and have previous been known to have RNAi-associated phenotypes (DOMEIER et 
al. 2000; DUDLEY et al. 2002; SQUIRRELL et al. 2006), to examine their loss’ effects on enhanced 
RNAi. Because DCAP-1 is part of the mRNA decapping complex, MES-4 is important for 
germline maintenance and RNA metabolism, and SMG-7 is part of the nonsense mediated decay 
complex, they all have mechanistic potential for eliminating mRNAs. The eri-1(mg366);dcap-
1(ok2139), eri-1(mg366);mes-4(ok2326), and the eri-1(mg366);smg-7(r1197) double mutants all 
did not behave like the eri-1(mg366);pgl-1(bn101) mutant on unc-73(RNAi) (Figure 5.3F); loss 
of dcap-1, mes-4, and smg-7 essentially had no effect on the eri-1 enhanced RNAi response. 
Therefore, it seems that PGL-1 does not contribute to enhanced RNAi via facilitating DCAP-1, 
MES-4, or SMG-7 mechanisms. 
 
pgl-1 loss does not impact lin-3 growth pathway 
The rb gene family normally represses gene expression; their mutants are enhanced for RNAi 
because there is an induction of germline expressed genes in the soma (WANG et al. 2005; WU et 
al. 2012). One result of this unrepressed expression is inappropriate induction of growth; in the 
232 
 
Rb mutants, there’s a multi-vulva (Muv) phenotype because of unrepressed epidermal growth 
induction (Figure 5.3G) (SAFFER et al. 2011). To determine whether pgl-1 functions in the 
growth pathway, we looked for the repression of the Muv phenotype in lin-15ab(n765) and EGF 
growth factor (lin-3) receptor constitutive mutant let-23(sa62) backgrounds (Figure 5.3I). While 
the lin-15ab(n765);pgl-1(bn101) double mutant was no longer Muv (Figure 5.3H), the let-
23(sa62);pgl-1(bn101) double mutant still was (Figure 5.3J). Therefore, it seems that pgl-1 
functions to repress in the rb pathway rather than in a general growth response pathway. 
 
pgl-1 knockdown does not affect daf-16::gfp nuclear localization 
Starved worms are more responsive to RNAi (ZHUANG and HUNTER 2012) and rb mutants have 
a perturbed daf-16 starvation response (KIRIENKO et al. 2008). To test if pgl-1 acts to enhance 
RNAi via the starvation response, we tested for daf-16::gfp nuclear localization which occurs in 
the absence of food and is abnormally high in lin-35(n745) mutants regardless of food status 
(KIRIENKO et al. 2008). We found that knocking down pgl-1, which induced a temperature-
sensitive sterility phenotype much like pgl-1 loss does (Figure 5.3L), had no effect on the daf-
16::gfp nuclear localization in either wild type or lin-35(n745) backgrounds (Figure 5.3K). 
Therefore, it seems that pgl-1 loss does not perturb the daf-16 starvation response pathway as a 
mechanism of enhancing RNAi. 
 
pgl-1 is not overexpressed in eri-1 and rrf-3 mutants 
Although not previously reported, it could be possible that the eri mutants, like the rb mutants, 
misexpress some components of the germline, including pgl-1, to cause their enhanced RNAi 
phenotype. qPCR of 15ºC hour 122 adult eri-1(mg366), rrf-3(pk1426), and lin-35(n745) worms 
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for their expression levels of pgl-1 and mex-3 were normalized to N2 wild type expression 
(Figure 5.3M). Compared to the “amount” of germline approximated by mex-3 expression, lin-
35(n745) mutants have overexpression of pgl-1, consistent with previous reports (WANG et al. 
2005). eri-1 or rrf-3 loss does not seem to perturb pgl-1 expression. Therefore, it seems pgl-1 
overexpression is unlikely to be a mechanism of eri-class enhanced RNAi. 
 
Two classes of systemically mobile transgene silencing 
During our analysis of pgl-1’s role in transgene silencing (Figure 5.3A-C), we analyzed the 
relationship between pgl-1 loss and enhanced transgene silencing induced by rb mutations. We 
discovered that the rb mutant’s enhanced transgene silencing (Figure 5.4G) is not affected by 
either nrde-3 loss or pgl-1 loss (Figure 5.4H, I), unlike the eri mutant’s (Figure 5.4D, E). While 
our hypothesis that the rb mutant’s transgene silencing depended on pgl-1 was incorrect, our data 
do suggest two distinct classes or mechanisms of enhanced transgene silencing (Figure 5.4). 
 Previous work has shown that part of the eri class mutants’ enhanced transgene silencing 
depended on the systemic double stranded RNA channel SID-1 (JOSE et al. 2009), suggesting 
that these silencing signals are likely mobile. We observed that in an eri-1(mg366);lin-
15ab(n765);sur-5::gfp background (Figure 5.5D, F), the transgene silencing is significantly 
more prominent than in either eri-1(mg366);sur-5::gfp (Figure 5.5B, F) or lin-15ab(n765);sur-
5::gfp (Figure 5.5C, F) backgrounds. This suggested that the two distinct classes of transgene 
silencing are additive in effect. We therefore examined a lin-15(n765);sid-1(qt9) mutant and 
observed that its transgene silencing was significantly reduced (Figure 5.5E, F). This 
observation suggests that, like the eri class enhanced transgene silencing, the rb mutants’ 
enhanced transgene silencing is likely also mobile and systemic. 
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Representative micrographs of (A) wild type, (B) nrde-3(gg66), (C) pgl-1(bn101), (D) eri-
1(mg366), (E) eri-1(mg366);nrde-3(gg66), (F) eri-1(mg366);pgl-1(bn101), (G) lin-15ab(n765), 
(H) lin-15ab(n765);nrde-3(gg66), and (I)  lin-15ab(n765);pgl-1(bn101) strains expressing a 
Psur-5::gfp transgene. In the eri-1(mg366) background, there is extensive silencing of gfp (red 
arrows) in the intestinal cells; in the eri-1(mg366);nrde-3(gg66) strains, there is no such 
extensive transgene silencing. The eri-1(mg366);pgl-1(bn101) strain still exhibits extensive 
silencing of gfp (red arrows) in the intestinal cells, suggesting no alleviation of spontaneous 
transgene silencing. In the lin-15ab(n765) background, there is extensive silencing of gfp (red 
arrows) in the intestinal cells. The lin-15ab(n765);nrde-3(gg66) and lin-15ab(n765);pgl-
1(bn101) strains still exhibits extensive silencing of gfp (red arrows) in the intestinal cells, 
suggesting no alleviation of spontaneous transgene silencing. 
Figure 5.4: eri-1 and lin-15ab depend on different mechanisms for transgene silencing 
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Figure 5.4 (Continued): eri-1 and lin-15ab depend on different mechanisms for transgene 
silencing 
236 
 
Figure 5.5: lin-15ab transgene silencing partially depends on sid-1  
(A-E) Representative micrographs of (A) wild type, (B) eri-1(mg366), (C) lin-15ab(n765), (D) 
eri-1(mg366);lin-15ab(n765), and (E)  sid-1(qt9);lin-15ab(n765) strains expressing a Psur-
5::gfp transgene. In the eri-1(mg366) and lin-15ab(n765) backgrounds, there is extensive 
silencing of gfp (red arrows) in the intestinal cells. In the eri-1(mg366);lin-15ab(n765) strains, 
there is even greater transgene silencing (red arrows). The sid-1(qt9);lin-15ab(n765) strain 
exhibits significantly reduced levels of gfp silencing. (F) The enhanced transgene silencing 
(TGS) is quantified by counting the gfp-positive intestinal nuclei in worms from each strain 
background, with each worm quantified represented by a black dot and with the median denoted 
in red. The mean and standard deviations are indicated below each strain. p-values are 
determined by t-test. There is a significant difference in potency between eri-1- and lin-15ab- 
induced enhanced TGS, with the two mutations’ effects additive in the double mutant. The lin-
15ab enhanced TGS is also significantly reduced in a sid-1(-) mutant background.  
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Figure 5.5 (Continued): lin-15ab transgene silencing partially depends on sid-1 
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nrde-3 and pgl-1 are required for enhanced RNAi in eri mutants 
DISCUSSION 
Our analysis shows that pgl-1 is a likely eri-effector. Similar to nrde-3, pgl-1 mutants are weakly 
Rde (Figure 5.1), pgl-1 overexpression enhances RNAi (Figure 5.1B-C), pgl-1 mutants disrupt 
the expression of endo-siRNA regulated genes (Figure 5.2), and loss of pgl-1 attenuates the Eri 
phenotypes, at least for some genes (Figure 5.1D-E). Remarkably, the simultaneous loss of both 
pgl-1 and nrde-3 broadly depletes enhanced RNAi in the eri-1 mutant background (Figure 5.1D-
E).  This result suggests that these two genes define the totality of eri-1 and likely endo-siRNA 
competitive effector pathways. 
PGL-1 expression and/or localization is expanded in the Rb pathway mutants, including 
lin-15 and lin-35, that enhance RNAi and lead to efficient transgene silencing (WANG et al. 
2005; WU et al. 2012).  However, pgl-1 mutants abrogated lin-15 and lin-35 enhancement for the 
same genes pgl-1 is important for in eri-1 enhancement (Table 5.3). Furthermore, lin-15; pgl-1 
and lin-35; pgl-1 double mutants continued to show RNAi enhancement for nrde-3-dependent 
gene targets. Thus, the importance of pgl-1 for enhanced RNAi is not likely via the Rb pathway. 
Attempts to correlate pgl-1 phenotypes to previously defined RNAi mechanisms were not 
informative, thus failing to reveal how pgl-1 activity contributes to gene silencing (Figure 5.2, 
5.3). However, our analysis clearly establishes that pgl-1 contributes to both exogenous and 
endogenous RNAi (Figure 5.1, 5.2).  
 
pgl-1 mutant small RNA deep sequencing likely to yield broader perspectives on its roles 
While we were unable to attribute any of the aforementioned common and/or rb-associated 
RNAi mechanisms to pgl-1, our results do show an effect on endo-RNAi in pgl-1 mutants 
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(Figure 5.2). A recent report has suggested that perinuclear structures similar to P-granules are 
important for siRNA amplification due to RRF-1 recruitment in both exogenous and endogenous 
contexts (PHILLIPS et al. 2012). Therefore, future small RNA deep sequencing should yield rich 
results for the many roles that pgl-1 likely plays. Like the eri mutants, sequencing and analysis of 
its small RNA profile will likely shed light on its endogenous roles and contributions to RNAi 
silencing. 
 
The following preliminary protocols were developed for extracting total small RNAs from wild 
type, eri-1(mg366), and pgl-1(bn101) C. elegans worms. It requires further optimization for 
preparing Illumina sequencing-quality samples, and is thus currently undergoing 
troubleshooting. However, the framework is thoroughly developed for a full preparation of small 
RNA sequencing, and it is based off of protocols provided courtesy of Dr. Weifeng Gu and Dr. 
Darryl Conte of University of Massachusetts Worcester. 
MATERIALS AND METHODS FOR SMALL RNA SEQUENCING 
 
General Notes: 
-Steps in red can and should be continued into the next phase without a -80°C freeze down or 
overnight delay. 
-Whenever possible, add as much isopropanol as the tube volume will take when precipitating 
RNA; with glycogen, greater volume of isopropanol means better pelleting. 
-To keep reagents as RNase-free as possible, all stocks should only be opened in a tissue-culture 
hood and mixtures should be prepared there; for reagents coming in large bottles, take into the 
TC hood, open up, wipe mouth with RNase-out wipe, pour out an aliquot into a RNase-free 
epitube, wipe mouth again with RNase-out wipe, close, and take back to bench. 
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STEP ZERO 
(1) I will start with ~200-350 µL1 of L4 worms frozen at -80°C
(2) Rinse glass-metal douncer by ddH2O, RNase-Out, and then DEPC-treated ddH2O. 
Repeat this step in between different samples.  
 in ddH2O. 
(3) Prepare 1 phase lock gel column per sample by spinning at 13,000 rpm for 1 minute in 
Biofuge spinner at RT. 
(4) Add 400 µL
(5) Vortex Trizol-worm mixture vigorously at RT as it thaws until it’s a slurry. 
 Trizol to iced-worm sample tube. 
(6) Take up solution in RNase-free glass Pasteur pipette and transfer into glass douncer 
placed on ice. Make sure to pipette into the douncer’s vertical chamber, and avoid liquid 
touching the upper pouring chamber. 
(7) Dounce the slurry in a twisting motion 20 times on ice. 
(8) Transfer worm lysis to the phase-lock gel tube by glass pipette. Do not exceed 750 µL 
total volume.2
(9) Add 
 
80 µL of chloroform into each tube.3
(10) Turn up and down the tube for mixing for 1 minute. 
 
(11) Let the tubes rest at RT for 5 minutes. 
(12) Centrifuge at 12,000 rpm for 15 minutes at 4°C in Eppendorf spinner.4
(13) Transfer the top aqueous layer into a new RNase-free siliconized epitube. There 
may be some phase-lock gel at the top of the aqueous layer after the spin. Poke a hole 
through it using a pipette tip, and then using a fresh tip, go in and pipette. In eluting to a 
 
                                                 
1 10 HG large plates grown full, bleach synchronized for one hour, and then grown to L4s on 5 NG larges at 15°C 
2 According to Eppendorf manufacturer’s protocols, the phase-lock heavy columns can ONLY be used with Trizol. 
NEITHER RiboZol/RNAzol NOR saturated Phenol alone will work.  
3 Trizol to chloroform ratio should always be 5:1. 
4 ~15K x g; there should be no “worm pellet” at the bottom after this spin if Trizol vortexing/douncing had worked 
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new tube, leave the tip in the air and pipette out to the new tube to make sure the residual 
gel at the tip do not enter. The gel plug should be at an angle after the spin, so take up 
fluid from the tube vertically to ensure that ALL the aqueous layer gets taken.5
(14) Add (in this order) 
 
50 µL of 5M NaCl, 2.5 µL of 20 mg/mL glycogen6 and 650-
900 µL7
(15) Mix by inverting for 1 minute. 
 isopropanol into these tubes. 
(16) Leave in -80°C
(17) Spin at 10,000 rpm for 15 minutes at 
 for an hour to precipitate RNA. 
4°C Eppendorf spinner.8
(18) Pipette out the supernatant while avoiding the pellet. 
 
(19) Wash with 500µL of ice-cold EtOH.9
(20) Spin at 13,000 rpm for 1 minute at 
 
4°C in Biofuge spinner.10
(21) Remove the supernatant while avoiding the pellet. Do not let the pellet dry 
completely. 
 
(22) Immediately dissolve in 83µL of DEPC-treated ddH2O.11
(23) (If necessary) Let re-suspension occur at RT
  
12
(24) Quantitate what the concentration is with a 1/10X solution using 
 while repeatedly pipetting up and 
down at regular intervals. 
1 µL of this 
RNA. If it is >12,000 ng/µL, split into two and dilute to 80 µL each.13
(25) These epitubes can be stored 
  
-80ºC
                                                 
5 Will be about 400 to 500 µL. 
 after this step. 
6 for a 0.05 µg/µl concentration in ~1mL solution 
7 or whatever makes adds up to at least 1mL, but no less than 1X volume of extraction 
8 ~11K x g; spin as a frozen ice block 
9 This is to remove leftover salt, so no need to dislodge the pellet. 
10 ~11K x g 
11 Can do two aliquots of 42 µL if the pellets are thin and there are two samples to combine 
12 With glycogen, if this tube is on ice, it’ll solidify easily 
13 Want <1mg of RNA in 80 µL 
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STEP 1A 
1) Prepare in 1 siliconized epitube added in the following order: 80 µL total RNA14, 400 µL 
MirVana lysis/binding buffer, and 48 µL
2) Mix up and down by pipetting, and keep at RT for 5 minutes. 
 MirVana homogenate buffer. 
3) Add 176 µL
4) Spin at 6.4K rpm for 4 minutes at RT in Biofuge spinner.
 EtOH, mix by pipetting. 
15
5) Transfer supernatant to new siliconized epitube. 
  
6) Add in 800 µL
7) Mix by inverting for 1 minute. 
 isopropanol. 
8) Leave in -80°C
9) Spin at 13.8K rpm for 15 minutes in the 
 for an hour to precipitate RNA. 
4°C Eppendorf spinner.16
10) Pipette out the supernatant while avoiding the pellet. 
 
11) Wash with 500 µL
12) Spin at 13,000 rpm for 1 minute at 
 of ice-cold 70% EtOH. 
4°C
13) Remove the supernatant while avoiding the pellet.
 in Biofuge spinner. 
17
14) Dissolve in 
 
22 µL
15) (If necessary) Let re-suspension occur at RT while repeatedly pipetting up and down at 
regular intervals. 
 of TE.  
16) Quantitate what the concentration is with a 1/5X solution using 2 µL
                                                 
14 <12K ng/µl 
 of this RNA. 
Depending on the enrichment efficiency, there can be up to 10% of previous amount 
recovered from Step I #24. 
15 ~2500 x g; this is to pellet the large RNA. There should be a small but visible pellet. 
16 Pellets small RNAs. 20,000 x g for 15 minutes at 4°C. Eppendorf rotor FA-45-30-11 has a 9.5cm radius. Fischer 
siliconized epitubes can take up to 30,000 x g. Smaller pellet than previous spin. 
17 Pellet at this step becomes dislodged easily, so be careful when removing the supernatant. 
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17) Ideally, half of this can be stored at -80°C
STEP 1B – PART I 
 for backup while the other half is used directly 
for the next step. 
1) Wash the two gel plates18, 2 spatulas, 2 razors, 1 stirrer, 2 pairs of tweezers, 1 pair of 
scissors, 1 glass pasteur pipette, and 3 beakers (2x 100mL & 1L) in RNase Out, wrap 
individually in aluminum foil, and bake at 250°C overnight in high-temp oven.19
2) For things that are not glass or metal, like the combs for the wells, spacer, 1 blue plastic 
pestle per sample, and glass plate with spacer, 
  
soak
3) Make 
 in RNase Out (preferably overnight), 
then rinse off in RNase-free water. 
10 mL of 10% APS by adding 1 g of APS and filling volume up to 10 mL with 
ddH2O in a 15 mL falcon. Aliquot (~500 µL) and keep in -20°C
4) Set up the gel plates: 
a. Line up the bottom spacer as close to the edge of the bottom plate as possible, and then 
seal the bottom 
. 
and the sides
                                                 
18 Plate with rubber spacer glued in should NOT be baked 
 of the spacer with a steady stream injection (18 gauge 
syringe) of Vaseline. 
b. Align the top plate and press them together. 
c. Using electrical tape, seal the bottom edge of the plates. Add extra flaps to the sides of 
the bottom because those spots are most likely to leak. 
d. Using three metal clips on each side, clamp the two plates together. The bottom 
corners are most susceptible to leaking, so clamp that area especially tightly. 
e. Make sure the bottom clips are even and symmetrical, flip the clasps onto the glass, 
and the clips themselves serve as a base stand. 
19 Mark aluminum foil with a sharpie; the ink should become stale if it was heated; autoclave tape should be 
browned out, but keep it on the foil (and not the glassware) as it will stick. 
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f. Pour freshly opened molecular grade ddH2O into the gel rig and let it sit for 10 
minutes. See if there are any egregious leaks; if so, start over from part (c). If not, pour 
out water, and wick off the last bits with a paper towel, let it stand while proceeding to 
the next step. 
5) Plug in a balance in the hood. 
6) To make a 15cm x 14cm x 1mm (30 mL) of 15% PAGE (19:1) / 7M Urea, add the 
following to a beaker:  
a. 12.6 g Urea 
b. 11.26 ml 40% acrylamide/bis-acrylamide (19:1) solution 
c. 3 mL 10X TBE buffer 
d. 6.5 mL
7) Plug in a hot plate stirrer and heat to 
 ddH2O. 
40°C
8) Warm the beaker and stir to mix the solution and dissolve the urea. 
 in the hood. 
9) In the 1L beaker, add in 100mL 10X TBE and 900mL
10) Add in 
 molecular grade ddH2O. Mix by 
stirring with an RNase-free spatula. 
150 μl 10% ammonium persulfate (APS) and 15 μl
11) Add in large wide combs to 
 TEMED to the gel beaker, 
swirl the beaker, and then immediately pour the gel by tilting the plates back and pouring 
into the crevice in a FAST steady stream to avoid air bubbles. Pour all the way to the top 
because otherwise combs will cause air bubbles at the bottom of the wells. 
1/3 inch depth if possible. If there are any air bubbles at the 
bottom of the wells, even if tiny, pull out and try again, because the wells needs to be 
perfectly horizontal at the bottom. 
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12) There will be some well wall height loss due to evaporation or slow leakage, so don’t 
wick off any overflow as they’ll serve as a buffer. Try to keep the lanes in the middle of 
the gel as good as possible – no air bubbles, no well wall loss due to leak, perfectly 
horizontal bottoms – because that’s where to preferentially load. 
13) Takes about 45 minutes for the gel to fully solidify. Leak check: corners near the side 
well will most likely to drop in level immediately if there is a leak. Stay watching the gel 
for the first 10-15 minutes to check for leaks. 
14) Unless a leak is egregious, there are two ways to fix a slow leak: 
a. pour the leftover gel solution from beaker onto the combs while tilting the plates back, 
that should add more volume to the leaking parts 
b. push the combs a little deeper into the gel and that’ll raise the height of the well walls 
(try using part (a) first!) 
15) Remove bottom clips and the tape. To remove the bottom spacer, poke one corner 
slightly into the gel with a spatula to get the other corner to pop out beyond the glass 
plates, and then use tweezers to pull the entire spacer out using that dislodged corner. 
16) Fill bottom reservoir with 1X TBE, clamp plates onto the rig, including a dummy plate 
on the other side. Make sure the clamps to the rig reach the very top of the plates because 
that causes the least obvious leaks. 
17) Using a bent 18 gauge syringe, inject 1X TBE into the space at the bottom of the gel 
where the spacer was to get rid of that air bubble. Inject and push sideways eliminates the 
air bubble most effectively.  
18) Fill out the top reservoir with 1X TBE as well. 
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19) Pull out the comb and rinse the wells of the gel with 1X TBE using an RNase-free 
Pasteur pipette. There should be some acrylamide being forced up from the wells as it is 
rinsed hard several times. 
20) Pre-run the gel in 1x TBE buffer for 30 min at 200 V. 
21) Mix samples and small RNA ladder (Zymo ssRNA: 29, 25, 21, 17 is pretty good) with 
loading dye provided with the MirVana kit. Try to limit loading to 10 µL of 
sample/ladder mixed with 10 µL
22) Heat samples to 
 of loading buffer per lane. 
70°C
23) Check upper reservoir buffer levels before loading. If they have dropped up, top it off 
again. Otherwise, what’s loaded will float out into the buffer if the buffer level is at the 
level of the mouth of the plates. 
 for 2 min, then immediately chill by transferring samples onto ice. 
24) Load the samples into the lanes using a newly opened box of needle-point tips. Pick the 
best lanes for loading. 
25) Run gel at 200 V until the Bromophenol blue (bottom band in MirVana loading buffer, 
which is purplish blue) migrates 4-4.5 inches.20
26) Prepare for SybrGold staining as follows: 
a. Warm vial to RT, and spin briefly. 
b. Rinse a polypropenlene container thoroughly with RNase-Out. 
c. Add 
  
10 μL of SybrGold to 50 mL
27) When the gel is finished running, remove the clamps and using a spatula, pop open the 
glass plates by snapping at the top corner right above a vertical spacer. 
 of 1X TBE in an RNase-free 50mL tube and mix by 
vortexing. 
d. immediately wrap this mixture in aluminum foil 
                                                 
20 Takes about 1 hour per inch of migration in this type of gel 
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28) Using a razor, remove extraneous portions of the gel before staining. Keep the entire 
length of a lane intact! Leave the wells on, and cut a mark somehow to indicate gel up-
down orientation.21
29) Place resized gel and staining solution in container, then swirl on shaker for one hour at 
25 RPM, while covering it with aluminum foil.
 
22
30) After staining, place the gel into Saran wrap that’s been washed with RNase-Out, wrap it 
up, and place on top of a glass plate, before placing in UV box. 
 
31) Place two UV rulers above and to the left of the gel. Using a UV imager, use between 
8/30 to 16/30 second exposure to get the gel, and then bright light to image the rulers. 
32) Cut between the 15 and 30 mer regions in the hood, using the imaged rulers as a 
reference for x,y axis position. 
33) Place gel fragments into 1.5 mL siliconized tubes and grind them using blue plastic 
pestles. Grind until the gel is in tiny bits. 
34) For every 2 reactions, prepare a mixture by adding 60 μL 5M NaCl to 940 μL
35) Add 
 TE pH 
7.5. 
500 μL
36) Briefly vortex. The mixture should already be a slurry. Grind it some more with the blue 
plastic pestles. 
 of above mixture into gel fragment tube.  
37) Parafilm the opening of the tube. Vortex overnight in 4°C
STEP 1B – PART II 
 by double-back rubber banding 
tubes to vortex: two across horizontal axis and one straight across the length of the tube. 
                                                 
21 Because the dyes’ colors get removed during the wash 
22 Look at the swirling pattern before covering to make sure the liquid is getting all of the gel. 
 248 
 
1) Cut off the tip of a filtered P1000 tip23 using baked scissors, and filter the slurry 
mixture through TWO 0.45 um Nanosept filters by splitting into two aliquots of 
<500 μL and spinning them at 11.5K rpm24 in Eppendorf spinner for 10 minutes at 
4°C
2) Transfer the filtrate
.  
25 into a new siliconized tube.26
3) Add (in this order) 
 
75 µL of 5M NH4Ac27, 3.75 μL of 20 mg/mL glycogen28 and 
900 µL isopropanol to ~1.5 mL total volume
4) Mix by inverting for 1 minute. 
 into these tubes. 
5) Leave in -80°C
6) Spin at 13.8K rpm
 for an hour to precipitate RNA. 
29 for 15 minutes at 4°C
7) Pipette out the supernatant while avoiding the pellet. 
 Eppendorf spinner. 
8) Wash with 500 µL
9) Spin at 13,000 rpm for 1 minute at 
 of ice-cold 70% EtOH. 
4°C
10) Remove the supernatant while avoiding the pellet. 
 in Biofuge spinner. 
11) Dissolve in 10 µL
12) (If necessary) Let re-suspension occur at RT while repeatedly pipetting up and down 
at regular intervals. 
 of next step’s treatment/ligation mixture.  
STEP 2 and STEP 3 – PART I: 
1) On ice, prepare a 1/10X dilution of 10 mg/mL BSA, and dissolve 1 nm of modban30 in 
20 µL
                                                 
23 Using baked scissors 
 of DEPC-treated ddH2O for making 50 µM modban. 
24 14K x g 
25 Which contains the small RNAs 
26 There should be gel-like substance on the filter, and almost the entire volume in liquid form as the filtrate. 
27 For destaining the SybrGold 
28 for a 0.05 μg/ul concentration in ~1.5 mL solution 
29 ~20K x g 
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2) In an RNase-free PCR tube, add in the following order (multiplied by the number of 
samples):  
a. 1 µL of 10X TAP buffer  
b. 0.5 µL of 20U/µL Superasin 
c. 0.5 µL of TAP 
d. 8 µL
3) Dissolve the collected enriched small RNA pellet from previous step in this mixture. 
 of ddH2O 
4) Incubate the reaction in PCR machine at 37°C
5) Prepare 3 phase-lock gel columns per sample by 1 minute 13K rpm spins. 
 for 1 hour. 
6) Add 190 µL
7) Transfer RNA incubation to a phase-lock gel column, and then add in 
 ddH2O to these TAP-tubes and mix. 
200 µL
8) Mix by gently inverting the tubes. 
 Acid 
Phenol:Chloroform:IAA (125:24:1) pH 4.5. 
9) Centrifuge at 12,000 rpm for 5 minutes at 4°C
10) Transfer the top aqueous layer
 in Eppendorf spinner. 
31 into a new phase-lock gel column, and then add in 200 
µL
11) Mix by gently inverting the tubes. 
 Acid Phenol:Chloroform:IAA (125:24:1) pH 4.5. 
12) Centrifuge at 12,000 rpm for 5 minutes at 4°C
13) Transfer the top aqueous layer into a new phase-lock gel column, and then add in 
 in Eppendorf spinner. 
40 µL
14) Mix by gently inverting the tubes. 
 
Chloroform:IAA (24:1). 
                                                                                                                                                             
30 3’ adapter 
31 There may be some phase-lock gel at the top of the aqueous layer after the spin. Poke a hole through it using a 
pipette tip, and then using a fresh tip, go in and pipette up. In eluting to a new tube, leave the tip in the air and 
pipette out to the new tube to make sure the residual gel at the tip do not enter. The gel plug should be at an angle 
after the spin, so just pipette up the fluid from the tube vertically so that ALL the aqueous layer gets taken up. 
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15) Centrifuge at 12,000 rpm for 5 minutes at 4°C
16) Transfer the top aqueous layer into an RNase-free siliconized epitube.  
 in Eppendorf spinner. 
17) Add (in this order) 20 µL of 3M NaAc pH 5.2 and 800 µL32
18) Mix by inverting for 1 minute. 
 ethanol into these tubes. 
19) Leave in -80°C
20) On ice, prepare the following in a RNase-free PCR tube (multiply for each additional 
sample + 1 no RNA control): 
a. 
 for an hour to precipitate RNA. 
1 µL 10X T4 ligase buffer  
b. 0.5 µL 20U/µL Superasin 
c. 1 µL 1 mg/mL BSA  
d. 2 µL 10U/µL T4 RNA Ligase 1  
e. 1 µL 50 µM modban  
f. 1 µL DMSO 
g. 3.5 µL
21) Spin frozen RNA cube at 13.8K rpm for 15 minutes at 
 ddH2O 
4°C Eppendorf spinner.33
22) Pipette out the supernatant while avoiding the pellet. 
 
23) Wash with 500µL of ice-cold 70% EtOH.34
24) Spin at 13,000 rpm for 1 minute at 
 
4°C
25) Remove the supernatant while avoiding the pellet. Do not let the pellet dry completely. 
 in Biofuge spinner. 
26) Immediately dissolve in 10µL
                                                 
32 4X+ volume of extraction 
 of ligation reaction prepared above. Pipette up and down 
and rinse the walls of the tube until it is thoroughly mixed. 
33 ~20K x g; spin as a frozen ice block 
34 This is to remove leftover salt, so no need to dislodge the pellet. 
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27) Transfer to a new RNase-free PCR tube, and incubate in a PCR machine at 15°C for 2 
hours and then 4°C
STEP 3 – PART II: 
 overnight. 
1) FOLLOW STEP 1B PART I protocols for running the reaction out in a PAGE gel (blue 
4+ inches from well)35
2) Use DNA ladder instead. The 3’ adapter is 19 bp in length. Modban-modban self-
ligation, if they happen, will be 38 bp in length. Be sure to run that no-RNA control! 
CMO16385 and CMO16386 should demarcate the correct range (33 and 48). Bands 
should be in 22+19=41 and 26+19=45 range. Mix and load 
, with the following modifications: 
2µL
STEP 3 – PART III and STEP 5: 
 of each of the 50 ng/µL 
DNA size ladders. 
1) FOLLOW STEP 1B PART II protocols for filtering gel slice’s RNA, with the following 
notes: 
2) Keep cutting out and using the -RNA for subsequent measurements as well! 
3) As the RNA is being frozen at -80°C, prepare a 100µM stock of the 5’ RNA adapter, by 
adding 10x nm amount in µL DEPC-treated ddH20. 
4) As the RNA is being frozen at -80°C, prepare the following ligation mixes (1 unique mix 
per barcode + the -RNA control): 
a. 
Each stock corresponds to one 
barcode. 
1 µL 10X T4 ligase buffer  
b. 1 µL 10mM ATP 
c. 0.5 µL 20U/µL Superasin 
d. 1 µL
                                                 
35 For resolving adapter-dimers from true RNA-adapter complexes 
 1 mg/mL BSA 
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e. 2 µL 10U/µL T4 RNA Ligase 1 
f. 1 µL 100 µM 5’ adapter barcode 
g. 1 µL DMSO 
h. 2.5 µL
5) Dissolve pellets from gel-extracted TAP-3’-ligated RNAs in ligation buffer above. 
 ddH2O. 
6) Pipette up and down and rinse the walls of the tube until it is thoroughly mixed. 
7) Transfer to a new RNase-free PCR tube, and incubate in a PCR machine at 15°C for 6 
hours and then 4°C
STEP 5 – PART II: 
 overnight. 
1) FOLLOW STEP 1B PART I protocols for running the reaction out in a PAGE gel (blue 
4+ inches from well), with the following modifications: 
2) Use DNA ladder instead. The 5’ adapter is 21 bp in length. CMO16387 and CMO16388 
should demarcate the correct range (54, 69 respectively). Bands should be in 
19+21+22=62 and 19+21+26=66 range. Mix and load 2µL
STEP 5 – PART III and STEP 6: 
 of each of the 50 ng/µL DNA 
size ladders.  
1) FOLLOW STEP 1B PART II protocols for filtering gel slice’s RNA. 
2) While ligated RNAs are in -80°C precipitating, On ice, prepare the following in a RNase-
free PCR tube (multiply for each additional sample): a. 0.5 µL 100 µM RT DNA oligo  
b. 1 µL 10 mM dNTP mix 
c. 8.5 µL
3) Immediately dissolve doubly-ligated RNA pellet in 
 ddH2O 
10µL of cocktail reaction prepared 
above. Pipette up and down and rinse the walls of the tube until it is thoroughly mixed. 
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4) Transfer to a new RNase-free PCR tube, and incubate in a PCR machine at 
65°C for 5 minutes and then ice
5) Add into the tubes on ice the following:  
a. 
 for 2 minutes. 
4 µL 5X SSIII buffer  
b. 2 µL 100 mM DTT 
c. 0.5 µL 20U/µL Superasin 
d. 0.5 µL
6) Incubate in a PCR machine 
 SSIII enzyme 
50°C for 1 hour, and then 85°C
7) Add in 
 for 5 minutes. 
1 µL RNase H to each tube, and incubate at 37°C
8) Can freeze at 
 for 20 minutes. 
-20 or -80°C
STEP 7:  
. 
1) Prepare a PCR mixture (and multiply by the number of samples – be sure to include a -
cDNA sample): 
a. 5 µL 10X Taq Buffer 
b. 0.5 µL short F primer 
c. 0.5 µL short R primer 
d. 5 µL 2.5mM dNTPs 
e. 0.5 µL ExTaq 
f. 36.5 µL
2) Add 
 ddH2O 
48 µL of above mixture to 2 µL of each sample’s cDNA and mix by pipetting. 
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3) Run the following PCR program: (i) 94°C for 30 seconds, (ii) 94°C for 20 seconds, (iii) 
55°C for 20 seconds, (iv) 72°C for 20 seconds, (v) back to (ii) for 20 to 35 cycles, (vi) 
72°C for 30 seconds, (vii) 4°C hold in the Eppendorf PCR machine.36
4) Prepare a PCR mixture (and multiply by the number of samples – be sure to include a -
cDNA sample): 
a. 
 
5 µL 10X Taq Buffer 
b. 1 µL long F primer 
c. 1 µL long R primer 
d. 5 µL 2.5mM dNTPs 
e. 0.5 µL ExTaq 
f. 12.5 µL
5) Add 
 ddH2O 
25 µL of above mixture to 25 µL
6) Run the same PCR program in Step 3 with two different cycle numbers. For low 
abundance preps, use 35 and 45 cycles. 
 of a sample from PCR in Step 3 (split into two). 
7) Make a 150mL
8) Check to see if there are any bands ~110bp range. If too much other bands: 
a. if too much ABOVE the 110, decrease the second PCR cycle number  
b. if too much BELOW the 110, decrease the first PCR cycle number 
 3% agarose gel with ethidium bromide, run out PCR samples with a 
1KB+ ladder, at 85V for 2.5 hours. 
9) If there are ~110 bp bands, perform PCR with rest of cDNA accordingly, run out on non-
denaturing 8% PAGE gel and excise to extract the DNA for cloning QC and Solexa 
sequencing. 
                                                 
36 Because of the short incubation periods, the shift between temperatures is sometimes longer than the cycle itself in 
older PCR machines. 
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The materials and reagents used in this protocol are listed in Table 5.4. The primers used in this 
protocol were designed specifically for the sequencing preparation guidelines; these proprietary 
barcodes are available upon request through major sequencing facilities and Illumina sequencing 
kits.
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Reagent 
Table 5.4: Reagents used in preliminary small RNA sequencing protocol 
Vendor 
RNase-free 40% acrylamide/bis-acrylamide 
(19:1) solution, 100mL EMD Millipore 
RNase-free TEMED, 25mL EMD Millipore 
Siliconized Microcentrifuge Tubes, 1.5mL Fischer Scientific 
Phase Lock Gel, 2mL, Heavy Fischer Scientific 
TE, pH 7.5, RNase-free, 1L IDT 
DEPC-treated water, 1L Life Technologies 
Trizol, 100 mL Life Technologies 
mirVana™ miRNA Isolation Kit Life Technologies 
5M NH4Acetate, RNase-free, 100mL Life Technologies 
RNase-free 5M NaCl, 100mL Life Technologies 
RNase-free 10X TBE, 4x1L Life Technologies 
RNase-free urea, 1 kg Life Technologies 
SYBR Gold Nucleic Acid Gel Stain   Life Technologies 
RNase-free Ammonium Persulfate, 25g Promega 
Anhydrous chloroform, 100mL Sigma-Aldrich 
Ethanol, molecular grade, 200 proof, 500mL Sigma-Aldrich 
Glycogen, RNA-grade, 0.2mL of 20mg/mL Thermo Scientific 
Nanosep MF, 0.45 µm, 24x VWR 
RNase-out refills, 1L VWR 
PTFE-coated spatula VWR 
PTFE Tissue Grinder, Serrated Plunger, 2mL VWR 
Polystyrene Weigh Boats, 20mL VWR 
2-Propanol, ACS Grade, 1L VWR 
PTFE Tissue Grinder, Glass Vessel, 2mL VWR   
ZR small-RNA Ladder, 10 ug Zymo Research 
RNase-free 40% acrylamide/bis-acrylamide 
(19:1) solution, 100mL EMD Millipore 
Nanosep MF, 0.45 µm, 24x VWR 
NaAc, 3M, pH 5.2, RNase-free EMD Millipore 
Tobacco Acid Pyrophosphatase (TAP), 
10U/uL, 100 units  Epicentre 
SUPERase•In (20 U/μL) Life Technologies 
T4 RNA Ligase 1 (ssRNA Ligase) NEB 
RNase-free BSA NEB 
RNase-free DMSO-50mL Sigma-Aldrich 
RNase-free dNTP mix, 10 mM, 0.2mL Sigma-Aldrich 
SuperScript III RT, 200U/uL, 10,00 Units Life Technologies 
RNase H, 10U/uL, 200 units Life Technologies 
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Chapter Six 
The influence of competition among C. elegans small RNA pathways on development 
 
The contents were previously published in ZHUANG, J. J., and C. P. HUNTER, 2012. The Influence of Competition 
Among C. elegans Small RNA Pathways on Development. Genes 3: 671-685. Permission to reuse via the 
Multidisciplinary Digital Publishing Institute Open Access Creative Commons Attribution License. 
260 
 
Small RNAs play a variety of regulatory roles, including highly conserved developmental 
functions. Caenorhabditis elegans not only possesses most known small RNA pathways, it is 
also an easy system to study their roles and interactions during development. It has been 
proposed that in C. elegans, some small RNA pathways compete for access to common limiting 
resources. The strongest evidence supporting this model is that disrupting the production or 
stability of endogenous short interfering RNAs (endo-siRNAs) enhances sensitivity to 
experimentally induced exogenous RNA interference (exo-RNAi). Here, we examine the 
relationship between the endo-siRNA and microRNA (miRNA) pathways, and find that, 
consistent with competition among these endogenous small RNA pathways, endo-siRNA 
pathway mutants may enhance miRNA efficacy. Furthermore, we show that exo-RNAi may also 
compete with both endo-siRNAs and miRNAs. Our data thus provide support that all known 
Dicer-dependent small RNA pathways may compete for limiting common resources. Finally, we 
observed that both endo-siRNA mutants and animals experiencing exo-RNAi have increased 
expression of miRNA-regulated stage-specific developmental genes. These observations suggest 
that perturbing the small RNA flux and/or the induction of exo-RNAi, even in wild-type animals, 
may impact development via effects on the endo-RNAi and microRNA pathways.   
ABSTRACT 
 
 Non-coding RNAs regulate a myriad of biological processes (FISCHER 2010; KAIKKONEN 
et al. 2011). Two broad classes of highly conserved non-coding regulatory RNA pathways were 
discovered in the nematode Caenorhabditis elegans. First, microRNAs (miRNAs) were 
identified as transcribed RNAs corresponding to mutant loci that disrupted stage-specific 
INTRODUCTION 
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developmental processes (LEE et al. 1993; REINHART et al. 2000). These small RNAs are 
complementary to nucleotide sequences in the 3’UTR of inferred target mRNAs and act to 
inhibit translation and/or mRNA target stability (LEE et al. 1993; PASQUINELLI et al. 2000; 
REINHART et al. 2000). Subsequent genomic analysis identified scores of 22 nucleotide miRNAs, 
many broadly conserved in plants and animals (KAWAJI and HAYASHIZAKI 2008; PASQUINELLI et 
al. 2000). Second, mechanistic investigation of the widely used technique of RNA interference 
(RNAi) revealed the existence of regulatory pathways that produce and use short interfering 
RNAs (siRNAs), whether derived from exogenous dsRNA (exo-siRNAs) or endogenous loci 
(endo-siRNAs) (FIRE et al. 1998; GENT et al. 2010; GRISHOK 2005; LEE et al. 2006; TABARA et 
al. 1999). Investigations in other systems, including Drosophila, Arabidopsis, and mammalian 
cultures, have identified additional non-coding RNA pathways, including piwi-interacting RNA 
(piRNAs) and long non-coding RNA (lncRNAs), both of which have also been found in C. 
elegans (DAS et al. 2008; SIFUENTES-ROMERO et al. 2011; WILUSZ et al. 2009). The biological 
processes regulated by these small RNAs are quite extensive, including germline maintenance 
(DAS et al. 2008), chromosomal segregation (CLAYCOMB et al. 2009), protection against 
transgenic parasites (OHTA et al. 2008), multi-generational inheritance of RNAi signals (GU et 
al. 2012), and developmental regulation (AZIMZADEH JAMALKANDI and MASOUDI-NEJAD 2011). 
 Genetic screens have identified mutants in C. elegans with enhanced exo-RNAi 
responses (Eri mutants) (DUCHAINE et al. 2006; FISCHER et al. 2008; KENNEDY et al. 2004; 
PAVELEC et al. 2009; SIMMER et al. 2002). Confoundingly, these mutants which enhance exo-
RNAi disrupt endo-RNAi (DUCHAINE et al. 2006; FISCHER et al. 2008; GENT et al. 2009; 
PAVELEC et al. 2009). One proposed explanation is that endo-RNAi and exo-RNAi pathways 
compete for one or more limited common enzymatic resources, so that reduced endo-RNAi 
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activity (FISCHER et al. 2011; GENT et al. 2010) results in greater flux of small RNAs through the 
exo-RNAi pathway (DUCHAINE et al. 2006; LEE et al. 2006).  Additional support for this 
competition model is provided by the identification of limiting RNAi components that are both 
necessary for the enhanced RNAi response and, when over-expressed, confer enhanced RNAi 
(DUCHAINE et al. 2006; YIGIT et al. 2006).    
Although competition has only been inferred between endo- and exo-RNAi pathways, 
because C. elegans has only one dicer homolog – dcr-1 – this competition model has been 
hypothesized to include other small RNA pathways, particularly the microRNA pathway 
(DUCHAINE et al. 2006; YIGIT et al. 2006). This model proposes that various dcr-1-dependent 
non-coding RNAs compete for limited common enzymatic resources, including RNA-dependent 
RNA polymerases (RdRPs) that produce abundant secondary siRNAs and secondary siRNA 
binding Argonouates (SAGOs) (DUCHAINE et al. 2006) (Figure 6.1A). Consistent with this 
model, over-expression of some of these resources, specifically the secondary Agos SAGO-1 and 
SAGO-2, can enhance exo-RNAi (DUCHAINE et al. 2006; YIGIT et al. 2006). However, direct 
evidence to support this broader competition model is lacking, especially with respect to small 
RNA pathways other than exo- and endo-RNAi. Moreover, many of these non-coding small 
RNAs, particularly miRNAs like lin-4 and let-7, are developmentally regulated (LEE et al. 1993; 
REINHART et al. 2000), which challenges simple interpretations of the extent of competition. For 
instance, the loss of one RNAi pathway may impact development, which in turn affects the 
production or stability of another pathway’s small RNAs. Such competition would not be for 
common RNAi resources, but rather reflect an indirect result of the physiological changes. The 
fact that weak alleles or maternal rescue of dicer causes sickly phenotypes in animals (KNIGHT 
and BASS 2001; PAVELEC et al. 2009) may suggest that this is a realistic concern. 
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Here, we examine the relationship between endo-RNAi and miRNAi pathways and show 
that, although the eri-1 mutant partially rescues the let-7 mutant’s physiological defects, thus 
apparently enhancing residual let-7 activity, Eri mutants also show increased expression of let-7 
targets lin-14, lin-41, and daf-12, thus appearing to simultaneously decrease let-7 activity. 
Similarly, we show that engaging the exo-RNAi pathway, by exposing animals to gfp dsRNA, 
also appears to reduce the efficacy of both endoRNAi and miRNAi pathways.  Finally, we 
observed that the relative expression of stage-specific developmental genes differs amongst 
small RNA pathway mutants, suggesting that in addition to competition for common limiting 
RNAi resources, perturbing small RNA flux also impacts developmental regulation.  This may 
have large and indirect effects on the activity of endogenous small RNA pathways. 
 
Rescue of let-7 phenotypes by the eri-1 mutant 
RESULTS AND DISCUSSION 
To determine whether the eri pathway competes with the miRNA pathway (Figure 
6.1A), we sought to determine whether, like the genetic interaction between the exo-RNAi and 
endo-RNAi pathways, similarly disrupting the endo-RNAi pathway could abrogate miRNA 
developmental defects.  To detect changes in miRNA pathway efficacy, we scored fertility and 
vulva integrity (KETTING et al. 2001) of let-7(n2853) single and let-7(n2853);eri-1(mg366) 
double mutant animals. The n2853 allele is a partial loss-function mutation that remains viable at 
15ºC (REINHART et al. 2000). We found that the eri-1;let-7 double mutant exhibited a significant 
reduction in the burst vulva phenotype (Figure 6.1B), and an increase in brood size compared to 
the let-7(n2853) single mutant (Figure 6.1C). Although the rescue was incomplete, these results 
indicate a genetic interaction between these two small RNA pathways. Because the disruption of 
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(A) Schematic of proposed competing small RNA pathways. MicroRNAs, experimentally 
introduced double stranded RNAs (dsRNA), and endogenous short interfering RNAs (endo-
siRNAs) were proposed (YIGIT et al. 2006) to compete for limiting shared resources, including 
the single C. elegans DICER homolog, dcr-1, the RNA-directed RNA polymerase RRF-1, and 
the secondary Argonautes (SAGOs), including the C. elegans specific worm Argonautes 
(WAGOs) that mediated siRNA-dependent silencing. The competition for limiting shared 
resources implies that reduced flux through one pathway allows for increased access to limiting 
resources for the other pathways. (B) Spontaneous vulva bursting rate of let-7(n2853) single 
(n=9) and eri-1(mg366);let-7(n2853) double (n=10) mutants  at 15ºC. The average of n complete 
broods is shown. The eri-1(mg366) single mutant does not exhibit any burst vulva phenotype. 
(C) Average brood size of let-7(n2853) and eri-1(mg366) single mutants (n=5) and eri-
1(mg366);let-7(n2853) double mutants (n=8) at 15ºC. Standard deviations are shown. p-values 
are calculated by t-test. 
Figure 6.1:  eri-1 dependent let-7 reduction-of-function phenotypes 
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Figure 6.1 (Continued):  eri-1 dependent let-7 reduction-of-function phenotypes 
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endogenous siRNAs seems to suppress the let-7 phenotypes, the implication is that the endo-
siRNA pathway may compete with the miRNA pathway. To our knowledge, this is the first 
reported genetic interaction between these two pathways. 
 
eri-1 mutant worms have higher expression of let-7 regulated genes at mid-L4 
To determine whether the observed genetic interaction reflects enhanced miRNA efficacy 
(rather than indirect effects, for example loss of a specific siRNA), we measured the abundance 
of let-7 regulatory targets, which increase in abundance in let-7 mutants (REINHART et al. 2000).  
If eri-1-mediated repression of let-7 is via reduced competition and consequently the production 
of higher let-7 levels or more effective use of let-7 miRNA, then the target genes should decrease 
in abundance in the eri-1 mutant relative to wild type.  However, if the phenotypic suppression 
of let-7(2853) in an eri-1 mutant background is indirect, then no effect on let-7 target mRNA 
levels is expected. An advantage of assaying target mRNA levels is that the competition model 
does not make any predictions about which stage of small RNA processing or activity the 
competition occurs. This means the production, stability, or even efficacy of small RNAs could 
be rate-limiting. A complication is that let-7 regulates temporally expressed genes, thus it is 
critical to measure RNA levels from precisely staged animals. Therefore, RNA was extracted 
from mid-fourth larval stage (L4) worms hatch-synchronized to within 1 hour and then raised at 
15ºC for an additional 69 hours. As an additional level of control, we normalized gene 
expression to bli-1, an L4-specific collagen gene that is not known to be regulated by 
endogenous small RNAs (PAGE 1997). Thus, in essence, developmental time is redundantly 
staged, by both “human time” – 69 hours post-hatching – as well as “worm time” – bli-1 mRNA 
expression. Surprisingly, we observed that the let-7-regulated genes lin-14, lin-41, and daf-12 
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(PASQUINELLI et al. 2000) all showed increased expression in an eri-1 mutant background 
(Figure 6.2A). To ensure that this is not unique to bli-1 normalization, we assayed for expression 
levels of lin-41 normalized to the glyceraldehyde 3-phosphate dehydrogenase gpd-3, a stably 
expressed housekeeping gene that is commonly used for C. elegans mRNA normalization 
(WELKER et al. 2010). Again, lin-41 showed increased expression in an eri-1 mutant background 
(Figure 6.2A), suggesting that this observation is not a normalization artifact. Thus, let-7-
regulated genes are affected by endo-siRNA depletion, but rather than an increase in let-7 
activity, we observed an increase in target mRNA levels, which suggests an apparent decrease in 
let-7 efficacy. 
 
All Eri mutants have higher expression of let-7-regulated genes at mid-L4 
Biochemically, the endo-siRNA pathway is diverse and includes RdRPs (RRF-3), 
siRNases (ERI-1), RNA binding Tudor domain proteins (ERI-5), helicases (ERI-4, ERI-6/7), and 
Agos (ERI-8). To determine whether the observed increase in let-7 target mRNA levels is 
specific to eri-1(mg366), or represents a more general effect of reduced function in the endo-
siRNA pathway, we determined the expression levels of lin-14 and lin-41 in rrf-3(pk1426), dcr-
1/eri-4(mg375), eri-6/7(tm1917), and ergo-1/eri-8(gg100) mutant backgrounds. Consistent with 
our eri-1 observations, these mutants also showed increased expression of the two let-7 targets 
(Figure 6.2B), suggesting that a functional endo-siRNA pathway is important for let-7 efficacy.   
Included in these experiments were three independent controls. First, as expected, lin-14 
and lin-41 expression increased between 20 to 60 fold in let-7(n2853) mutants compared to N2 
wild type. Similarly, the viable dcr-1(mg375) allele showed a very strong upward effect on the 
let-7 target mRNA levels, as would be expected for a mutation that directly affects miRNA 
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(A) bli-1 normalized abundance of the let-7-repressed lin-14, lin-41, and daf-12 transcripts in 
eri-1(mg366) mid-L4 animals (69 hours post hatching at 15°C) relative to N2 wild type.  gpd-3 
normalized lin-41 transcripts in eri-1(mg366) mid-L4 animals relative to N2 is indicated by “lin-
41/[gpd-3]c”.  (B) bli-1 normalized abundance of the lin-14 and lin-41 transcripts in the 
indicated endo-RNAi and control (N2 and sid-1(qt9)) mid-L4 animals.  (C) Developmental 
analysis of lin-41 transcripts during the L4-stage in eri-1(mg366) and N2 strains, normalized to 
gpd-3. Although lin-41 transcripts become rare, Ct values remained reliable through 69 hours 
post hatching (≤30); but by 73 hours post hatching, Ct values were greater than 34 and therefore 
considered undetectable and unreliable(KARLEN et al. 2007; SHEN et al. 2010). Error bars 
indicate standard deviation in (A) and (B), and 95% confidence interval in (C). * indicates 
p<0.05; ** indicates p<0.01; no asterisks indicate statistical insignificance. p-values are 
calculated by t-test. 
Figure 6.2: Expression of let-7-regulated transcripts in endo-RNAi mutant backgrounds 
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Figure 6.2 (Continued): Expression of let-7-regulated transcripts in endo-RNAi mutant 
backgrounds
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biogenesis(PAVELEC et al. 2009).  Finally, as a negative control, we assayed lin-14 and lin-41 
expression levels in a sid-1(qt9) background.  Because C. elegans miRNAs seem to act cell 
autonomously (ZHANG and FIRE 2010), their activity should not require the systemic double-
stranded RNA channel SID-1. As expected, lin-14 and lin-41 expression levels were 
indistinguishable between sid-1(qt9) and N2 animals (Figure 6.2B).  
 
eri-1 mutants may have delayed down-regulation of lin-41 
Our findings thus far indicate that mutations in the endo-siRNA pathway phenotypically 
suppress let-7, consistent with the proposed competition model, whereas the effect on the let-7 
target mRNAs was opposite to expectations, showing an increase instead of a decrease (Figure 
6.2A, B). While there are many possible explanations, including post-transcriptional silencing 
versus translational repression, one possibility that should be considered and that can be directly 
tested is that developmental time is affected in the endo-RNAi mutants. let-7 acts as a temporal 
developmental switch, down-regulating target genes to control stage-specific differentiation.  
Therefore, minor effects on let-7 temporal activity would be amplified. Although we attempted 
to control for this possibility by normalizing mRNA levels to the L4-specific collagen bli-1, the 
apparent increase in the abundance of let-7 target transcripts in endo-RNAi mutants may reflect a 
developmental time point before let-7 accumulates to effective levels. That is, the endo-RNAi 
mutants may slow worm developmental time relative to human time, delaying both accumulation 
of let-7 and the predicted transition to L4 gene expression patterns. To test this hypothesis, we 
collected RNA from hatch-synchronized worms raised at 15ºC for 61, 63, 69 and 73 hours to 
measure lin-41 levels prior, during, and after let-7 regulation.   
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Consistent with previous observations, in a wild type background, lin-41 levels were high 
at the beginning of the L4 stage (hours 61 to 65), but dropped to undetectable levels at later L4 
stages (hours 69 to 73) (REINHART et al. 2000) (Figure 6.2C). Interestingly, in an eri-1(-) 
background, lin-41 transcript levels remained at the higher level for at least an additional four 
hours. In wild type, the decrease in lin-41 levels was detectable at 65 hours, whereas in eri-1 
mutants, the decrease was first detectable at 69 hours. This seems to suggest that there was a 
temporal delay in the decrease of lin-41 expression (Figure 6.2C).  Although the number of time 
points is limited, these observations are consistent with a hypothesis that developmental time 
runs slower in endo-RNAi mutants.  Consequently, miRNAs would not be as effective at a 
particular human time point (i.e. hour 69) because the eri-1(-) worms haven’t reached the 
equivalent worm time (mid-L4) for a maximum let-7 efficacy.  
However, other trivial explanations may also fit the data, including a very likely 
possibility that data points at hours 65 and 69 were noise fluctuations in two genes’ expression 
between the two strains (Figure 6.2C). Unfortunately, we were unable to distinctly quantify 
differences in let-7 transcripts itself because of its relative rarity and the relatively subtle 
differences in expression between mutants, which prevented us from drawing additional support 
for this delayed development hypothesis. 
 
Perturbations to small RNA pathways affect developmental timing 
Therefore, to test, confirm, and generally expand the hypothesis that development is 
slowed in endo-RNAi mutants, we performed real-time PCR to measure the relative expression 
levels of a variety of stage-specific mRNAs relative to stable housekeeping genes.  The collagen 
bli-1 is transcribed specifically during the L4 stage(PAGE 1997).  Consistent with our hypothesis, 
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bli-1 transcript levels relative to gpd-3 transcript levels – which are transcribed stably throughout 
development (WELKER et al. 2010; ZHANG et al. 2012) – were reduced in all the endo-RNAi 
mutants compared to N2 wild type (Figure 6.3A).  As with let-7 target genes, the systemic RNAi 
mutant sid-1(qt9) had no detectable effect.  Furthermore, both let-7(n2853) and dcr-1/eri-
4(mg375) mutants, which are known to have significant sickness (PASQUINELLI et al. 2000; 
PAVELEC et al. 2009; REINHART et al. 2000; ZHUANG and HUNTER 2011), showed much larger 
bli-1 versus gpd-3 differences than the other endo-RNAi mutants (Figure 6.3A). Finally, the 
ergo-1/eri-8(gg100) allele, which causes the least sterility and brood size reduction (ZHUANG and 
HUNTER 2011) of the tested endo-RNAi mutants, showed only a small and not statistically 
significant reduction in relative bli-1 transcript levels (Figure 6.3A).  
These findings suggests that either endo-RNAi mutants slow development leading to 
lower bli-1 levels 69 hours post hatching, or that these mutants affect metabolism leading to an 
increase in gpd-3 levels. To control for this second possibility, we used two additional stably 
expressed housekeeping genes: ama-1 (a measure of RNAPII levels) and pmp-3 (a measure of 
peroxisome activity) (ZHANG et al. 2012), in addition to gpd-3, to normalize bli-1 transcript 
levels (Figure 6.3B). We found that eri-1 mutants have lower expression of bli-1 relative to all 
three stable housekeeping markers compared to N2 and sid-1(qt9) mutants. This analysis 
confirms that at 69 hours post hatching, eri-1(mg375) worms compared to N2 and sid-1(qt9) 
worms likely exhibit slowed development. Therefore, these results further suggest that the endo-
RNAi mutants reduce the accumulation of L4 specific bli-1 transcript due to a delay in 
development. 
Combined with the measurements of lin-41 transcripts (Figure 6.2C), these results seem 
to suggest that endo-RNAi mutants delay development to the mid-L4 stage. To determine 
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(A) gpd-3 normalized bli-1 transcript abundance at mid-L4 (69 hours post hatching at 15°C) in 
the indicated mutants. (B) Relative bli-1 transcript levels in eri-1(mg366) compared to N2 and 
sid-1(qt9) at mid-L4, normalized to the three indicated housekeeping genes. (C) Relative 
expression of the indicated developmental stage-specific genes at the denoted stages in eri-
1(mg366) and rrf-3(pk1426) mutants compared to N2.  At 15°C, L1 worms had their RNA 
extracted 22 hours post-hatching, L4 worms had their RNA extracted 69 hours post-hatching, 
young adult (“YA”) worms had their RNA extracted 80 hours post-hatching, and mature adults 
(“MA”) worms had their RNA extracted 100 hours post-hatching. Error bars indicate standard 
deviation. * indicates p<0.05; ** indicates p<0.01; no asterisks indicate statistical insignificance. 
p-values are calculated by t-test. 
Figure 6.3: Abundance of developmentally regulated transcripts in endo-RNAi mutants 
274 
 
 
Figure 6.3 (Continued): Abundance of developmentally regulated transcripts in endo-RNAi 
mutants 
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whether other developmental transitions are delayed in endo-RNAi mutants, we measured in 
both eri-1 and rrf-3 mutants the relative transcript levels of the L1 specific collagen dpy-13 
(JOHNSTONE and BARRY 1996) 22 hours after hatching, the yolk protein gene vit-2 (SCHEDIN et 
al. 1991) in young adult 80 hours after hatching, and the germline specific RNA binding protein 
mex-3 (YANAI et al. 2008) in mature adults 100 hours after hatching. We found that when 
compared to N2, the eri-1 and rrf-3 mutants showed significantly lower dpy-13, bli-1, and vit-2 
relative expression levels (Figure 6.3C). However, the expression levels of the germline specific 
mex-3 were not affected in either mutant (Figure 6.3C). These results confirm that endo-RNAi 
mutants display mild developmental delays throughout development, but that by the mature adult 
stage 24 hours past the last molt, the effect is either no longer distinguishable or that mex-3 is not 
a sufficiently sensitive temporal marker. 
 
Impact of developmental timing disturbances on expression studies 
The developmental delay associated with endo-RNAi mutants may introduce a 
confounding factor for gene expression and RNAi phenotypic studies. Specifically, we detected 
two to four fold differences in measured developmental transcript levels in endo-RNAi mutants 
relative to wild type (Figure 6.3A). Because these differences are likely associated with 
developmental delays (Figure 6.2C), small changes in gene expression may not reflect a causal 
relationship between small RNA regulation and transcript abundance. Thus, careful calibration 
for developmental markers may be required before assigning significance to gene expression 
changes less than 4-fold among the many current C. elegans gene-expression datasets performed 
in endo-RNAi mutants (GENT et al. 2010). In addition, many exoRNAi studies use endo-RNAi 
276 
 
mutant backgrounds for their enhanced exo-RNAi phenotype, possibly further subtly 
confounding the findings. 
 
Exogenous RNAi causes higher expression of some let-7- and rrf-3- regulated genes 
The competition model for interactions among the small RNA pathways further predicts 
that engaging the exo-RNAi pathway will reduce available resources for microRNA-regulated 
gene expression, resulting in increased target gene expression. To test this prediction, we 
compared the expression of lin-14 and lin-41 between control animals and the same strain 
exposed to dsRNA. Specifically, a strain expressing the ubiquitous sur-5::gfp transgene was 
grown on either empty vector L4440 bacteria (control) or gfp-dsRNA expressing bacteria (exo-
RNAi(+)) (Figure 6.4A). RNA was then extracted from mid-L4 (69 hour hatch-synchronized) 
worms raised at 15ºC on each of the bacteria.  Quantitative PCR analysis showed that the lin-14 
and lin-41 transcripts, normalized to bli-1, were both elevated when this strain was grown on 
gfp-RNAi food (Figure 6.4B). Similar results are obtained when transcripts levels were 
normalized to gpd-3 (Figure 6.4B). 
 To similarly test for competition between the exo-RNAi pathway and the endo-RNAi 
pathway, we measured the transcript levels of the recently identified rrf-3-siRNA targets 
F14F7.5 and Y43F8B.9 (GENT et al. 2010). As a control, we found these transcripts to be nearly 
sixty-fold and nearly eight-fold, respectively, more abundant in rrf-3(pk1426) mutant than in 
wild type mid-L4 worms, similar to previously published findings (GENT et al. 2010).  
Consistent with the competition model, gfp(RNAi)-treated animals exhibited higher expression 
levels of the Y43F8B.9 gene (Figure 6.4B). However, we found that gfp(RNAi)-treated animals 
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(A) Photomicrograph of ~200µL of sur-5::gfp animals grown on control (empty L4440 vector) 
or gfp(RNAi) bacteria prior to RNA extraction. Scale bar indicates 1 mm. (B) bli-1 normalized 
relative lin-14, lin-41, F14F7.5, and Y43F8B.9 transcript levels in mid-L4 (69 hours post 
hatching at 15°C) gfp(RNAi)-treated sur-5::gfp animals compared to L4440 vector-fed sur-5::gfp 
animals. gpd-3 normalized lin-14 transcripts in mid-L4 gfp(RNAi)-treated sur-5::gfp animals 
compared to L4440 vector-fed sur-5::gfp animals is indicated by “lin-14/[gpd-3]”.  (C) gpd-3 
normalized relative bli-1 transcript levels in mid-L4 gfp(RNAi)-treated sur-5::gfp animals 
compared to L4440 vector-fed sur-5::gfp animals. * indicates p<0.05; ** indicates p<0.01; no 
asterisks indicate statistical insignificance.  p-values are calculated by t-test. 
Figure 6.4: The effect of exogenous RNAi on transcript abundance of miRNA- and endo-RNAi-
regulated genes 
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did not exhibit significant differences in expression levels of F14F7.5 compared to vector 
L4440-treated animals (Figure 6.4B). 
Our results support expanding the competition model to include the microRNA pathway. 
We hypothesize that mounting an exo-RNAi response reallocates common resources necessary 
for miRNA and endo-RNAi pathways towards the exo-RNAi pathway, resulting in less effective 
repression of let-7 and rrf-3 target genes. To our knowledge, this is the first reported 
investigation of the interaction between exoRNAi and miRNA functions. Furthermore, while 
prior studies of the competition between endoRNAi and exoRNAi focused on the enhanced 
exoRNAi phenotype of endo-RNAi mutants, we presented data showing that engaging the exo-
RNAi pathway compromises the silencing of at least one endoRNAi target.   
Interestingly, engaging the exo-RNAi pathway also reduced a worm’s relative bli-1 
expression at mid-L4 (Figure 6.4C). This result is consistent with delayed development 
associated with reduced endo-RNAi activity (Figure 6.2C). We therefore propose that reduced 
small RNA flux through endo-RNAi pathways enhances miRNA and exo-RNAi pathways by 
enabling greater access to limiting resources as well as independently delaying development.  
 
Chicken and egg: Development and small RNAs? 
Our findings show that perturbed small RNA flux delays development. This may be 
caused by interference with miRNA-mediated regulation of the heterochronic genes that control 
temporal transitions, or the delayed expression of the heterochronic genes may simply reflect 
non-specific developmental delays. In either case the effects are likely to recursive, such that 
small initial differences are amplified as development progresses. As more small RNA deep 
sequencing data and analysis becomes available, it will be intriguing to analyze development 
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from the perspective of small RNAs as master regulators. From an experimental standpoint, it is 
already important to consider such assumptions. Our data strongly suggest that endo-RNAi 
pathways are important for development, and although subtle, the effects may confound gene 
expression studies. 
 
Conclusions and Future Scope 
Recent publications report on competitive regulation schemes akin to the C. elegans 
small RNA competition model (LEE et al. 2006) for RNAs in mammalian systems (CESANA et 
al. 2011; KARRETH et al. 2011; KHVOROVA and WOLFSON 2012; SUMAZIN et al. 2011; TAY et al. 
2011). These reports identify competitive endogenous RNAs (ceRNAs) that soak up miRNAs 
involved in tumorigenicity (KHVOROVA and WOLFSON 2012). The use of miRNA profiling to 
diagnose cancer is becoming common, thus our findings in C. elegans, which suggest that 
developmental timing is intricately tied to small RNA expression, provides a cautionary caveat to 
these approaches.  That is, while the functions of these ceRNAs are robustly demonstrated in 
vitro, when and how they are expressed in vivo for their putative regulation of miRNAs is not 
fully known. It is reasonable to assume that these ceRNAs are spatially and temporally regulated. 
Defects in tumors growth can impact small RNA expression, thus attributing causal relationships 
when developmental factors may indirectly affect both miRNAs and ceRNAs should be done 
with caution. 
Therapeutic delivery of small RNAs has been a commercial goal of RNAi for many years 
(LEUSCHNER et al. 2011). Because the mammalian RNAi response apparently lacks an amplified 
secondary response (STEIN et al. 2003), and the C. elegans limiting RNAi resources are largely 
involved in the biogenesis or execution of the secondary response, analogies to the C. elegans 
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competition model were deemed inapplicable. However, our observation that engaging the 
exoRNAi pathway via experimental dsRNA can cause developmental delays suggests that the 
indirect aspect of the C. elegans small RNA competition can still serve as a model. Off-target 
effects have long been assumed to result from promiscuous siRNA binding, but our results 
suggest that perturbed small-RNA flux may also indirectly misregulate biological processes, 
including development. 
  
Strains 
MATERIALS AND METHODS 
The following strains were used: (FX1917) eri-6/7(tm1917), (GR1373) eri-1(mg366), 
(HC195) nrIs20 (sur-5::NLS-GFP), (HC196) sid-1(qt9), (HC793) eri-1(mg366);let-7(n2853), 
(MT7626) let-7(n2853), (NL2099) rrf-3(pk1426), (YY168) ergo-1/eri-8(gg100), and (YY470) 
dcr-1/eri-4(mg375). All strains and assays were maintained and performed at 15ºC as previously 
described (BRENNER 1974). 
 
gfp(RNAi) 
gfp(RNAi) assays were performed as previously described (TIMMONS and FIRE 1998). 
Bacteria engineered to express dsRNA against gfp were prepared as previously described 
(WINSTON et al. 2002). 
 
Reverse transcription real-time PCR 
Hatch-synchronized to within 1 hour, worms from NG large plates, gfp(RNAi) plates, or 
L4440 vector plates grown at 15ºC for needed number of hours were pooled, washed extensively 
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(M9) and then allowed to swim for 20 minutes to clear gut content.  RNA was isolated with 
proteinase K (Omega) followed by phenol:chloroform extraction (Amresco).  The RNA pellets 
were subjected to DNase I (Roche) treatment, and cleaned by RNeasy (Qiagen) per 
manufacturer’s instructions.  All initial RNA input concentrations were normalized to ~30-
200ng/µL. 
Reverse transcription was performed using 20µL reactions of ~150-600ng of input RNA 
by Thermoscript RT (Invitrogen), using gene specific RT primers (available upon request). 
cDNA quantification was performed using 2µL of the RT reaction in a 50µL QuantiTect SYBR 
Green (Qiagen) reaction with nested PCR primers.  The PCR reaction cycles were: 15 minutes 
95 degrees, 15 seconds 94 degrees, 30 seconds 52 degrees, 1 minute 72 degrees, read, cycle to 
step 2 for 45 cycles, using an Eppendorf Mastercycler Realplex4 and Noiseband quantification.  
Subsequent analysis was performed using the ΔCT approach for expression normalized to 
another gene, or the ΔΔCT approach for expression normalized to another gene and then relative 
to wild type’s expression (LIVAK and SCHMITTGEN 2001).  
Three to five biological replicates of worms were combined for an RNA prep. This RNA 
was then quantified in triplicates (error bar generation), and repeated two to four times 
(representative shown), to determine the precision of relative RNA abundance, similar to prior 
small RNA qPCR experiments (FISCHER et al. 2011). 
 
AZIMZADEH JAMALKANDI, S., and A. MASOUDI-NEJAD, 2011 RNAi pathway integration in 
Caenorhabditis elegans development. Funct Integr Genomics 11: 389-405. 
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The history of the endo-siRNA field is intricately tied with the history of RNAi and 
general small RNA biology. Advances from within the endo-siRNA field and from studies of 
other small RNAs have pushed along our understanding of the cellular roles of endogenous small 
RNAs, as well as their relationship to experimental RNAi and its efficacy. More specifically, the 
advances made in the eri field can be categorized as arising from genetic and genomic 
approaches. Tracing the history of these advances (Figure 7.1) sheds light on where the field is 
headed, as well as broadens the context of how these findings may advance the RNAi field in 
general. 
HISTORICAL CONTEXTS 
 
Genomic Approach 
The first perspective from which to examine the eri field is through looking at large-scale 
genomic analyses from the last twelve years. Advances in DNA sequencing technology have 
made tremendous progress during this time period (BENTLEY et al. 2008). The eri field has taken 
full advantage of those advances, as well as spearheading its own advances for sequencing 
(AMBROS et al. 2003; LAU et al. 2001; RUBY et al. 2006). Specifically, the newly available next-
generation sequencing technologies offer the ability to sequence directly on a flow cell channel, 
thus spatially separating while simultaneously capturing millions of individual sequencing reads 
(HOLT and JONES 2008). The level of density offered by such technologies is precisely what’s 
needed to examine the tremendously plentiful, though subtly different, small RNA populations. 
After the discovery of the first microRNAs lin-4 and let-7, the Bartel and Ambros groups 
set out to sequence endogenous small RNAs in C. elegans in hopes of finding new microRNAs. 
While doing so, they inadvertently discovered new classes of endo-siRNAs (AMBROS et al. 
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2003; RUBY et al. 2006), thus starting a field that will eventually cross paths with the eris. 
Because microRNAs undergo many processing steps before maturity (SOKOL 2012), the two 
groups prepared their RNA libraries differently in hopes of capturing different microRNA 
species (or at different points of abundances). The Bartel group used direct ligation of size-
selected RNAs onto the 5’ adapter, thus selecting for small RNA populations with a 5’ 
monophosphate (RUBY et al. 2006). The Ambros group phosphatase-treated size-selected RNAs, 
then kinase-treated the RNAs prior to 5’ adapter ligation (AMBROS et al. 2003); as it turns out, 
this capture method selected for RNA populations with a 5’ triphosphate (PAK and FIRE 2007). 
While both groups discovered a 22mer species that predominately begin with a G (thus named 
22Gs), the 5’ monophosphate bias also discovered a rarer 26mer species that also predominately 
beings with a G (thus named 26Gs) (AMBROS et al. 2003; RUBY et al. 2006). Interestingly 
enough, ppp22Gs have two free hydroxyl groups in their 3’ terminus, but p26Gs seem to have at 
least its 3’ OH group modified (RUBY et al. 2006; VASALE et al. 2010). 
Around the time these first deep-sequencing experiments were being performed, genetic 
analysis from the Bass, Zamore, and Plasterk groups discovered that the enzyme Dicer was 
essential to all small RNAi pathways (HUTVAGNER et al. 2001; KETTING et al. 2001; KNIGHT and 
BASS 2001). This led to a study in which Duchaine and Mello used proteomics to analyze all the 
cellular gene products that interact with DICER (DUCHAINE et al. 2006). They discovered, as 
expected, genes whose mutation causes an RNAi-defective phenotype. Surprisingly, they also 
discovered genes whose mutation causes an enhanced RNAi phenotype. This finding, along with 
Lee and Ambros’ discovery that Eri mutants are missing many endo-siRNAs, led to the now 
generally accepted model of enhanced RNAi (LEE et al. 2006). 
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It was proposed then in 2006 that ERI genes produce endo-siRNAs, and these endo-
siRNAs compete with experimentally introduced RNAi triggers for a common, limiting pool of 
resources. Therefore, eliminating an eri gene reduces this competition, hence making 
experimental RNAi more effective (DUCHAINE et al. 2006; LEE et al. 2006). 
Subsequently, Yigit and Mello discovered that the C. elegans Argonautes acted in phases, 
with distinct primary and secondary rounds (YIGIT et al. 2006). Almost simultaneously, Pak and 
Fire discovered that C. elegans siRNA species, both endogenous and experimental, come in two 
populations: one rare and 5’ monophosphated, and one abundant and 5’ triphosphated (PAK and 
FIRE 2007). These two discoveries thus suggested that RNAi occurs in two rounds. The 
distinctions between endogenous and exogenous RNAi and between primary and secondary 
RNAi therefore shaped the eri field to build the model that stands today.  
Recently, Gent and Fire discovered that the endo-RNAi RdRP mutant rrf-3 lacks 26Gs 
and 22Gs (GENT et al. 2010); Welker and Bass discovered that the Dicer helicase mutant eri-4 
also lacks 26Gs and 22Gs (WELKER et al. 2010); Vasale and Mello discovered that the endo-
RNAi Ago mutant ergo-1/eri-8 lacks 26Gs and 22Gs (VASALE et al. 2010); and finally, Fischer 
and Ruvkun discovered that the Eri mutant eri-6/7 also lacks 26Gs and 22Gs (FISCHER et al. 
2011). Based on the molecular nature of these genes and small RNAs, a model hypothesizes that 
endo-siRNAs are made de novo by the RdRP RRF-3, with assistance by ERI-4 and ERI-6/7, and 
the Ago ERI-8 acts as the initial effector. However, the relationship between the rarer 26Gs and 
more abundant 22Gs remains unclear from these findings alone. 
Simultaneous to these discoveries, Gu and Mello discovered that the exo-RNAi genes 
drh-3, elk-1, and rrf-1 are required only for making 22Gs (GU et al. 2009), while Maniar and 
Fire similarly discovered that the exo-RNAi genes rde-4 and ego-1 are also required only for 
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making 22Gs (MANIAR and FIRE 2011). Claycomb and Mello also discovered that the secondary 
Agos CSR-1 and WAGOs use 22Gs (CLAYCOMB et al. 2009). Combined with the model above, 
these findings suggest that the ERI genes act more upstream and make the rarer 26Gs, which get 
amplified by the RdRPs RRF-1 or EGO-1, with help from DRH-3, ELK-1, and RDE-4, into the 
abundant 22Gs which interacts with downstream Agos (CONINE et al. 2010; VASALE et al. 2010). 
 
Genetic Approach 
The second perspective from which to examine the eri field is through looking at 
classical genetic analyses from the last nine years. After the discovery of the first controlled case 
of experimental RNAi (FIRE et al. 1998), the Fire and Ahringer groups set out to utilize RNAi as 
a convenient and systematic method for reverse genetics in C. elegans (KAMATH and AHRINGER 
2003; KAMATH et al. 2003; TIMMONS and FIRE 1998). Though RNAi was potent and specific 
under most contexts, there were limits to this potency. Certain tissues or gene targets are not very 
tractable to RNAi (ZHUANG and HUNTER 2012), a fact highlighted by the fortuitous discovery of 
the enhanced RNAi mutant rrf-3 (SIMMER et al. 2003). 
To examine the precise nature of the negative regulation of RNAi, Kennedy and Rukvun 
began a systematic screen for enhancers of RNAi by looking for silencing of a neuronal gfp that 
is normally intractable to gfp(RNAi) (KENNEDY et al. 2004). Using this screen, eri-1, rrf-3, eri-3, 
eri-5, and eri-6/7 were discovered (DUCHAINE et al. 2006; FISCHER et al. 2008; KENNEDY et al. 
2004). In order to find more Eri mutants, Pavelec and Kennedy screened for enhanced pan-
operon silencing (PAVELEC et al. 2009), and discovered dcr-1/eri-4, ergo-1/eri-8, and eri-9. 
During this second screen, it was observed that some Eri mutants were temperature sensitive 
sterile at 25°C while others were not. This led to the finding that the eri genes produce endo-
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siRNAs important for proper spermatogenesis (GENT et al. 2009; PAVELEC et al. 2009), which 
spurred the deep-sequencing of these mutants for their small RNA profiles as previously 
described. 
Meanwhile, Guang and Kennedy performed a screen opposite of the second Eri screen: 
for defective pan-operon silencing; they discovered the nuclear Ago NRDE-3 and the nuclear 
factors NRDE-1,2,4 (BURKHART et al. 2011; GUANG et al. 2010; GUANG et al. 2008). It was 
found that NRDE-3 shuttles endo-siRNAs made by the ERIs into the nucleus, interacts with 
NRDE-1,2,4, and uses the siRNA guide to match a cognate nascent pre-mRNA to block RNA 
polymerase II transcription and induce H3K9 methylation for epigenetic transcriptional silencing 
(BURKHART et al. 2011; GUANG et al. 2010).  
These seminal findings linked endo-siRNAs to functions inside the nucleus, specifically 
transcriptional gene silencing and epigenetics. The patent implication of this is that it is likely the 
mechanism behind trans-generational RNAi that’s been previously observed in worms 
(VASTENHOUW et al. 2006) and previously carefully characterized in plants (DJUPEDAL and 
EKWALL 2009). Indeed, Burton and Kennedy along with Gu and Fire found that both exo- and 
endo-siRNAs can indeed drive H3K9 methylation through NRDE-1,2,4 to induce trans-
generational RNAi silencing (BURTON et al. 2011; GU et al. 2012a). This finding that an 
experience in the somatic cells – externally encountered dsRNAs inducing gene silencing –
during the lifetime of an animal can be passed onto the next generation is quite revolutionary 
because of its Lamarckian implications. 
To fully realize this implication, Buckley and Kennedy specifically screened for a trans-
generational RNAi defective mutant, and discovered the germline nuclear Ago HRDE-1 
(BUCKLEY et al. 2012). hrde-1 is thought to be responsible for resetting the H3K9 methylation 
293 
 
marks in the germline in each generation in response to encountered endo-siRNA, and is thus 
vital for maintaining germline immortality (BUCKLEY et al. 2012). 
In parallel to the discovery of the eri class of enhanced RNAi mutants, Wang and Ruvkun 
discovered that mutations to the rb tumor suppressor transcription factor family also enhanced 
RNAi (WANG et al. 2005). It was initially hypothesized that because germline cells in C. elegans 
are more sensitive to RNAi (SMARDON et al. 2000), the rb mutants were turning somatic cells 
into germline-like, thus enhancing RNAi (WANG et al. 2005). This hypothesis has been recently 
partially confirmed, as sequencing of rb mutants revealed that many RNAi factors which are 
predominantly expressed in the germline are indeed overexpressed in the rb mutant worms (WU 
et al. 2012). 
 
Next experiments 
FUTURE DIRECTIONS 
 Since the most recent findings in the eri field have implicated exo-siRNAs and endo-
siRNAs in inheritance (BUCKLEY et al. 2012), the previously discussed Lamarckian implications 
are very significant. The findings by Buckley and Kennedy robustly demonstrate a mechanism in 
place to respond to and transmit small RNA messages through the generations. However, to truly 
demonstrate a Lamarckian method of inheritance, there needs to be one additional step of 
experimentally demonstrating how signals experienced by the somatic cells are translated into 
small RNAs for passage to the germline and subsequent generations. For example, after 
subjecting C. elegans to a stress like heat or osmotic shock, it’d be very interesting to determine 
a precise gene circuit in the soma that responds to this stress, encodes small RNAs in response to 
this stress, and modifies the germline accordingly to pass this “stressed” gene expression profile 
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onto the next generations. If such a mechanism can be demonstrated, then the next generation(s) 
should accordingly respond to the same stress in a much more efficient manner. Such a discovery 
would then truly provide the endogenous relevance of the siRNA-mediated inheritance 
mechanism currently elucidated as the endpoint of the eri pathway. 
 
Stylistic shift 
 Currently, the awe of using deep-sequencing technology for small RNA profiling is 
allowing more and more building blocks of the RNAi pathway to have their impacts on small 
RNA production analyzed. Combined with the genetic studies discussed above, soon there will 
be enough small RNA profiles of RNAi mutants to begin drawing comparisons and even 
predictions from analogous contexts once the overarching model is confirmed. I predict that 
future studies after that point, then, will refocus on the genetic interactions, rather than genomic 
analysis, and use the available small RNA profiles as a confirmatory tool.  
This trend is already beginning to appear in recent literature of the eri field. For instance, 
in Buckley et al., the seminal finding that hrde-1 drives trans-generational memory of H3K9 
methylation is mostly observed through easier-to-manipulate experimental siRNAs; the known 
endo-siRNA loci were analyzed to confirm the endogenous relevance of this finding (BUCKLEY 
et al. 2012). Similarly, my findings of the roles of NRDE-3 was performed mostly through 
experimentally introduced RNAi triggers, such as feeding RNAi and transitive RNAi; the 
subsequently deduced relationships such as the eri-nrde-3 interactions were confirmed via 
profiling expression levels of known endo-siRNA targets. 
The benefits of this stylistic shift are twofold. First, for those outside of the eri field 
hoping to utilize RNAi merely as a technology, which was the first purpose of screening for 
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enhanced RNAi mutants anyways, there is better contextualization of small RNA data. The 
refocus onto the genetics will help a broader audience understand which components of the 
RNAi pathway are limiting and essential, and can thus perhaps be over-expressed for facilitating 
RNAi sensitivity in other systems. For most audiences, knowing that thousands of endo-siRNA 
reads ultimately converge onto NRDE-3 or HRDE-1 for transcriptional gene silencing and 
germline maintenance is more meaningful than knowing what the nature of those reads were. 
Second, for those in the eri field, the refocus on genetics can crystallize findings into “choke-
points.” Had it not been the genetic analysis of the Eri and Nrde mutants, merely having the 
sequencing data of rrf-3, ergo-1, and eri-6/7 would not have easily led to the mechanistic model 
of shuttling siRNAs from the cytoplasm to the nucleus for germline maintenance, especially 
given the immense number of endo-siRNAs missing and the germline-soma role separation of 
EGO-1 and RRF-1 mutants (MANIAR and FIRE 2011; VASALE et al. 2010). In other words, 
having the enormous amount of sequencing data available for all endogenous RNAi pathway 
genes will ultimately have to lead back to crystallizing how those endo-siRNAs’ expressions are 
controlled at a higher level, and genetic pathway analysis will shed much light on that question. 
 
Content shift 
 In terms of the contents of future studies then, I predict the field will circle back to more 
fully characterize each individual gene of the endogenous RNAi pathway once the overall 
framework – through sequencing – has been confirmed and fully explored, especially because 
many important lingering questions remain. For instance, why do helicases (DRH-3, ERI-4) play 
such prominent roles in endo-siRNA stability? How are mRNAs targeted by endo-siRNAs 
ultimately eliminated? And what are the roles of the ERI genes other than RRF-3 and ERGO-1? 
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Fully characterizing the individual genes in question, beyond what endo-siRNAs they produce, 
would go a long way in answering these questions. 
 One method of answering these questions is through biochemistry. For instance, Gabel 
and Ruvkun resolved the longstanding question of if ERI-1’s 3’-to-5’ exonuclease activity is 
directly used as a negative regulator of siRNAs (KENNEDY et al. 2004). They showed that this 
activity is irrelevant to maintaining endo-siRNAs and is used for a different purpose of trimming 
5.8S rRNAs (GABEL and RUVKUN 2008). In another example, Thivierge and Duchaine showed 
that the subtle differences in Eri responses amongst the eri mutants (ZHUANG and HUNTER 2011) 
is because they form differential complexes with DICER; ERI-1/ERI-3/DCR-1 forms a distinct 
complex from RRF-3/ERI-5/DCR-1 (THIVIERGE et al. 2011). A second method of answering 
these questions is through genetics. As more and more Rde and Eri mutants are discovered, their 
reported phenotypes are understandably more and more subtle (ZHANG et al. 2012) because the 
earlier mutants were likely easier to screen for. These weak RNAi phenotypes only exhibit 
themselves prominently under certain genetic contexts. For instance, my work has shown that 
nrde-3 mutants only have a weak RNAi defect on their own, but they’re completely defective for 
transitive RNAi, and in a pgl-1 mutant background, they completely abolish the Eri response. In 
another example, the C. elegans RdRP RRF-2 was thought to have no known function (SIJEN et 
al. 2001), until sequencing showed that it is over-expressed in rb mutants, spurring Wu and 
Ruvkun to discover that it is involved in germline RNAi (WU et al. 2012). 
 Future in-depth studies of individual components of the RNAi machinery will therefore 
shed much new light through this blend of genetics and biochemistry. In many regards, the 
current efforts of small RNA profiling is very much akin to previous microarray studies, which 
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usually gave an informative survey of trends, but ultimately still required individual gene-by-
gene analysis to fully comprehend a genetic pathway in-depth. 
 However, one area of research which I believe remains extremely exciting regardless of a 
genomics versus genetics prioritization is the chemical nature of the small RNAs themselves. A 
prominent question arising from the nature of the small RNAs concerns their ends. Until Pak and 
Fire used a 5’-unbiased cloning approach, most endo-siRNAs were missing from sequencing 
(PAK and FIRE 2007). Then analogously, it could be argued that perhaps 26Gs are not as rare as 
their sequencing profiles indicate, but are instead inefficiently cloned because of their 3’-OH 
modification (RUBY et al. 2006). Kamminga and Ketting recently reported that a lack of HENN-
1 methylation in C. elegans piRNAs does not completely disrupt their stability, but does 
thoroughly impact the stability of some 26G endo-siRNAs (KAMMINGA et al. 2012), suggesting 
inherent differences in the chemical nature of small RNAs classes, which deserves future 
investigation. In fact, the same report suggests that the requirement of 26Gs for 3’ methylation is 
also correlated with the Ago they associate with. An even broader question would be to 
understand why there is a preponderance of G at the beginning of endo-siRNAs. If it’s meant to 
act as a cap like in mRNAs, why are ~40% of endo-siRNAs without the G also the same length 
as the ones with G? And if it’s meant to act as a conserved “starting sequence” like piRNAs, why 
are most endo-siRNAs very different beyond the first nucleotide? The genetic tools available in 
C. elegans and the push in RNAi biotechnology for chemical modifications to increase delivery 
stability (BRAMSEN and KJEMS 2013) lead me to believe this area of research, with its many 
unanswered questions, will be highly topical in the future. 
 
Context shift 
298 
 
The third and most important realm of future studies, I believe, will try to reconcile the 
different forms of transcriptional regulation via RNAi mechanisms. Wu and Ruvkun have 
recently showed that the expression of RNAi genes themselves is regulated at the transcriptional 
level by the RB tumor suppressor family (WU et al. 2012). It’d be interesting to examine what 
the relationship between this “higher” level of transcriptional gene silencing driven by protein 
transcription factors versus those driven by endo-siRNAs is. One way to look at such a 
relationship is to deep-sequence individual rb mutant (or at least representatives of their classes) 
and analyze its small RNA expression profile versus that of a RNAi mutant whose regulation 
depends on that particular RB. 
An even broader contextual perspective is to examine the relationship between different 
small RNA driven silencing processes, especially now that RNAi in the nucleus and RNAi 
transcriptional gene silencing has been well-established (Table 7.1). Currently, one area of 
intense interest in small RNA biology is the study of piRNAs (ISHIZU et al. 2012), in part due to 
its high conservation across species (KUMAR and CHEN 2012). The precise mechanism of piRNA 
origin and generation is currently not completely clear (BATISTA et al. 2008; GU et al. 2012b), 
but its ultimate “conversion” to 22G endo-siRNAs for its germline silencing activities, at least in 
C. elegans (LEE et al. 2012), seems to suggest that it is likely related to other endo-siRNA 
processes. Another highly topical area of research is the study of long noncoding RNAs (LEE 
2012). A recent report suggested that perhaps some lncRNAs serve as templates for primary 
endo-siRNA production in C. elegans (NAM and BARTEL 2012). Understanding these 
relationships will be a seminal breakthrough because it’d broaden the horizons of analyzing all 
small RNAs, rather than the currently somewhat myopic approaches of examining individual 
pathways and outputs. 
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Primary Round 
Table 7.1: Classes of endo-siRNAs, their effectors, and functions 
 
Secondary Round 
 
Function(s) RdRP Ago siRNA RdRP Ago siRNA 
   
?? PRG-1/2 21U EGO-1* WAGO 22G 
Germline gene silencing 
High temp. fertility 
Transposon silencing 
Trans-generational silencing 
   
RRF-3 ALG-3/4 26G EGO-1* WAGO 22G High temp. sperm viability 
   
RRF-3 ERGO-1 26G RRF-1 WAGO 22G Gene duplication silencing 
   
?? EGO-1 CSR-1 22G Proper chromosomal segregation 
 
The RNA-dependent RNA polymerase (RdRP), the Argonaute effector (Ago), and the nature of 
the short-interfering RNA (siRNA) involved in each of the four currently known distinct endo-
siRNA pathways. A secondary round is categorized as the round which produces siRNAs that 
perform the listed gene regulatory functions. Asterisks indicate inferences drawn based on tissue 
of action and known expression patterns of EGO-1 versus RRF-1; all other entries have direct 
experimental evidence. 
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Therefore, I believe the eri field will ultimately converge and emerge with the rest of 
small RNA biology research to shed light on the importance of a fundamental and ancient 
biomolecule. The RNA world may have never left. 
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Addendum 
Analyses of sid-1 homologs 
Experiments performed with assistance from Elizabeth Y. Wang 
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The presence of systemic RNAi in C. elegans is one of the reasons why RNAi is so 
potent in these nematodes (JOSE and HUNTER 2007). The dsRNA channel SID-1 is a major 
mechanism of systemic RNAi in C. elegans (JOSE et al. 2009; SHIH et al. 2009; WINSTON et al. 
2002) and is extremely well-conserved across evolution (ZHUANG and HUNTER 2012). While 
there has been some reports of sid-1 homologs in other systems inducing systemic RNAi (DONG 
and FRIEDRICH 2005; DUXBURY et al. 2005), the exact endogenous function(s) of any sid-1-
related genes has not been well reported, not even for C. elegans.  
INTRODUCTION 
Interestingly enough, SID-1 homologs are present in organisms ranging from single-cell 
amoebas to mammals (DIEZ-ROUX et al. 2011; XU and HAN 2008), sometimes in contexts that 
make systemic RNAi unlikely. Furthermore, the C. elegans sid-1 gene is not the closest relative 
to the mouse Sidt2 gene; rather, it is one of the other five C. elegans sid-1 homologs chup-1 
that’s more closely related (ZHUANG and HUNTER 2012).  
Like I demonstrated for NRDE-3 in Chapter 4 and PGL-1 in Chapter 5, overexpressing 
SID-1 has also been previously shown to cause an enhanced RNAi phenotype (CALIXTO et al. 
2010). Therefore, investigating the nature of sid-1’s contribution to the mechanism of RNAi is 
extremely relevant in understanding the regulation of small RNAs. While there has been 
tremendous progress in understanding the characteristics of SID-1, its homologs in C. elegans 
have not been nearly as well-characterized, despite their aforementioned pertinence. 
Here, I list and annotate the five C. elegans sid-1 homologs with respect to homology to 
the mouse Sidt2 gene. I then describe the mutant alleles available for these genes and their 
limitations. Finally, I demonstrate using a unique RNAi knockdown method that some of these 
homologs do cause an Rde phenotype when targeted via RNAi. 
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Using a BLAST search using mouse Sidt2 amino acid sequence against the C. elegans 
genome, I discovered five sid-1 homologs. I named these genes 
RESULTS AND DISCUSSION 
sid
sidl-1, also known as C08A9.3, has 739 amino acids. It has two alleles: (1) tm760, which 
deletes the tiny first exon that one splice form doesn’t use, and (2) gk235, which also deletes the 
tiny first exon that one splice form doesn’t use and inserts 6 bases. Its prominent homology is 
that it contains an N-terminal region similar to mouse Sidt2 N-terminal region, and it contains a 
C-terminal region similar to latter three-quarters of the C-terminal region of the C. elegans sid-1. 
-1-like (sidl).  
sidl-2, also known as ZK721.1, tag-130, or chup-1, has 756 amino acids. It has one allele: 
gk245, which deletes the 5’UTR and the first two exons. Its prominent homology is that it 
contains an N-terminal region similar to mouse Sidt2 N-terminal region, and it contains a C-
terminal region similar to first one-quarter of the N-terminal region of the C. elegans sid-1. 
sidl-3, also known as C30E1.6, has 247 amino acids. There are no alleles available for 
this gene. Its prominent homology is that it is similar to the C-terminal latter one-fifth of the C. 
elegans sid-1. 
sidl-4, also known as C30E1.4, has 239 amino acids. There are no alleles available for 
this gene. Its prominent homology is that it is similar to the mouse Sidt2 N-terminal region. Its 
genomic proximity to sidl-3 (within 10KB) and their relatively small sizes may suggest that sidl-
3 and sidl-4 are two “half” gene products. 
sidl-5, also known as Y37H2C.1, has 718 amino acids. It has one allele: tm5525, which 
deletes the first four exons. Its prominent homology is that it is similar to the mouse Sidt2 N-
terminal region. 
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Previous analysis of sidl-2(gk245) has shown that it is not Rde to feeding RNAi (Jennifer 
Whangbo, unpublished). I attempted to analyze sidl-1(gk235) on bli-1(RNAi) and discovered that 
it responded quite similarly to N2 wild type: 51/118 versus 68/103 with blisters, respectively. 
The limitation with the gk235 allele is that it only eliminates one exon that is part of another gene 
(sod-3) and which one predicted isoform does not even use. Combined with the fact that no 
C08A9.3 mRNA transcript has ever been detected, the penetrance of the gk235 allele in knocking 
out sidl-1 is in doubt. I also attempted to analyze sidl-5(tm5525) on dpy-11(RNAi) and unc-
22(RNAi), and discovered that it also responded exactly the same as the N2 wild type. The 
limitation with the other sidl genes is that there are no mutant alleles available.  
Therefore, to analyze if their loss of function affected RNAi, I along with Elizabeth 
Wang performed RNAi knockdown of the sidl genes to analyze their effects on RNAi sensitivity. 
To ensure efficacy of this RNAi-of-RNAi setup, we fed the worms dsRNA against sidl in one 
generation and dsRNA against dpy-11 in the second generation, because simultaneous double 
RNAi has been shown to be ineffective (MIN et al. 2010). To ensure maximum knockdown of 
the sidl genes, we took advantage of the fact that the Eri phenotype is maternally rescued. 
Therefore, we allowed an eri-1 hermaphrodite and several gfp-marked wild type N2 males to 
mate on a sidl(RNAi) or control gfp(RNAi) plate. We then placed the cross progeny (F1) on a 
dpy-11(RNAi) plate and scored their progeny (F2) for Dpy (Figure 8.1). The rationale for the 
setup is to have the sidl knockdown occur in an Eri background, while the eri-1/+ hets are the 
worms exposed to the dpy-11 knockdown. And because of maternal rescue, the wild type eri 
copy in the cross progeny hets ensured that their progeny (the scored F2s) are all phenotypically 
wild type as well. Since we’re examining for possible Rde phenotypes, even if maternal rescue 
goes awry, the bias is towards an enhanced RNAi response, thus negating any false positives. 
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eri-1 hermaphrodites at L3 were placed in the presence of marked wild type males on a plate 
with bacteria engineered to express dsRNA against the sidl genes. The F1 cross progeny were 
then transferred to the assay readout plate with bacteria engineered to express dsRNA against 
dpy-11. The F2 progeny, which are all phenotypically non-Eri because of the maternal rescue by 
the heterozygous F1 mother, are scored for the penetrance of the Dpy-11 phenotype.  
Figure 8.1: Cross to test the effects of RNAi of sidl genes 
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 As a control and proof-of-principle that this Eri RNAi-of-RNAi knockdown is more 
efficacious than merely performing the same experiment on N2 wild type worms, we tested the 
effects of sid-1(RNAi) using this cross. RNAi knockdown of sid-1 has previously been shown to 
be ineffective, presumably because functional SID-1 is necessary to uptake additional sid-1 
dsRNA (Jennifer Whangbo, unpublished). However, using this new RNAi knockdown method, I 
observed that sid-1(RNAi) treated worms were nearly completely insensitive to dpy-11(RNAi), 
whereas the gfp(RNAi) treated worms were still fully sensitive to dpy-11(RNAi) (Figure 8.2). 
 We subsequently assayed sidl-1(RNAi), sidl-2(RNAi), sidl-3(RNAi), and sidl-4(RNAi) 
treated worms for sensitivity to dpy-11(RNAi), and discovered that sidl-1 and sidl-3 knockdown 
caused a large drop in sensitivity to dpy-11(RNAi) (Figures 8.3, 8.4). In all cases, the gfp(RNAi) 
treated worms were still fully sensitive to dpy-11(RNAi). This suggests that perhaps sidl-1 and 
sidl-3 also contribute to systemic RNAi, although perhaps at a subtler level than sid-1. 
 Because of their homology, there is always concern that the RNAi knockdowns caused an 
off-target effect to induce sid-1 knockdown instead. However, the homology between the sidl 
genes and sid-1 is largely at the amino acid level. sidl-1’s feeding RNAi clone used (KAMATH 
and AHRINGER 2003) covers nucleotides 1456 until stop. This stretch, when subjected to pairwise 
BLASTn against entire sid-1 sequence, comes up with only one region of an 11mer matching; no 
other matches are reported for even the remainder of the transcript. sidl-4’s feeding RNAi clone 
used (KAMATH and AHRINGER 2003) covers ATG until nucleotide 828. This stretch, when 
subjected to pairwise BLASTn against entire sid-1 sequence, also comes up with only one region 
of an 16mer matching; no other matches are reported for even the remainder of the transcript. 
sidl-2 and sidl-3 transcripts have no matches at all when subjected to pairwise BLASTn against 
entire sid-1 sequence. RNAi off-target effects causing the reported results thus seem unlikely. 
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N2 worms fed OD600nm 2.0 dpy-11(RNAi) starting from L3 and imaged in the next generation 
looks very Dpy (A). Conversely, sidl-1(RNAi)-treated animals also fed OD600nm 2.0 dpy-
11(RNAi) starting from L3 and imaged in the next generation does not look Dpy (B). Both 
images are magnified and scaled the same. Red bar indicates 0.1mm. 
Figure 8.2: Expressivity of Rde phenotype caused by sidl-1(RNAi) knockdown 
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gfp(RNAi)-treated worms fed OD600nm 2.0 dpy-11(RNAi) starting from L3 and imaged in the next 
generation looks very Dpy (A). Conversely, sidl-3(RNAi)-treated animals also fed OD600nm 2.0 
dpy-11(RNAi) starting from L3 and imaged in the next generation does not look very Dpy (B). 
Both images are magnified and scaled the same. 
Figure 8.3: Expressivity of Rde phenotype caused by sidl-3(RNAi) knockdown 
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Various indicated RNAi-treated worms were fed OD600nm 2.0 dpy-11(RNAi) starting from L3 and 
imaged in the next generation for the Dpy-11 phenotype. The observed pattern was 
representative of the experiment repeated three times. 
Figure 8.4: Penetrance of Rde phenotype caused by sidl(RNAi) knockdowns 
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 Two areas of subsequent analysis could further elucidate the exact nature of the sidl 
genes’ possible contributions to systemic RNAi or other sid-1-related endogenous functions. 
First, because there are no (robust) mutant alleles available for sidl-1 and sidl-3, genetic analysis 
needs to be performed via overexpression. Driving these genes via the sid-1 promoter in a C. 
elegans transgene could help understand the nature of possible redundancy amongst these 
homologs for contributing to RNAi. Furthermore, expressing sidl-1 or sidl-3 cDNA in 
Drosophila S2 cells can help shed light on these gene products’ molecular interactions with 
RNAs (MCEWAN et al. 2012; SHIH and HUNTER 2011). Second, recent observations that C. 
elegans sid-1 may have stress and/or starvation phenotypes (Jacqueline Brooks, Kenneth Pang, 
Stephen Banse, and Eric Wu, unpublished) may help create a suite of new assays for testing the 
sidl genes’ possible endogenous roles. For example, sidl-2 and sidl-5 have robust mutant alleles 
available but do not seem to cause an Rde phenotype when knocked down/out, suggesting 
perhaps their role is more related to sid-1’s contributions to the stress response than systemic 
RNAi. Our findings that some, but not all, sidl genes have an Rde phenotype upon knockdown 
are the first characterizations of an important gene family. These findings lay the foundation for 
future in-depth analysis. 
 
CALIXTO, A., D. CHELUR, I. TOPALIDOU, X. CHEN and M. CHALFIE, 2010 Enhanced neuronal 
RNAi in C. elegans using SID-1. Nat Methods 7: 554-559. 
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